# RGD-PIPELINE: ftp-file-extracts # MODULE: annotations-version-1.1.9 (Oct 10, 2019) # GENERATED-ON: 2025/02/08 # PURPOSE: annotations about active Rat objects extracted from RGD database # ONTOLOGY: ChEBI: ChEBI Ontology # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: multiple values in a single column are separated by '|' # #COLUMN INFORMATION: # #1 RGD_ID unique RGD_ID of the annotated object #2 OBJECT_SYMBOL official symbol of the annotated object #3 OBJECT_NAME official name of the annotated object #4 OBJECT_TYPE annotated object data type: one of ['gene','qtl','strain'] #5 TERM_ACC_ID ontology term accession id #6 TERM_NAME ontology term name #7 QUALIFIER optional qualifier #8 EVIDENCE evidence #9 WITH with info #10 ASPECT aspect #11 REFERENCES db references (Reference RGDID|PUBMED ID) #12 CREATED_DATE created date #13 ASSIGNED_BY assigned by #14 MESH_OMIM_ID MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only) #15 CURATION_NOTES curation notes provided by RGD curators #16 ORIGINAL_REFERENCE original reference RGD_ID OBJECT_SYMBOL OBJECT_NAME OBJECT_TYPE TERM_ACC_ID TERM_NAME QUALIFIER EVIDENCE WITH ASPECT REFERENCES CREATED_DATE ASSIGNED_BY MESH_OMIM_ID CURATION_NOTES ORIGINAL_REFERENCE 10045371 Mir155hg Mir155 host gene gene CHEBI:145535 pevonedistat affects expression ISO RGD:1350378 E RGD:6480464 20191203 CTD MESH:C539933 pevonedistat affects the expression of MIR155HG mRNA PMID:24634471 10045371 Mir155hg Mir155 host gene gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:1350378 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in increased expression of MIR155HG; Lipopolysaccharides results in increased expression of MIR155HG mRNA PMID:35438468|PMID:35811015 10045371 Mir155hg Mir155 host gene gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1350378 E RGD:6480464 20221101 CTD MESH:D008070 METTL14 protein affects the reaction [Lipopolysaccharides results in increased expression of MIR155HG]; MIR155HG promotes the reaction [Lipopolysaccharides results in increased expression of CD274 mRNA]; MIR155HG promotes the reaction [Lipopolysaccharides results in increased expression of CD274 protein]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155HG mRNA] PMID:35438468|PMID:35811015 10045371 Mir155hg Mir155 host gene gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1350378 E RGD:6480464 20151215 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in decreased expression of BIC mRNA PMID:20660070 10045371 Mir155hg Mir155 host gene gene CHEBI:17026 progesterone multiple interactions ISO RGD:1350378 E RGD:6480464 20151215 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in decreased expression of BIC mRNA PMID:20660070 10045371 Mir155hg Mir155 host gene gene CHEBI:17347 testosterone increases expression ISO RGD:1350378 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone results in increased expression of MIR155HG mRNA PMID:33359661 10045371 Mir155hg Mir155 host gene gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1350378 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of MIR155HG mRNA PMID:23557933 10045371 Mir155hg Mir155 host gene gene CHEBI:28112 nickel atom increases expression ISO RGD:1350378 E RGD:6480464 20151215 CTD MESH:D009532 Nickel results in increased expression of MIR155HG mRNA PMID:25583101 10045371 Mir155hg Mir155 host gene gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1350378 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of MIR155HG mRNA PMID:33212167 10045371 Mir155hg Mir155 host gene gene CHEBI:29678 sodium arsenite increases stability ISO RGD:1350378 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased stability of MIR155HG mRNA PMID:25493608 10045371 Mir155hg Mir155 host gene gene CHEBI:29678 sodium arsenite multiple interactions ISO RGD:11040463 E RGD:6480464 20220405 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA PMID:34876320 10045371 Mir155hg Mir155 host gene gene CHEBI:29852 methylarsonic acid multiple interactions ISO RGD:11040463 E RGD:6480464 20220405 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA PMID:34876320 10045371 Mir155hg Mir155 host gene gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1350378 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of MIR155HG promoter PMID:27901495 10045371 Mir155hg Mir155 host gene gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1350378 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of MIR155HG mRNA PMID:38382870 10045371 Mir155hg Mir155 host gene gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1350378 E RGD:6480464 20221101 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR155HG mRNA] PMID:35811015 10045371 Mir155hg Mir155 host gene gene CHEBI:48765 dimethylarsinic acid multiple interactions ISO RGD:11040463 E RGD:6480464 20220405 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA PMID:34876320 10045371 Mir155hg Mir155 host gene gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:1350378 E RGD:6480464 20160705 CTD MESH:C029938 nickel sulfate results in decreased expression of MIR155HG mRNA PMID:22714537 10045371 Mir155hg Mir155 host gene gene CHEBI:72564 temozolomide increases expression ISO RGD:1350378 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of MIR155HG mRNA PMID:31758290 10045371 Mir155hg Mir155 host gene gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:11040463 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of MIR155HG mRNA PMID:38648751 10045371 Mir155hg Mir155 host gene gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1350378 E RGD:6480464 20220510 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether results in increased expression of MIR155HG mRNA PMID:26705709 10045371 Mir155hg Mir155 host gene gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:11040463 E RGD:6480464 20220405 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MIR155HG mRNA PMID:34876320 10045415 Kantr KANTR integral membrane protein gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1623164 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA PMID:25510870 10045415 Kantr KANTR integral membrane protein gene CHEBI:18258 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1623164 E RGD:6480464 20151215 CTD MESH:D014284 Triiodothyronine results in increased expression of KANTR mRNA PMID:25172293 10045415 Kantr KANTR integral membrane protein gene CHEBI:27470 folic acid decreases expression ISO RGD:1623164 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of KANTR mRNA PMID:25629700 10045415 Kantr KANTR integral membrane protein gene CHEBI:27470 folic acid multiple interactions ISO RGD:1623164 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KANTR mRNA PMID:22206623 10045415 Kantr KANTR integral membrane protein gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:7779000 E RGD:6480464 20221004 CTD MESH:D012822 Silicon Dioxide results in decreased expression of KANTR mRNA PMID:34973136 10045415 Kantr KANTR integral membrane protein gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1623164 E RGD:6480464 20151215 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA PMID:25510870 10045415 Kantr KANTR integral membrane protein gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1623164 E RGD:6480464 20151215 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KANTR mRNA PMID:25510870 10045415 Kantr KANTR integral membrane protein gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:7779000 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of KANTR mRNA PMID:37042841 10045415 Kantr KANTR integral membrane protein gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:7779000 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of KANTR mRNA PMID:38568856 10045415 Kantr KANTR integral membrane protein gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1623164 E RGD:6480464 20171114 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of KANTR mRNA PMID:28903501 10045415 Kantr KANTR integral membrane protein gene CHEBI:36386 dichloroacetic acid decreases expression ISO RGD:1623164 E RGD:6480464 20171114 CTD MESH:D003999 Dichloroacetic Acid results in decreased expression of KANTR mRNA PMID:28962523 10045415 Kantr KANTR integral membrane protein gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1623164 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KANTR mRNA PMID:22206623 10045415 Kantr KANTR integral membrane protein gene CHEBI:84070 sodium arsenate decreases expression ISO RGD:1623164 E RGD:6480464 20190702 CTD MESH:C009277 sodium arsenate results in decreased expression of KANTR mRNA PMID:30953684 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:6480342 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of CAHM mRNA PMID:25812627 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:6480342 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in decreased expression of CAHM mRNA PMID:31614463 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:6480342 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of CAHM mRNA PMID:30851411 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:6480342 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of CAHM mRNA PMID:25812627 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:6480342 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of CAHM mRNA PMID:25812627 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:38940 sunitinib decreases expression ISO RGD:6480342 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of CAHM mRNA PMID:31533062 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:39867 valproic acid decreases expression ISO RGD:6480342 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in decreased expression of CAHM mRNA PMID:26272509 10059728 Cahm colon adenocarcinoma hypermethylated gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:6480342 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of CAHM mRNA PMID:30851411 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1318052 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of BAIAP3 mRNA PMID:38218311 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:132267 triptonide increases expression ISO RGD:1611478 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of BAIAP3 mRNA PMID:33045310 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1318052 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of BAIAP3 mRNA PMID:25812627 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:15743 butanal increases expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:C018475 butyraldehyde results in increased expression of BAIAP3 mRNA PMID:26079696 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:16236 ethanol affects expression ISO RGD:1611478 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of BAIAP3 mRNA PMID:30319688 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol affects the expression of BAIAP3 mRNA PMID:32145629 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:16598 DDE decreases expression ISO RGD:1318052 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in decreased expression of BAIAP3 mRNA PMID:38568856 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of BAIAP3 mRNA PMID:33387578 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1318052 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of BAIAP3 mRNA PMID:37042841 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:17153 propanal increases expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:C005556 propionaldehyde results in increased expression of BAIAP3 mRNA PMID:26079696 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:174733 Licochalcone B increases expression ISO RGD:1318052 E RGD:6480464 20210706 CTD MESH:C541528 licochalcone B results in increased expression of BAIAP3 mRNA PMID:33647349 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1611478 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of BAIAP3 mRNA PMID:34319233 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:17967 urethane increases expression ISO RGD:1318052 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of BAIAP3 mRNA PMID:28818685 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:2504 aflatoxin B1 affects methylation ISO RGD:1318052 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 affects the methylation of BAIAP3 intron PMID:30157460 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:25812 ozone multiple interactions ISO RGD:1611478 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of BAIAP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of BAIAP3 mRNA PMID:34911549 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:2679 amphetamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in decreased expression of BAIAP3 mRNA PMID:30779732 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240903 CTD MESH:C010974 Glyphosate results in decreased expression of BAIAP3 mRNA PMID:38314887 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1611478 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of BAIAP3 mRNA PMID:28960355 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:27889 lead(0) affects expression ISO RGD:1318052 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of BAIAP3 mRNA PMID:28903495 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1318052 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of BAIAP3 mRNA PMID:27392435 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:28088 genistein increases expression ISO RGD:1611478 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in increased expression of BAIAP3 mRNA PMID:32186404 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1611478 E RGD:6480464 20160210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of BAIAP3 mRNA PMID:26377647 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1318052 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of BAIAP3 mRNA PMID:33212167 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1318052 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of BAIAP3 mRNA PMID:32763439 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1318052 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in decreased expression of BAIAP3 mRNA PMID:34032870 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1318052 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of BAIAP3 exon; Benzo(a)pyrene results in increased methylation of BAIAP3 promoter PMID:27901495 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1318052 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of BAIAP3 mRNA PMID:25895662 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1611478 E RGD:6480464 20200310 CTD MESH:D012822 Silicon Dioxide results in increased expression of BAIAP3 mRNA PMID:29341224 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1611478 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of BAIAP3 gene PMID:35295148 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of BAIAP3 mRNA PMID:34492290 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20151208 CTD MESH:C006780 bisphenol A results in decreased expression of BAIAP3 mRNA PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1318052 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of BAIAP3 gene PMID:31601247 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA PMID:36041667 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:3423 carmustine decreases expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:D002330 Carmustine results in decreased expression of BAIAP3 mRNA PMID:15980968 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA PMID:36041667 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1611478 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of BAIAP3 mRNA PMID:38685157 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BAIAP3 mRNA PMID:36041667 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:34682 diazinon increases methylation ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:D003976 Diazinon results in increased methylation of BAIAP3 gene PMID:22964155 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1318052 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of BAIAP3 mRNA PMID:37042841 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:35456 cadmium dichloride affects expression ISO RGD:1611478 E RGD:6480464 20180828 CTD MESH:D019256 Cadmium Chloride affects the expression of BAIAP3 mRNA PMID:29408670 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:1318052 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of BAIAP3 mRNA PMID:25812627 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:1318052 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of BAIAP3 mRNA PMID:25812627 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1318052 E RGD:6480464 20211207 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of BAIAP3 mRNA PMID:25812627 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:39867 valproic acid affects expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:D014635 Valproic Acid affects the expression of BAIAP3 mRNA PMID:25979313 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1318052 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of BAIAP3 gene PMID:29154799 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1611478 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of BAIAP3 mRNA PMID:28973697 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:46024 trichostatin A affects expression ISO RGD:1318052 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of BAIAP3 mRNA PMID:28542535 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:6809 methamphetamine increases expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:D008694 Methamphetamine results in increased expression of BAIAP3 mRNA PMID:25290377 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:84069 pentanal increases expression ISO RGD:1318052 E RGD:6480464 20151208 CTD MESH:C046012 pentanal results in increased expression of BAIAP3 mRNA PMID:26079696 10059729 Baiap3 BAI1-associated protein 3 gene CHEBI:9747 Triptolide increases expression ISO RGD:1611478 E RGD:6480464 20210706 CTD MESH:C001899 triptolide results in increased expression of BAIAP3 mRNA PMID:32835833 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:10429 beta-lapachone increases expression ISO RGD:2304161 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of MIRLET7BHG mRNA PMID:38218311 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:2304161 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of MIRLET7BHG mRNA PMID:25812627 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:17606 diiodine multiple interactions ISO RGD:9999811 E RGD:6480464 20231003 CTD MESH:D007455 [Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LNCPPARA mRNA PMID:36706583 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:9999811 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LNCPPARA mRNA PMID:36331819 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:27899 cisplatin decreases expression ISO RGD:2304161 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in decreased expression of MIRLET7BHG mRNA PMID:27392435 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:28619 acrylamide increases expression ISO RGD:2304161 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in increased expression of MIRLET7BHG mRNA PMID:32763439 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:2304161 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of MIRLET7BHG mRNA PMID:38568856 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:2304161 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of MIRLET7BHG promoter PMID:27901495 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:2304161 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MIRLET7BHG gene PMID:31601247 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2304161 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MIRLET7BHG gene PMID:31601247 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:2304161 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in increased methylation of MIRLET7BHG gene PMID:31601247 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:2304161 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of MIRLET7BHG mRNA PMID:25812627 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:2304161 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of MIRLET7BHG mRNA PMID:24449571 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:2304161 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of MIRLET7BHG mRNA PMID:25812627 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:9999811 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LNCPPARA mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LNCPPARA mRNA PMID:36331819 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:39867 valproic acid increases methylation ISO RGD:2304161 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of MIRLET7BHG gene PMID:29154799 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:46661 asbestos affects response to substance ISO RGD:2304161 E RGD:6480464 20161115 CTD MESH:D001194 MIRLET7BHG gene SNP affects the susceptibility to Asbestos PMID:26199339 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:8502 6-propyl-2-thiouracil multiple interactions ISO RGD:9999811 E RGD:6480464 20231003 CTD MESH:D011441 [Propylthiouracil co-treated with Iodine deficiency] results in increased expression of LNCPPARA mRNA PMID:36706583 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:9495 thiram decreases expression ISO RGD:2304161 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of MIRLET7BHG mRNA PMID:38568856 10398754 Mirlet7bhg Mirlet7b host gene gene CHEBI:9763 trovafloxacin increases expression ISO RGD:9999811 E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in increased expression of LNCPPARA mRNA PMID:35537566 10401149 Mtln mitoregulin gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:2292400 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of MTLN mRNA PMID:37995155 10401149 Mtln mitoregulin gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:2303856 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of MTLN mRNA PMID:37042841 10401149 Mtln mitoregulin gene CHEBI:27470 folic acid multiple interactions ISO RGD:2292400 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTLN mRNA PMID:22206623 10401149 Mtln mitoregulin gene CHEBI:28748 doxorubicin increases expression ISO RGD:2303856 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of MTLN mRNA PMID:29803840 10401149 Mtln mitoregulin gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:2303856 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of MTLN mRNA PMID:38568856 10401149 Mtln mitoregulin gene CHEBI:29678 sodium arsenite increases expression ISO RGD:2303856 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in increased expression of MTLN mRNA PMID:34032870 10401149 Mtln mitoregulin gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:2303856 E RGD:6480464 20241105 CTD MESH:D001564 [AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in decreased expression of MTLN mRNA PMID:38036013 10401149 Mtln mitoregulin gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:2303856 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MTLN gene PMID:31601247 10401149 Mtln mitoregulin gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2292400 E RGD:6480464 20181113 CTD MESH:C006780 bisphenol A results in decreased expression of MTLN mRNA PMID:30245210|PMID:35598803 10401149 Mtln mitoregulin gene CHEBI:33216 bisphenol A increases expression ISO RGD:2292400 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of MTLN mRNA PMID:32156529|PMID:38074096 10401149 Mtln mitoregulin gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2303856 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of MTLN gene PMID:31601247 10401149 Mtln mitoregulin gene CHEBI:34575 bisphenol F decreases expression ISO RGD:2292400 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of MTLN mRNA PMID:38685157 10401149 Mtln mitoregulin gene CHEBI:34761 fenthion increases expression ISO RGD:2292400 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in increased expression of MTLN mRNA PMID:34813904 10401149 Mtln mitoregulin gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:2303856 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of MTLN mRNA PMID:29024780 10401149 Mtln mitoregulin gene CHEBI:39867 valproic acid decreases expression ISO RGD:2303856 E RGD:6480464 20151215 CTD MESH:D014635 Valproic Acid results in decreased expression of MTLN mRNA PMID:23179753 10401149 Mtln mitoregulin gene CHEBI:4811 epoxiconazole increases expression ISO RGD:2292400 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in increased expression of MTLN mRNA PMID:35436446 10401149 Mtln mitoregulin gene CHEBI:5063 fipronil multiple interactions ISO RGD:2303856 E RGD:6480464 20190219 CTD MESH:C082360 [fipronil co-treated with DEET] results in increased expression of MTLN mRNA PMID:28991164 10401149 Mtln mitoregulin gene CHEBI:7071 N,N-diethyl-m-toluamide multiple interactions ISO RGD:2303856 E RGD:6480464 20190219 CTD MESH:D003671 [fipronil co-treated with DEET] results in increased expression of MTLN mRNA PMID:28991164 10401149 Mtln mitoregulin gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:2292400 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTLN mRNA PMID:22206623 10401149 Mtln mitoregulin gene CHEBI:9495 thiram decreases expression ISO RGD:2303856 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of MTLN mRNA PMID:38568856 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:16130 DDT increases expression ISO RGD:5490463 E RGD:6480464 20151215 CTD MESH:D003634 DDT results in increased expression of CARMN mRNA PMID:25014179 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:17153 propanal decreases expression ISO RGD:5490463 E RGD:6480464 20151215 CTD MESH:C005556 propionaldehyde results in decreased expression of CARMN mRNA PMID:26079696 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:5490463 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of CARMN gene PMID:27153756 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:28112 nickel atom decreases expression ISO RGD:5490463 E RGD:6480464 20151215 CTD MESH:D009532 Nickel results in decreased expression of CARMN mRNA PMID:24768652|PMID:25583101 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:5490463 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of CARMN mRNA PMID:29301061 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:29678 sodium arsenite increases stability ISO RGD:5490463 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased stability of CARMN mRNA PMID:25493608 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:5490463 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of CARMN promoter PMID:27901495 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:7181169 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of CARMN promoter PMID:27901495 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:33216 bisphenol A increases expression ISO RGD:7181169 E RGD:6480464 20181113 CTD MESH:C006780 bisphenol A results in increased expression of CARMN mRNA PMID:30245210 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:33216 bisphenol A increases methylation ISO RGD:5490463 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of CARMN gene PMID:31601247 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:34575 bisphenol F decreases expression ISO RGD:7181169 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of CARMN mRNA PMID:38685157 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:5490463 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of CARMN mRNA PMID:24449571 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:39478 buta-1,3-diene decreases expression ISO RGD:7181169 E RGD:6480464 20180703 CTD MESH:C031763 1,3-butadiene results in decreased expression of CARMN mRNA PMID:29038090 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:39867 valproic acid increases expression ISO RGD:5490463 E RGD:6480464 20160607 CTD MESH:D014635 Valproic Acid results in increased expression of CARMN mRNA PMID:26705709 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:39867 valproic acid increases methylation ISO RGD:5490463 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of CARMN gene PMID:29154799 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:46024 trichostatin A increases expression ISO RGD:5490463 E RGD:6480464 20160210 CTD MESH:C012589 trichostatin A results in increased expression of CARMN mRNA PMID:26705709 10401674 Carmn cardiac mesoderm enhancer-associated non-coding RNA gene CHEBI:81781 tebuconazole decreases expression ISO RGD:5490463 E RGD:6480464 20190219 CTD MESH:C087114 tebuconazole results in decreased expression of CARMN mRNA PMID:30458266 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1346817 E RGD:6480464 20180417 CTD MESH:D005557 Formaldehyde results in decreased expression of IGKV4-1 mRNA PMID:23649840 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1346817 E RGD:6480464 20180417 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of IGKV4-1 mRNA PMID:23649840 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:28445 vincristine decreases expression ISO RGD:1346817 E RGD:6480464 20180417 CTD MESH:D014750 Vincristine results in decreased expression of IGKV4-1 mRNA PMID:23649840 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:11266467 E RGD:6480464 20220913 CTD MESH:D012822 Silicon Dioxide results in increased expression of IGKV8-27 mRNA PMID:29341224 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1346817 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased expression of IGKV4-1 protein PMID:31675489 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:47696 2,4,6-tribromophenol increases expression ISO RGD:1346817 E RGD:6480464 20220308 CTD MESH:C004554 2,4,6-tribromophenol results in increased expression of IGKV4-1 mRNA PMID:31675489 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:51081 nitrates multiple interactions ISO RGD:11266467 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of IGKV8-27 mRNA PMID:35964746 11052049 Igkv8-30l1 immunoglobulin kappa chain variable 8-30 like 1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1346817 E RGD:6480464 20220308 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IGKV4-1 protein PMID:31675489 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of DA2-19 mRNA PMID:33387578 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of DA2-19 mRNA PMID:33387578 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in increased expression of DA2-19 mRNA PMID:28959563 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DA2-19 mRNA PMID:35163327 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DA2-19 mRNA PMID:35163327 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20160607 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of DA2-19 mRNA PMID:21346803 11081208 Da2-19 uncharacterized LOC302729 gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20160607 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of DA2-19 mRNA PMID:21346803 11359066 Cnot6l2 CCR4-NOT transcription complex, subunit 6 like 2 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240903 CTD MESH:C010974 Glyphosate results in decreased expression of CNOT6L2 mRNA PMID:38314887 11361547 Inafm2 InaF motif containing 2 gene CHEBI:164200 triclosan decreases expression ISO RGD:7247411 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of INAFM2 mRNA PMID:30510588 11361547 Inafm2 InaF motif containing 2 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:7247411 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of INAFM2 mRNA PMID:37042841 11361547 Inafm2 InaF motif containing 2 gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:7247411 E RGD:6480464 20160906 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of INAFM2 mRNA PMID:26272509 11361547 Inafm2 InaF motif containing 2 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:7247411 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA PMID:27188386 11361547 Inafm2 InaF motif containing 2 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:7247411 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of INAFM2 mRNA PMID:30851411 11361547 Inafm2 InaF motif containing 2 gene CHEBI:28748 doxorubicin affects expression ISO RGD:7247411 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin affects the expression of INAFM2 mRNA PMID:29803840 11361547 Inafm2 InaF motif containing 2 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1609984 E RGD:6480464 20180220 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of INAFM2 mRNA PMID:27195522 11361547 Inafm2 InaF motif containing 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:7247411 E RGD:6480464 20161025 CTD MESH:C006780 bisphenol A results in decreased expression of INAFM2 mRNA PMID:27685785 11361547 Inafm2 InaF motif containing 2 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1609984 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of INAFM2 gene PMID:31683443 11361547 Inafm2 InaF motif containing 2 gene CHEBI:34569 Benzo[k]fluoranthene decreases expression ISO RGD:1609984 E RGD:6480464 20160906 CTD MESH:C022921 benzo(k)fluoranthene results in decreased expression of INAFM2 mRNA PMID:26377693 11361547 Inafm2 InaF motif containing 2 gene CHEBI:34761 fenthion decreases expression ISO RGD:1609984 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of INAFM2 mRNA PMID:34813904 11361547 Inafm2 InaF motif containing 2 gene CHEBI:34837 methidathion decreases expression ISO RGD:1609984 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in decreased expression of INAFM2 mRNA PMID:34813904 11361547 Inafm2 InaF motif containing 2 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:7247411 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of INAFM2 mRNA PMID:37042841 11361547 Inafm2 InaF motif containing 2 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:7247411 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of INAFM2 mRNA PMID:24449571 11361547 Inafm2 InaF motif containing 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:7247411 E RGD:6480464 20160906 CTD MESH:D014635 Valproic Acid affects the expression of INAFM2 mRNA PMID:25979313 11361547 Inafm2 InaF motif containing 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:7247411 E RGD:6480464 20160906 CTD MESH:D014635 Valproic Acid results in increased expression of INAFM2 mRNA PMID:26272509|PMID:29154799 11361547 Inafm2 InaF motif containing 2 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:7247411 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA PMID:27188386 11361547 Inafm2 InaF motif containing 2 gene CHEBI:46024 trichostatin A increases expression ISO RGD:7247411 E RGD:6480464 20160906 CTD MESH:C012589 trichostatin A results in increased expression of INAFM2 mRNA PMID:26272509 11361547 Inafm2 InaF motif containing 2 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1609984 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of INAFM2 mRNA PMID:35964746 11361547 Inafm2 InaF motif containing 2 gene CHEBI:51348 tetraphene decreases expression ISO RGD:1609984 E RGD:6480464 20160906 CTD MESH:C030935 benz(a)anthracene results in decreased expression of INAFM2 mRNA PMID:26377693 11361547 Inafm2 InaF motif containing 2 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1609984 E RGD:6480464 20160906 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of INAFM2 mRNA PMID:25566086 11361547 Inafm2 InaF motif containing 2 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:7247411 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of INAFM2 mRNA PMID:30851411 11361547 Inafm2 InaF motif containing 2 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:7247411 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA PMID:27188386 11361547 Inafm2 InaF motif containing 2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:7247411 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INAFM2 mRNA PMID:27188386 11362385 Mindy4b MINDY family member 4B gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:2306135 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of MINDY4B promoter PMID:30157460 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:17234 glucose multiple interactions ISO RGD:11284073 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA PMID:37567420 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:17634 D-glucose multiple interactions ISO RGD:11284073 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA PMID:37567420 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:28088 genistein increases expression ISO RGD:11284073 E RGD:6480464 20210803 CTD MESH:D019833 Genistein results in increased expression of IGKV1-133 mRNA PMID:32186404 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:28757 fructose multiple interactions ISO RGD:11284073 E RGD:6480464 20231031 CTD MESH:D005632 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA PMID:37567420 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:28854 2,4-D multiple interactions ISO RGD:11284073 E RGD:6480464 20231031 CTD MESH:D015084 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA PMID:37567420 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:29678 sodium arsenite multiple interactions ISO RGD:11284073 E RGD:6480464 20220405 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA PMID:34876320 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:29852 methylarsonic acid multiple interactions ISO RGD:11284073 E RGD:6480464 20220405 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA PMID:34876320 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:11284073 E RGD:6480464 20210803 CTD MESH:C009495 titanium dioxide results in increased expression of IGKV1-133 mRNA PMID:23557971 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:42758 aldehydo-D-glucose multiple interactions ISO RGD:11284073 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of IGKV1-133 mRNA PMID:37567420 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:48765 dimethylarsinic acid multiple interactions ISO RGD:11284073 E RGD:6480464 20220405 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA PMID:34876320 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:65585 carnosic acid decreases expression ISO RGD:11284073 E RGD:6480464 20230404 CTD MESH:C018381 salvin results in decreased expression of IGKV1-133 protein PMID:35926579 11362919 Igkvl-ps13 immunoglobulin kappa variable like, pseudogene 13 gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:11284073 E RGD:6480464 20220405 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IGKV1-133 mRNA PMID:34876320 11363847 Zfp568 zinc finger protein 568 gene CHEBI:132267 triptonide increases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:C084079 triptonide results in increased expression of ZFP568 mRNA PMID:33045310 11363847 Zfp568 zinc finger protein 568 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1617313 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ZFP568 mRNA PMID:37995155 11363847 Zfp568 zinc finger protein 568 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP568 mRNA PMID:26251327 11363847 Zfp568 zinc finger protein 568 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ZFP568 promoter PMID:26251327 11363847 Zfp568 zinc finger protein 568 gene CHEBI:15443 inulin multiple interactions ISO RGD:1617313 E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP568 mRNA PMID:36331819 11363847 Zfp568 zinc finger protein 568 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1617313 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP568 mRNA PMID:36331819 11363847 Zfp568 zinc finger protein 568 gene CHEBI:23995 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D005038 Ethylnitrosourea results in increased mutagenesis of ZFP568 gene PMID:15755804 11363847 Zfp568 zinc finger protein 568 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ZFP568 mRNA PMID:19770486 11363847 Zfp568 zinc finger protein 568 gene CHEBI:25812 ozone multiple interactions ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZFP568 mRNA PMID:34911549 11363847 Zfp568 zinc finger protein 568 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ZFP568 mRNA PMID:31919559 11363847 Zfp568 zinc finger protein 568 gene CHEBI:27470 folic acid decreases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D005492 Folic Acid results in decreased expression of ZFP568 mRNA PMID:25629700 11363847 Zfp568 zinc finger protein 568 gene CHEBI:27998 tungsten decreases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D014414 Tungsten results in decreased expression of ZFP568 mRNA PMID:30912803 11363847 Zfp568 zinc finger protein 568 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ZFP568 mRNA PMID:21570461 11363847 Zfp568 zinc finger protein 568 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ZFP568 mRNA PMID:19770486 11363847 Zfp568 zinc finger protein 568 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ZFP568 mRNA PMID:19770486 11363847 Zfp568 zinc finger protein 568 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230110 CTD MESH:C006780 bisphenol A results in decreased expression of ZFP568 mRNA PMID:25181051 11363847 Zfp568 zinc finger protein 568 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1617313 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP568 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP568 mRNA PMID:36331819 11363847 Zfp568 zinc finger protein 568 gene CHEBI:39867 valproic acid affects expression ISO RGD:1617313 E RGD:6480464 20230110 CTD MESH:D014635 Valproic Acid affects the expression of ZFP568 mRNA PMID:17963808 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:132082 entinostat decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C118739 entinostat results in decreased expression of PCDHB7 mRNA PMID:26272509 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:132082 entinostat multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA PMID:27188386 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:15354 choline multiple interactions ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA PMID:20938992 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20230126 CTD MESH:D014241 Trichloroethylene results in decreased expression of PCDHB7 mRNA PMID:33387578 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA PMID:20938992 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20230126 CTD MESH:D013739 [bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA PMID:26496021 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of PCDHB7 gene PMID:27153756 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:27470 folic acid decreases expression ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:D005492 Folic Acid results in decreased expression of PCDHB7 mRNA PMID:25629700 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA PMID:20938992 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:C024565 ethylene dichloride results in increased expression of PCDHB7 mRNA PMID:28960355 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of PCDHB7 mRNA PMID:20106945 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:28420 p-chloromercuribenzoic acid multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D020245 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA PMID:27188386 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of PCDHB7 exon; Benzo(a)pyrene affects the methylation of PCDHB7 promoter PMID:27901495 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C015001 arsenite results in increased methylation of PCDHB7 promoter PMID:23974009 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:31575 ethylparaben decreases expression ISO RGD:1314071 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in decreased expression of PCDHB7 mRNA PMID:37690743 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene PMID:31601247 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230126 CTD MESH:C006780 bisphenol A results in decreased expression of PCDHB7 mRNA PMID:25181051|PMID:30816183|PMID:32528016 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C006780 bisphenol A results in increased methylation of PCDHB7 gene PMID:31601247 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230126 CTD MESH:C006780 [bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA PMID:26496021 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene PMID:31601247 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA PMID:35163327 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:35299 dibenz[a,h]anthracene increases expression ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:C026486 1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA PMID:26377693 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA PMID:35163327 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C473478 Sunitinib results in decreased expression of PCDHB7 mRNA PMID:31533062 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:39867 valproic acid affects expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D014635 Valproic Acid affects the expression of PCDHB7 mRNA PMID:25979313 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D014635 Valproic Acid results in decreased expression of PCDHB7 mRNA PMID:23179753|PMID:24383497|PMID:26272509 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D014635 Valproic Acid results in decreased methylation of PCDHB7 gene PMID:29154799 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA PMID:27188386 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:D016572 Cyclosporine results in decreased expression of PCDHB7 mRNA PMID:20106945 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C012589 trichostatin A results in decreased expression of PCDHB7 mRNA PMID:26272509 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:46024 trichostatin A multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C012589 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA PMID:27188386 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:47807 sulforaphane decreases expression ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:C016766 sulforaphane results in decreased expression of PCDHB7 mRNA PMID:30529165 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20230126 CTD MESH:D019813 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of PCDHB7 mRNA PMID:27840820 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA PMID:27188386 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:82527 Ptaquiloside decreases expression ISO RGD:1314072 E RGD:6480464 20230126 CTD MESH:C043680 ptaquiloside results in decreased expression of PCDHB7 mRNA PMID:23274088 11368541 Pcdhb15 protocadherin beta 15 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1314071 E RGD:6480464 20230126 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA PMID:27188386 11370628 Gapdh-ps24 Glyceraldehyde-3-phosphate dehydrogenase, pseudogene 24 gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240903 CTD MESH:C010974 Glyphosate results in decreased expression of GAPDH-PS24 mRNA PMID:38314887 11371108 Speer4cl6 spermatogenesis associated glutamate (E)-rich protein 4C like 6 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240903 CTD MESH:C010974 Glyphosate results in increased expression of SPEER4CL6 mRNA PMID:38314887 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:132267 triptonide increases expression ISO RGD:1611476 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of CCDC194 mRNA PMID:33045310 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:13208416 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in increased expression of CCDC194 mRNA PMID:35811015 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:13208416 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC194 mRNA PMID:35811015 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:174733 Licochalcone B increases expression ISO RGD:13208416 E RGD:6480464 20210706 CTD MESH:C541528 licochalcone B results in increased expression of CCDC194 mRNA PMID:33647349 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1611476 E RGD:6480464 20240402 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of CCDC194 mRNA PMID:35716406 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:13208416 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of CCDC194 mRNA PMID:33212167 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:13208416 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of CCDC194 mRNA PMID:38568856 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1611476 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of CCDC194 mRNA PMID:37682722 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:31575 ethylparaben decreases expression ISO RGD:13208416 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in decreased expression of CCDC194 mRNA PMID:37690743 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:13208416 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of CCDC194 mRNA PMID:37042841 11373735 Ccdc194 coiled-coil domain containing 194 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:13208416 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCDC194 mRNA PMID:35811015 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:132082 entinostat decreases expression ISO RGD:1321102 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in decreased expression of PCDHB6 mRNA PMID:26272509 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:132082 entinostat multiple interactions ISO RGD:1321102 E RGD:6480464 20161228 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA PMID:27188386 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:15743 butanal increases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:C018475 butyraldehyde results in increased expression of PCDHB6 mRNA PMID:26079696 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:16494 lipoic acid multiple interactions ISO RGD:1321103 E RGD:6480464 20161018 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA] PMID:23608068 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:17153 propanal increases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:C005556 propionaldehyde results in increased expression of PCDHB6 mRNA PMID:26079696 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1321103 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of PCDHB13 mRNA PMID:34319233 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D016604 Aflatoxin B1 affects the expression of PCDHB6 protein PMID:20106945 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:27470 folic acid decreases expression ISO RGD:1321103 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of PCDHB6 mRNA PMID:25629700 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1321102 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of PCDHB6 mRNA PMID:38460933 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:27899 cisplatin increases expression ISO RGD:1321102 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in increased expression of PCDHB6 mRNA PMID:27392435 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1321102 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of PCDHB6 mRNA PMID:27392435 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:28088 genistein increases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D019833 Genistein results in increased expression of PCDHB6 mRNA PMID:20884965 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1321102 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of PCDHB6 exon; Benzo(a)pyrene affects the methylation of PCDHB6 promoter PMID:27901495 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:29865 benzo[a]pyrene increases mutagenesis ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D001564 Benzo(a)pyrene results in increased mutagenesis of PCDHB6 gene PMID:25435355 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1321103 E RGD:6480464 20161018 CTD MESH:D001564 Benzo(a)pyrene promotes the reaction [AHR protein binds to PCDHB6 promoter] PMID:19654925 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:C015001 arsenite results in increased methylation of PCDHB6 promoter PMID:23974009 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:30314 (R)-lipoic acid multiple interactions ISO RGD:1321103 E RGD:6480464 20161018 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA] PMID:23608068 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of PCDHB6 mRNA PMID:25895662 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20161018 CTD MESH:C006780 bisphenol A results in decreased expression of PCDHB6 mRNA PMID:25181051 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of PCDHB6 mRNA PMID:34947998 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20161018 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of PCDHB6 mRNA PMID:21266533 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D019256 Cadmium Chloride results in decreased expression of PCDHB6 mRNA PMID:26472689 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1321102 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of PCDHB6 mRNA PMID:31533062 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D014635 Valproic Acid results in decreased expression of PCDHB6 mRNA PMID:24383497 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1321102 E RGD:6480464 20161018 CTD MESH:D016572 Cyclosporine results in increased expression of PCDHB6 mRNA PMID:20106945 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:45716 vorinostat decreases expression ISO RGD:1321102 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of PCDHB6 mRNA PMID:27188386 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1321102 E RGD:6480464 20161025 CTD MESH:C012589 trichostatin A results in decreased expression of PCDHB6 mRNA PMID:27188386 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1321102 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of PCDHB6 mRNA PMID:38460933 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:53444 potassium dichromate decreases expression ISO RGD:1321103 E RGD:6480464 20161018 CTD MESH:D011192 Potassium Dichromate results in decreased expression of PCDHB6 mRNA PMID:23608068 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:53444 potassium dichromate multiple interactions ISO RGD:1321103 E RGD:6480464 20161018 CTD MESH:D011192 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of PCDHB6 mRNA] PMID:23608068 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:75455 2-palmitoylglycerol increases expression ISO RGD:1321102 E RGD:6480464 20240109 CTD MESH:C114956 2-palmitoylglycerol results in increased expression of PCDHB6 mRNA PMID:37199045 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1321102 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA PMID:27188386 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1321102 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to PCDHB6 gene] PMID:28238834 11376545 Pcdhb13 protocadherin beta 13 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1321102 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB6 mRNA PMID:27188386 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1316561 E RGD:6480464 20160906 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RTL1 mRNA PMID:20188158 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate affects expression ISO RGD:1316561 E RGD:6480464 20160906 CTD MESH:D004051 Diethylhexyl Phthalate affects the expression of RTL1 mRNA; Diethylhexyl Phthalate affects the expression of RTL1 mRNA alternative form PMID:21636974 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:2208 purine-6-thiol decreases expression EXP E RGD:6480464 20160906 CTD MESH:D015122 Mercaptopurine results in decreased expression of RTL1 mRNA PMID:23358152 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1602404 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of RTL1 promoter PMID:27901495 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1316561 E RGD:6480464 20180220 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of RTL1 mRNA PMID:27195522 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:301 (-)-alpha-phellandrene decreases expression ISO RGD:1602404 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of RTL1 mRNA PMID:25075043 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:31575 ethylparaben decreases expression ISO RGD:1602404 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in decreased expression of RTL1 mRNA PMID:37690743 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1316561 E RGD:6480464 20160906 CTD MESH:C006780 bisphenol A affects the expression of RTL1 mRNA; bisphenol A affects the expression of RTL1 mRNA alternative form PMID:21636974 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20160906 CTD MESH:C006780 bisphenol A results in decreased expression of RTL1 mRNA PMID:25181051 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1316561 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of RTL1 promoter PMID:27312807 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1316561 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of RTL1 mRNA PMID:37019170 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of RTL1 mRNA PMID:32680482 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1602404 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of RTL1 gene PMID:29154799 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:50035 alpha-phellandrene decreases expression ISO RGD:1602404 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of RTL1 mRNA PMID:25075043 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:50667 mercaptopurine decreases expression EXP E RGD:6480464 20160906 CTD MESH:D015122 Mercaptopurine results in decreased expression of RTL1 mRNA PMID:23358152 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1316561 E RGD:6480464 20160906 CTD MESH:D010634 Phenobarbital results in increased expression of RTL1 mRNA; Phenobarbital results in increased expression of RTL1 mRNA alternative form PMID:23091169|PMID:28541575 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1602404 E RGD:6480464 20190219 CTD MESH:D010634 Phenobarbital results in increased expression of RTL1 mRNA alternative form PMID:28541575 11378340 Rtl1 retrotransposon-like 1 gene CHEBI:94796 3,7-dihydropurine-6-thione decreases expression EXP E RGD:6480464 20170307 CTD MESH:D015122 Mercaptopurine results in decreased expression of RTL1 mRNA PMID:23358152 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of CEACAM21 mRNA PMID:35811015 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEACAM21 mRNA PMID:35811015 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20230725 CTD MESH:D004958 [bisphenol A co-treated with Estradiol] results in increased expression of CEACAM15 mRNA PMID:26496021 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1605603 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of CEACAM21 mRNA PMID:37042841 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:25812 ozone multiple interactions ISO RGD:1623866 E RGD:6480464 20230725 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEACAM15 mRNA PMID:27106289 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:2682 amphotericin B increases expression ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:D000666 Amphotericin B analog results in increased expression of CEACAM21 mRNA PMID:28534445 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of CEACAM21 5' UTR PMID:27901495 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:29866 arsenite(3-) affects expression ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:C015001 arsenite affects the expression of CEACAM21 mRNA PMID:22959463 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEACAM21 mRNA PMID:19710929 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230725 CTD MESH:C006780 bisphenol A results in decreased expression of CEACAM15 mRNA PMID:25181051 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230725 CTD MESH:C006780 [bisphenol A co-treated with Estradiol] results in increased expression of CEACAM15 mRNA PMID:26496021 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1605603 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of CEACAM21 mRNA PMID:37042841 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of CEACAM21 mRNA PMID:36326898 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of CEACAM21 mRNA PMID:24449571 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEACAM21 mRNA PMID:35811015 11382285 Ceacam15 CEA cell adhesion molecule 15 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1605603 E RGD:6480464 20230725 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to CEACAM21 gene] PMID:28238834 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VPS37C mRNA PMID:20188158 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1605989 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of VPS37C mRNA PMID:33167477 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1605989 E RGD:6480464 20170210 CTD MESH:D019327 Copper Sulfate results in decreased expression of VPS37C mRNA PMID:19549813 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:2430 aconitine increases expression EXP E RGD:6480464 20210309 CTD MESH:D000157 Aconitine results in increased expression of VPS37C protein PMID:33236894 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1605989 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of VPS37C 3' UTR PMID:30157460 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:25812 ozone multiple interactions ISO RGD:1605989 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of VPS37C mRNA PMID:35430440 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of VPS37C mRNA PMID:31150632 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1618244 E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of VPS37C mRNA PMID:31919559 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1605989 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of VPS37C mRNA PMID:23557933 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of VPS37C mRNA PMID:22298810 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of VPS37C mRNA PMID:21570461 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D013749 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VPS37C mRNA PMID:25975270 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1605989 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of VPS37C mRNA PMID:29803840 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1605989 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of VPS37C 5' UTR PMID:27901495 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D001564 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of VPS37C mRNA] PMID:22228805 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D012822 Silicon Dioxide results in increased expression of VPS37C mRNA PMID:23221170 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1618244 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of VPS37C gene PMID:35295148 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of VPS37C mRNA PMID:34492290 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of VPS37C mRNA PMID:18648102 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1605989 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of VPS37C gene PMID:31601247 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in increased expression of VPS37C mRNA PMID:25181051 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:33216 bisphenol A increases expression ISO RGD:1605989 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in increased expression of VPS37C mRNA PMID:25047013 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:1618244 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in increased methylation of VPS37C exon PMID:33297965 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1605989 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of VPS37C mRNA PMID:37042841 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:35456 cadmium dichloride decreases methylation EXP E RGD:6480464 20170210 CTD MESH:D019256 Cadmium Chloride results in decreased methylation of VPS37C promoter PMID:22457795 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:35559 furan increases methylation EXP E RGD:6480464 20170210 CTD MESH:C039281 furan results in increased methylation of VPS37C gene PMID:22079235 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:39867 valproic acid affects expression ISO RGD:1605989 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid affects the expression of VPS37C mRNA PMID:25979313 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:39867 valproic acid affects expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid affects the expression of VPS37C mRNA PMID:17292431 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1605989 E RGD:6480464 20170210 CTD MESH:D016572 Cyclosporine results in increased expression of VPS37C mRNA PMID:20106945|PMID:25562108 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:46195 paracetamol affects expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D000082 Acetaminophen affects the expression of VPS37C mRNA PMID:17562736 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of VPS37C mRNA PMID:25554681 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:6842 methoxychlor affects methylation EXP E RGD:6480464 20230905 CTD MESH:D008731 Methoxychlor affects the methylation of VPS37C gene PMID:35440735 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1618244 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of VPS37C mRNA PMID:22206623 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:7590 nitrofen decreases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in decreased expression of VPS37C mRNA PMID:33484710 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1605989 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to VPS37C gene] PMID:28238834 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:84070 sodium arsenate increases expression ISO RGD:1618244 E RGD:6480464 20190702 CTD MESH:C009277 sodium arsenate results in increased expression of VPS37C mRNA PMID:30953684 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:8489 propiconazole increases expression ISO RGD:1618244 E RGD:6480464 20170210 CTD MESH:C045950 propiconazole results in increased expression of VPS37C mRNA PMID:21278054 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:9495 thiram increases expression ISO RGD:1605989 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of VPS37C mRNA PMID:38568856 11384366 Vps37c VPS37C subunit of ESCRT-I gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20170210 CTD MESH:C025643 vinclozolin results in decreased expression of VPS37C mRNA PMID:23034163 11384727 Smim43 small integral membrane protein 43 gene CHEBI:132082 entinostat increases expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C118739 entinostat results in increased expression of SMIM43 mRNA PMID:26272509 11384727 Smim43 small integral membrane protein 43 gene CHEBI:132082 entinostat multiple interactions ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA PMID:27188386 11384727 Smim43 small integral membrane protein 43 gene CHEBI:16469 17beta-estradiol affects expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D004958 Estradiol affects the expression of SMIM43 mRNA PMID:22574217 11384727 Smim43 small integral membrane protein 43 gene CHEBI:28088 genistein decreases expression ISO RGD:5136450 E RGD:6480464 20210202 CTD MESH:D019833 Genistein results in decreased expression of SMIM43 mRNA PMID:32186404 11384727 Smim43 small integral membrane protein 43 gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C004925 methylmercuric chloride results in increased expression of SMIM43 mRNA PMID:28001369 11384727 Smim43 small integral membrane protein 43 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of TMEM155 promoter PMID:27901495 11384727 Smim43 small integral membrane protein 43 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of TMEM155 exon PMID:27901495 11384727 Smim43 small integral membrane protein 43 gene CHEBI:30614 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SMIM43 mRNA PMID:20382639 11384727 Smim43 small integral membrane protein 43 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1604239 E RGD:6480464 20210504 CTD MESH:C006780 bisphenol A results in decreased expression of SMIM43 mRNA PMID:33476716 11384727 Smim43 small integral membrane protein 43 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:5136450 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of SMIM43 mRNA PMID:37019170 11384727 Smim43 small integral membrane protein 43 gene CHEBI:39867 valproic acid affects expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D014635 Valproic Acid affects the expression of SMIM43 mRNA PMID:25979313 11384727 Smim43 small integral membrane protein 43 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D014635 Valproic Acid results in decreased methylation of SMIM43 gene PMID:29154799 11384727 Smim43 small integral membrane protein 43 gene CHEBI:39867 valproic acid increases expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:D014635 Valproic Acid results in increased expression of SMIM43 mRNA PMID:28001369 11384727 Smim43 small integral membrane protein 43 gene CHEBI:46024 trichostatin A increases expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C012589 trichostatin A results in increased expression of SMIM43 mRNA PMID:24935251 11384727 Smim43 small integral membrane protein 43 gene CHEBI:4953 exemestane increases expression ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C056516 exemestane results in increased expression of SMIM43 mRNA PMID:17254854 11384727 Smim43 small integral membrane protein 43 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA PMID:27188386 11384727 Smim43 small integral membrane protein 43 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1604239 E RGD:6480464 20210202 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM43 mRNA PMID:27188386 11394442 Vom1r113 vomeronasal 1 receptor 113 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230801 CTD MESH:C006780 bisphenol A results in decreased expression of VMN1R83 mRNA PMID:25181051 11394442 Vom1r113 vomeronasal 1 receptor 113 gene CHEBI:39867 valproic acid affects expression ISO RGD:1550904 E RGD:6480464 20230801 CTD MESH:D014635 Valproic Acid affects the expression of VMN1R83 mRNA PMID:17963808 11394460 Znf660 zinc finger protein 660 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D014212 Tretinoin results in decreased expression of ZNF660 mRNA PMID:21934132|PMID:33167477 11394460 Znf660 zinc finger protein 660 gene CHEBI:15379 dioxygen increases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D010100 Oxygen deficiency results in increased expression of ZNF660 mRNA PMID:24236059 11394460 Znf660 zinc finger protein 660 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D001151 Arsenic affects the methylation of ZNF660 gene PMID:25304211 11394460 Znf660 zinc finger protein 660 gene CHEBI:27889 lead(0) affects expression ISO RGD:1346042 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of ZNF660 mRNA PMID:28903495 11394460 Znf660 zinc finger protein 660 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ZNF660 mRNA PMID:32109520 11394460 Znf660 zinc finger protein 660 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1346042 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ZNF660 mRNA PMID:29803840 11394460 Znf660 zinc finger protein 660 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1346042 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in decreased expression of ZNF660 mRNA PMID:22714537 11394460 Znf660 zinc finger protein 660 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1346042 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ZNF660 5' UTR; Benzo(a)pyrene results in increased methylation of ZNF660 promoter PMID:27901495 11394460 Znf660 zinc finger protein 660 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of ZNF660 mRNA PMID:25895662 11394460 Znf660 zinc finger protein 660 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1346042 E RGD:6480464 20180116 CTD MESH:C543008 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA PMID:28628672 11394460 Znf660 zinc finger protein 660 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1346042 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA PMID:28628672 11394460 Znf660 zinc finger protein 660 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1346042 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ZNF660 mRNA PMID:37042841 11394460 Znf660 zinc finger protein 660 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D014635 Valproic Acid results in decreased expression of ZNF660 mRNA PMID:23179753|PMID:24935251|PMID:26272509 11394460 Znf660 zinc finger protein 660 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1346042 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of ZNF660 gene PMID:29154799 11394460 Znf660 zinc finger protein 660 gene CHEBI:4031 cyclosporin A decreases methylation ISO RGD:1346042 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in decreased methylation of ZNF660 promoter PMID:27989131 11394460 Znf660 zinc finger protein 660 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1346042 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA PMID:28628672 11394460 Znf660 zinc finger protein 660 gene CHEBI:45716 vorinostat decreases expression ISO RGD:1346042 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of ZNF660 mRNA PMID:27188386 11394460 Znf660 zinc finger protein 660 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:C012589 trichostatin A results in decreased expression of ZNF660 mRNA PMID:24935251|PMID:26272509 11394460 Znf660 zinc finger protein 660 gene CHEBI:46024 trichostatin A multiple interactions ISO RGD:1346042 E RGD:6480464 20161025 CTD MESH:C012589 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA PMID:27188386 11394460 Znf660 zinc finger protein 660 gene CHEBI:47217 arsane affects methylation ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:D001151 Arsenic affects the methylation of ZNF660 gene PMID:25304211 11394460 Znf660 zinc finger protein 660 gene CHEBI:4791 endosulfan increases expression ISO RGD:1346042 E RGD:6480464 20170516 CTD MESH:D004726 Endosulfan results in increased expression of ZNF660 mRNA PMID:26615145 11394460 Znf660 zinc finger protein 660 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1346042 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZNF660 mRNA PMID:28628672 11394460 Znf660 zinc finger protein 660 gene CHEBI:5292 geldanamycin increases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:C001277 geldanamycin results in increased expression of ZNF660 mRNA PMID:26705709 11394460 Znf660 zinc finger protein 660 gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:1346042 E RGD:6480464 20160906 CTD MESH:C029938 nickel sulfate results in decreased expression of ZNF660 mRNA PMID:22714537 11394460 Znf660 zinc finger protein 660 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1346042 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA PMID:27188386 11394460 Znf660 zinc finger protein 660 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1346042 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ZNF660 gene] PMID:28238834 11394460 Znf660 zinc finger protein 660 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in increased expression of ZNF660 mRNA PMID:32109520 11394460 Znf660 zinc finger protein 660 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1346042 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF660 mRNA PMID:27188386 11405111 Vom1r75 vomeronasal 1 receptor 75 gene CHEBI:16602 trichloroethene decreases methylation EXP E RGD:6480464 20200211 CTD MESH:D014241 Trichloroethylene results in decreased methylation of VOM1R75 gene PMID:27618143 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:3403707 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of C5ORF58 mRNA PMID:35811015 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:3403707 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of C5ORF58 mRNA PMID:37042841 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:27470 folic acid decreases expression ISO RGD:3403707 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of C5ORF58 mRNA PMID:21867686 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:27889 lead(0) increases expression ISO RGD:3403707 E RGD:6480464 20160906 CTD MESH:D007854 Lead results in increased expression of C5ORF58 mRNA PMID:19921347 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:28112 nickel atom increases expression ISO RGD:3403707 E RGD:6480464 20160906 CTD MESH:D009532 Nickel results in increased expression of C5ORF58 mRNA PMID:24768652|PMID:25583101 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:28201 rotenone decreases expression ISO RGD:3403707 E RGD:6480464 20181016 CTD MESH:D012402 Rotenone results in decreased expression of C5ORF58 mRNA PMID:29955902 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:3403707 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of C5ORF58 mRNA PMID:26705709 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:39867 valproic acid affects expression ISO RGD:3403707 E RGD:6480464 20160906 CTD MESH:D014635 Valproic Acid affects the expression of C5ORF58 mRNA PMID:25979313 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:39867 valproic acid increases expression ISO RGD:3403707 E RGD:6480464 20170516 CTD MESH:D014635 Valproic Acid results in increased expression of C5ORF58 mRNA PMID:28001369 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:39867 valproic acid increases methylation ISO RGD:3403707 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of C5ORF58 gene PMID:29154799 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:3403707 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of C5ORF58 mRNA PMID:35811015 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:47286 CU-O LINKAGE increases expression ISO RGD:3403707 E RGD:6480464 20170307 CTD MESH:C030973 cupric oxide results in increased expression of C5ORF58 mRNA PMID:22077320 11411272 C10h5orf58 similar to human chromosome 5 open reading frame 58 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:3403707 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of C5ORF58 mRNA PMID:26705709 11414885 Hoxa1 homeobox A1 gene CHEBI:132082 entinostat multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA PMID:27188386 11414885 Hoxa1 homeobox A1 gene CHEBI:132098 methoxyacetic acid increases expression ISO RGD:732851 E RGD:6480464 20230905 CTD MESH:C013598 methoxyacetic acid results in increased expression of HOXA1 mRNA PMID:32496642 11414885 Hoxa1 homeobox A1 gene CHEBI:132098 methoxyacetic acid multiple interactions ISO RGD:732851 E RGD:6480464 20230905 CTD MESH:C013598 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [methoxyacetic acid results in increased expression of HOXA1 mRNA] PMID:32496642 11414885 Hoxa1 homeobox A1 gene CHEBI:132267 triptonide increases expression ISO RGD:732851 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of HOXA1 mRNA PMID:33045310 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid affects expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin affects the expression of HOXA1 PMID:15722554 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid increases expression EXP E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in increased expression of HOXA1 mRNA PMID:16989981|PMID:20488242 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in increased expression of HOXA1; Tretinoin results in increased expression of HOXA1 mRNA PMID:16038797|PMID:16604517|PMID:16788091|PMID:19897914|PMID:32496642|PMID:36189433|PMID:8838863 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in increased expression of HOXA1 mRNA PMID:17185360|PMID:17218384|PMID:21934132|PMID:33167477 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014212 [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of HOXA1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA1 mRNA; Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA] PMID:16038797|PMID:24005908|PMID:36189433 11414885 Hoxa1 homeobox A1 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin promotes the reaction [CXCL8 protein results in increased expression of HOXA1 mRNA polymorphism] PMID:17218384 11414885 Hoxa1 homeobox A1 gene CHEBI:15379 dioxygen decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D010100 Oxygen deficiency results in decreased expression of HOXA1 mRNA PMID:24205000 11414885 Hoxa1 homeobox A1 gene CHEBI:16236 ethanol decreases expression ISO RGD:732851 E RGD:6480464 20200804 CTD MESH:D000431 Ethanol results in decreased expression of HOXA1 mRNA; Ethanol results in decreased expression of HOXA1 protein PMID:19091803 11414885 Hoxa1 homeobox A1 gene CHEBI:16236 ethanol multiple interactions ISO RGD:732851 E RGD:6480464 20200804 CTD MESH:D000431 Folic Acid inhibits the reaction [Ethanol results in decreased expression of HOXA1 mRNA] PMID:19091803 11414885 Hoxa1 homeobox A1 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D006861 Hydrogen Peroxide affects the expression of HOXA1 mRNA PMID:20044591 11414885 Hoxa1 homeobox A1 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:737614 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of HOXA1 mRNA PMID:35811015 11414885 Hoxa1 homeobox A1 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:737614 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA1 mRNA PMID:35811015 11414885 Hoxa1 homeobox A1 gene CHEBI:164200 triclosan increases expression ISO RGD:737614 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in increased expression of HOXA1 mRNA PMID:30510588 11414885 Hoxa1 homeobox A1 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D004958 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] PMID:20823114 11414885 Hoxa1 homeobox A1 gene CHEBI:167162 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:737614 E RGD:6480464 20220208 CTD MESH:C011669 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:16842 formaldehyde increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D005557 Formaldehyde results in increased expression of HOXA1 mRNA PMID:23649840 11414885 Hoxa1 homeobox A1 gene CHEBI:16980 geranial multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C007076 citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:732851 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA1 mRNA PMID:36189433 11414885 Hoxa1 homeobox A1 gene CHEBI:17336 all-trans-retinol increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014801 Vitamin A results in increased expression of HOXA1; Vitamin A results in increased expression of HOXA1 mRNA PMID:23696197|PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:17336 all-trans-retinol multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014801 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 3,4-methylenedioxy-beta-nitrostyrene inhibits the reaction [Vitamin A results in increased expression of HOXA1]; 4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; BAY 11-7085 inhibits the reaction [Vitamin A results in increased expression of HOXA1]; bisphenol A inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1]; citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; di-n-pentyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Diethylstilbestrol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Disulfiram inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; Genistein inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA]; nitrofen inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197|PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:17347 testosterone decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D013739 Testosterone results in decreased expression of HOXA1 mRNA PMID:19693291 11414885 Hoxa1 homeobox A1 gene CHEBI:17650 cortisol multiple interactions ISO RGD:737614 E RGD:6480464 20220208 CTD MESH:D006854 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:2038 5-azacytidine increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D001374 Azacitidine results in increased expression of HOXA1 mRNA PMID:20823114 11414885 Hoxa1 homeobox A1 gene CHEBI:2038 5-azacytidine multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D001374 Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] PMID:20823114 11414885 Hoxa1 homeobox A1 gene CHEBI:20993 aldehydo-D-glucosamine decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D005944 Glucosamine results in decreased expression of HOXA1 mRNA PMID:17178593 11414885 Hoxa1 homeobox A1 gene CHEBI:23316 citral multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C007076 citral inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of HOXA1 gene PMID:27153756 11414885 Hoxa1 homeobox A1 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D009151 Mustard Gas results in increased expression of HOXA1 mRNA PMID:15674843 11414885 Hoxa1 homeobox A1 gene CHEBI:2567 alendronic acid affects expression EXP E RGD:6480464 20170210 CTD MESH:D019386 Alendronate affects the expression of HOXA1 mRNA PMID:16079270 11414885 Hoxa1 homeobox A1 gene CHEBI:27470 folic acid multiple interactions ISO RGD:732851 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid inhibits the reaction [Ethanol results in decreased expression of HOXA1 mRNA] PMID:19091803 11414885 Hoxa1 homeobox A1 gene CHEBI:27656 camptothecin decreases response to substance ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D002166 HOXA1 mRNA results in decreased susceptibility to Camptothecin PMID:25269479 11414885 Hoxa1 homeobox A1 gene CHEBI:27656 camptothecin multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D002166 Camptothecin inhibits the reaction [Vitamin A results in increased expression of HOXA1] PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:27881 resveratrol decreases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C059514 resveratrol results in decreased expression of HOXA1 mRNA PMID:20878097 11414885 Hoxa1 homeobox A1 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:737614 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of HOXA1 mRNA PMID:23557933 11414885 Hoxa1 homeobox A1 gene CHEBI:28088 genistein increases expression ISO RGD:732851 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in increased expression of HOXA1 mRNA PMID:32186404 11414885 Hoxa1 homeobox A1 gene CHEBI:28088 genistein multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D019833 Genistein inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of HOXA1 mRNA PMID:24058054 11414885 Hoxa1 homeobox A1 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:737614 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of HOXA1 mRNA PMID:33212167 11414885 Hoxa1 homeobox A1 gene CHEBI:28393 beta-D-glucosamine decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D005944 Glucosamine results in decreased expression of HOXA1 mRNA PMID:17178593 11414885 Hoxa1 homeobox A1 gene CHEBI:28694 copper atom multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of HOXA1 mRNA PMID:20971185 11414885 Hoxa1 homeobox A1 gene CHEBI:28834 deoxycholic acid multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D003840 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA PMID:16556975 11414885 Hoxa1 homeobox A1 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:737614 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of HOXA1 5' UTR; Benzo(a)pyrene results in decreased methylation of HOXA1 exon; Benzo(a)pyrene results in decreased methylation of HOXA1 promoter PMID:27901495 11414885 Hoxa1 homeobox A1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:737614 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of HOXA1 3' UTR PMID:27901495 11414885 Hoxa1 homeobox A1 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of HOXA1 mRNA PMID:20971185 11414885 Hoxa1 homeobox A1 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D012822 Silicon Dioxide results in decreased expression of HOXA1 mRNA PMID:19073995|PMID:33720480 11414885 Hoxa1 homeobox A1 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20170210 CTD MESH:D000643 Ammonium Chloride affects the expression of HOXA1 mRNA PMID:16483693 11414885 Hoxa1 homeobox A1 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:732851 E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of HOXA1 mRNA PMID:29264374 11414885 Hoxa1 homeobox A1 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:732851 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of HOXA1 promoter PMID:35295148 11414885 Hoxa1 homeobox A1 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HOXA1 mRNA PMID:19710929 11414885 Hoxa1 homeobox A1 gene CHEBI:33198 D-gluconic acid multiple interactions EXP E RGD:6480464 20170210 CTD MESH:C030691 [gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA PMID:16556975 11414885 Hoxa1 homeobox A1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of HOXA1 mRNA PMID:25181051 11414885 Hoxa1 homeobox A1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of HOXA1 mRNA PMID:26063408|PMID:31288075 11414885 Hoxa1 homeobox A1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:732851 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of HOXA1 mRNA PMID:30951980 11414885 Hoxa1 homeobox A1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in increased expression of HOXA1 mRNA PMID:27685785 11414885 Hoxa1 homeobox A1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:338412 (-)-anisomycin multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D000841 Anisomycin promotes the reaction [Tretinoin results in increased expression of HOXA1 mRNA] PMID:16038797 11414885 Hoxa1 homeobox A1 gene CHEBI:3387 carbamazepine affects expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D002220 Carbamazepine affects the expression of HOXA1 mRNA PMID:25979313 11414885 Hoxa1 homeobox A1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:732851 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of HOXA1 mRNA PMID:30951980 11414885 Hoxa1 homeobox A1 gene CHEBI:34440 4-nonylphenol multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C041594 4-nonylphenol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:34575 bisphenol F increases expression ISO RGD:732851 E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of HOXA1 mRNA PMID:30951980 11414885 Hoxa1 homeobox A1 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:732851 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of HOXA1 mRNA PMID:37019170 11414885 Hoxa1 homeobox A1 gene CHEBI:34680 dipentyl phthalate multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C034171 di-n-pentyl phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:34687 dibutyl phthalate multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D003993 Dibutyl Phthalate inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D004052 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA PMID:18164116 11414885 Hoxa1 homeobox A1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of HOXA1 mRNA PMID:32680482 11414885 Hoxa1 homeobox A1 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D019256 Cadmium Chloride results in decreased expression of HOXA1 mRNA PMID:12160620 11414885 Hoxa1 homeobox A1 gene CHEBI:39481 chloroprene decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D002737 Chloroprene results in decreased expression of HOXA1 mRNA PMID:23125180 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid affects expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid affects the expression of HOXA1 mRNA PMID:17292431|PMID:26072468 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid affects expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid affects the expression of HOXA1 mRNA PMID:25979313|PMID:26072468 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid increases expression EXP E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid analog results in increased expression of HOXA1 mRNA; Valproic Acid results in increased expression of HOXA1 mRNA PMID:16989981 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid results in increased expression of HOXA1 mRNA PMID:21427059|PMID:27693483 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid results in increased expression of HOXA1 mRNA PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D014635 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Valproic Acid results in increased expression of HOXA1 mRNA]; [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA PMID:27693483 11414885 Hoxa1 homeobox A1 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA PMID:27188386 11414885 Hoxa1 homeobox A1 gene CHEBI:4027 cyclophosphamide affects response to substance ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D003520 HOXA1 protein affects the susceptibility to Cyclophosphamide PMID:16217747 11414885 Hoxa1 homeobox A1 gene CHEBI:41922 diethylstilbestrol decreases expression EXP E RGD:6480464 20170210 CTD MESH:D004054 Diethylstilbestrol results in decreased expression of HOXA1 protein PMID:22198180 11414885 Hoxa1 homeobox A1 gene CHEBI:41922 diethylstilbestrol multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D004054 Diethylstilbestrol inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:4393 (-)-demecolcine increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D003703 Demecolcine results in increased expression of HOXA1 mRNA PMID:23649840 11414885 Hoxa1 homeobox A1 gene CHEBI:46195 paracetamol increases expression ISO RGD:737614 E RGD:6480464 20180313 CTD MESH:D000082 Acetaminophen results in increased expression of HOXA1 mRNA PMID:26690555 11414885 Hoxa1 homeobox A1 gene CHEBI:46345 5-fluorouracil decreases expression ISO RGD:737614 E RGD:6480464 20180703 CTD MESH:D005472 Fluorouracil results in decreased expression of HOXA1 mRNA PMID:24737281 11414885 Hoxa1 homeobox A1 gene CHEBI:4659 disulfiram multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D004221 Disulfiram inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737614 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXA1 mRNA PMID:35811015 11414885 Hoxa1 homeobox A1 gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20170210 CTD MESH:D004726 Endosulfan results in increased expression of HOXA1 protein PMID:22198180 11414885 Hoxa1 homeobox A1 gene CHEBI:47977 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D005944 Glucosamine results in decreased expression of HOXA1 mRNA PMID:17178593 11414885 Hoxa1 homeobox A1 gene CHEBI:48765 dimethylarsinic acid decreases expression EXP E RGD:6480464 20170210 CTD MESH:D002101 Cacodylic Acid results in decreased expression of HOXA1 mRNA PMID:16122865 11414885 Hoxa1 homeobox A1 gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20170210 CTD MESH:D004997 Ethinyl Estradiol affects the expression of HOXA1 mRNA PMID:16079270 11414885 Hoxa1 homeobox A1 gene CHEBI:50095 bucladesine multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D003994 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] PMID:20823114 11414885 Hoxa1 homeobox A1 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of HOXA1 mRNA; Nanotubes, Carbon results in decreased expression of HOXA1 mRNA PMID:25554681 11414885 Hoxa1 homeobox A1 gene CHEBI:53001 nickel sulfate increases expression ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C029938 nickel sulfate results in increased expression of HOXA1 mRNA PMID:22714537 11414885 Hoxa1 homeobox A1 gene CHEBI:53620 methylisothiazolinone increases expression ISO RGD:737614 E RGD:6480464 20200714 CTD MESH:C011506 2-methyl-4-isothiazolin-3-one results in increased expression of HOXA1 mRNA PMID:31629900 11414885 Hoxa1 homeobox A1 gene CHEBI:62878 XAV939 multiple interactions ISO RGD:737614 E RGD:6480464 20220208 CTD MESH:C544261 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:65329 LY294002 multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Vitamin A results in increased expression of HOXA1] PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:6716 medroxyprogesterone acetate multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:D017258 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA; Azacitidine inhibits the reaction [[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of HOXA1 mRNA] PMID:20823114 11414885 Hoxa1 homeobox A1 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:732851 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of HOXA1 mRNA PMID:22206623 11414885 Hoxa1 homeobox A1 gene CHEBI:75261 arotinoid acid multiple interactions ISO RGD:737614 E RGD:6480464 20220208 CTD MESH:C038864 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:7553 niclosamide increases expression ISO RGD:732851 E RGD:6480464 20191114 CTD MESH:D009534 Niclosamide results in increased expression of HOXA1 PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:7590 nitrofen multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C007350 nitrofen inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:76359 butylated hydroxyanisole decreases expression ISO RGD:732851 E RGD:6480464 20180116 CTD MESH:D002083 Butylated Hydroxyanisole results in decreased expression of HOXA1 mRNA PMID:28927898 11414885 Hoxa1 homeobox A1 gene CHEBI:77013 beta-naphthoflavone multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D019324 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HOXA1 mRNA PMID:18164116 11414885 Hoxa1 homeobox A1 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA PMID:27188386 11414885 Hoxa1 homeobox A1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP E RGD:6480464 20170303 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HOXA1 mRNA PMID:27291303 11414885 Hoxa1 homeobox A1 gene CHEBI:81766 hexaconazole affects expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C409722 hexaconazole affects the expression of HOXA1 mRNA PMID:21195148 11414885 Hoxa1 homeobox A1 gene CHEBI:81922 flusilazole affects expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C061365 flusilazole affects the expression of HOXA1 mRNA PMID:21195148 11414885 Hoxa1 homeobox A1 gene CHEBI:81922 flusilazole increases expression EXP E RGD:6480464 20170725 CTD MESH:C061365 flusilazole results in increased expression of HOXA1 mRNA PMID:28263823 11414885 Hoxa1 homeobox A1 gene CHEBI:81922 flusilazole increases expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C061365 flusilazole results in increased expression of HOXA1 mRNA PMID:21192963 11414885 Hoxa1 homeobox A1 gene CHEBI:82436 decabromodiphenyl ether decreases expression EXP E RGD:6480464 20170210 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of HOXA1 mRNA PMID:23640034 11414885 Hoxa1 homeobox A1 gene CHEBI:85990 panobinostat multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA PMID:27188386 11414885 Hoxa1 homeobox A1 gene CHEBI:86290 6-bromoindirubin-3'-oxime multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C483321 [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of HOXA1 mRNA PMID:27693483 11414885 Hoxa1 homeobox A1 gene CHEBI:8772 raloxifene affects expression EXP E RGD:6480464 20170210 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of HOXA1 mRNA PMID:16079270 11414885 Hoxa1 homeobox A1 gene CHEBI:90441 WIN 18446 multiple interactions ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C002491 N,N'-bis(dichloroacetyl)-1,8-octamethylenediamine inhibits the reaction [Vitamin A results in increased expression of HOXA1 mRNA] PMID:23696197 11414885 Hoxa1 homeobox A1 gene CHEBI:91091 CHIR 99021 multiple interactions ISO RGD:737614 E RGD:6480464 20220208 CTD MESH:C473711 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA1 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA1 mRNA PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:737614 E RGD:6480464 20170210 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXA1 mRNA PMID:27188386|PMID:34480604 11414885 Hoxa1 homeobox A1 gene CHEBI:92658 kenpaullone increases expression ISO RGD:732851 E RGD:6480464 20211109 CTD MESH:C119620 kenpaullone results in increased expression of HOXA1 PMID:26820057 11414885 Hoxa1 homeobox A1 gene CHEBI:9665 triadimefon affects expression ISO RGD:732851 E RGD:6480464 20170210 CTD MESH:C032910 triadimefon affects the expression of HOXA1 mRNA PMID:21195148 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1617055 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of HS3ST4 mRNA PMID:37995155 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:16548 chlordecone decreases expression ISO RGD:1617055 E RGD:6480464 20201103 CTD MESH:D007631 Chlordecone results in decreased expression of HS3ST4 mRNA PMID:29980752 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1352921 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of HS3ST4 gene PMID:27153756 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:27470 folic acid decreases expression ISO RGD:1617055 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of HS3ST4 mRNA PMID:25629700 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:1352921 E RGD:6480464 20160913 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of HS3ST4 mRNA PMID:26272509 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1352921 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA PMID:27188386 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1352921 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of HS3ST4 mRNA PMID:23557933 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:28748 doxorubicin increases expression ISO RGD:1352921 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of HS3ST4 mRNA PMID:30031762 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1352921 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of HS3ST4 5' UTR; Benzo(a)pyrene results in increased methylation of HS3ST4 exon; Benzo(a)pyrene results in increased methylation of HS3ST4 promoter PMID:27901495 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:29866 arsenite(3-) increases expression ISO RGD:1617055 E RGD:6480464 20210504 CTD MESH:C015001 arsenite results in increased expression of HS3ST4 mRNA PMID:33053406 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1617055 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of HS3ST4 mRNA PMID:32156529 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:39867 valproic acid affects expression ISO RGD:1352921 E RGD:6480464 20160913 CTD MESH:D014635 Valproic Acid affects the expression of HS3ST4 mRNA PMID:25979313 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:45716 vorinostat multiple interactions ISO RGD:1352921 E RGD:6480464 20161213 CTD MESH:C111237 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA PMID:27188386 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:6809 methamphetamine affects response to substance ISO RGD:1352921 E RGD:6480464 20160913 CTD MESH:D008694 HS3ST4 gene SNP affects the susceptibility to Methamphetamine PMID:18316681 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:6842 methoxychlor affects methylation EXP E RGD:6480464 20230905 CTD MESH:D008731 Methoxychlor affects the methylation of HS3ST4 gene PMID:35440735 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1352921 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA PMID:27188386 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1352921 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to HS3ST4 gene] PMID:28238834 11422907 Hs3st4 heparan sulfate-glucosamine 3-sulfotransferase 4 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1352921 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HS3ST4 mRNA PMID:27188386 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFTRAF1 mRNA PMID:20188158 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D014212 Tretinoin results in increased expression of ZFTRAF1 mRNA PMID:23724009 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:16236 ethanol affects splicing ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D000431 Ethanol affects the splicing of ZFTRAF1 mRNA PMID:30319688 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of ZFTRAF1 protein PMID:31163220 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1557821 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of CYHR1 mRNA PMID:33754040 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:18407 hydrogen cyanide decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D006856 Hydrogen Cyanide results in decreased expression of ZFTRAF1 mRNA PMID:33914522 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:18721 3-chloropropane-1,2-diol increases expression EXP E RGD:6480464 20230221 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of ZFTRAF1 protein PMID:34915118 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:22977 cadmium atom increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D002104 Cadmium results in increased expression of ZFTRAF1 mRNA PMID:24376830 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D019327 Copper Sulfate results in decreased expression of ZFTRAF1 mRNA PMID:19549813 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of ZFTRAF1 mRNA PMID:23649840 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:24814 indole-3-methanol affects expression EXP E RGD:6480464 20230404 CTD MESH:C016517 indole-3-carbinol affects the expression of ZFTRAF1 mRNA PMID:21396975 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ZFTRAF1 mRNA PMID:19770486 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of ZFTRAF1 mRNA PMID:23649840 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:25812 ozone multiple interactions ISO RGD:1344193 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of CYHR1 mRNA PMID:35430440 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFTRAF1 mRNA PMID:22206623 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D001151 Arsenic affects the methylation of ZFTRAF1 gene PMID:25304211 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:27585 selenomethionine affects expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D012645 Selenomethionine affects the expression of ZFTRAF1 mRNA PMID:17222674 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:27856 acetamide decreases expression EXP E RGD:6480464 20230404 CTD MESH:C030686 acetamide results in decreased expression of ZFTRAF1 mRNA PMID:31881176 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of ZFTRAF1 mRNA PMID:23557933 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D009532 Nickel results in decreased expression of ZFTRAF1 mRNA PMID:23195993|PMID:25583101 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ZFTRAF1 mRNA PMID:21570461 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20230404 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ZFTRAF1 mRNA PMID:21215274 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C000228 aristolochic acid I results in increased expression of ZFTRAF1 mRNA PMID:33212167 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:28869 menadione affects expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D024483 Vitamin K 3 affects the expression of ZFTRAF1 mRNA PMID:20044591 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ZFTRAF1 mRNA PMID:22228805 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ZFTRAF1 3' UTR PMID:27901495 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:31638 fulvestrant increases methylation ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C070081 Fulvestrant results in increased methylation of ZFTRAF1 gene PMID:31601247 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1557821 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of CYHR1 gene PMID:35295148 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1557821 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of CYHR1 gene PMID:35295148 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20230404 CTD MESH:D013853 Thioacetamide results in decreased expression of ZFTRAF1 mRNA PMID:34492290 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:C006253 pirinixic acid results in increased expression of ZFTRAF1 mRNA PMID:17426115 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33191 potassium cyanide increases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D011190 Potassium Cyanide results in increased expression of ZFTRAF1 mRNA PMID:33914522 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20230404 CTD MESH:C006780 bisphenol A affects the expression of ZFTRAF1 mRNA PMID:30816183|PMID:34947998 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230404 CTD MESH:C006780 bisphenol A results in decreased expression of ZFTRAF1 mRNA PMID:32528016 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C006780 bisphenol A results in decreased expression of ZFTRAF1 protein PMID:33376534 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230404 CTD MESH:C006780 bisphenol A results in increased expression of ZFTRAF1 mRNA PMID:25181051 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA PMID:36041667 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA PMID:28628672 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA PMID:36041667 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFTRAF1 mRNA PMID:36041667 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20230404 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ZFTRAF1 mRNA PMID:21266533 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA PMID:28628672 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20230404 CTD MESH:D010269 Paraquat results in decreased expression of ZFTRAF1 mRNA PMID:32680482 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1344193 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of CYHR1 mRNA PMID:37042841 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:35033 triphenyl phosphate increases expression EXP E RGD:6480464 20230404 CTD MESH:C005445 triphenyl phosphate results in increased expression of ZFTRAF1 mRNA PMID:30589522 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1344193 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of CYHR1 mRNA PMID:38568856 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:3750 clofibrate decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D002994 Clofibrate results in decreased expression of ZFTRAF1 mRNA PMID:17585979|PMID:23811191 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:3750 clofibrate multiple interactions ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA] PMID:17585979 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D014635 Valproic Acid affects the expression of ZFTRAF1 mRNA PMID:17963808 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D014635 Valproic Acid results in increased methylation of ZFTRAF1 gene PMID:29154799 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA PMID:28628672 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:46195 paracetamol affects expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D000082 Acetaminophen affects the expression of ZFTRAF1 mRNA PMID:17562736 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:46195 paracetamol increases expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D000082 Acetaminophen results in increased expression of ZFTRAF1 mRNA PMID:22230336 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:46195 paracetamol multiple interactions ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZFTRAF1 mRNA] PMID:17585979 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:47217 arsane affects methylation ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D001151 Arsenic affects the methylation of ZFTRAF1 gene PMID:25304211 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:C109476 epoxiconazole results in decreased expression of ZFTRAF1 mRNA PMID:35436446 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZFTRAF1 mRNA PMID:28628672 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:50594 carbon nanotube affects expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D037742 Nanotubes, Carbon affects the expression of ZFTRAF1 mRNA PMID:25554681 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ZFTRAF1 mRNA PMID:25554681 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ZFTRAF1 mRNA PMID:25620056 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1557821 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZFTRAF1 mRNA PMID:35964746 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:73755 1,2-dimethylhydrazine affects expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D019813 1,2-Dimethylhydrazine affects the expression of ZFTRAF1 mRNA PMID:22206623 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ZFTRAF1 mRNA PMID:22206623 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFTRAF1 mRNA PMID:22206623 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:8489 propiconazole decreases expression ISO RGD:1557821 E RGD:6480464 20230404 CTD MESH:C045950 propiconazole results in decreased expression of ZFTRAF1 mRNA PMID:21278054 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:9195 Soman decreases expression EXP E RGD:6480464 20230404 CTD MESH:D012999 Soman results in decreased expression of ZFTRAF1 mRNA PMID:19281266 11425062 Zftraf1 zinc finger TRAF type containing 1 gene CHEBI:9464 testosterone enanthate affects expression ISO RGD:1344193 E RGD:6480464 20230221 CTD MESH:C004648 testosterone enanthate affects the expression of ZFTRAF1 mRNA PMID:17440010 11426996 Mymx myomixer, myoblast fusion factor gene CHEBI:132267 triptonide increases expression ISO RGD:1620251 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of MYMX mRNA PMID:33045310 11426996 Mymx myomixer, myoblast fusion factor gene CHEBI:28618 1,4-dichlorobenzene increases expression ISO RGD:1620251 E RGD:6480464 20171114 CTD MESH:C018511 4-dichlorobenzene results in increased expression of MYMX mRNA PMID:26975756 11426996 Mymx myomixer, myoblast fusion factor gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1620251 E RGD:6480464 20210706 CTD MESH:D004390 Chlorpyrifos results in decreased expression of MYMX mRNA PMID:32715474 11428339 Hsfx3l heat shock transcription factor family, X-linked member 3 like gene CHEBI:30812 iron dichloride decreases expression ISO RGD:12801022 E RGD:6480464 20231003 CTD MESH:C029451 ferrous chloride results in decreased expression of HSFX3 mRNA PMID:35984750 11428339 Hsfx3l heat shock transcription factor family, X-linked member 3 like gene CHEBI:8984 sodium dodecyl sulfate increases expression ISO RGD:12801022 E RGD:6480464 20230620 CTD MESH:D012967 Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA PMID:31734321 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:15343 acetaldehyde affects expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D000079 Acetaldehyde affects the expression of EVX1 mRNA PMID:22634333 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:15354 choline multiple interactions ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene PMID:20938992 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in decreased expression of EVX1 mRNA PMID:15498508 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in decreased expression of EVX1 mRNA PMID:16604517 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene PMID:20938992 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:17347 testosterone increases expression ISO RGD:1558128 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone deficiency results in increased expression of EVX1 mRNA PMID:33848595 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of EVX1 gene PMID:27153756 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:27470 folic acid decreases expression ISO RGD:1344299 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of EVX1 mRNA PMID:21867686 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EVX1 gene PMID:20938992 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D001151 Arsenic affects the methylation of EVX1 gene PMID:25304211 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1344299 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of EVX1 mRNA PMID:23557933 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of EVX1 mRNA PMID:21570461 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of EVX1 mRNA PMID:24058054 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:29287 gold atom increases expression ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D006046 Gold results in increased expression of EVX1 mRNA PMID:25523186 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1558128 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of EVX1 mRNA PMID:37682722 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1344299 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of EVX1 exon; Benzo(a)pyrene affects the methylation of EVX1 promoter PMID:27901495 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:30050 gold(0) increases expression ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D006046 Gold results in increased expression of EVX1 mRNA PMID:25523186 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:32181 tamibarotene decreases expression ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:C061133 tamibarotene results in decreased expression of EVX1 mRNA PMID:15498508 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1558128 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of EVX1 gene; titanium dioxide results in decreased methylation of EVX1 promoter PMID:35295148 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1558128 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of EVX1 gene PMID:35295148 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of EVX1 mRNA PMID:25181051 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of EVX1 mRNA PMID:26063408|PMID:34585602 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1558128 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of EVX1 mRNA PMID:32156529 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1344299 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in decreased methylation of EVX1 gene PMID:31601247 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:1558128 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in increased methylation of EVX1 exon PMID:33297965 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1558128 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of EVX1 mRNA PMID:37019170 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of EVX1 mRNA PMID:24449571 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:46666 crocidolite asbestos decreases methylation ISO RGD:1344299 E RGD:6480464 20230207 CTD MESH:D017638 Asbestos, Crocidolite results in decreased methylation of EVX1 promoter PMID:29626692 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:46678 amosite asbestos decreases methylation ISO RGD:1344299 E RGD:6480464 20230207 CTD MESH:D017639 Asbestos, Amosite results in decreased methylation of EVX1 promoter PMID:29626692 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:47217 arsane affects methylation ISO RGD:1344299 E RGD:6480464 20170210 CTD MESH:D001151 Arsenic affects the methylation of EVX1 gene PMID:25304211 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:D011192 Potassium Dichromate results in increased expression of EVX1 mRNA PMID:23608068 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:7590 nitrofen increases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of EVX1 mRNA PMID:33484710 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:81922 flusilazole affects expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:C061365 flusilazole affects the expression of EVX1 mRNA PMID:22634333 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20170210 CTD MESH:D011441 Propylthiouracil results in decreased expression of EVX1 mRNA PMID:24780913 11434685 Evx1 even-skipped homeobox 1 gene CHEBI:88522 Monobutylphthalate affects expression ISO RGD:1558128 E RGD:6480464 20170210 CTD MESH:C028577 monobutyl phthalate affects the expression of EVX1 mRNA PMID:19162170 11436011 Zfp470 zinc finger protein 470 gene CHEBI:15930 atrazine increases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D001280 Atrazine results in increased expression of ZNF470 mRNA PMID:22378314 11436011 Zfp470 zinc finger protein 470 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1603830 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ZNF470 mRNA PMID:37042841 11436011 Zfp470 zinc finger protein 470 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ZNF470 gene PMID:27153756 11436011 Zfp470 zinc finger protein 470 gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C004925 methylmercuric chloride results in decreased expression of ZNF470 mRNA PMID:28001369 11436011 Zfp470 zinc finger protein 470 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ZNF470 promoter PMID:27901495 11436011 Zfp470 zinc finger protein 470 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C543008 bisphenol S results in increased methylation of ZNF470 gene PMID:31601247 11436011 Zfp470 zinc finger protein 470 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1603830 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ZNF470 mRNA PMID:37042841 11436011 Zfp470 zinc finger protein 470 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1603830 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of ZNF470 mRNA PMID:38568856 11436011 Zfp470 zinc finger protein 470 gene CHEBI:38940 sunitinib increases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C473478 Sunitinib results in increased expression of ZNF470 mRNA PMID:31533062 11436011 Zfp470 zinc finger protein 470 gene CHEBI:39178 clothianidin increases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C480342 clothianidin results in increased expression of ZNF470 mRNA PMID:31626844 11436011 Zfp470 zinc finger protein 470 gene CHEBI:39867 valproic acid affects expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D014635 Valproic Acid affects the expression of ZNF470 mRNA PMID:25979313 11436011 Zfp470 zinc finger protein 470 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D014635 Valproic Acid results in decreased expression of ZNF470 mRNA PMID:26272509 11436011 Zfp470 zinc finger protein 470 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA PMID:27188386 11436011 Zfp470 zinc finger protein 470 gene CHEBI:4918 O-methyleugenol decreases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C005223 methyleugenol results in decreased expression of ZNF470 mRNA PMID:32234424 11436011 Zfp470 zinc finger protein 470 gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C029938 nickel sulfate results in decreased expression of ZNF470 mRNA PMID:22714537 11436011 Zfp470 zinc finger protein 470 gene CHEBI:72564 temozolomide increases expression ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C047246 Temozolomide results in increased expression of ZNF470 mRNA PMID:31758290 11436011 Zfp470 zinc finger protein 470 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C516138 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA PMID:27188386 11436011 Zfp470 zinc finger protein 470 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1603830 E RGD:6480464 20230404 CTD MESH:C459179 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF470 mRNA PMID:27188386 11436036 Prss48 serine protease 48 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of PRSS48 mRNA PMID:33387578 11436036 Prss48 serine protease 48 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases methylation ISO RGD:1621203 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased methylation of PRSS48 gene PMID:34319233 11436036 Prss48 serine protease 48 gene CHEBI:27470 folic acid decreases expression ISO RGD:1621203 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of PRSS48 mRNA PMID:25629700 11436036 Prss48 serine protease 48 gene CHEBI:28201 rotenone increases expression ISO RGD:1605534 E RGD:6480464 20181016 CTD MESH:D012402 Rotenone results in increased expression of PRSS48 mRNA PMID:29955902 11436036 Prss48 serine protease 48 gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:1605534 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of PRSS48 mRNA PMID:30851411 11436036 Prss48 serine protease 48 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1621203 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of PRSS48 mRNA PMID:37682722 11436036 Prss48 serine protease 48 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1621203 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in decreased methylation of PRSS48 exon PMID:33297965 11436036 Prss48 serine protease 48 gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:1605534 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of PRSS48 mRNA PMID:30851411 11436036 Prss48 serine protease 48 gene CHEBI:9495 thiram increases expression ISO RGD:1605534 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of PRSS48 mRNA PMID:38568856 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:132267 triptonide increases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:C084079 triptonide results in increased expression of FLYWCH2 mRNA PMID:33045310 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FLYWCH2 mRNA PMID:20188158 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:16236 ethanol affects expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D000431 Ethanol affects the expression of FLYWCH2 mRNA PMID:30319688 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:16563 tetrahydropalmatine decreases expression ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:C014215 tetrahydropalmatine results in decreased expression of FLYWCH2 protein PMID:20109541 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1602659 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of FLYWCH2 mRNA PMID:37042841 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1602659 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of FLYWCH2 protein PMID:37730182 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FLYWCH2 protein PMID:23301498 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FLYWCH2 mRNA PMID:22206623 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:1602659 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of FLYWCH2 protein PMID:35688186 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of FLYWCH2 mRNA PMID:21570461 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20220203 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of FLYWCH2 mRNA PMID:34747641 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D013749 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FLYWCH2 promoter] PMID:19654925 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:C000228 aristolochic acid I results in increased expression of FLYWCH2 mRNA PMID:33212167 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1602659 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of FLYWCH2 mRNA PMID:38568856 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of FLYWCH2 mRNA PMID:22228805 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of FLYWCH2 mRNA PMID:22228805 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of FLYWCH2 5' UTR PMID:27901495 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of FLYWCH2 mRNA PMID:18648102 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:C006253 pirinixic acid results in decreased expression of FLYWCH2 mRNA PMID:23811191 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FLYWCH2 mRNA PMID:19710929 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20220203 CTD MESH:C006780 bisphenol A affects the expression of FLYWCH2 mRNA PMID:30816183|PMID:34947998 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1332127 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of FLYWCH2 mRNA PMID:38685157 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1332127 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of FLYWCH2 mRNA PMID:37019170 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:34905 paraquat multiple interactions ISO RGD:1332127 E RGD:6480464 20230905 CTD MESH:D010269 [Maneb co-treated with Paraquat] results in decreased expression of FLYWCH2 mRNA PMID:36117858 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:35455 1-naphthyl isothiocyanate increases expression EXP E RGD:6480464 20220203 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of FLYWCH2 mRNA PMID:30723492 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1602659 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of FLYWCH2 mRNA PMID:38568856 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:41774 tamoxifen affects expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D013629 Tamoxifen affects the expression of FLYWCH2 mRNA PMID:17555576 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D004997 Ethinyl Estradiol affects the expression of FLYWCH2 mRNA PMID:17555576 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:5014 fenvalerate increases expression EXP E RGD:6480464 20220203 CTD MESH:C017690 fenvalerate results in increased expression of FLYWCH2 mRNA PMID:30307764 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of FLYWCH2 mRNA PMID:25554681 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:52497 maneb multiple interactions ISO RGD:1332127 E RGD:6480464 20230905 CTD MESH:D008344 [Maneb co-treated with Paraquat] results in decreased expression of FLYWCH2 mRNA PMID:36117858 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1602659 E RGD:6480464 20220215 CTD MESH:D011192 Potassium Dichromate results in increased expression of FLYWCH2 protein PMID:23718831 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1332127 E RGD:6480464 20220215 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FLYWCH2 mRNA PMID:22206623 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP E RGD:6480464 20220308 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in increased expression of FLYWCH2 mRNA PMID:32109520 11436072 Flywch2 FLYWCH family member 2 gene CHEBI:9495 thiram decreases expression ISO RGD:1602659 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of FLYWCH2 mRNA PMID:38568856 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:136608 Theaflavin 3,3'-digallate affects expression ISO RGD:1602147 E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate affects the expression of SPACDR mRNA PMID:34925699 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:1602147 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in decreased expression of SPACDR mRNA PMID:31614463 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:174733 Licochalcone B increases expression ISO RGD:1602147 E RGD:6480464 20210706 CTD MESH:C541528 licochalcone B results in increased expression of SPACDR mRNA PMID:33647349 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:17833 gentamycin decreases expression EXP E RGD:6480464 20221004 CTD MESH:D005839 Gentamicins results in decreased expression of SPACDR mRNA PMID:33387578 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1602147 E RGD:6480464 20161018 CTD MESH:D001151 Arsenic affects the methylation of SPACDR gene PMID:25304211 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20221004 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of SPACDR mRNA PMID:33387578 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1602147 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of SPACDR mRNA PMID:33212167 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:28694 copper atom multiple interactions ISO RGD:1602147 E RGD:6480464 20161018 CTD MESH:D003300 [Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA PMID:24690739 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1602147 E RGD:6480464 20161018 CTD MESH:D003300 [Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA PMID:24690739 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:150340542 E RGD:6480464 20230808 CTD MESH:D004390 Chlorpyrifos results in increased expression of SPACDR mRNA PMID:37019170 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:34837 methidathion increases expression ISO RGD:150340542 E RGD:6480464 20230808 CTD MESH:C005828 methidathion results in increased expression of SPACDR mRNA PMID:34813904 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20221004 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SPACDR mRNA PMID:33453195 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1602147 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of SPACDR mRNA PMID:24449571 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:39867 valproic acid increases methylation ISO RGD:1602147 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of SPACDR gene PMID:29154799 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20221004 CTD MESH:D000082 Acetaminophen results in increased expression of SPACDR mRNA PMID:33387578 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:4659 disulfiram multiple interactions ISO RGD:1602147 E RGD:6480464 20161018 CTD MESH:D004221 [Disulfiram binds to Copper] which results in decreased expression of SPACDR mRNA PMID:24690739 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:47217 arsane affects methylation ISO RGD:1602147 E RGD:6480464 20161018 CTD MESH:D001151 Arsenic affects the methylation of SPACDR gene PMID:25304211 11442159 Spacdr sperm acrosome developmental regulator gene CHEBI:53620 methylisothiazolinone increases expression ISO RGD:1602147 E RGD:6480464 20200714 CTD MESH:C011506 2-methyl-4-isothiazolin-3-one results in increased expression of SPACDR mRNA PMID:31629900 11445134 Smim34 small integral membrane protein 34 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:13208721 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of SMIM34 mRNA PMID:30851411 11445134 Smim34 small integral membrane protein 34 gene CHEBI:34911 permethrin increases expression ISO RGD:13208721 E RGD:6480464 20230606 CTD MESH:D026023 Permethrin results in increased expression of SMIM34 mRNA PMID:37047231 11445134 Smim34 small integral membrane protein 34 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:13208721 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of SMIM34 mRNA PMID:30851411 11447466 Zfp712 zinc finger protein 712 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D014212 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein PMID:15894607 11447466 Zfp712 zinc finger protein 712 gene CHEBI:15443 inulin multiple interactions ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP712 mRNA PMID:36331819 11447466 Zfp712 zinc finger protein 712 gene CHEBI:15930 atrazine decreases expression ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D001280 Atrazine results in decreased expression of ZNF28 mRNA PMID:22378314 11447466 Zfp712 zinc finger protein 712 gene CHEBI:16236 ethanol increases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D000431 Ethanol results in increased expression of ZFP712 mRNA PMID:30319688 11447466 Zfp712 zinc finger protein 712 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1352869 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ZNF28 mRNA PMID:37042841 11447466 Zfp712 zinc finger protein 712 gene CHEBI:25812 ozone multiple interactions ISO RGD:1352869 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF28 mRNA PMID:35430440 11447466 Zfp712 zinc finger protein 712 gene CHEBI:27470 folic acid decreases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D005492 Folic Acid results in decreased expression of ZFP712 mRNA PMID:25629700 11447466 Zfp712 zinc finger protein 712 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D004317 Doxorubicin results in decreased expression of ZNF28 mRNA PMID:29803840 11447466 Zfp712 zinc finger protein 712 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1352869 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of ZNF28 mRNA PMID:38568856 11447466 Zfp712 zinc finger protein 712 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ZNF28 intron PMID:30157460 11447466 Zfp712 zinc finger protein 712 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ZNF28 promoter PMID:27901495 11447466 Zfp712 zinc finger protein 712 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ZFP712 promoter PMID:27901495 11447466 Zfp712 zinc finger protein 712 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ZNF28 protein PMID:15894607 11447466 Zfp712 zinc finger protein 712 gene CHEBI:30621 diarsenic trioxide multiple interactions ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C006632 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein PMID:15894607 11447466 Zfp712 zinc finger protein 712 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1622203 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ZFP712 gene PMID:35295148 11447466 Zfp712 zinc finger protein 712 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:C543008 bisphenol S results in decreased expression of ZFP712 mRNA PMID:30951980 11447466 Zfp712 zinc finger protein 712 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C543008 bisphenol S results in increased methylation of ZNF28 gene PMID:31601247 11447466 Zfp712 zinc finger protein 712 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ZFP712 mRNA PMID:37019170 11447466 Zfp712 zinc finger protein 712 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1352869 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ZNF28 mRNA PMID:37042841 11447466 Zfp712 zinc finger protein 712 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1352869 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ZNF28 mRNA PMID:38382870 11447466 Zfp712 zinc finger protein 712 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFP712 mRNA PMID:36331819 11447466 Zfp712 zinc finger protein 712 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:D014635 Valproic Acid results in increased methylation of ZNF28 gene PMID:29154799 11447466 Zfp712 zinc finger protein 712 gene CHEBI:47807 sulforaphane increases expression ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C016766 sulforaphane results in increased expression of ZNF28 mRNA PMID:31838189 11447466 Zfp712 zinc finger protein 712 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ZNF28 protein PMID:15894607 11447466 Zfp712 zinc finger protein 712 gene CHEBI:49900 arsenous acid multiple interactions ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C032793 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ZNF28 protein PMID:15894607 11447466 Zfp712 zinc finger protein 712 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ZFP712 mRNA PMID:25554681 11447466 Zfp712 zinc finger protein 712 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1622203 E RGD:6480464 20230808 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ZFP712 mRNA PMID:22206623 11447466 Zfp712 zinc finger protein 712 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1352869 E RGD:6480464 20230808 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ZNF28 gene] PMID:28238834 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1346508 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in increased expression of DMRTC1 mRNA PMID:23724009 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:15930 atrazine increases expression ISO RGD:1346508 E RGD:6480464 20170210 CTD MESH:D001280 Atrazine results in increased expression of DMRTC1 mRNA PMID:22378314 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1346508 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of DMRTC1 gene PMID:27153756 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1619135 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of DMRTC1A mRNA PMID:28960355 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1346508 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of DMRTC1 mRNA PMID:23557933 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1346508 E RGD:6480464 20170210 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of DMRTC1 mRNA PMID:25895662 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:32161 sulfadimethoxine decreases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in decreased expression of DMRTC1A mRNA PMID:30047161 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of DMRTC1A mRNA PMID:30816183|PMID:32528016|PMID:34947998 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:33216 bisphenol A increases expression ISO RGD:1619135 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of DMRTC1A mRNA PMID:32156529 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:39867 valproic acid increases methylation ISO RGD:1346508 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of DMRTC1 gene PMID:29154799 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:40036 amitrole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in decreased expression of DMRTC1A mRNA PMID:30047161 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:46790 2-methoxyethanol increases expression EXP E RGD:6480464 20170210 CTD MESH:C005219 methyl cellosolve results in increased expression of DMRTC1A mRNA PMID:21061450 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:50673 methimazole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in decreased expression of DMRTC1A mRNA PMID:30047161 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:6121 ketamine increases expression EXP E RGD:6480464 20170210 CTD MESH:D007649 Ketamine results in increased expression of DMRTC1A mRNA PMID:20080153 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20230606 CTD MESH:D010634 Phenobarbital results in decreased expression of DMRTC1A mRNA PMID:30047161 11451771 Dmrtc1a DMRT-like family C1a gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in decreased expression of DMRTC1A mRNA PMID:30047161 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1601807 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of IGSF22 mRNA PMID:35811015 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1601807 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGSF22 mRNA PMID:35811015 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:17153 propanal decreases expression ISO RGD:1601807 E RGD:6480464 20160906 CTD MESH:C005556 propionaldehyde results in decreased expression of IGSF22 mRNA PMID:26079696 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1601807 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of IGSF22 mRNA PMID:31163220 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:27889 lead(0) affects expression ISO RGD:1601807 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of IGSF22 mRNA PMID:28903495 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1601807 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of IGSF22 promoter PMID:27901495 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1601807 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of IGSF22 5' UTR PMID:27901495 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1601807 E RGD:6480464 20160906 CTD MESH:D000082 Acetaminophen results in decreased expression of IGSF22 mRNA PMID:22230336 11452860 Igsf22 immunoglobulin superfamily member 22 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1601807 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGSF22 mRNA PMID:35811015 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:132267 triptonide decreases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C084079 triptonide results in decreased expression of ALG13 mRNA PMID:33045310 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:15368 acrolein multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA PMID:32699268|PMID:32845096 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:15379 dioxygen multiple interactions ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG13 mRNA PMID:30529165 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:15930 atrazine increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D001280 Atrazine results in increased expression of ALG13 mRNA PMID:22378314 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D006861 Hydrogen Peroxide affects the expression of ALG13 mRNA PMID:20044591 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:16243 quercetin increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D011794 Quercetin results in increased expression of ALG13 mRNA PMID:21632981 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA PMID:25510870 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1550222 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of ALG13 mRNA PMID:33754040 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:177802 Cuprizon decreases expression EXP E RGD:6480464 20230808 CTD MESH:D003471 Cuprizone results in decreased expression of ALG13 mRNA PMID:26577399 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:177802 Cuprizon increases expression EXP E RGD:6480464 20230808 CTD MESH:D003471 Cuprizone results in increased expression of ALG13 mRNA PMID:27523638 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:17823 calcitriol decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D002117 Calcitriol results in decreased expression of ALG13 mRNA PMID:16002434 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:25812 ozone multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA; [Volatile Organic Compounds co-treated with Ozone] affects the expression of ALG13 mRNA PMID:32699268|PMID:32845096 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C024565 ethylene dichloride results in decreased expression of ALG13 mRNA PMID:28189721|PMID:28960355 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ALG13 mRNA PMID:22574217 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20230808 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ALG13 mRNA PMID:21215274|PMID:32109520 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20230808 CTD MESH:D013749 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALG13 mRNA] PMID:21215274 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C000228 aristolochic acid I results in decreased expression of ALG13 mRNA PMID:33212167 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:28694 copper atom multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of ALG13 mRNA PMID:20971185 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D004317 Doxorubicin results in decreased expression of ALG13 mRNA PMID:29803840 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C017947 sodium arsenite results in decreased expression of ALG13 mRNA PMID:28595984|PMID:34032870 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C017947 sodium arsenite results in decreased expression of ALG13 mRNA PMID:36209798 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ALG13 intron PMID:30157460 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ALG13 promoter PMID:27901495 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:29866 arsenite(3-) affects expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C015001 arsenite affects the expression of ALG13 mRNA PMID:22959463 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of ALG13 mRNA PMID:20971185 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ALG13 mRNA PMID:15761015 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1550222 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of ALG13 gene; titanium dioxide results in increased methylation of ALG13 promoter PMID:35295148 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:1351399 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ALG13 mRNA PMID:38479592 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230808 CTD MESH:C006780 bisphenol A results in decreased expression of ALG13 mRNA PMID:25181051 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C006780 bisphenol A results in decreased expression of ALG13 protein PMID:33376534 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C006780 bisphenol A results in decreased methylation of ALG13 gene PMID:31601247 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230808 CTD MESH:C006780 bisphenol A results in increased expression of ALG13 mRNA PMID:34947998 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA PMID:25510870 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ALG13 mRNA PMID:25510870 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:34567 benzo[e]pyrene decreases methylation ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C026487 benzo(e)pyrene results in decreased methylation of ALG13 intron PMID:30157460 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20230808 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ALG13 mRNA PMID:21266533 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C018021 cobaltous chloride results in decreased expression of ALG13 mRNA PMID:19376846 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of ALG13 mRNA PMID:24449571 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of ALG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of ALG13 mRNA PMID:32699268 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:39867 valproic acid affects expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D014635 Valproic Acid affects the expression of ALG13 mRNA PMID:23179753|PMID:25192806|PMID:26272509 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:39867 valproic acid decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D014635 Valproic Acid results in decreased expression of ALG13 mRNA PMID:24935251|PMID:25716160|PMID:28001369 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:39867 valproic acid increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D014635 Valproic Acid results in increased expression of ALG13 mRNA PMID:24383497|PMID:24935251|PMID:28001369 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA PMID:27188386 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:46790 2-methoxyethanol increases expression EXP E RGD:6480464 20230808 CTD MESH:C005219 methyl cellosolve results in increased expression of ALG13 mRNA PMID:21061450 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:49900 arsenous acid increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ALG13 mRNA PMID:15761015 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of ALG13 mRNA PMID:25554681 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20230808 CTD MESH:D005485 Flutamide results in increased expression of ALG13 mRNA PMID:24136188 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:C015559 trimellitic anhydride results in increased expression of ALG13 mRNA PMID:19042947 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:6067 isotretinoin decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D015474 Isotretinoin results in decreased expression of ALG13 mRNA PMID:20436886 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:63630 tolcapone decreases expression EXP E RGD:6480464 20230808 CTD MESH:C066340 Tolcapone results in decreased expression of ALG13 mRNA PMID:24136188 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:6820 methapyrilene decreases methylation ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D008701 Methapyrilene results in decreased methylation of ALG13 intron PMID:30157460 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1550222 E RGD:6480464 20230808 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ALG13 mRNA PMID:22206623 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:7719 ochratoxin A decreases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C025589 ochratoxin A results in decreased expression of ALG13 mRNA PMID:19287073 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C516138 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA PMID:27188386 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:C459179 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ALG13 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALG13 mRNA PMID:27188386 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:9495 thiram increases expression ISO RGD:1351399 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of ALG13 mRNA PMID:38568856 11453602 Alg13 ALG13, UDP-N-acetylglucosaminyltransferase subunit gene CHEBI:9546 thimerosal increases expression ISO RGD:1351399 E RGD:6480464 20230808 CTD MESH:D013849 Thimerosal results in increased expression of ALG13 mRNA PMID:27188386 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of APOL7A mRNA] PMID:19467301 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D004958 Estradiol results in increased expression of APOL7A mRNA PMID:30077407 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D004958 [Polyphenols co-treated with Estradiol] results in increased expression of APOL7A mRNA PMID:30077407 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D004051 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of APOL7A mRNA PMID:28433925 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of APOL7A mRNA PMID:19770486 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:25812 ozone multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of APOL7A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of APOL7A mRNA PMID:34911549 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of APOL7A mRNA PMID:27339419|PMID:31919559 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:28088 genistein increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D019833 Genistein results in increased expression of APOL7A mRNA PMID:32186404 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of APOL7A mRNA PMID:28922406 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of APOL7A mRNA PMID:28433925 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C017947 sodium arsenite results in decreased expression of APOL7A mRNA PMID:37682722 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:29678 sodium arsenite multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA PMID:34876320 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:29852 methylarsonic acid multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA PMID:34876320 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of APOL7A mRNA PMID:23735875 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C009495 titanium dioxide results in increased expression of APOL7A mRNA PMID:23557971 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C006253 pirinixic acid results in decreased expression of APOL7A mRNA PMID:23811191 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C006780 bisphenol A results in increased expression of APOL7A mRNA PMID:32156529 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C006780 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of APOL7A mRNA PMID:28433925 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C014024 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of APOL7A mRNA PMID:28433925 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:34837 methidathion decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C005828 methidathion results in decreased expression of APOL7A mRNA PMID:34813904 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of APOL7A mRNA PMID:27413110|PMID:28903501 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:3750 clofibrate decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D002994 Clofibrate results in decreased expression of APOL7A mRNA PMID:23811191 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:38922 dibenzofurans increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D000072318 Dibenzofurans results in increased expression of APOL7A mRNA PMID:34254344 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:39483 sodium dichromate decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C016104 sodium bichromate results in decreased expression of APOL7A mRNA PMID:22155349 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:41774 tamoxifen decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D013629 Tamoxifen results in decreased expression of APOL7A mRNA PMID:25123088 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:46195 paracetamol affects expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D000082 Acetaminophen affects the expression of APOL7A mRNA PMID:17562736 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:47807 sulforaphane increases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C016766 sulforaphane results in increased expression of APOL7A mRNA PMID:30529165 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C109476 epoxiconazole results in decreased expression of APOL7A mRNA PMID:35436446 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:48765 dimethylarsinic acid multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA PMID:34876320 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:50594 carbon nanotube affects expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D037742 Nanotubes, Carbon affects the expression of APOL7A mRNA PMID:25554681 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of APOL7A mRNA; Nanotubes, Carbon results in decreased expression of APOL7A mRNA PMID:25620056 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:73755 1,2-dimethylhydrazine affects expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:D019813 1,2-Dimethylhydrazine affects the expression of APOL7A mRNA PMID:22206623 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1621467 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of APOL7A mRNA PMID:38648751 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of APOL7A mRNA PMID:34876320 11460844 Apol7al1 apolipoprotein L7a like 1 gene CHEBI:8489 propiconazole decreases expression ISO RGD:1621467 E RGD:6480464 20240423 CTD MESH:C045950 propiconazole results in decreased expression of APOL7A mRNA PMID:21278054 11466397 Cyp2c6-ps2 cytochrome P450, family 2, subfamily C, polypeptide 6, pseudogene 2 gene CHEBI:35036 fentin chloride increases expression EXP E RGD:6480464 20231205 CTD MESH:C012594 triphenyltin chloride results in increased expression of CYP2C6-PS2 mRNA PMID:37156404 11468112 Hoxa2 homeobox A2 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1353431 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of HOXA2 mRNA PMID:38218311 11468112 Hoxa2 homeobox A2 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in increased expression of HOXA2 mRNA PMID:17185360|PMID:21934132 11468112 Hoxa2 homeobox A2 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:731539 E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA2 mRNA PMID:36189433 11468112 Hoxa2 homeobox A2 gene CHEBI:164200 triclosan increases expression ISO RGD:1353431 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in increased expression of HOXA2 mRNA PMID:30510588 11468112 Hoxa2 homeobox A2 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of HOXA2 mRNA PMID:33387578 11468112 Hoxa2 homeobox A2 gene CHEBI:17234 glucose increases expression EXP E RGD:6480464 20170210 CTD MESH:D005947 Glucose results in increased expression of HOXA2 mRNA PMID:21818840 11468112 Hoxa2 homeobox A2 gene CHEBI:17234 glucose multiple interactions ISO RGD:731539 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA PMID:37567420 11468112 Hoxa2 homeobox A2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1353431 E RGD:6480464 20230905 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of HOXA2 mRNA PMID:36695872 11468112 Hoxa2 homeobox A2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:731539 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of HOXA2 mRNA PMID:36189433 11468112 Hoxa2 homeobox A2 gene CHEBI:17634 D-glucose increases expression EXP E RGD:6480464 20170210 CTD MESH:D005947 Glucose results in increased expression of HOXA2 mRNA PMID:21818840 11468112 Hoxa2 homeobox A2 gene CHEBI:17634 D-glucose multiple interactions ISO RGD:731539 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA PMID:37567420 11468112 Hoxa2 homeobox A2 gene CHEBI:17650 cortisol multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:D006854 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1353431 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of HOXA2 mRNA PMID:31163220 11468112 Hoxa2 homeobox A2 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of HOXA2 mRNA PMID:33387578 11468112 Hoxa2 homeobox A2 gene CHEBI:188938 Allylamine affects expression EXP E RGD:6480464 20220208 CTD MESH:D000499 Allylamine affects the expression of HOXA2 mRNA PMID:15910882 11468112 Hoxa2 homeobox A2 gene CHEBI:24527 herbicide multiple interactions ISO RGD:731539 E RGD:6480464 20231031 CTD MESH:D006540 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA PMID:37567420 11468112 Hoxa2 homeobox A2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of HOXA2 gene PMID:27153756 11468112 Hoxa2 homeobox A2 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D009151 Mustard Gas results in decreased expression of HOXA2 mRNA PMID:15674843 11468112 Hoxa2 homeobox A2 gene CHEBI:27086 tributylstannane multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in decreased expression of HOXA2 mRNA PMID:31129395 11468112 Hoxa2 homeobox A2 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1353431 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in decreased expression of HOXA2 mRNA PMID:27392435 11468112 Hoxa2 homeobox A2 gene CHEBI:27928 parathion increases methylation ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D010278 Parathion results in increased methylation of HOXA2 promoter PMID:22847954 11468112 Hoxa2 homeobox A2 gene CHEBI:28088 genistein increases expression ISO RGD:731539 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in increased expression of HOXA2 mRNA PMID:32186404 11468112 Hoxa2 homeobox A2 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D009532 Nickel results in decreased expression of HOXA2 mRNA PMID:24768652|PMID:25583101 11468112 Hoxa2 homeobox A2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of HOXA2 mRNA PMID:21570461 11468112 Hoxa2 homeobox A2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of HOXA2 mRNA PMID:19897914 11468112 Hoxa2 homeobox A2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of HOXA2 mRNA PMID:19933214|PMID:24058054 11468112 Hoxa2 homeobox A2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXA2 mRNA PMID:17942748 11468112 Hoxa2 homeobox A2 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of HOXA2 mRNA PMID:28959563 11468112 Hoxa2 homeobox A2 gene CHEBI:28680 cytarabine increases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D003561 Cytarabine results in increased expression of HOXA2 mRNA PMID:21198554 11468112 Hoxa2 homeobox A2 gene CHEBI:28757 fructose multiple interactions ISO RGD:731539 E RGD:6480464 20231031 CTD MESH:D005632 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA PMID:37567420 11468112 Hoxa2 homeobox A2 gene CHEBI:29073 L-ascorbic acid multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:D001205 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:29073 L-ascorbic acid multiple interactions ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D001205 Ascorbic Acid inhibits the reaction [Valproic Acid results in decreased expression of HOXA2 mRNA] PMID:19655241 11468112 Hoxa2 homeobox A2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1353431 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of HOXA2 mRNA PMID:38568856 11468112 Hoxa2 homeobox A2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:731539 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of HOXA2 mRNA PMID:37682722 11468112 Hoxa2 homeobox A2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1353431 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of HOXA2 exon PMID:27901495 11468112 Hoxa2 homeobox A2 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of HOXA2 mRNA PMID:25895662 11468112 Hoxa2 homeobox A2 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1353431 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of HOXA2 mRNA PMID:26705709 11468112 Hoxa2 homeobox A2 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20170210 CTD MESH:D000643 Ammonium Chloride affects the expression of HOXA2 mRNA PMID:16483693 11468112 Hoxa2 homeobox A2 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:C009495 titanium dioxide results in decreased expression of HOXA2 mRNA PMID:29264374 11468112 Hoxa2 homeobox A2 gene CHEBI:33216 bisphenol A affects methylation ISO RGD:731539 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A affects the methylation of HOXA2 promoter PMID:27334623 11468112 Hoxa2 homeobox A2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of HOXA2 mRNA PMID:25181051 11468112 Hoxa2 homeobox A2 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1353431 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of HOXA2 gene PMID:31601247 11468112 Hoxa2 homeobox A2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in increased expression of HOXA2 mRNA PMID:22687993|PMID:30951980 11468112 Hoxa2 homeobox A2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with tributyltin] results in decreased expression of HOXA2 mRNA PMID:31129395 11468112 Hoxa2 homeobox A2 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:1353431 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in increased methylation of HOXA2 gene PMID:31601247 11468112 Hoxa2 homeobox A2 gene CHEBI:34696 dieldrin affects methylation ISO RGD:731539 E RGD:6480464 20241105 CTD MESH:D004026 Dieldrin affects the methylation of HOXA2 gene PMID:38995845 11468112 Hoxa2 homeobox A2 gene CHEBI:35559 furan decreases methylation EXP E RGD:6480464 20170516 CTD MESH:C039281 furan results in decreased methylation of HOXA2 gene PMID:27387713 11468112 Hoxa2 homeobox A2 gene CHEBI:35559 furan increases expression EXP E RGD:6480464 20170516 CTD MESH:C039281 furan results in increased expression of HOXA2 mRNA PMID:27387713 11468112 Hoxa2 homeobox A2 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of HOXA2 mRNA PMID:22698814 11468112 Hoxa2 homeobox A2 gene CHEBI:38689 fonofos increases methylation ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:D004397 Fonofos results in increased methylation of HOXA2 promoter PMID:22847954 11468112 Hoxa2 homeobox A2 gene CHEBI:38960 terbufos increases methylation ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:C012568 terbufos results in increased methylation of HOXA2 promoter PMID:22847954 11468112 Hoxa2 homeobox A2 gene CHEBI:39421 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1353431 E RGD:6480464 20190910 CTD MESH:C076994 perfluorooctane sulfonic acid affects the expression of HOXA2 mRNA PMID:30738844 11468112 Hoxa2 homeobox A2 gene CHEBI:39481 chloroprene decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D002737 Chloroprene results in decreased expression of HOXA2 mRNA PMID:23125180 11468112 Hoxa2 homeobox A2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid results in decreased expression of HOXA2 mRNA; Valproic Acid results in decreased expression of HOXA2 protein PMID:19655241 11468112 Hoxa2 homeobox A2 gene CHEBI:39867 valproic acid increases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid results in increased expression of HOXA2 mRNA PMID:24896083 11468112 Hoxa2 homeobox A2 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D014635 Ascorbic Acid inhibits the reaction [Valproic Acid results in decreased expression of HOXA2 mRNA] PMID:19655241 11468112 Hoxa2 homeobox A2 gene CHEBI:42758 aldehydo-D-glucose increases expression EXP E RGD:6480464 20170210 CTD MESH:D005947 Glucose results in increased expression of HOXA2 mRNA PMID:21818840 11468112 Hoxa2 homeobox A2 gene CHEBI:42758 aldehydo-D-glucose multiple interactions ISO RGD:731539 E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HOXA2 mRNA PMID:37567420 11468112 Hoxa2 homeobox A2 gene CHEBI:48765 dimethylarsinic acid decreases expression EXP E RGD:6480464 20170210 CTD MESH:D002101 Cacodylic Acid results in decreased expression of HOXA2 mRNA PMID:16122865 11468112 Hoxa2 homeobox A2 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of HOXA2 mRNA PMID:17942748 11468112 Hoxa2 homeobox A2 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXA2 mRNA PMID:17942748 11468112 Hoxa2 homeobox A2 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1353431 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of HOXA2 mRNA PMID:26705709 11468112 Hoxa2 homeobox A2 gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:C029938 nickel sulfate results in increased expression of HOXA2 mRNA PMID:22714537 11468112 Hoxa2 homeobox A2 gene CHEBI:62878 XAV939 multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:C544261 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:72544 flavonoids increases expression EXP E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in increased expression of HOXA2 mRNA PMID:18035473 11468112 Hoxa2 homeobox A2 gene CHEBI:75261 arotinoid acid multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:C038864 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1353431 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to HOXA2 gene] PMID:28238834 11468112 Hoxa2 homeobox A2 gene CHEBI:8107 phenytoin decreases expression ISO RGD:731539 E RGD:6480464 20170210 CTD MESH:D010672 Phenytoin results in decreased expression of HOXA2 mRNA; Phenytoin results in decreased expression of HOXA2 protein PMID:10789828 11468112 Hoxa2 homeobox A2 gene CHEBI:91091 CHIR 99021 multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:C473711 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of HOXA2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1353431 E RGD:6480464 20220208 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of HOXA2 mRNA PMID:34480604 11468112 Hoxa2 homeobox A2 gene CHEBI:9495 thiram decreases expression ISO RGD:1353431 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of HOXA2 mRNA PMID:38568856 11468112 Hoxa2 homeobox A2 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1353431 E RGD:6480464 20170210 CTD MESH:C057693 troglitazone results in decreased expression of HOXA2 mRNA PMID:19140230 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:132267 triptonide increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:C084079 triptonide results in increased expression of SPRR2A2 mRNA PMID:33045310 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of SPRR2A2 mRNA PMID:33484791 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D004051 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of SPRR2A2 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA] PMID:33484791 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:25812 ozone increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D010126 Ozone results in increased expression of SPRR2A2 mRNA PMID:31626304|PMID:33026818 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:25812 ozone multiple interactions ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SPRR2A2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPRR2A2 mRNA PMID:34911549 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:27563 arsenic atom multiple interactions ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA PMID:32525701 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:C024565 ethylene dichloride results in increased expression of SPRR2A2 mRNA PMID:28960355 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of SPRR2E mRNA PMID:23152189 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1354484 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of SPRR2E mRNA PMID:38568856 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of SPRR2A2 mRNA PMID:23735875 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of SPRR2E 3' UTR; Benzo(a)pyrene results in increased methylation of SPRR2E promoter PMID:27901495 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:C009495 titanium dioxide results in decreased expression of SPRR2A2 mRNA PMID:29264374 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:C006253 pirinixic acid results in decreased expression of SPRR2A2 mRNA PMID:12727805 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SPRR2E mRNA PMID:26472689 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D014635 Valproic Acid results in decreased methylation of SPRR2E gene PMID:29154799 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:47217 arsane multiple interactions ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA PMID:32525701 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of SPRR2A2 mRNA; Nanotubes, Carbon results in increased expression of SPRR2A2 mRNA PMID:25554681 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:64213 cantharidin increases expression ISO RGD:2313363 E RGD:6480464 20230704 CTD MESH:D002193 Cantharidin results in increased expression of SPRR2A2 mRNA PMID:36907384 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:77013 beta-naphthoflavone increases expression ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of SPRR2E mRNA PMID:32151702 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:7823 oxazepam decreases expression ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D010076 Oxazepam results in decreased expression of SPRR2A2 mRNA PMID:12727805 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to SPRR2E gene] PMID:28238834 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:1354484 E RGD:6480464 20230321 CTD MESH:C009277 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SPRR2E mRNA PMID:32525701 11469006 Sprr2a2 small proline-rich protein 2A2 gene CHEBI:9288 streptozocin multiple interactions ISO RGD:2313363 E RGD:6480464 20221213 CTD MESH:D013311 [Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of SPRR2A2 mRNA; [Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SPRR2A2 mRNA] PMID:33484791 11469551 Fam180b family with sequence similarity 180 member B gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:2298817 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of FAM180B mRNA PMID:33212167 11469551 Fam180b family with sequence similarity 180 member B gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:2298817 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of FAM180B promoter PMID:27901495 11469551 Fam180b family with sequence similarity 180 member B gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:2298817 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of FAM180B mRNA PMID:38382870 11469551 Fam180b family with sequence similarity 180 member B gene CHEBI:39867 valproic acid increases methylation ISO RGD:2298817 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of FAM180B gene PMID:29154799 11470817 Krtap9-1-ps1 keratin associated protein 9-1, pseudogene 1 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:1343161 E RGD:6480464 20170530 CTD MESH:D002392 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of KRTAP9-9 mRNA PMID:24763279 11470817 Krtap9-1-ps1 keratin associated protein 9-1, pseudogene 1 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1343161 E RGD:6480464 20170530 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of KRTAP9-9 gene PMID:27153756 11470817 Krtap9-1-ps1 keratin associated protein 9-1, pseudogene 1 gene CHEBI:27363 zinc atom decreases expression ISO RGD:1343161 E RGD:6480464 20170530 CTD MESH:D015032 Zinc deficiency results in decreased expression of KRTAP9-9 mRNA PMID:18356318 11470817 Krtap9-1-ps1 keratin associated protein 9-1, pseudogene 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1343161 E RGD:6480464 20170530 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of KRTAP9-9 mRNA PMID:22316170 11470817 Krtap9-1-ps1 keratin associated protein 9-1, pseudogene 1 gene CHEBI:30185 zinc(0) decreases expression ISO RGD:1343161 E RGD:6480464 20170530 CTD MESH:D015032 Zinc deficiency results in decreased expression of KRTAP9-9 mRNA PMID:18356318 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:1350112 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in increased expression of HHLA2 mRNA PMID:35811015 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1350112 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HHLA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HHLA2 mRNA PMID:35811015 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1350112 E RGD:6480464 20160906 CTD MESH:D004958 Estradiol results in increased expression of HHLA2 mRNA PMID:23019147 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:23994 ethyl methanesulfonate decreases expression ISO RGD:1350112 E RGD:6480464 20160906 CTD MESH:D005020 Ethyl Methanesulfonate results in decreased expression of HHLA2 mRNA PMID:23649840 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1350112 E RGD:6480464 20160906 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of HHLA2 mRNA PMID:23649840 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1350112 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of HHLA2 promoter PMID:27901495 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1350112 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of HHLA2 5' UTR PMID:27901495 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1350112 E RGD:6480464 20200519 CTD MESH:C006780 bisphenol A results in decreased expression of HHLA2 mRNA PMID:31715268 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1350112 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of HHLA2 gene PMID:29154799 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:46195 paracetamol increases expression ISO RGD:1350112 E RGD:6480464 20180313 CTD MESH:D000082 Acetaminophen results in increased expression of HHLA2 mRNA PMID:26690555 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:46557 zoledronic acid increases expression ISO RGD:1350112 E RGD:6480464 20161213 CTD MESH:C088658 zoledronic acid results in increased expression of HHLA2 mRNA PMID:24714768 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1350112 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HHLA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HHLA2 mRNA PMID:35811015 11472061 Hhla2 HHLA2 member of B7 family gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1350112 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to HHLA2 gene] PMID:28238834 11479453 Mtcl3 MTCL family member 3 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:D014212 Tretinoin results in decreased expression of MTCL3 mRNA PMID:21934132 11479453 Mtcl3 MTCL family member 3 gene CHEBI:16236 ethanol affects expression ISO RGD:1316772 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of MTCL3 mRNA PMID:30319688 11479453 Mtcl3 MTCL family member 3 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1347447 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in increased expression of MTCL3 mRNA PMID:30165855 11479453 Mtcl3 MTCL family member 3 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1347447 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of MTCL3 gene PMID:27153756 11479453 Mtcl3 MTCL family member 3 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1316772 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of MTCL3 mRNA PMID:28960355 11479453 Mtcl3 MTCL family member 3 gene CHEBI:27899 cisplatin decreases expression ISO RGD:1347447 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in decreased expression of MTCL3 mRNA PMID:27392435 11479453 Mtcl3 MTCL family member 3 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1347447 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in decreased expression of MTCL3 mRNA PMID:27392435 11479453 Mtcl3 MTCL family member 3 gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:C004925 methylmercuric chloride results in increased expression of MTCL3 mRNA PMID:23179753 11479453 Mtcl3 MTCL family member 3 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1347447 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of MTCL3 promoter PMID:27901495 11479453 Mtcl3 MTCL family member 3 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1347447 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of MTCL3 3' UTR; Benzo(a)pyrene results in increased methylation of MTCL3 5' UTR PMID:27901495 11479453 Mtcl3 MTCL family member 3 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:C015001 arsenite results in increased methylation of MTCL3 promoter PMID:23974009 11479453 Mtcl3 MTCL family member 3 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1347447 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of MTCL3 mRNA PMID:26705709 11479453 Mtcl3 MTCL family member 3 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1316772 E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of MTCL3 mRNA PMID:29264374 11479453 Mtcl3 MTCL family member 3 gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:1316772 E RGD:6480464 20170725 CTD MESH:C007738 [1-methylanthracene co-treated with fluoranthene] results in increased expression of MTCL3 mRNA PMID:28329830 11479453 Mtcl3 MTCL family member 3 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1316772 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of MTCL3 mRNA PMID:32156529 11479453 Mtcl3 MTCL family member 3 gene CHEBI:34342 3-methylcholanthrene multiple interactions ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:D008748 Methylcholanthrene promotes the reaction [AHR protein binds to MTCL3 promoter] PMID:20348232 11479453 Mtcl3 MTCL family member 3 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression ISO RGD:1316772 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in decreased expression of MTCL3 mRNA PMID:30951980 11479453 Mtcl3 MTCL family member 3 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1316772 E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in decreased expression of MTCL3 mRNA PMID:30951980 11479453 Mtcl3 MTCL family member 3 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1347447 E RGD:6480464 20241105 CTD MESH:D019256 Cadmium Chloride results in decreased expression of MTCL3 mRNA PMID:38382870 11479453 Mtcl3 MTCL family member 3 gene CHEBI:39867 valproic acid affects expression ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:D014635 Valproic Acid affects the expression of MTCL3 mRNA PMID:25979313 11479453 Mtcl3 MTCL family member 3 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1347447 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of MTCL3 gene PMID:29154799 11479453 Mtcl3 MTCL family member 3 gene CHEBI:39867 valproic acid increases expression ISO RGD:1347447 E RGD:6480464 20161018 CTD MESH:D014635 Valproic Acid results in increased expression of MTCL3 mRNA PMID:23179753|PMID:24383497 11479453 Mtcl3 MTCL family member 3 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1347447 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA PMID:27188386 11479453 Mtcl3 MTCL family member 3 gene CHEBI:45716 vorinostat decreases expression ISO RGD:1347447 E RGD:6480464 20161213 CTD MESH:C111237 Vorinostat results in decreased expression of MTCL3 mRNA PMID:27188386 11479453 Mtcl3 MTCL family member 3 gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in increased expression of MTCL3 mRNA PMID:33387578 11479453 Mtcl3 MTCL family member 3 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1347447 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of MTCL3 mRNA PMID:26705709 11479453 Mtcl3 MTCL family member 3 gene CHEBI:6121 ketamine decreases expression EXP E RGD:6480464 20161018 CTD MESH:D007649 Ketamine results in decreased expression of MTCL3 mRNA PMID:20080153 11479453 Mtcl3 MTCL family member 3 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1347447 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA PMID:27188386 11479453 Mtcl3 MTCL family member 3 gene CHEBI:81892 Brodifacoum increases expression EXP E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in increased expression of MTCL3 protein PMID:28903499 11479453 Mtcl3 MTCL family member 3 gene CHEBI:82436 decabromodiphenyl ether increases expression EXP E RGD:6480464 20161018 CTD MESH:C010902 decabromobiphenyl ether results in increased expression of MTCL3 mRNA PMID:23640034 11479453 Mtcl3 MTCL family member 3 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1347447 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTCL3 mRNA PMID:27188386 11479453 Mtcl3 MTCL family member 3 gene CHEBI:9546 thimerosal decreases expression ISO RGD:1347447 E RGD:6480464 20161025 CTD MESH:D013849 Thimerosal results in decreased expression of MTCL3 mRNA PMID:27188386 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1343753 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of PCDHB16 mRNA PMID:25812627 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:16236 ethanol decreases expression ISO RGD:1343753 E RGD:6480464 20240604 CTD MESH:D000431 Ethanol results in decreased expression of PCDHB16 mRNA PMID:25566775 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1343753 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of PCDHB16 mRNA PMID:35811015 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1343753 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDHB16 mRNA PMID:35811015 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20220607 CTD MESH:D014241 Trichloroethylene results in decreased expression of PCDHB16L mRNA PMID:33387578 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:17153 propanal increases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C005556 propionaldehyde results in increased expression of PCDHB16 mRNA PMID:26079696 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:174733 Licochalcone B decreases expression ISO RGD:1343753 E RGD:6480464 20210706 CTD MESH:C541528 licochalcone B results in decreased expression of PCDHB16 mRNA PMID:33647349 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of PCDHB16 gene PMID:27153756 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1343753 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of PCDHB16 mRNA PMID:32763439 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:D004317 Doxorubicin results in decreased expression of PCDHB16 mRNA PMID:29803840 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1343753 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of PCDHB16 5' UTR; Benzo(a)pyrene affects the methylation of PCDHB16 exon; Benzo(a)pyrene affects the methylation of PCDHB17 promoter PMID:27901495 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C015001 arsenite results in increased methylation of PCDHB16 promoter PMID:23974009 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170321 CTD MESH:C006780 bisphenol A results in decreased expression of PCDHB16 mRNA PMID:25181051 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:1343753 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of PCDHB16 gene PMID:31601247 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1343753 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of PCDHB16 mRNA PMID:25812627 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1343753 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of PCDHB16 mRNA PMID:31533062 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:39867 valproic acid increases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:D014635 Valproic Acid results in increased expression of PCDHB16 mRNA PMID:23179753|PMID:27188386 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:D016572 Cyclosporine results in decreased expression of PCDHB16 mRNA PMID:20106945 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:45716 vorinostat decreases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C111237 Vorinostat results in decreased expression of PCDHB16 mRNA PMID:27188386 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C012589 trichostatin A results in decreased expression of PCDHB16 mRNA PMID:24935251|PMID:26272509 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:46024 trichostatin A multiple interactions ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C012589 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA PMID:27188386 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1343753 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDHB16 mRNA PMID:35811015 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C516138 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA PMID:27188386 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1343753 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to PCDHB16 gene] PMID:28238834 11492646 Pcdhb16 protocadherin beta 16 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1343753 E RGD:6480464 20190219 CTD MESH:C459179 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB16 mRNA PMID:27188386 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:1343074 E RGD:6480464 20160906 CTD MESH:D002392 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of GPR32 mRNA PMID:24763279 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:15743 butanal increases expression ISO RGD:1343074 E RGD:6480464 20160906 CTD MESH:C018475 butyraldehyde results in increased expression of GPR32 mRNA PMID:26079696 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:18305 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:1343074 E RGD:6480464 20160906 CTD MESH:D001104 Arbutin results in increased expression of GPR32 mRNA PMID:17103032 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1343074 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR32 mRNA PMID:35301059 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1343074 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of GPR32 exon PMID:27901495 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:1343074 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of GPR32 gene PMID:31601247 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1343074 E RGD:6480464 20180116 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA PMID:28628672 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:3423 carmustine decreases expression ISO RGD:1343074 E RGD:6480464 20160906 CTD MESH:D002330 Carmustine results in decreased expression of GPR32 mRNA PMID:15980968 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:1343074 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of GPR32 exon PMID:30157460 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1343074 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA PMID:28628672 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1343074 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR32 mRNA PMID:35301059 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1343074 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of GPR32 gene PMID:29154799 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1343074 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA PMID:28628672 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:43572 kojic acid increases expression ISO RGD:1343074 E RGD:6480464 20160906 CTD MESH:C011890 kojic acid results in increased expression of GPR32 mRNA PMID:16595896 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1343074 E RGD:6480464 20180313 CTD MESH:D000082 Acetaminophen results in decreased expression of GPR32 mRNA PMID:26690555 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1343074 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of GPR32 mRNA PMID:28628672 11496573 Gpr32 G protein-coupled receptor 32 gene CHEBI:6820 methapyrilene increases methylation ISO RGD:1343074 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of GPR32 exon PMID:30157460 11496771 Smim40 small integral membrane protein 40 gene CHEBI:132267 triptonide increases expression ISO RGD:1616348 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of SMIM40 mRNA PMID:33045310 11496771 Smim40 small integral membrane protein 40 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1616348 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of SMIM40 mRNA PMID:37995155 11496771 Smim40 small integral membrane protein 40 gene CHEBI:15443 inulin multiple interactions ISO RGD:1616348 E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SMIM40 mRNA PMID:36331819 11496771 Smim40 small integral membrane protein 40 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1616348 E RGD:6480464 20210202 CTD MESH:C009495 titanium dioxide results in decreased expression of SMIM40 mRNA PMID:29264374 11496771 Smim40 small integral membrane protein 40 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1616348 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of SMIM40 mRNA PMID:37019170 11496771 Smim40 small integral membrane protein 40 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1616348 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SMIM40 mRNA PMID:36331819 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1318007 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of EPS8L3 mRNA PMID:38218311 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:15354 choline multiple interactions ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA PMID:20938992 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of EPS8L3 mRNA PMID:33387578 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA PMID:20938992 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1318008 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of EPS8L3 mRNA PMID:34319233 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D004051 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter PMID:23359474 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:1318007 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of EPS8L3 intron PMID:30157460 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:184401 3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine affects response to substance ISO RGD:1318007 E RGD:6480464 20220104 CTD MESH:C045421 EPS8L3 protein affects the susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine PMID:19223546 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 affects the expression of EPS8L3 protein PMID:20106945 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of EPS8L3 gene PMID:27153756 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS8L3 mRNA PMID:20938992 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:27666 actinomycin D increases expression ISO RGD:1318007 E RGD:6480464 20240806 CTD MESH:D003609 Dactinomycin results in increased expression of EPS8L3 mRNA PMID:38460933 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:1318007 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of EPS8L3 protein PMID:35688186 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1318007 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of EPS8L3 mRNA PMID:27392435 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of EPS8L3 mRNA PMID:20106945|PMID:21632981 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPS8L3 mRNA PMID:17942748 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20170210 CTD MESH:D003300 Copper deficiency results in increased expression of EPS8L3 mRNA PMID:26033743 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1318007 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of EPS8L3 mRNA PMID:29301061 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1318008 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of EPS8L3 mRNA PMID:37682722 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1318007 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of EPS8L3 5' UTR; Benzo(a)pyrene affects the methylation of EPS8L3 intron PMID:27901495|PMID:30157460 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of EPS8L3 mRNA PMID:21632981|PMID:32234424 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20170210 CTD MESH:D003300 Copper deficiency results in increased expression of EPS8L3 mRNA PMID:26033743 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:31638 fulvestrant increases methylation ISO RGD:1318007 E RGD:6480464 20220308 CTD MESH:C070081 Fulvestrant results in increased methylation of EPS8L3 gene PMID:31601247 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:3179 bromobenzene increases expression EXP E RGD:6480464 20200915 CTD MESH:C032036 bromobenzene results in increased expression of EPS8L3 mRNA PMID:32479839 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A results in decreased expression of EPS8L3 mRNA PMID:25181051 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1318008 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of EPS8L3 promoter PMID:27312807 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20170210 CTD MESH:C006780 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter PMID:23359474 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:34031 1,1-dichloroethene increases expression ISO RGD:1318008 E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of EPS8L3 mRNA PMID:26682919 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:1318007 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of EPS8L3 intron PMID:30157460 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:34687 dibutyl phthalate multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D003993 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EPS8L3 promoter PMID:23359474 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:35559 furan increases expression EXP E RGD:6480464 20170516 CTD MESH:C039281 furan results in increased expression of EPS8L3 mRNA PMID:27387713 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1318007 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of EPS8L3 mRNA PMID:29154799 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D016572 Cyclosporine results in decreased expression of EPS8L3 mRNA PMID:20106945|PMID:27989131 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D016572 Cyclosporine results in increased expression of EPS8L3 mRNA PMID:25562108 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1318007 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of EPS8L3 mRNA PMID:29067470 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:48981 quinolin-8-ol increases expression ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:D015125 Oxyquinoline results in increased expression of EPS8L3 mRNA PMID:21632981 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20170210 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of EPS8L3 mRNA PMID:17557909 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of EPS8L3 mRNA PMID:17942748 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1318008 E RGD:6480464 20170210 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPS8L3 mRNA PMID:17942748 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:4918 O-methyleugenol increases expression ISO RGD:1318007 E RGD:6480464 20200714 CTD MESH:C005223 methyleugenol results in increased expression of EPS8L3 mRNA PMID:32234424 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:6820 methapyrilene increases methylation ISO RGD:1318007 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of EPS8L3 intron PMID:30157460 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1318008 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of EPS8L3 mRNA PMID:22206623 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:7553 niclosamide increases expression ISO RGD:1318007 E RGD:6480464 20191114 CTD MESH:D009534 Niclosamide results in increased expression of EPS8L3 mRNA PMID:28284560 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:76290 PhIP affects response to substance ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:C049584 EPS8L3 protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine PMID:19223546 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:76604 MeIQx affects response to substance ISO RGD:1318007 E RGD:6480464 20170210 CTD MESH:C036990 EPS8L3 protein affects the susceptibility to 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline PMID:19223546 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:79997 GW 4064 increases expression ISO RGD:1318008 E RGD:6480464 20170303 CTD MESH:C412815 GW 4064 results in increased expression of EPS8L3 mRNA PMID:26655953 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:82362 N-Nitrosopyrrolidine increases expression ISO RGD:1318007 E RGD:6480464 20200714 CTD MESH:D009242 N-Nitrosopyrrolidine results in increased expression of EPS8L3 mRNA PMID:32234424 11498829 Eps8l3 EPS8 signaling adaptor L3 gene CHEBI:9986 vinclozolin decreases methylation EXP E RGD:6480464 20191112 CTD MESH:C025643 vinclozolin results in decreased methylation of EPS8L3 gene PMID:30207508|PMID:31079544 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:10106 zearalenone decreases expression ISO RGD:10162 E RGD:6480464 20230404 CTD MESH:D015025 Zearalenone results in decreased expression of ANP32A protein PMID:36252740 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:132267 triptonide decreases expression ISO RGD:10162 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ANP32A mRNA PMID:33045310 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:10162 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of ANP32A mRNA PMID:37995155 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANP32A mRNA] PMID:31150632 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D014212 Tretinoin results in decreased expression of ANP32A mRNA PMID:21934132 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:15930 atrazine affects methylation EXP E RGD:6480464 20230905 CTD MESH:D001280 Atrazine affects the methylation of ANP32A gene PMID:35440735 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:15930 atrazine increases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D001280 Atrazine results in increased expression of ANP32A mRNA; Atrazine results in increased expression of ANP32A protein PMID:25275270 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16240 hydrogen peroxide increases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of ANP32A mRNA PMID:18951874 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16243 quercetin decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D011794 Quercetin results in decreased expression of ANP32A protein PMID:19207037 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16469 17beta-estradiol affects localization ISO RGD:1606331 E RGD:6480464 20230502 CTD MESH:D004958 Estradiol affects the localization of ANP32A protein PMID:36534342 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D004958 Estradiol results in decreased expression of ANP32A mRNA PMID:19484750 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20170210 CTD MESH:D004958 Estradiol results in increased expression of ANP32A mRNA PMID:20068009 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:165219 PCB138 increases expression EXP E RGD:6480464 20201208 CTD MESH:C029790 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of ANP32A protein PMID:21673325 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16548 chlordecone increases expression ISO RGD:10162 E RGD:6480464 20210810 CTD MESH:D007631 Chlordecone results in increased expression of ANP32A mRNA PMID:33711761 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16598 DDE increases expression ISO RGD:1606331 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased expression of ANP32A mRNA PMID:38568856 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D005557 Formaldehyde results in decreased expression of ANP32A mRNA PMID:23649840 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:17347 testosterone increases expression ISO RGD:10162 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone deficiency results in increased expression of ANP32A mRNA PMID:33848595 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:17362 quinoline decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:C037219 quinoline analog results in decreased expression of ANP32A protein PMID:18645022 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D004051 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter PMID:23359474 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20170210 CTD MESH:D005839 Gentamicins results in increased expression of ANP32A mRNA PMID:22061828 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:17967 urethane decreases expression ISO RGD:1606331 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of ANP32A mRNA PMID:28818685 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:10162 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANP32A mRNA PMID:36331819 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:18291 manganese atom multiple interactions ISO RGD:10162 E RGD:6480464 20221101 CTD MESH:D008345 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA PMID:35690225 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D019327 Copper Sulfate results in decreased expression of ANP32A mRNA PMID:19549813 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:23994 ethyl methanesulfonate decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D005020 Ethyl Methanesulfonate results in decreased expression of ANP32A mRNA PMID:23649840 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:2430 aconitine decreases expression EXP E RGD:6480464 20210309 CTD MESH:D000157 Aconitine results in decreased expression of ANP32A protein PMID:33236894 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ANP32A mRNA PMID:19770486 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ANP32A gene PMID:27153756 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of ANP32A mRNA PMID:23649840 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:25812 ozone increases expression EXP E RGD:6480464 20210209 CTD MESH:D010126 Ozone results in increased expression of ANP32A protein PMID:33146391 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:25812 ozone multiple interactions ISO RGD:1606331 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ANP32A mRNA PMID:35430440 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ANP32A mRNA PMID:31150632 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ANP32A mRNA PMID:27339419|PMID:31919559 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ANP32A mRNA] PMID:31150632 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27470 folic acid decreases expression ISO RGD:10162 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ANP32A mRNA PMID:25629700 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27470 folic acid decreases expression ISO RGD:1606331 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ANP32A mRNA PMID:21867686 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27470 folic acid multiple interactions ISO RGD:10162 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANP32A mRNA PMID:22206623 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1606331 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ANP32A protein PMID:38460933 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27690 acetazolamide increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D000086 Acetazolamide results in increased expression of ANP32A mRNA PMID:19274763 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27744 glyphosate increases expression ISO RGD:10162 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of ANP32A protein PMID:37208198 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:10162 E RGD:6480464 20170613 CTD MESH:C024565 ethylene dichloride results in increased expression of ANP32A mRNA PMID:28189721|PMID:28960355 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1606331 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of ANP32A mRNA PMID:23557933 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27889 lead(0) multiple interactions ISO RGD:10162 E RGD:6480464 20231003 CTD MESH:D007854 [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron PMID:33445541 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27899 cisplatin decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D002945 Cisplatin results in decreased expression of ANP32A mRNA PMID:21151649 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27899 cisplatin decreases expression ISO RGD:1606331 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in decreased expression of ANP32A mRNA PMID:27594783 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D002945 Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA] PMID:21858171 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28088 genistein decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D019833 Genistein results in decreased expression of ANP32A mRNA PMID:18847459 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ANP32A mRNA PMID:34747641 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ANP32A mRNA PMID:21570461 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ANP32A mRNA PMID:19933214 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D013749 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ANP32A mRNA PMID:25975270 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28201 rotenone decreases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in decreased expression of ANP32A mRNA PMID:28374803 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1606331 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ANP32A mRNA PMID:33212167 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28694 copper atom multiple interactions ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of ANP32A mRNA PMID:20971185 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28748 doxorubicin affects expression ISO RGD:1606331 E RGD:6480464 20180515 CTD MESH:D004317 Doxorubicin affects the expression of ANP32A protein PMID:29385562 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1606331 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ANP32A mRNA PMID:29803840 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29678 sodium arsenite affects expression ISO RGD:1606331 E RGD:6480464 20180515 CTD MESH:C017947 sodium arsenite affects the expression of ANP32A mRNA PMID:29319823 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1606331 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ANP32A mRNA PMID:38568856 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29678 sodium arsenite increases expression ISO RGD:10162 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in increased expression of ANP32A protein PMID:29044176 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ANP32A mRNA PMID:21964900 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ANP32A mRNA PMID:20064835 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ANP32A mRNA PMID:21839799 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ANP32A mRNA PMID:22228805 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ANP32A protein PMID:17292933 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:29866 arsenite(3-) affects localization ISO RGD:1606331 E RGD:6480464 20230502 CTD MESH:C015001 arsenite affects the localization of ANP32A protein PMID:36534342 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of ANP32A mRNA PMID:20971185 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of ANP32A mRNA PMID:25895662 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANP32A mRNA PMID:20382639 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20170210 CTD MESH:D000643 Ammonium Chloride affects the expression of ANP32A mRNA PMID:16483693 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:31767 lead diacetate multiple interactions ISO RGD:10162 E RGD:6480464 20231003 CTD MESH:C008261 [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron PMID:33445541 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:31941 oxaliplatin multiple interactions EXP E RGD:6480464 20170210 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANP32A mRNA PMID:25729387 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32234 titanium dioxide affects expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C009495 titanium dioxide affects the expression of ANP32A mRNA PMID:23557971 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:10162 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased expression of ANP32A mRNA PMID:35295148 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:10162 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ANP32A gene; titanium dioxide results in decreased methylation of ANP32A promoter PMID:35295148 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:10162 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of ANP32A gene PMID:35295148 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C006253 pirinixic acid results in decreased expression of ANP32A mRNA PMID:18445702 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20170210 CTD MESH:C006253 pirinixic acid results in increased expression of ANP32A mRNA PMID:12832660|PMID:19162173 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32509 pirinixic acid increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C006253 pirinixic acid results in increased expression of ANP32A mRNA PMID:23811191 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:32585 4-hydroxynon-2-enal decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C027576 4-hydroxy-2-nonenal results in decreased expression of ANP32A mRNA PMID:19191707 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20170210 CTD MESH:C006780 bisphenol A affects the expression of ANP32A mRNA PMID:25181051|PMID:30903817 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A affects expression ISO RGD:1606331 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ANP32A mRNA PMID:30903817 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ANP32A mRNA PMID:30816183|PMID:34947998 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A decreases expression ISO RGD:10162 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ANP32A mRNA PMID:33221593 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A increases expression ISO RGD:1606331 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ANP32A mRNA; bisphenol A results in increased expression of ANP32A protein PMID:33376534|PMID:33670352 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20170210 CTD MESH:C006780 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter PMID:23359474 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:10162 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in increased methylation of ANP32A exon PMID:33297965 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34565 benzo[b]fluoranthene affects expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C006703 benzo(b)fluoranthene affects the expression of ANP32A mRNA PMID:26377693 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34569 Benzo[k]fluoranthene decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C022921 benzo(k)fluoranthene results in decreased expression of ANP32A mRNA PMID:26377693 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34575 bisphenol F increases expression ISO RGD:1606331 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ANP32A protein PMID:34186270 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34682 diazinon increases methylation ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D003976 Diazinon results in increased methylation of ANP32A gene PMID:22964155 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ANP32A mRNA PMID:21266533 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34687 dibutyl phthalate multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D003993 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ANP32A promoter PMID:23359474 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34837 methidathion decreases expression ISO RGD:10162 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in decreased expression of ANP32A mRNA PMID:34813904 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D004052 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA PMID:18164116 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1606331 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ANP32A mRNA PMID:37042841 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:35154 manganese(0) multiple interactions ISO RGD:10162 E RGD:6480464 20221101 CTD MESH:D008345 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA PMID:35690225 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:C018021 cobaltous chloride results in decreased expression of ANP32A mRNA PMID:19376846 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:3750 clofibrate decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D002994 Clofibrate results in decreased expression of ANP32A mRNA PMID:17585979 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:38757 isoflavones affects expression ISO RGD:1606331 E RGD:6480464 20170303 CTD MESH:D007529 Isoflavones affects the expression of ANP32A mRNA PMID:16365062 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:38940 sunitinib decreases expression ISO RGD:1606331 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of ANP32A mRNA PMID:31533062 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:3908 coumestrol increases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D003375 Coumestrol results in increased expression of ANP32A mRNA PMID:19167446 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10162 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ANP32A mRNA PMID:36331819 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:39867 valproic acid decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D014635 Valproic Acid results in decreased expression of ANP32A mRNA PMID:21427059 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:39867 valproic acid decreases expression ISO RGD:1606331 E RGD:6480464 20170516 CTD MESH:D014635 Valproic Acid results in decreased expression of ANP32A mRNA PMID:28001369 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:39867 valproic acid increases methylation ISO RGD:1606331 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ANP32A gene PMID:29154799 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D016572 Cyclosporine results in decreased expression of ANP32A mRNA PMID:20106945|PMID:25562108 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:45863 paclitaxel affects response to substance ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D017239 ANP32A protein affects the susceptibility to Paclitaxel PMID:16217747 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46195 paracetamol affects expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D000082 Acetaminophen affects the expression of ANP32A mRNA PMID:17562736 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46195 paracetamol decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D000082 Acetaminophen results in decreased expression of ANP32A mRNA PMID:18544908 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46195 paracetamol decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D000082 Acetaminophen results in decreased expression of ANP32A mRNA PMID:21420995|PMID:29067470 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46666 crocidolite asbestos decreases expression ISO RGD:10162 E RGD:6480464 20200915 CTD MESH:D017638 Asbestos, Crocidolite results in decreased expression of ANP32A mRNA PMID:29279043 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46680 serpentine asbestos increases methylation ISO RGD:1606331 E RGD:6480464 20180828 CTD MESH:D017632 Asbestos, Serpentine results in increased methylation of ANP32A gene PMID:29523930 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1606331 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ANP32A protein PMID:38460933 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:47105 1-bromopropane increases expression EXP E RGD:6480464 20170210 CTD MESH:C118559 1-bromopropane results in increased expression of ANP32A protein PMID:21925529 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:10162 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ANP32A mRNA PMID:35436446 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ANP32A mRNA; Nanotubes, Carbon results in decreased expression of ANP32A mRNA PMID:25554681|PMID:25620056 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1606331 E RGD:6480464 20171010 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of ANP32A mRNA PMID:28673683 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:5062 finasteride increases expression EXP E RGD:6480464 20170210 CTD MESH:D018120 Finasteride results in increased expression of ANP32A mRNA PMID:24136188 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:51081 nitrates multiple interactions ISO RGD:10162 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANP32A mRNA PMID:35964746 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:5118 fluoxetine decreases expression EXP E RGD:6480464 20170210 CTD MESH:D005473 Fluoxetine results in decreased expression of ANP32A mRNA PMID:17033635 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:5130 flurbiprofen increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D005480 Flurbiprofen results in increased expression of ANP32A mRNA PMID:16949054 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:51348 tetraphene increases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C030935 benz(a)anthracene results in increased expression of ANP32A mRNA PMID:26377693 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:6078 ivermectin decreases expression ISO RGD:1606331 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ANP32A protein PMID:32959892 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:63041 manganese(II) chloride multiple interactions ISO RGD:10162 E RGD:6480464 20221101 CTD MESH:C025340 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ANP32A mRNA PMID:35690225 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:63632 topotecan affects response to substance ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D019772 ANP32A protein affects the susceptibility to Topotecan PMID:16217747 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:63632 topotecan decreases expression EXP E RGD:6480464 20170210 CTD MESH:D019772 Topotecan results in decreased expression of ANP32A mRNA PMID:25729387 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:63632 topotecan multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANP32A mRNA PMID:25729387 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:64090 tert-butyl hydroperoxide decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D020122 tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA PMID:15336504 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:64317 isoprenaline decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:D007545 Isoproterenol results in decreased expression of ANP32A mRNA PMID:20003209|PMID:21335049 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20220705 CTD MESH:D008012 Lidocaine results in increased expression of ANP32A mRNA PMID:35283115 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:6820 methapyrilene increases expression EXP E RGD:6480464 20170210 CTD MESH:D008701 Methapyrilene results in increased expression of ANP32A mRNA PMID:22484513 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:72544 flavonoids decreases expression EXP E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in decreased expression of ANP32A mRNA PMID:18035473 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1606331 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ANP32A protein PMID:34186270 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:10162 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANP32A mRNA PMID:22206623 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:7494 nefazodone decreases expression EXP E RGD:6480464 20170210 CTD MESH:C051752 nefazodone results in decreased expression of ANP32A mRNA PMID:24136188 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:76987 metacetamol decreases expression ISO RGD:10162 E RGD:6480464 20170210 CTD MESH:C026137 3-hydroxyacetanilide results in decreased expression of ANP32A mRNA PMID:18544908 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:77013 beta-naphthoflavone multiple interactions EXP E RGD:6480464 20170210 CTD MESH:D019324 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ANP32A mRNA PMID:18164116 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:8249 piroxicam decreases expression ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D010894 Piroxicam results in decreased expression of ANP32A mRNA PMID:21858171 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:8249 piroxicam multiple interactions ISO RGD:1606331 E RGD:6480464 20170210 CTD MESH:D010894 Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA] PMID:21858171 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:84070 sodium arsenate increases expression ISO RGD:10162 E RGD:6480464 20170303 CTD MESH:C009277 sodium arsenate results in increased expression of ANP32A mRNA PMID:21795629 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20170210 CTD MESH:D011441 Propylthiouracil results in decreased expression of ANP32A mRNA PMID:24780913 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:9495 thiram decreases expression ISO RGD:1606331 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ANP32A mRNA PMID:38568856 11508551 Anp32a acidic nuclear phosphoprotein 32 family member A gene CHEBI:9986 vinclozolin affects expression EXP E RGD:6480464 20170210 CTD MESH:C025643 vinclozolin affects the expression of ANP32A mRNA PMID:19015723 1302933 Mcpt1l3 mast cell protease 1-like 3 gene CHEBI:24814 indole-3-methanol affects expression EXP E RGD:6480464 20120613 CTD MESH:C016517 indole-3-carbinol affects the expression of MCPT1L3 mRNA PMID:21396975 1302933 Mcpt1l3 mast cell protease 1-like 3 gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in decreased expression of MCPT1L3 mRNA PMID:23869203 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1549984 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of ST8SIA5 mRNA PMID:37995155 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:15367 all-trans-retinoic acid affects expression ISO RGD:1549984 E RGD:6480464 20220111 CTD MESH:D014212 Tretinoin affects the expression of ST8SIA5 mRNA PMID:34627992 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1549984 E RGD:6480464 20220111 CTD MESH:D014212 3,3'-dichlorobiphenyl affects the reaction [Tretinoin affects the expression of ST8SIA5 mRNA]; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ST8SIA5 mRNA PMID:34627992|PMID:36189433 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:15743 butanal increases expression ISO RGD:1349184 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ST8SIA5 mRNA PMID:26079696 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1349184 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of ST8SIA5 mRNA PMID:35811015 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1349184 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ST8SIA5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST8SIA5 mRNA PMID:35811015 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1549984 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA PMID:25510870 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of ST8SIA5 mRNA PMID:33387578 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:17153 propanal increases expression ISO RGD:1349184 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in increased expression of ST8SIA5 mRNA PMID:26079696 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1549984 E RGD:6480464 20121009 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of ST8SIA5 mRNA PMID:22401849 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1549984 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ST8SIA5 mRNA PMID:36189433 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:17347 testosterone decreases expression ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of ST8SIA5 mRNA PMID:20403060 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1349184 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ST8SIA5 gene PMID:25304211 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1349184 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ST8SIA5 mRNA PMID:23557933 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:27889 lead(0) affects methylation ISO RGD:1349184 E RGD:6480464 20230307 CTD MESH:D007854 Lead affects the methylation of ST8SIA5 gene PMID:31636367 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1549984 E RGD:6480464 20150512 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST8SIA5 mRNA PMID:17942748 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:28619 acrylamide increases expression ISO RGD:1349184 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in increased expression of ST8SIA5 mRNA PMID:32763439 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1349184 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ST8SIA5 mRNA PMID:29803840 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1349184 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ST8SIA5 promoter PMID:27901495 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1349184 E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ST8SIA5 mRNA PMID:21871943 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ST8SIA5 mRNA PMID:15894712 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1349184 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ST8SIA5 3' UTR PMID:27901495 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:D001564 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of ST8SIA5 mRNA PMID:15894712 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29866 arsenite(3-) decreases expression ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:C015001 arsenite results in decreased expression of ST8SIA5 mRNA PMID:15894712 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1349184 E RGD:6480464 20140610 CTD MESH:C015001 arsenite results in increased methylation of ST8SIA5 promoter PMID:23974009 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:C015001 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of ST8SIA5 mRNA PMID:15894712 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:301 (-)-alpha-phellandrene decreases expression ISO RGD:1349184 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of ST8SIA5 mRNA PMID:25075043 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1549984 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ST8SIA5 gene; titanium dioxide results in decreased methylation of ST8SIA5 promoter PMID:35295148 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ST8SIA5 mRNA PMID:25181051|PMID:34947998 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA PMID:36041667 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1549984 E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA PMID:25510870 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1549984 E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA PMID:25510870 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1549984 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of ST8SIA5 gene PMID:31683443 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA PMID:36041667 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ST8SIA5 mRNA PMID:36041667 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ST8SIA5 mRNA PMID:21266533 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:34905 paraquat multiple interactions ISO RGD:1549984 E RGD:6480464 20230905 CTD MESH:D010269 [Maneb co-treated with Paraquat] results in increased expression of ST8SIA5 mRNA PMID:36117858 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of ST8SIA5 mRNA PMID:33453195 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1349184 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of ST8SIA5 mRNA PMID:31533062 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:39867 valproic acid affects expression ISO RGD:1349184 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ST8SIA5 mRNA PMID:25979313 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:39867 valproic acid increases expression ISO RGD:1349184 E RGD:6480464 20170516 CTD MESH:D014635 Valproic Acid results in increased expression of ST8SIA5 mRNA PMID:28001369 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:39867 valproic acid increases expression ISO RGD:1549984 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid results in increased expression of ST8SIA5 mRNA PMID:21427059 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1349184 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ST8SIA5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ST8SIA5 mRNA PMID:35811015 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:47217 arsane affects methylation ISO RGD:1349184 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ST8SIA5 gene PMID:25304211 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1549984 E RGD:6480464 20150512 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ST8SIA5 mRNA PMID:17942748 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1549984 E RGD:6480464 20150512 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ST8SIA5 mRNA PMID:17942748 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:50035 alpha-phellandrene decreases expression ISO RGD:1349184 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of ST8SIA5 mRNA PMID:25075043 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:52497 maneb multiple interactions ISO RGD:1549984 E RGD:6480464 20230905 CTD MESH:D008344 [Maneb co-treated with Paraquat] results in increased expression of ST8SIA5 mRNA PMID:36117858 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1549984 E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate results in increased expression of ST8SIA5 mRNA PMID:23608068 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1549984 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ST8SIA5 mRNA PMID:22206623 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:8093 phenylephrine increases expression EXP E RGD:6480464 20150512 CTD MESH:D010656 Phenylephrine results in increased expression of ST8SIA5 mRNA PMID:18158353 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ST8SIA5 mRNA PMID:32109520 1302934 St8sia5 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ST8SIA5 mRNA PMID:24780913 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:15354 choline multiple interactions ISO RGD:1551965 E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene PMID:20938992 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1602031 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in increased expression of NUDT19 mRNA PMID:21934132 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:1602031 E RGD:6480464 20120412 CTD MESH:D006861 Hydrogen Peroxide affects the expression of NUDT19 mRNA PMID:20044591 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1602031 E RGD:6480464 20121218 CTD MESH:D004958 Estradiol results in increased expression of NUDT19 mRNA PMID:23019147 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:16598 DDE increases expression ISO RGD:1602031 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased expression of NUDT19 mRNA PMID:38568856 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1551965 E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene PMID:20938992 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1602031 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of NUDT19 mRNA PMID:37042841 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:17967 urethane increases expression ISO RGD:1602031 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of NUDT19 mRNA PMID:28818685 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1551965 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT19 mRNA PMID:36331819 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1602031 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of NUDT19 mRNA PMID:19549813 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1551965 E RGD:6480464 20121113 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT19 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NUDT19 gene PMID:20938992|PMID:22206623 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:27998 tungsten increases expression ISO RGD:1551965 E RGD:6480464 20190910 CTD MESH:D014414 Tungsten results in increased expression of NUDT19 mRNA PMID:30912803 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28088 genistein decreases expression ISO RGD:1551965 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of NUDT19 mRNA PMID:32186404 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551965 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of NUDT19 mRNA PMID:21570461 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of NUDT19 mRNA PMID:18796159 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28201 rotenone increases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in increased expression of NUDT19 mRNA PMID:28374803 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1602031 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of NUDT19 mRNA PMID:20971185 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1551965 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of NUDT19 protein PMID:28918527 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1602031 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of NUDT19 mRNA PMID:29803840 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1602031 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of NUDT19 mRNA PMID:38568856 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:29865 benzo[a]pyrene increases mutagenesis ISO RGD:1602031 E RGD:6480464 20160315 CTD MESH:D001564 Benzo(a)pyrene results in increased mutagenesis of NUDT19 gene PMID:25435355 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1602031 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of NUDT19 mRNA PMID:20971185 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1551965 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of NUDT19 gene PMID:35295148 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1551965 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUDT19 mRNA PMID:19710929 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of NUDT19 mRNA PMID:30816183|PMID:32528016 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1551965 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of NUDT19 mRNA PMID:33221593 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1602031 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in increased expression of NUDT19 protein PMID:34186270 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of NUDT19 gene PMID:28505145 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:3387 carbamazepine affects expression ISO RGD:1602031 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of NUDT19 mRNA PMID:25979313 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1602031 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of NUDT19 protein PMID:34186270 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1602031 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA PMID:28628672 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:1602031 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of NUDT19 protein PMID:34186270 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34761 fenthion decreases expression ISO RGD:1551965 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of NUDT19 mRNA PMID:34813904 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602031 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA PMID:28628672 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:34837 methidathion decreases expression ISO RGD:1551965 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in decreased expression of NUDT19 mRNA PMID:34813904 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1602031 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of NUDT19 mRNA PMID:37042841 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1602031 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of NUDT19 mRNA PMID:38568856 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:36467 ciguatoxin CTX1B affects expression ISO RGD:1551965 E RGD:6480464 20121009 CTD MESH:D002922 Ciguatoxins affects the expression of NUDT19 mRNA PMID:18353800 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:38658 dicrotophos increases expression ISO RGD:1602031 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of NUDT19 mRNA PMID:28302478 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:38940 sunitinib increases expression ISO RGD:1602031 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of NUDT19 mRNA PMID:31533062 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1551965 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUDT19 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUDT19 mRNA PMID:36331819 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:39867 valproic acid affects expression ISO RGD:1551965 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of NUDT19 mRNA PMID:17292431 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:39867 valproic acid affects expression ISO RGD:1602031 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of NUDT19 mRNA PMID:25979313 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:39867 valproic acid increases expression ISO RGD:1602031 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of NUDT19 mRNA PMID:23179753 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1602031 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of NUDT19 mRNA PMID:20106945 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1602031 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA PMID:28628672 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1551965 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of NUDT19 mRNA PMID:28973697 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:46024 trichostatin A affects expression ISO RGD:1602031 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of NUDT19 mRNA PMID:28542535 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1602031 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NUDT19 mRNA PMID:28628672 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of NUDT19 mRNA PMID:24136188 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:53076 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1551965 E RGD:6480464 20120412 CTD MESH:D010081 Oxazolone results in increased expression of NUDT19 mRNA PMID:11379042 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1602031 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of NUDT19 protein PMID:32959892 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:6402 leflunomide increases expression EXP E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of NUDT19 mRNA PMID:24136188 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1551965 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of NUDT19 mRNA PMID:22206623 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1551965 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT19 mRNA PMID:22206623 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1602031 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to NUDT19 gene] PMID:28238834 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1551965 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of NUDT19 mRNA PMID:38648751 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:8489 propiconazole increases expression ISO RGD:1551965 E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in increased expression of NUDT19 mRNA PMID:21278054 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of NUDT19 mRNA PMID:21346803 1302935 Nudt19 nudix hydrolase 19 gene CHEBI:9495 thiram decreases expression ISO RGD:1602031 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of NUDT19 mRNA PMID:38568856 1302936 C1rl complement C1r subcomponent like gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1346889 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of C1RL mRNA PMID:38218311 1302936 C1rl complement C1r subcomponent like gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1549998 E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of C1RL mRNA PMID:26251327 1302936 C1rl complement C1r subcomponent like gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1346889 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of C1RL mRNA PMID:33167477 1302936 C1rl complement C1r subcomponent like gene CHEBI:15743 butanal decreases expression ISO RGD:1346889 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in decreased expression of C1RL mRNA PMID:26079696 1302936 C1rl complement C1r subcomponent like gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1346889 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in decreased expression of C1RL mRNA PMID:30165855 1302936 C1rl complement C1r subcomponent like gene CHEBI:16548 chlordecone increases expression ISO RGD:1549998 E RGD:6480464 20210810 CTD MESH:D007631 Chlordecone results in increased expression of C1RL mRNA PMID:33711761 1302936 C1rl complement C1r subcomponent like gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of C1RL mRNA PMID:33387578 1302936 C1rl complement C1r subcomponent like gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1549998 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of C1RL mRNA PMID:34319233 1302936 C1rl complement C1r subcomponent like gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of C1RL mRNA PMID:33387578 1302936 C1rl complement C1r subcomponent like gene CHEBI:17967 urethane decreases expression ISO RGD:1346889 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of C1RL mRNA PMID:28818685 1302936 C1rl complement C1r subcomponent like gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1549998 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of C1RL mRNA PMID:36331819 1302936 C1rl complement C1r subcomponent like gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1346889 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of C1RL mRNA PMID:19549813 1302936 C1rl complement C1r subcomponent like gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1346889 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of C1RL mRNA PMID:23649840 1302936 C1rl complement C1r subcomponent like gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1346889 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of C1RL mRNA PMID:22100608|PMID:27153756 1302936 C1rl complement C1r subcomponent like gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1346889 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of C1RL mRNA PMID:23649840 1302936 C1rl complement C1r subcomponent like gene CHEBI:25812 ozone multiple interactions ISO RGD:1549998 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of C1RL mRNA PMID:34911549 1302936 C1rl complement C1r subcomponent like gene CHEBI:27086 tributylstannane multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in decreased expression of C1RL mRNA PMID:31129395 1302936 C1rl complement C1r subcomponent like gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of C1RL mRNA PMID:31150632 1302936 C1rl complement C1r subcomponent like gene CHEBI:27470 folic acid decreases expression ISO RGD:1549998 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of C1RL mRNA PMID:25629700 1302936 C1rl complement C1r subcomponent like gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1346889 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of C1RL mRNA PMID:38460933 1302936 C1rl complement C1r subcomponent like gene CHEBI:27856 acetamide decreases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of C1RL mRNA PMID:31881176 1302936 C1rl complement C1r subcomponent like gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1346889 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of C1RL mRNA PMID:27392435 1302936 C1rl complement C1r subcomponent like gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1549998 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of C1RL mRNA PMID:21570461 1302936 C1rl complement C1r subcomponent like gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of C1RL mRNA PMID:33387578 1302936 C1rl complement C1r subcomponent like gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346889 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of C1RL mRNA PMID:20106945|PMID:21632981 1302936 C1rl complement C1r subcomponent like gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:1346889 E RGD:6480464 20170516 CTD MESH:C004925 methylmercuric chloride results in decreased expression of C1RL mRNA PMID:28001369 1302936 C1rl complement C1r subcomponent like gene CHEBI:28619 acrylamide decreases expression ISO RGD:1346889 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of C1RL mRNA PMID:32763439 1302936 C1rl complement C1r subcomponent like gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1346889 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of C1RL mRNA PMID:38568856 1302936 C1rl complement C1r subcomponent like gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1549998 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of C1RL mRNA PMID:37682722 1302936 C1rl complement C1r subcomponent like gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1346889 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of C1RL mRNA PMID:20064835 1302936 C1rl complement C1r subcomponent like gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1346889 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of C1RL promoter PMID:27901495 1302936 C1rl complement C1r subcomponent like gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1549998 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of C1RL 3' UTR; Benzo(a)pyrene results in increased methylation of C1RL exon PMID:27901495 1302936 C1rl complement C1r subcomponent like gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1346889 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of C1RL mRNA PMID:25895662 1302936 C1rl complement C1r subcomponent like gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in decreased expression of C1RL mRNA PMID:23411599|PMID:34492290 1302936 C1rl complement C1r subcomponent like gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:1549998 E RGD:6480464 20170725 CTD MESH:C007738 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of C1RL mRNA PMID:28329830 1302936 C1rl complement C1r subcomponent like gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of C1RL mRNA PMID:30816183|PMID:32145629 1302936 C1rl complement C1r subcomponent like gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1549998 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of C1RL protein PMID:35999755 1302936 C1rl complement C1r subcomponent like gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of C1RL mRNA PMID:25181051 1302936 C1rl complement C1r subcomponent like gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of C1RL gene PMID:28505145 1302936 C1rl complement C1r subcomponent like gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with tributyltin] results in decreased expression of C1RL mRNA PMID:31129395 1302936 C1rl complement C1r subcomponent like gene CHEBI:3387 carbamazepine affects expression ISO RGD:1346889 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of C1RL mRNA PMID:25979313 1302936 C1rl complement C1r subcomponent like gene CHEBI:34107 1-nitropyrene decreases expression ISO RGD:1346889 E RGD:6480464 20140415 CTD MESH:C032668 1-nitropyrene results in decreased expression of C1RL mRNA PMID:19041380 1302936 C1rl complement C1r subcomponent like gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1346889 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in decreased methylation of C1RL gene PMID:31601247 1302936 C1rl complement C1r subcomponent like gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1549998 E RGD:6480464 20191112 CTD MESH:C543008 [bisphenol S co-treated with LIF protein] results in increased expression of C1RL mRNA PMID:30951980 1302936 C1rl complement C1r subcomponent like gene CHEBI:34761 fenthion increases expression ISO RGD:1549998 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in increased expression of C1RL mRNA PMID:34813904 1302936 C1rl complement C1r subcomponent like gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1346889 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of C1RL mRNA PMID:37042841 1302936 C1rl complement C1r subcomponent like gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of C1RL mRNA PMID:33453195 1302936 C1rl complement C1r subcomponent like gene CHEBI:35559 furan decreases expression EXP E RGD:6480464 20150414 CTD MESH:C039281 furan results in decreased expression of C1RL mRNA PMID:25539665 1302936 C1rl complement C1r subcomponent like gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1346889 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of C1RL mRNA PMID:19376846 1302936 C1rl complement C1r subcomponent like gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1346889 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of C1RL mRNA PMID:24449571 1302936 C1rl complement C1r subcomponent like gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1549998 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of C1RL mRNA PMID:36331819 1302936 C1rl complement C1r subcomponent like gene CHEBI:39867 valproic acid affects expression ISO RGD:1346889 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of C1RL mRNA PMID:25979313 1302936 C1rl complement C1r subcomponent like gene CHEBI:39867 valproic acid affects expression ISO RGD:1549998 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of C1RL mRNA PMID:17292431 1302936 C1rl complement C1r subcomponent like gene CHEBI:39867 valproic acid decreases expression ISO RGD:1346889 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in decreased expression of C1RL mRNA PMID:23179753|PMID:28001369|PMID:29154799 1302936 C1rl complement C1r subcomponent like gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1346889 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of C1RL gene PMID:29154799 1302936 C1rl complement C1r subcomponent like gene CHEBI:39867 valproic acid increases expression ISO RGD:1346889 E RGD:6480464 20140909 CTD MESH:D014635 Valproic Acid results in increased expression of C1RL mRNA PMID:24935251 1302936 C1rl complement C1r subcomponent like gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1346889 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of C1RL mRNA PMID:20106945|PMID:25562108 1302936 C1rl complement C1r subcomponent like gene CHEBI:4031 cyclosporin A increases methylation ISO RGD:1346889 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in increased methylation of C1RL promoter PMID:27989131 1302936 C1rl complement C1r subcomponent like gene CHEBI:46024 trichostatin A increases expression ISO RGD:1346889 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in increased expression of C1RL mRNA PMID:24935251 1302936 C1rl complement C1r subcomponent like gene CHEBI:46195 paracetamol affects expression ISO RGD:1549998 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of C1RL mRNA PMID:17562736 1302936 C1rl complement C1r subcomponent like gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of C1RL mRNA PMID:33387578 1302936 C1rl complement C1r subcomponent like gene CHEBI:46195 paracetamol decreases expression ISO RGD:1346889 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of C1RL mRNA PMID:29067470 1302936 C1rl complement C1r subcomponent like gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1346889 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of C1RL mRNA PMID:38460933 1302936 C1rl complement C1r subcomponent like gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1549998 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of C1RL mRNA PMID:35436446 1302936 C1rl complement C1r subcomponent like gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression ISO RGD:1346889 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of C1RL mRNA PMID:19194470 1302936 C1rl complement C1r subcomponent like gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1549998 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of C1RL mRNA PMID:25620056 1302936 C1rl complement C1r subcomponent like gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1346889 E RGD:6480464 20191008 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of C1RL mRNA PMID:29348435 1302936 C1rl complement C1r subcomponent like gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1549998 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of C1RL mRNA PMID:22206623 1302936 C1rl complement C1r subcomponent like gene CHEBI:9495 thiram decreases expression ISO RGD:1346889 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of C1RL mRNA PMID:38568856 1302936 C1rl complement C1r subcomponent like gene CHEBI:9546 thimerosal decreases expression ISO RGD:1346889 E RGD:6480464 20161025 CTD MESH:D013849 Thimerosal results in decreased expression of C1RL mRNA PMID:27188386 1302936 C1rl complement C1r subcomponent like gene CHEBI:9763 trovafloxacin decreases expression ISO RGD:1549998 E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in decreased expression of C1RL mRNA PMID:35537566 1302937 Krt13 keratin 13 gene CHEBI:116509 diuron decreases expression EXP E RGD:6480464 20141223 CTD MESH:D004237 Diuron results in decreased expression of KRT13 mRNA PMID:25152437 1302937 Krt13 keratin 13 gene CHEBI:132844 glycidyl methacrylate decreases expression ISO RGD:1349257 E RGD:6480464 20230704 CTD MESH:C007870 glycidyl methacrylate results in decreased expression of KRT13 protein PMID:36641056 1302937 Krt13 keratin 13 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1349257 E RGD:6480464 20140211 CTD MESH:D014212 Tretinoin results in decreased expression of KRT13 mRNA PMID:17185354 1302937 Krt13 keratin 13 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1349257 E RGD:6480464 20160607 CTD MESH:D014212 Tretinoin results in increased expression of KRT13 mRNA PMID:23830798 1302937 Krt13 keratin 13 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1332221 E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in increased expression of KRT13 mRNA PMID:15289156|PMID:19484750 1302937 Krt13 keratin 13 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1349257 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in increased expression of KRT13 mRNA PMID:31614463 1302937 Krt13 keratin 13 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]; Estradiol promotes the reaction [ESR2 protein affects the expression of KRT13 mRNA] PMID:16849584|PMID:20404318 1302937 Krt13 keratin 13 gene CHEBI:165219 PCB138 decreases expression EXP E RGD:6480464 20201208 CTD MESH:C029790 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KRT13 mRNA PMID:23829299 1302937 Krt13 keratin 13 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of KRT13 mRNA PMID:33387578 1302937 Krt13 keratin 13 gene CHEBI:17594 hydroquinone decreases expression ISO RGD:1349257 E RGD:6480464 20190910 CTD MESH:C031927 hydroquinone results in decreased expression of KRT13 mRNA PMID:31256213 1302937 Krt13 keratin 13 gene CHEBI:18258 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:D014284 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT13 mRNA PMID:14761676 1302937 Krt13 keratin 13 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1349257 E RGD:6480464 20120501 CTD MESH:D019327 Copper Sulfate results in decreased expression of KRT13 mRNA PMID:20599845 1302937 Krt13 keratin 13 gene CHEBI:23414 copper(II) sulfate increases expression ISO RGD:1349257 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in increased expression of KRT13 mRNA PMID:19549813 1302937 Krt13 keratin 13 gene CHEBI:254496 7,12-dimethyltetraphene increases expression ISO RGD:1332221 E RGD:6480464 20240604 CTD MESH:D015127 9,10-Dimethyl-1,2-benzanthracene results in increased expression of KRT13 protein PMID:38307155 1302937 Krt13 keratin 13 gene CHEBI:25812 ozone increases expression ISO RGD:1332221 E RGD:6480464 20200211 CTD MESH:D010126 Ozone results in increased expression of KRT13 mRNA PMID:31626304|PMID:33026818 1302937 Krt13 keratin 13 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1349257 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT13 protein PMID:38598786 1302937 Krt13 keratin 13 gene CHEBI:27641 cycloheximide multiple interactions ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:D003513 [afimoxifene co-treated with Cycloheximide] results in increased expression of KRT13 mRNA PMID:16849584 1302937 Krt13 keratin 13 gene CHEBI:27744 glyphosate increases methylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of KRT13 gene PMID:31011160 1302937 Krt13 keratin 13 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1332221 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of KRT13 mRNA PMID:28960355 1302937 Krt13 keratin 13 gene CHEBI:28088 genistein increases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D019833 Genistein results in increased expression of KRT13 mRNA PMID:15289156 1302937 Krt13 keratin 13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of KRT13 mRNA PMID:22298810 1302937 Krt13 keratin 13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of KRT13 mRNA PMID:17035482 1302937 Krt13 keratin 13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:D013749 [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of KRT13 mRNA PMID:14761676 1302937 Krt13 keratin 13 gene CHEBI:28619 acrylamide affects expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide affects the expression of KRT13 mRNA PMID:28959563 1302937 Krt13 keratin 13 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1332221 E RGD:6480464 20120814 CTD MESH:D003300 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA PMID:15467011 1302937 Krt13 keratin 13 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1332221 E RGD:6480464 20170516 CTD MESH:D012969 Sodium Fluoride results in increased expression of KRT13 protein PMID:27548804 1302937 Krt13 keratin 13 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1349257 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in decreased expression of KRT13 mRNA PMID:12634122 1302937 Krt13 keratin 13 gene CHEBI:29678 sodium arsenite decreases methylation ISO RGD:1349257 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in decreased methylation of KRT13 gene PMID:24570342 1302937 Krt13 keratin 13 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1349257 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of KRT13 mRNA; sodium arsenite results in increased expression of KRT13 protein PMID:19524636|PMID:24570342|PMID:34032870 1302937 Krt13 keratin 13 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1349257 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of KRT13 promoter PMID:27901495 1302937 Krt13 keratin 13 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1349257 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of KRT13 exon PMID:27901495 1302937 Krt13 keratin 13 gene CHEBI:29866 arsenite(3-) increases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:C015001 arsenite results in increased expression of KRT13 mRNA PMID:18929588 1302937 Krt13 keratin 13 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:C015001 TRP53 protein affects the reaction [arsenite results in increased expression of KRT13 mRNA] PMID:18929588 1302937 Krt13 keratin 13 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1332221 E RGD:6480464 20120814 CTD MESH:D003300 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA PMID:15467011 1302937 Krt13 keratin 13 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1349257 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of KRT13 protein PMID:25419056 1302937 Krt13 keratin 13 gene CHEBI:31206 ammonium chloride increases expression EXP E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride results in increased expression of KRT13 protein PMID:16483693 1302937 Krt13 keratin 13 gene CHEBI:3139 bleomycin A2 increases expression ISO RGD:1332221 E RGD:6480464 20230307 CTD MESH:D001761 Bleomycin results in increased expression of KRT13 mRNA PMID:36087614 1302937 Krt13 keratin 13 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:C070081 Fulvestrant inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA] PMID:16849584 1302937 Krt13 keratin 13 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of KRT13 mRNA PMID:20059764 1302937 Krt13 keratin 13 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:C006253 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of KRT13 mRNA] PMID:20059764 1302937 Krt13 keratin 13 gene CHEBI:33007 chromium(6+) affects expression ISO RGD:1332221 E RGD:6480464 20171010 CTD MESH:C074702 chromium hexavalent ion affects the expression of KRT13 mRNA PMID:28472532 1302937 Krt13 keratin 13 gene CHEBI:33128 C60 fullerene decreases expression EXP E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in decreased expression of KRT13 mRNA PMID:19167457 1302937 Krt13 keratin 13 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of KRT13 mRNA PMID:25181051 1302937 Krt13 keratin 13 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1349257 E RGD:6480464 20181016 CTD MESH:C006780 bisphenol A results in decreased expression of KRT13 mRNA; bisphenol A results in decreased expression of KRT13 protein PMID:29718440|PMID:33376534 1302937 Krt13 keratin 13 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1332221 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of KRT13 mRNA PMID:32156529 1302937 Krt13 keratin 13 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1349257 E RGD:6480464 20241001 CTD MESH:C006780 bisphenol A results in decreased expression of and results in increased methylation of KRT13 mRNA PMID:38354435 1302937 Krt13 keratin 13 gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP E RGD:6480464 20141111 CTD MESH:C016340 o,p'-DDT results in increased expression of KRT13 mRNA PMID:24096037 1302937 Krt13 keratin 13 gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1332221 E RGD:6480464 20141111 CTD MESH:C016340 o,p'-DDT results in increased expression of KRT13 mRNA PMID:24096037 1302937 Krt13 keratin 13 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl increases expression EXP E RGD:6480464 20140114 CTD MESH:C009407 2,5,2',5'-tetrachlorobiphenyl results in increased expression of KRT13 mRNA PMID:23829299 1302937 Krt13 keratin 13 gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of KRT13 mRNA PMID:21266533 1302937 Krt13 keratin 13 gene CHEBI:34768 furfural multiple interactions ISO RGD:1349257 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT13 protein PMID:38598786 1302937 Krt13 keratin 13 gene CHEBI:34873 N-nitrosodiethylamine decreases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in decreased expression of KRT13 mRNA PMID:17942915 1302937 Krt13 keratin 13 gene CHEBI:34873 N-nitrosodiethylamine increases expression ISO RGD:1349257 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in increased expression of KRT13 mRNA PMID:21527772 1302937 Krt13 keratin 13 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KRT13 protein PMID:20935162 1302937 Krt13 keratin 13 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D004052 MET protein inhibits the reaction [Diethylnitrosamine results in decreased expression of KRT13 mRNA] PMID:17942915 1302937 Krt13 keratin 13 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1349257 E RGD:6480464 20190507 CTD MESH:D019256 Cadmium Chloride results in increased expression of KRT13 protein PMID:30572105 1302937 Krt13 keratin 13 gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of KRT13 mRNA PMID:24386269 1302937 Krt13 keratin 13 gene CHEBI:41774 tamoxifen increases expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen results in increased expression of KRT13 mRNA PMID:19400957 1302937 Krt13 keratin 13 gene CHEBI:41774 tamoxifen increases expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen results in increased expression of KRT13 mRNA PMID:19400957 1302937 Krt13 keratin 13 gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:1332221 E RGD:6480464 20120918 CTD MESH:D004054 Diethylstilbestrol results in increased expression of KRT13 mRNA PMID:15171707|PMID:15289156|PMID:15591538 1302937 Krt13 keratin 13 gene CHEBI:44616 afimoxifene increases expression ISO RGD:1349257 E RGD:6480464 20200211 CTD MESH:C016601 afimoxifene results in increased expression of KRT13 mRNA PMID:16849584 1302937 Krt13 keratin 13 gene CHEBI:44616 afimoxifene multiple interactions ISO RGD:1349257 E RGD:6480464 20200211 CTD MESH:C016601 [afimoxifene co-treated with Cycloheximide] results in increased expression of KRT13 mRNA; Estradiol inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA]; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of KRT13 mRNA] PMID:16849584 1302937 Krt13 keratin 13 gene CHEBI:45863 paclitaxel decreases response to substance ISO RGD:1349257 E RGD:6480464 20161213 CTD MESH:D017239 KRT13 mRNA results in decreased susceptibility to Paclitaxel PMID:16322897 1302937 Krt13 keratin 13 gene CHEBI:46195 paracetamol affects expression ISO RGD:1332221 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of KRT13 mRNA PMID:17562736 1302937 Krt13 keratin 13 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of KRT13 mRNA PMID:33387578 1302937 Krt13 keratin 13 gene CHEBI:48765 dimethylarsinic acid increases expression ISO RGD:1332221 E RGD:6480464 20200804 CTD MESH:D002101 Cacodylic Acid results in increased expression of KRT13 mRNA PMID:32052077 1302937 Krt13 keratin 13 gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20140311 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of KRT13 mRNA PMID:19400957|PMID:24096037 1302937 Krt13 keratin 13 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1332221 E RGD:6480464 20140311 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of KRT13 mRNA PMID:19400957|PMID:24096037 1302937 Krt13 keratin 13 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1349257 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of KRT13 protein PMID:25419056 1302937 Krt13 keratin 13 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1332221 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of KRT13 mRNA; Nanotubes, Carbon results in increased expression of KRT13 mRNA PMID:25554681 1302937 Krt13 keratin 13 gene CHEBI:507499 tricetin decreases expression ISO RGD:1349257 E RGD:6480464 20240903 CTD MESH:C469689 tricetin results in decreased expression of KRT13 mRNA PMID:38654487 1302937 Krt13 keratin 13 gene CHEBI:51687 chrysene increases expression ISO RGD:1332221 E RGD:6480464 20160119 CTD MESH:C031180 chrysene results in increased expression of KRT13 mRNA PMID:26377693 1302937 Krt13 keratin 13 gene CHEBI:52774 pentane-2,3-dione increases expression ISO RGD:1349257 E RGD:6480464 20190507 CTD MESH:C013186 2,3-pentanedione results in increased expression of KRT13 mRNA PMID:30710127 1302937 Krt13 keratin 13 gene CHEBI:53444 potassium dichromate decreases expression ISO RGD:1332221 E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate results in decreased expression of KRT13 mRNA PMID:23608068 1302937 Krt13 keratin 13 gene CHEBI:69120 withaferin A decreases expression ISO RGD:1349257 E RGD:6480464 20210608 CTD MESH:C009684 withaferin A results in decreased expression of KRT13 mRNA PMID:33665778 1302937 Krt13 keratin 13 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1332221 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of KRT13 mRNA PMID:22206623 1302937 Krt13 keratin 13 gene CHEBI:75261 arotinoid acid decreases expression ISO RGD:1349257 E RGD:6480464 20161025 CTD MESH:C038864 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of KRT13 mRNA PMID:8853895 1302937 Krt13 keratin 13 gene CHEBI:76326 N-nitrosomorpholine decreases expression EXP E RGD:6480464 20140107 CTD MESH:C002741 N-nitrosomorpholine results in decreased expression of KRT13 protein PMID:19716841 1302937 Krt13 keratin 13 gene CHEBI:77013 beta-naphthoflavone increases expression ISO RGD:1349257 E RGD:6480464 20200714 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of KRT13 mRNA PMID:32151702 1302937 Krt13 keratin 13 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1349257 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to KRT13 gene] PMID:28238834 1302937 Krt13 keratin 13 gene CHEBI:8069 phenobarbital multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D010634 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of KRT13 protein PMID:20935162 1302937 Krt13 keratin 13 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in increased expression of KRT13 mRNA PMID:32109520 1302937 Krt13 keratin 13 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of KRT13 mRNA PMID:24780913 1302937 Krt13 keratin 13 gene CHEBI:91108 SB 431542 increases expression ISO RGD:1349257 E RGD:6480464 20161220 CTD MESH:C459179 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT13 protein PMID:25670856 1302937 Krt13 keratin 13 gene CHEBI:9150 simvastatin increases expression ISO RGD:1349257 E RGD:6480464 20120501 CTD MESH:D019821 Simvastatin results in increased expression of KRT13 mRNA PMID:17428261 1302937 Krt13 keratin 13 gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1349257 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT13 protein PMID:38598786 1302937 Krt13 keratin 13 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1349257 E RGD:6480464 20210810 CTD MESH:C057693 Troglitazone results in decreased expression of KRT13 mRNA; Troglitazone results in decreased expression of KRT13 protein PMID:32822399 1302937 Krt13 keratin 13 gene CHEBI:9753 troglitazone multiple interactions ISO RGD:1349257 E RGD:6480464 20210810 CTD MESH:C057693 [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 mRNA; [Troglitazone co-treated with 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline] results in decreased expression of KRT13 protein PMID:32822399 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:2208 purine-6-thiol increases expression EXP E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA PMID:23358152 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:24814 indole-3-methanol affects expression EXP E RGD:6480464 20240326 CTD MESH:C016517 indole-3-carbinol affects the expression of MCPT1L2 mRNA PMID:21396975 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of MCPT8L2 mRNA PMID:34747641 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of MCPT8L2 mRNA PMID:16483693 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of MCPT8L2 mRNA PMID:32680482 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression EXP E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of MCPT8L2 mRNA PMID:30723492 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:50667 mercaptopurine increases expression EXP E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA PMID:23358152 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:50673 methimazole decreases expression EXP E RGD:6480464 20121009 CTD MESH:D008713 Methimazole results in decreased expression of MCPT8L2 mRNA PMID:22504374 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20180220 CTD MESH:D019813 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of MCPT8L2 mRNA PMID:27840820 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20121009 CTD MESH:D011441 Propylthiouracil results in decreased expression of MCPT8L2 mRNA PMID:22504374 1302938 Mcpt8l2 mast cell protease 8-like 2 gene CHEBI:94796 3,7-dihydropurine-6-thione increases expression EXP E RGD:6480464 20170307 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT1L2 mRNA; Mercaptopurine results in increased expression of MCPT8L2 mRNA PMID:23358152 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1349957 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of EEF1G mRNA PMID:38218311 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:1224 2-nitrofluorene increases expression EXP E RGD:6480464 20120412 CTD MESH:C019499 2-nitrofluorene results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of EEF1G mRNA PMID:25812627 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:144804 nickel subsulfide increases expression EXP E RGD:6480464 20191008 CTD MESH:C017557 nickel subsulfide results in increased expression of EEF1G mRNA PMID:21086188 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:15354 choline multiple interactions ISO RGD:1550009 E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA PMID:20938992 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D014212 Tretinoin results in decreased expression of EEF1G mRNA PMID:17218384 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20140812 CTD MESH:D000431 Ethanol results in decreased expression of EEF1G protein PMID:24646710 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20161025 CTD MESH:D000431 Ethanol results in increased expression of EEF1G protein PMID:19609968 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16236 ethanol multiple interactions ISO RGD:1550009 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of and affects the splicing of EEF1G mRNA PMID:30319688 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20130514 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of EEF1G protein PMID:23178681 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20130514 CTD MESH:D006861 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of EEF1G protein] PMID:23178681 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16336 hyaluronic acid multiple interactions EXP E RGD:6480464 20130514 CTD MESH:D006820 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of EEF1G protein] PMID:23178681 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in increased expression of EEF1G mRNA PMID:11179685 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D004958 3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of EEF1G mRNA] PMID:11179685 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1550009 E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA PMID:20938992 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:16796 melatonin multiple interactions ISO RGD:1550009 E RGD:6480464 20140408 CTD MESH:D008550 Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA] PMID:23963992 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:17362 quinoline increases expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:C037219 quinoline analog results in increased expression of EEF1G protein PMID:18645022 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1550009 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of EEF1G mRNA PMID:33754040 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:177802 Cuprizon multiple interactions ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:D003471 [Cuprizone co-treated with Benztropine] results in decreased expression of EEF1G protein; [Cuprizone co-treated with Haloperidol] results in decreased expression of EEF1G protein PMID:34122009 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1349957 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of EEF1G protein PMID:37730182 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression EXP E RGD:6480464 20170613 CTD MESH:D000517 alpha-Chlorohydrin analog results in decreased expression of EEF1G protein; alpha-Chlorohydrin results in decreased expression of EEF1G protein PMID:26072098 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:18721 3-chloropropane-1,2-diol increases expression EXP E RGD:6480464 20220705 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of EEF1G protein PMID:34915118 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:1349957 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EEF1G protein PMID:23301498 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:25187 p-menthan-3-ol decreases expression ISO RGD:1349957 E RGD:6480464 20190611 CTD MESH:D008610 Menthol results in decreased expression of EEF1G protein PMID:26760959 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:2663 amiodarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1349957 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EEF1G protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EEF1G protein PMID:38598786 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27214 uranium atom affects expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D014501 Uranium affects the expression of EEF1G mRNA PMID:15672453 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27470 folic acid multiple interactions ISO RGD:1550009 E RGD:6480464 20121113 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1G mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EEF1G mRNA PMID:20938992|PMID:22206623 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1349957 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of EEF1G gene PMID:25304211 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1349957 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of EEF1G protein PMID:38460933 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27732 caffeine increases expression ISO RGD:1349957 E RGD:6480464 20191008 CTD MESH:D002110 Caffeine results in increased expression of EEF1G protein PMID:31195006 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1349957 E RGD:6480464 20140812 CTD MESH:D002945 Cisplatin results in increased expression of and results in increased secretion of EEF1G protein PMID:24980261 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:27958 cocaine decreases expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D003042 Cocaine results in decreased expression of EEF1G mRNA PMID:15009677 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550009 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of EEF1G mRNA PMID:21570461 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of EEF1G mRNA PMID:32109520 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550009 E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of EEF1G mRNA PMID:19770486 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of EEF1G mRNA PMID:33387578 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550009 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of EEF1G mRNA PMID:17942748 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of EEF1G mRNA] PMID:11179685 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550009 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of EEF1G mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF1G mRNA PMID:16214954|PMID:17942748 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28201 rotenone decreases expression EXP E RGD:6480464 20221101 CTD MESH:D012402 Rotenone results in decreased expression of EEF1G protein PMID:35544339 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1349957 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of EEF1G protein PMID:33212167 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:1349957 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of EEF1G mRNA PMID:30851411 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:28748 doxorubicin increases expression ISO RGD:1349957 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of EEF1G mRNA PMID:29803840 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1349957 E RGD:6480464 20220405 CTD MESH:C017947 sodium arsenite results in decreased expression of EEF1G protein PMID:30528433 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of EEF1G mRNA PMID:19072884 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1349957 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of EEF1G promoter PMID:27901495 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1349957 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to EEF1G mRNA]; arsenite promotes the reaction [G3BP1 protein binds to EEF1G protein] PMID:32406909 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:3016 Benoxacor decreases expression ISO RGD:1550009 E RGD:6480464 20220405 CTD MESH:C085163 benoxacor results in decreased expression of EEF1G mRNA PMID:34850242 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:3023 benzbromarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:3048 benzatropine multiple interactions ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:D001590 [Cuprizone co-treated with Benztropine] results in decreased expression of EEF1G protein PMID:34122009 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1349957 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of EEF1G protein PMID:15894607 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:31653 glafenine increases expression EXP E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in increased expression of EEF1G mRNA PMID:24136188 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:31823 mercury dichloride multiple interactions ISO RGD:1349957 E RGD:6480464 20140812 CTD MESH:D008627 Mercuric Chloride results in increased expression of and results in increased secretion of EEF1G protein PMID:24980261 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1349957 E RGD:6480464 20190910 CTD MESH:C009495 titanium dioxide results in decreased expression of EEF1G protein PMID:30910687 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32497 thioacetamide affects expression EXP E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32509 pirinixic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1550009 E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of EEF1G mRNA PMID:23811191 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32687 piperonyl butoxide increases expression EXP E RGD:6480464 20120412 CTD MESH:D010882 Piperonyl Butoxide results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:32692 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP E RGD:6480464 20120412 CTD MESH:C016583 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33128 C60 fullerene decreases expression EXP E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in decreased expression of EEF1G mRNA PMID:19167457 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1349957 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of EEF1G mRNA; bisphenol A results in decreased expression of EEF1G protein PMID:29275510|PMID:33024228|PMID:34186270 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1550009 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of EEF1G protein PMID:35999755 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1349957 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of EEF1G gene PMID:31601247 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of EEF1G mRNA PMID:25181051|PMID:30816183|PMID:38750585 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of EEF1G gene PMID:28505145 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP E RGD:6480464 20141111 CTD MESH:C016340 o,p'-DDT results in increased expression of EEF1G mRNA PMID:24096037 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1550009 E RGD:6480464 20141111 CTD MESH:C016340 o,p'-DDT results in increased expression of EEF1G mRNA PMID:24096037 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:3423 carmustine increases expression ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D002330 Carmustine results in increased expression of EEF1G mRNA PMID:15980968 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1349957 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of EEF1G protein PMID:34186270 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1550009 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of EEF1G mRNA PMID:37019170 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34674 dextran sulfate decreases expression ISO RGD:1550009 E RGD:6480464 20230207 CTD MESH:D016264 Dextran Sulfate results in decreased expression of EEF1G protein PMID:35999755 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34768 furfural multiple interactions ISO RGD:1349957 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EEF1G protein PMID:38598786 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:34905 paraquat multiple interactions ISO RGD:1550009 E RGD:6480464 20140408 CTD MESH:D010269 [Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA] PMID:23963992 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1349957 E RGD:6480464 20140812 CTD MESH:D019256 Cadmium Chloride results in increased expression of and results in increased secretion of EEF1G protein PMID:24980261 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of EEF1G mRNA PMID:25812627 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1349957 E RGD:6480464 20220208 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of EEF1G mRNA PMID:33772556 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:1349957 E RGD:6480464 20120918 CTD MESH:C018021 cobaltous chloride results in increased expression of EEF1G mRNA PMID:17553155 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35807 N-nitrosodimethylamine increases expression EXP E RGD:6480464 20120412 CTD MESH:D004128 Dimethylnitrosamine results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1349957 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of EEF1G mRNA PMID:24449571 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:3750 clofibrate affects expression EXP E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:379896 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:1349957 E RGD:6480464 20120412 CTD MESH:D015741 Metribolone promotes the reaction [NDRG1 protein binds to EEF1G protein] PMID:17220478 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:1349957 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of EEF1G mRNA PMID:25812627 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:39285 chloropicrin affects expression ISO RGD:1349957 E RGD:6480464 20151215 CTD MESH:C100187 chloropicrin affects the expression of EEF1G mRNA PMID:26352163 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:39285 chloropicrin decreases expression ISO RGD:1349957 E RGD:6480464 20171010 CTD MESH:C100187 chloropicrin results in decreased expression of EEF1G mRNA PMID:28476498 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of EEF1G mRNA PMID:25812627 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1349957 E RGD:6480464 20220208 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of EEF1G mRNA PMID:33772556 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:4031 cyclosporin A multiple interactions ISO RGD:1349957 E RGD:6480464 20140812 CTD MESH:D016572 Cyclosporine results in increased expression of and results in increased secretion of EEF1G protein PMID:24980261 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:41774 tamoxifen affects expression ISO RGD:1550009 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of EEF1G mRNA PMID:17555576 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:41922 diethylstilbestrol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004054 Diethylstilbestrol results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:46053 2,4,6-trinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:D014303 Trinitrotoluene affects the expression of EEF1G mRNA PMID:21346803 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1349957 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of EEF1G protein PMID:38460933 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:47217 arsane affects methylation ISO RGD:1349957 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of EEF1G gene PMID:25304211 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:4886 L-ethionine affects expression EXP E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20140311 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of EEF1G mRNA PMID:24096037 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1550009 E RGD:6480464 20140311 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of EEF1G mRNA PMID:17555576|PMID:17942748|PMID:24096037 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1550009 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EEF1G mRNA PMID:17942748 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1349957 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of EEF1G protein PMID:15894607 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:5011 fenpyroximate decreases expression ISO RGD:1349957 E RGD:6480464 20210810 CTD MESH:C415144 fenpyroximate results in decreased expression of EEF1G mRNA PMID:33512557 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:50182 3,3'-diindolylmethane multiple interactions ISO RGD:1349957 E RGD:6480464 20180116 CTD MESH:C016392 3,3'-diindolylmethane promotes the reaction [Estradiol results in increased expression of EEF1G mRNA] PMID:11179685 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1550009 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of EEF1G mRNA; Nanotubes, Carbon results in increased expression of EEF1G mRNA PMID:25554681 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:51081 nitrates multiple interactions ISO RGD:1550009 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EEF1G mRNA PMID:35964746 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20120412 CTD MESH:D005485 Flutamide results in decreased expression of EEF1G mRNA PMID:21525395 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of EEF1G mRNA PMID:24136188 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:52497 maneb multiple interactions ISO RGD:1550009 E RGD:6480464 20140408 CTD MESH:D008344 [Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EEF1G mRNA] PMID:23963992 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:5613 haloperidol multiple interactions ISO RGD:1349957 E RGD:6480464 20211207 CTD MESH:D006220 [Cuprizone co-treated with Haloperidol] results in decreased expression of EEF1G protein PMID:34122009 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:6078 ivermectin decreases expression ISO RGD:1349957 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of EEF1G protein PMID:32959892 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:64153 tanespimycin decreases expression ISO RGD:1349957 E RGD:6480464 20200804 CTD MESH:C112765 tanespimycin analog results in decreased expression of EEF1G protein PMID:31370342 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:64153 tanespimycin multiple interactions ISO RGD:1349957 E RGD:6480464 20200804 CTD MESH:C112765 [tanespimycin co-treated with VER 155008] results in decreased expression of EEF1G protein PMID:31370342 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:6820 methapyrilene decreases expression EXP E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased expression of EEF1G protein PMID:30467583 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:6820 methapyrilene increases expression EXP E RGD:6480464 20120412 CTD MESH:D008701 Methapyrilene results in increased expression of EEF1G mRNA PMID:15890375 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:72564 temozolomide decreases expression ISO RGD:1349957 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in decreased expression of EEF1G mRNA PMID:31758290 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1349957 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of EEF1G protein PMID:34186270 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1550009 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1G mRNA PMID:22206623 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:7772 omeprazole affects expression EXP E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:1349957 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of EEF1G mRNA PMID:30851411 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in increased expression of EEF1G mRNA PMID:32109520 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1550009 E RGD:6480464 20200310 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether affects the expression of EEF1G mRNA PMID:30294300 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:8502 6-propyl-2-thiouracil affects expression EXP E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of EEF1G mRNA PMID:19483382 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:9381 T-2 toxin affects expression EXP E RGD:6480464 20151110 CTD MESH:D013605 T-2 Toxin affects the expression of EEF1G protein PMID:26141394 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1349957 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EEF1G protein PMID:38598786 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of EEF1G mRNA PMID:21346803 1302939 Eef1g eukaryotic translation elongation factor 1 gamma gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20150825 CTD MESH:C025643 vinclozolin results in decreased expression of EEF1G mRNA PMID:23034163 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NT5DC3 mRNA PMID:20188158 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:10002693 E RGD:6480464 20211102 CTD MESH:D002392 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TTC41P mRNA PMID:24763279 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:16548 chlordecone increases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D007631 Chlordecone results in increased expression of NT5DC3 mRNA PMID:33711761 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:10002693 E RGD:6480464 20211102 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of TTC41P gene PMID:27153756 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of NT5DC3 mRNA PMID:31919559 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:27998 tungsten decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D014414 Tungsten results in decreased expression of NT5DC3 mRNA PMID:30912803 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:28088 genistein decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D019833 Genistein results in decreased expression of NT5DC3 mRNA PMID:32186404 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of NT5DC3 mRNA PMID:21570461 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:10002693 E RGD:6480464 20211102 CTD MESH:C017947 sodium arsenite results in decreased expression of TTC41P mRNA PMID:34032870 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:3016 Benoxacor increases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:C085163 benoxacor results in increased expression of NT5DC3 mRNA PMID:34850242 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:C009495 titanium dioxide results in decreased expression of NT5DC3 mRNA PMID:29264374 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1626389 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of NT5DC3 gene PMID:35295148 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:C007738 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NT5DC3 mRNA PMID:28329830 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20211102 CTD MESH:C006780 bisphenol A results in decreased expression of TTC41P mRNA PMID:25181051 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1626389 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of NT5DC3 mRNA PMID:32156529 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1626389 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of NT5DC3 mRNA PMID:38685157 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:10002693 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of TTC41P mRNA PMID:38568856 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:46195 paracetamol affects expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D000082 Acetaminophen affects the expression of NT5DC3 mRNA PMID:17562736 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:C109476 epoxiconazole results in decreased expression of NT5DC3 mRNA PMID:35436446 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:64213 cantharidin decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D002193 Cantharidin results in decreased expression of NT5DC3 mRNA PMID:36907384 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of NT5DC3 mRNA PMID:22206623 1302940 Ttc41 tetratricopeptide repeat domain 41 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1626389 E RGD:6480464 20240903 CTD MESH:C057693 Troglitazone results in decreased expression of NT5DC3 mRNA PMID:28973697 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1602708 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of P2RY13 mRNA PMID:33167477 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:15422 ATP multiple interactions ISO RGD:1602708 E RGD:6480464 20121009 CTD MESH:D000255 MRS 2211 inhibits the reaction [P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]]; P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide] PMID:22129738 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16236 ethanol increases expression ISO RGD:1551996 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol results in increased expression of P2RY13 mRNA PMID:30319688 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16240 hydrogen peroxide multiple interactions ISO RGD:1602708 E RGD:6480464 20121009 CTD MESH:D006861 MRS 2211 inhibits the reaction [P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide]]; P2RY13 protein promotes the reaction [Adenosine Triphosphate results in decreased susceptibility to Hydrogen Peroxide] PMID:22129738 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1551996 E RGD:6480464 20161228 CTD MESH:D008070 P2RY13 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] PMID:24849676 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in decreased expression of P2RY13 mRNA PMID:32145629 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D004958 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA PMID:32741896 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of P2RY13 mRNA PMID:33387578 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:16602 trichloroethene increases methylation EXP E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in increased methylation of P2RY13 gene PMID:27618143 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1602708 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of P2RY13 mRNA PMID:37042841 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:17347 testosterone increases expression ISO RGD:1551996 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone deficiency results in increased expression of P2RY13 mRNA PMID:33848595 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D013739 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA PMID:32741896 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1551996 E RGD:6480464 20211109 CTD MESH:D013739 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of P2RY13 mRNA] PMID:33848595 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1551996 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY13 mRNA PMID:36331819 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:18721 3-chloropropane-1,2-diol affects expression EXP E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin affects the expression of P2RY13 mRNA PMID:28522335 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1602708 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY13 mRNA PMID:35301059 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:2504 aflatoxin B1 decreases expression EXP E RGD:6480464 20210309 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of P2RY13 mRNA PMID:33354967 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:25812 ozone multiple interactions ISO RGD:1551996 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of P2RY13 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of P2RY13 mRNA PMID:27106289|PMID:34911549 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:25812 ozone multiple interactions ISO RGD:1602708 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of P2RY13 mRNA PMID:35430440 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of P2RY13 mRNA PMID:31881176 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1602708 E RGD:6480464 20150609 CTD MESH:D009532 Nickel results in decreased expression of P2RY13 mRNA PMID:23195993 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28112 nickel atom increases expression ISO RGD:1602708 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of P2RY13 mRNA PMID:24768652|PMID:25583101 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20170516 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA PMID:27913140 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551996 E RGD:6480464 20170516 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA PMID:27913140 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1602708 E RGD:6480464 20170516 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of P2RY13 mRNA PMID:27913140 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of P2RY13 mRNA PMID:32109520 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1551996 E RGD:6480464 20160119 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of P2RY13 mRNA PMID:20819909|PMID:26290441 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551996 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to P2RY13 gene] PMID:20819909 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:28201 rotenone increases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in increased expression of P2RY13 mRNA PMID:28374803 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1551996 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of P2RY13 mRNA PMID:37682722 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:30512 silver atom increases expression ISO RGD:1551996 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in increased expression of P2RY13 mRNA PMID:27131904 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:30563 silicon dioxide increases expression EXP E RGD:6480464 20210706 CTD MESH:D012822 Silicon Dioxide results in increased expression of P2RY13 mRNA PMID:32721576 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1602708 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of P2RY13 protein PMID:25258189 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression ISO RGD:1551996 E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of P2RY13 mRNA PMID:18648102 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1551996 E RGD:6480464 20241105 CTD MESH:C006780 bisphenol A results in increased expression of P2RY13 mRNA PMID:38701888 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:34565 benzo[b]fluoranthene increases expression ISO RGD:1551996 E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of P2RY13 mRNA PMID:26377693 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1602708 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of P2RY13 mRNA PMID:37042841 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1602708 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P2RY13 mRNA PMID:35301059 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1602708 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of P2RY13 mRNA PMID:24449571 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1551996 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of P2RY13 mRNA PMID:36331819 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551996 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of P2RY13 mRNA PMID:28973697 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:48765 dimethylarsinic acid decreases expression EXP E RGD:6480464 20231031 CTD MESH:D002101 Cacodylic Acid results in decreased expression of P2RY13 mRNA PMID:37567419 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1602708 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of P2RY13 protein PMID:25258189 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1551996 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of P2RY13 mRNA; Nanotubes, Carbon results in increased expression of P2RY13 mRNA PMID:25554681 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:53063 2,4,6-trinitrobenzenesulfonic acid increases expression EXP E RGD:6480464 20150512 CTD MESH:D014302 Trinitrobenzenesulfonic Acid results in increased expression of P2RY13 mRNA PMID:23537331 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:63921 2-butoxyethanol decreases expression ISO RGD:1551996 E RGD:6480464 20120412 CTD MESH:C017096 n-butoxyethanol results in decreased expression of P2RY13 mRNA PMID:19812364 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1551996 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of P2RY13 mRNA PMID:22206623 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions EXP E RGD:6480464 20210406 CTD MESH:C074283 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of P2RY13 mRNA PMID:32741896 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:9141 silver(0) increases expression ISO RGD:1551996 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in increased expression of P2RY13 mRNA PMID:27131904 1302941 P2ry13 purinergic receptor P2Y13 gene CHEBI:9195 Soman decreases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of P2RY13 mRNA PMID:19281266 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression EXP E RGD:6480464 20201215 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BCAP31 mRNA PMID:30071829 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1349319 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of BCAP31 mRNA PMID:33167477 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:16236 ethanol multiple interactions ISO RGD:1552028 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of and affects the splicing of BCAP31 mRNA PMID:30319688 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1552028 E RGD:6480464 20121009 CTD MESH:D004958 Estradiol results in increased expression of BCAP31 mRNA PMID:22467019 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1349319 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of BCAP31 mRNA PMID:37042841 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552028 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of BCAP31 mRNA PMID:33754040 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:1349319 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of BCAP31 protein PMID:37730182 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552028 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCAP31 mRNA PMID:36331819 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:231515 lanthanum trichloride decreases expression EXP E RGD:6480464 20240702 CTD MESH:C028521 lanthanum chloride results in decreased expression of BCAP31 protein PMID:35090998 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:23995 N-ethyl-N-nitrosourea increases mutagenesis ISO RGD:1552028 E RGD:6480464 20180313 CTD MESH:D005038 Ethylnitrosourea results in increased mutagenesis of BCAP31 gene PMID:27776689 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:2430 aconitine increases expression EXP E RGD:6480464 20210309 CTD MESH:D000157 Aconitine results in increased expression of BCAP31 protein PMID:33236894 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:2654 aminoglutethimide decreases expression ISO RGD:1349319 E RGD:6480464 20150825 CTD MESH:D000616 Aminoglutethimide results in decreased expression of BCAP31 protein PMID:26102013 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1349319 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BCAP31 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BCAP31 protein PMID:38598786 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1552028 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCAP31 mRNA PMID:22206623 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:27881 resveratrol increases expression ISO RGD:1349319 E RGD:6480464 20120412 CTD MESH:C059514 resveratrol results in increased expression of BCAP31 mRNA PMID:19371625 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:27889 lead(0) affects expression ISO RGD:1349319 E RGD:6480464 20120918 CTD MESH:D007854 Lead affects the expression of BCAP31 mRNA PMID:22313790 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:27899 cisplatin increases expression ISO RGD:1349319 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in increased expression of BCAP31 mRNA PMID:27392435 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:27958 cocaine affects expression EXP E RGD:6480464 20120412 CTD MESH:D003042 Cocaine affects the expression of BCAP31 mRNA PMID:20187946 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552028 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of BCAP31 mRNA PMID:21570461 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of BCAP31 mRNA PMID:32109520 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of BCAP31 mRNA PMID:28959563 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:28619 acrylamide increases expression ISO RGD:1349319 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in increased expression of BCAP31 mRNA PMID:32763439 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:28748 doxorubicin increases expression ISO RGD:1349319 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of BCAP31 mRNA PMID:29803840 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1349319 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of BCAP31 mRNA PMID:38568856 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1349319 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of BCAP31 promoter PMID:27901495 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1552028 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of BCAP31 mRNA PMID:22228805 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1552028 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of BCAP31 gene PMID:35295148 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1349319 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of BCAP31 mRNA PMID:30903817 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of BCAP31 mRNA PMID:34947998 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1349319 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased expression of BCAP31 protein PMID:31675489 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of BCAP31 mRNA PMID:25181051 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1349319 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of BCAP31 mRNA; bisphenol A results in increased expression of BCAP31 protein PMID:33670352|PMID:34186270 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1349319 E RGD:6480464 20220308 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of BCAP31 protein PMID:31675489 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:33234 vitamin E increases expression ISO RGD:1349319 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in increased expression of BCAP31 mRNA PMID:19244175 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34567 benzo[e]pyrene decreases methylation ISO RGD:1349319 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in decreased methylation of BCAP31 intron PMID:30157460 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1349319 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA PMID:28628672 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34682 diazinon increases methylation ISO RGD:1349319 E RGD:6480464 20141014 CTD MESH:D003976 Diazinon results in increased methylation of BCAP31 gene PMID:22964155 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34768 furfural multiple interactions ISO RGD:1349319 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BCAP31 protein PMID:38598786 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349319 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA PMID:28628672 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:34837 methidathion decreases expression ISO RGD:1552028 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in decreased expression of BCAP31 mRNA PMID:34813904 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1349319 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of BCAP31 mRNA PMID:37042841 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:38940 sunitinib increases expression ISO RGD:1349319 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of BCAP31 mRNA PMID:31533062 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552028 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BCAP31 mRNA PMID:36331819 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:39867 valproic acid affects expression ISO RGD:1552028 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of BCAP31 mRNA PMID:17963808 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:39867 valproic acid increases expression ISO RGD:1349319 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of BCAP31 mRNA PMID:23179753|PMID:27188386 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1349319 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of BCAP31 gene PMID:29154799 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1349319 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA PMID:28628672 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression ISO RGD:1552028 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of BCAP31 mRNA PMID:28973697 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:46666 crocidolite asbestos decreases expression ISO RGD:1552028 E RGD:6480464 20200915 CTD MESH:D017638 Asbestos, Crocidolite results in decreased expression of BCAP31 mRNA PMID:29279043 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:47696 2,4,6-tribromophenol decreases expression ISO RGD:1349319 E RGD:6480464 20220308 CTD MESH:C004554 2,4,6-tribromophenol results in decreased expression of BCAP31 mRNA PMID:31675489 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20201103 CTD MESH:D004726 Endosulfan results in increased expression of BCAP31 mRNA PMID:31464424 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1349319 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BCAP31 mRNA PMID:28628672 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:5062 finasteride increases expression EXP E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of BCAP31 mRNA PMID:24136188 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1552028 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BCAP31 mRNA PMID:35964746 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of BCAP31 mRNA PMID:24136188 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:6067 isotretinoin decreases expression ISO RGD:1349319 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of BCAP31 mRNA PMID:20436886 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1349319 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of BCAP31 protein PMID:32959892 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:641 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1552028 E RGD:6480464 20160210 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in decreased expression of BCAP31 protein PMID:26558463 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:6820 methapyrilene decreases methylation ISO RGD:1349319 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased methylation of BCAP31 intron PMID:30157460 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1349319 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of BCAP31 protein PMID:34186270 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1552028 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of BCAP31 mRNA PMID:22206623 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1552028 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCAP31 mRNA PMID:22206623 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1349319 E RGD:6480464 20220308 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCAP31 protein PMID:31675489 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:82436 decabromodiphenyl ether decreases expression ISO RGD:1349319 E RGD:6480464 20220308 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of BCAP31 protein PMID:31675489 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1349319 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of BCAP31 protein PMID:37664457 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:9195 Soman decreases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of BCAP31 mRNA PMID:19281266 1302944 Bcap31 B-cell receptor-associated protein 31 gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1349319 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BCAP31 protein PMID:38598786 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1602193 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of NAPRT mRNA PMID:38218311 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:132267 triptonide increases expression ISO RGD:1558072 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of NAPRT mRNA PMID:33045310 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAPRT mRNA] PMID:31150632 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1602193 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in decreased expression of NAPRT mRNA PMID:30165855 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:177802 Cuprizon increases expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of NAPRT mRNA PMID:27523638 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1602193 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of NAPRT protein PMID:37730182 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1558072 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAPRT mRNA PMID:36331819 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression EXP E RGD:6480464 20220705 CTD MESH:D000517 alpha-Chlorohydrin results in decreased expression of NAPRT protein PMID:34915118 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1602193 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of NAPRT protein PMID:20106945 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:2679 amphetamine increases expression EXP E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in increased expression of NAPRT mRNA PMID:30779732 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190507 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of NAPRT mRNA PMID:30723492|PMID:31150632 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:1558072 E RGD:6480464 20160822 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of NAPRT mRNA PMID:27339419 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAPRT mRNA] PMID:31150632 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:27470 folic acid multiple interactions ISO RGD:1558072 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAPRT mRNA PMID:22206623 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of NAPRT mRNA PMID:21570461 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20151013 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of NAPRT mRNA PMID:21215274 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of NAPRT mRNA PMID:33387578 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of NAPRT mRNA PMID:18796159|PMID:19933214 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28619 acrylamide decreases expression ISO RGD:1602193 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of NAPRT mRNA PMID:32763439 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1602193 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of NAPRT mRNA PMID:29803840 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1558072 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of NAPRT mRNA PMID:37682722 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1602193 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of NAPRT mRNA PMID:38568856 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1602193 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of NAPRT mRNA PMID:20106945 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1602193 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of NAPRT exon; Benzo(a)pyrene results in decreased methylation of NAPRT promoter PMID:27901495 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:31767 lead diacetate decreases expression ISO RGD:1602193 E RGD:6480464 20240702 CTD MESH:C008261 lead acetate results in decreased expression of NAPRT mRNA PMID:38568856 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:31941 oxaliplatin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of NAPRT mRNA PMID:25729387 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:32161 sulfadimethoxine increases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of NAPRT1 mRNA PMID:30047161 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1558072 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of NAPRT1 enhancer; titanium dioxide results in decreased methylation of NAPRT1 gene PMID:35295148 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:C009495 titanium dioxide results in increased expression of NAPRT mRNA PMID:23557971 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20151013 CTD MESH:D013853 Thioacetamide results in decreased expression of NAPRT mRNA PMID:23411599|PMID:34492290 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1558072 E RGD:6480464 20161115 CTD MESH:C006780 bisphenol A results in decreased expression of NAPRT mRNA PMID:26063408 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20151013 CTD MESH:C006780 bisphenol A results in increased expression of NAPRT mRNA PMID:25181051|PMID:30816183 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:33216 bisphenol A increases expression ISO RGD:1558072 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of NAPRT mRNA PMID:33221593 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:33216 bisphenol A increases expression ISO RGD:1602193 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in increased expression of NAPRT protein PMID:34186270 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1558072 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of NAPRT gene PMID:31683443 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34567 benzo[e]pyrene decreases methylation ISO RGD:1602193 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in decreased methylation of NAPRT polyA tail PMID:30157460 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20151013 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of NAPRT mRNA PMID:21266533 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of NAPRT mRNA PMID:21266533 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34718 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1602193 E RGD:6480464 20210406 CTD MESH:D004137 Dinitrochlorobenzene binds to NAPRT protein PMID:32991956 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:34761 fenthion decreases expression ISO RGD:1558072 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of NAPRT mRNA PMID:34813904 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1602193 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of NAPRT mRNA PMID:37042841 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of NAPRT mRNA PMID:33453195 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression EXP E RGD:6480464 20230606 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of NAPRT1 mRNA PMID:30047161 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of NAPRT mRNA PMID:24386269 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:38102 triazines multiple interactions ISO RGD:1558072 E RGD:6480464 20180313 CTD MESH:D014227 Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of NAPRT mRNA] PMID:27469509 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:38922 dibenzofurans increases expression ISO RGD:1558072 E RGD:6480464 20230704 CTD MESH:D000072318 Dibenzofurans results in increased expression of NAPRT mRNA PMID:34254344 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:38940 sunitinib decreases expression ISO RGD:1602193 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of NAPRT mRNA PMID:31533062 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1558072 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NAPRT mRNA PMID:36331819 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:39867 valproic acid affects expression ISO RGD:1602193 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of NAPRT mRNA PMID:25979313 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:39867 valproic acid decreases expression ISO RGD:1602193 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in decreased expression of NAPRT mRNA PMID:23179753|PMID:29154799 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:39867 valproic acid increases methylation ISO RGD:1602193 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of NAPRT gene PMID:29154799 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:40036 amitrole increases expression EXP E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of NAPRT mRNA; Amitrole results in increased expression of NAPRT1 mRNA PMID:30047161|PMID:38685447 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D016572 Cyclosporine results in decreased expression of NAPRT mRNA PMID:19770486 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1602193 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of NAPRT mRNA PMID:20106945|PMID:27989131 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:46053 2,4,6-trinitrotoluene affects expression EXP E RGD:6480464 20151013 CTD MESH:D014303 Trinitrotoluene affects the expression of NAPRT mRNA PMID:21346803 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:46195 paracetamol affects expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D000082 Acetaminophen affects the expression of NAPRT mRNA PMID:17562736 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of NAPRT mRNA PMID:33387578 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of NAPRT mRNA PMID:29391264 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1558072 E RGD:6480464 20141111 CTD MESH:C109476 epoxiconazole results in decreased expression of NAPRT mRNA PMID:22334560|PMID:35436446 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:50673 methimazole increases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of NAPRT1 mRNA PMID:30047161 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:6078 ivermectin decreases expression ISO RGD:1602193 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of NAPRT protein PMID:32959892 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:63632 topotecan multiple interactions EXP E RGD:6480464 20161115 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of NAPRT mRNA PMID:25729387 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:63933 Aroclor 1254 increases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in increased expression of NAPRT mRNA PMID:23650126 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:6820 methapyrilene decreases methylation ISO RGD:1602193 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased methylation of NAPRT polyA tail PMID:30157460 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1558072 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of NAPRT mRNA PMID:22206623 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1558072 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAPRT mRNA PMID:22206623 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:7719 ochratoxin A decreases expression EXP E RGD:6480464 20151013 CTD MESH:C025589 ochratoxin A results in decreased expression of NAPRT mRNA PMID:23358140 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:81758 cyproconazole decreases expression ISO RGD:1558072 E RGD:6480464 20141111 CTD MESH:C093628 cyproconazole results in decreased expression of NAPRT mRNA PMID:22334560 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:8489 propiconazole decreases expression ISO RGD:1558072 E RGD:6480464 20140909 CTD MESH:C045950 propiconazole results in decreased expression of NAPRT mRNA PMID:22334560 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:8493 Propiverine affects binding EXP E RGD:6480464 20180410 CTD MESH:C015586 propiverine binds to NAPRT protein PMID:29273565 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of NAPRT1 mRNA PMID:30047161 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:9195 Soman increases expression EXP E RGD:6480464 20151013 CTD MESH:D012999 Soman results in increased expression of NAPRT mRNA PMID:19281266 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20151013 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of NAPRT mRNA PMID:21346803 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:9495 thiram decreases expression ISO RGD:1602193 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of NAPRT mRNA PMID:38568856 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:9546 thimerosal decreases expression ISO RGD:1602193 E RGD:6480464 20161025 CTD MESH:D013849 Thimerosal results in decreased expression of NAPRT mRNA PMID:27188386 1302945 Naprt nicotinate phosphoribosyltransferase gene CHEBI:9763 trovafloxacin increases expression ISO RGD:1558072 E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in increased expression of NAPRT mRNA PMID:35537566 1302946 Capn11 calpain 11 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1552037 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of CAPN11 mRNA PMID:37995155 1302946 Capn11 calpain 11 gene CHEBI:136608 Theaflavin 3,3'-digallate affects expression ISO RGD:1342957 E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate affects the expression of CAPN11 mRNA PMID:34925699 1302946 Capn11 calpain 11 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1552037 E RGD:6480464 20240402 CTD MESH:D014212 Tretinoin results in decreased expression of CAPN11 mRNA PMID:36189433 1302946 Capn11 calpain 11 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of CAPN11 mRNA PMID:33387578 1302946 Capn11 calpain 11 gene CHEBI:17642 pentachlorophenol increases expression ISO RGD:1552037 E RGD:6480464 20140311 CTD MESH:D010416 Pentachlorophenol results in increased expression of CAPN11 mRNA PMID:23892564 1302946 Capn11 calpain 11 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552037 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of CAPN11 mRNA PMID:34319233 1302946 Capn11 calpain 11 gene CHEBI:25187 p-menthan-3-ol decreases expression ISO RGD:1342957 E RGD:6480464 20190611 CTD MESH:D008610 Menthol results in decreased expression of CAPN11 mRNA PMID:26760959 1302946 Capn11 calpain 11 gene CHEBI:2663 amiodarone increases expression ISO RGD:1342957 E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone results in increased expression of CAPN11 mRNA PMID:19774075 1302946 Capn11 calpain 11 gene CHEBI:27363 zinc atom increases expression ISO RGD:1342957 E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in increased expression of CAPN11 mRNA PMID:22171008 1302946 Capn11 calpain 11 gene CHEBI:27363 zinc atom multiple interactions ISO RGD:1342957 E RGD:6480464 20120412 CTD MESH:D015032 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA PMID:16979875 1302946 Capn11 calpain 11 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1342957 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of CAPN11 gene PMID:25304211 1302946 Capn11 calpain 11 gene CHEBI:27563 arsenic atom decreases expression ISO RGD:1342957 E RGD:6480464 20240109 CTD MESH:D001151 Arsenic results in decreased expression of CAPN11 mRNA PMID:36861143 1302946 Capn11 calpain 11 gene CHEBI:27899 cisplatin affects expression ISO RGD:1342957 E RGD:6480464 20140513 CTD MESH:D002945 Cisplatin affects the expression of CAPN11 mRNA PMID:23300844 1302946 Capn11 calpain 11 gene CHEBI:28088 genistein decreases expression ISO RGD:1552037 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of CAPN11 mRNA PMID:32186404 1302946 Capn11 calpain 11 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552037 E RGD:6480464 20160210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of CAPN11 mRNA PMID:26377647|PMID:28922406 1302946 Capn11 calpain 11 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1552037 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of CAPN11 protein PMID:28918527 1302946 Capn11 calpain 11 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1552037 E RGD:6480464 20180220 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of CAPN11 mRNA PMID:27195522 1302946 Capn11 calpain 11 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1342957 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of CAPN11 3' UTR; Benzo(a)pyrene results in increased methylation of CAPN11 promoter PMID:27901495 1302946 Capn11 calpain 11 gene CHEBI:30185 zinc(0) increases expression ISO RGD:1342957 E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in increased expression of CAPN11 mRNA PMID:22171008 1302946 Capn11 calpain 11 gene CHEBI:30185 zinc(0) multiple interactions ISO RGD:1342957 E RGD:6480464 20120412 CTD MESH:D015032 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA PMID:16979875 1302946 Capn11 calpain 11 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1342957 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol S co-treated with Fulvestrant] results in increased methylation of CAPN11 gene PMID:31601247 1302946 Capn11 calpain 11 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1552037 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of CAPN11 gene PMID:35295148 1302946 Capn11 calpain 11 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of CAPN11 mRNA PMID:25181051 1302946 Capn11 calpain 11 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1552037 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of CAPN11 mRNA PMID:38074096 1302946 Capn11 calpain 11 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1552037 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased expression of CAPN11 mRNA PMID:32365465 1302946 Capn11 calpain 11 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of CAPN11 gene PMID:28505145 1302946 Capn11 calpain 11 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1552037 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of CAPN11 gene PMID:31683443 1302946 Capn11 calpain 11 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1342957 E RGD:6480464 20220308 CTD MESH:C543008 [bisphenol S co-treated with Fulvestrant] results in increased methylation of CAPN11 gene PMID:31601247 1302946 Capn11 calpain 11 gene CHEBI:34905 paraquat multiple interactions ISO RGD:1552037 E RGD:6480464 20121113 CTD MESH:D010269 [Paraquat co-treated with Maneb] affects the expression of CAPN11 mRNA PMID:22563483 1302946 Capn11 calpain 11 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1342957 E RGD:6480464 20120412 CTD MESH:D013755 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CAPN11 mRNA PMID:16979875 1302946 Capn11 calpain 11 gene CHEBI:38626 pyridaben decreases expression ISO RGD:1552037 E RGD:6480464 20121113 CTD MESH:C428725 pyridaben results in decreased expression of CAPN11 mRNA PMID:22563483 1302946 Capn11 calpain 11 gene CHEBI:46024 trichostatin A increases expression ISO RGD:1342957 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A results in increased expression of CAPN11 mRNA PMID:28542535 1302946 Capn11 calpain 11 gene CHEBI:46195 paracetamol affects response to substance ISO RGD:1342957 E RGD:6480464 20150825 CTD MESH:D000082 CAPN11 gene polymorphism affects the susceptibility to Acetaminophen PMID:26104854 1302946 Capn11 calpain 11 gene CHEBI:47217 arsane affects methylation ISO RGD:1342957 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of CAPN11 gene PMID:25304211 1302946 Capn11 calpain 11 gene CHEBI:47217 arsane decreases expression ISO RGD:1342957 E RGD:6480464 20240109 CTD MESH:D001151 Arsenic results in decreased expression of CAPN11 mRNA PMID:36861143 1302946 Capn11 calpain 11 gene CHEBI:50131 5-aza-2'-deoxycytidine affects expression ISO RGD:1342957 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine affects the expression of CAPN11 mRNA PMID:23300844 1302946 Capn11 calpain 11 gene CHEBI:51348 tetraphene increases expression ISO RGD:1552037 E RGD:6480464 20160119 CTD MESH:C030935 benz(a)anthracene results in increased expression of CAPN11 mRNA PMID:26377693 1302946 Capn11 calpain 11 gene CHEBI:52497 maneb multiple interactions ISO RGD:1552037 E RGD:6480464 20121113 CTD MESH:D008344 [Paraquat co-treated with Maneb] affects the expression of CAPN11 mRNA PMID:22563483 1302947 Prss59 protease, serine 59 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1552038 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased expression of PRSS59 mRNA PMID:35295148 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1353438 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of TACC3 mRNA PMID:38218311 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:132267 triptonide affects expression ISO RGD:1550045 E RGD:6480464 20210406 CTD MESH:C084079 triptonide affects the expression of TACC3 mRNA PMID:33045310 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1550045 E RGD:6480464 20120918 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TACC3 mRNA PMID:20188158 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:15354 choline multiple interactions ISO RGD:1550045 E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene PMID:20938992 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:15365 acetylsalicylic acid decreases expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D001241 Aspirin results in decreased expression of TACC3 mRNA PMID:15928584 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:15368 acrolein multiple interactions ISO RGD:1353438 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA PMID:32699268 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:15379 dioxygen decreases expression ISO RGD:1353438 E RGD:6480464 20160119 CTD MESH:D010100 Oxygen deficiency results in decreased expression of TACC3 mRNA PMID:26516004 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D006861 Hydrogen Peroxide affects the expression of TACC3 mRNA PMID:20044591 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol affects the expression of TACC3 mRNA PMID:32145629 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1353438 E RGD:6480464 20130122 CTD MESH:D004958 Estradiol results in increased expression of TACC3 mRNA PMID:16474171|PMID:19167446|PMID:20106945 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1550045 E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in increased expression of TACC3 mRNA PMID:19484750 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D004958 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA PMID:32741896 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1353438 E RGD:6480464 20230801 CTD MESH:D004958 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of TACC3 mRNA PMID:22217510 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1550045 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA PMID:25510870 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of TACC3 mRNA PMID:33387578 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16602 trichloroethene increases expression ISO RGD:1550045 E RGD:6480464 20150310 CTD MESH:D014241 Trichloroethylene results in increased expression of TACC3 mRNA PMID:25549359 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1550045 E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene PMID:20938992 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1353438 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of TACC3 mRNA PMID:37042841 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:17347 testosterone decreases expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of TACC3 mRNA PMID:21592394 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D013739 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA PMID:32741896 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA PMID:21592394 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:1353438 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of TACC3 protein PMID:37730182 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:17823 calcitriol decreases expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in decreased expression of TACC3 mRNA PMID:21592394 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA PMID:21592394 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:20993 aldehydo-D-glucosamine decreases expression EXP E RGD:6480464 20120501 CTD MESH:D005944 Glucosamine results in decreased expression of TACC3 mRNA PMID:17109745 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1353438 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of TACC3 mRNA PMID:19549813 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:1353438 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TACC3 protein PMID:23301498 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of TACC3 protein PMID:20106945 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20140610 CTD MESH:D016604 Aflatoxin B1 results in increased expression of TACC3 mRNA PMID:23630614|PMID:25378103 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1353438 E RGD:6480464 20150414 CTD MESH:D009151 Mustard Gas results in decreased expression of TACC3 mRNA PMID:25102026 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:25812 ozone decreases expression ISO RGD:1550045 E RGD:6480464 20140408 CTD MESH:D010126 Ozone results in decreased expression of TACC3 mRNA PMID:24336422 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:25812 ozone increases expression ISO RGD:1550045 E RGD:6480464 20150609 CTD MESH:D010126 Ozone results in increased expression of TACC3 mRNA PMID:25658374 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:25812 ozone multiple interactions ISO RGD:1353438 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TACC3 mRNA PMID:32699268 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:25812 ozone multiple interactions ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TACC3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TACC3 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of TACC3 mRNA] PMID:19555225|PMID:27106289|PMID:34911549 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27385 tetrachloromethane affects expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride affects the expression of TACC3 mRNA PMID:17484886 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1550045 E RGD:6480464 20160822 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of TACC3 mRNA PMID:27339419|PMID:29987408|PMID:31919559 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1353438 E RGD:6480464 20151110 CTD MESH:D005492 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA PMID:24657277 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1550045 E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene PMID:20938992 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1353438 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of TACC3 gene PMID:25304211 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:2762 antimycin A increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:D000968 Antimycin A results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:1353438 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of TACC3 protein PMID:35688186 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of TACC3 mRNA PMID:31881176 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1353438 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA PMID:19167446 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27889 lead(0) affects expression ISO RGD:1353438 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of TACC3 mRNA PMID:28903495 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:27899 cisplatin increases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D002945 Cisplatin results in increased expression of TACC3 mRNA PMID:21151649 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28088 genistein increases expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:D019833 Genistein results in increased expression of TACC3 mRNA PMID:16474171 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of TACC3 mRNA PMID:33387578 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of TACC3 mRNA PMID:34747641 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA PMID:17942748 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28201 rotenone decreases expression ISO RGD:1353438 E RGD:6480464 20181016 CTD MESH:D012402 Rotenone results in decreased expression of TACC3 mRNA PMID:29955902 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28201 rotenone increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:D012402 Rotenone results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:1353438 E RGD:6480464 20160119 CTD MESH:C004925 methylmercuric chloride results in increased expression of TACC3 mRNA PMID:26272509 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28216 methylmercury chloride multiple interactions ISO RGD:1353438 E RGD:6480464 20161025 CTD MESH:C004925 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA PMID:27188386 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1353438 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of TACC3 protein PMID:33212167 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28393 beta-D-glucosamine decreases expression EXP E RGD:6480464 20120501 CTD MESH:D005944 Glucosamine results in decreased expression of TACC3 mRNA PMID:17109745 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1353438 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA PMID:20971185 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:28794 coumarin decreases phosphorylation ISO RGD:1353438 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in decreased phosphorylation of TACC3 protein PMID:35688186 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1353438 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of TACC3 mRNA PMID:38568856 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1353438 E RGD:6480464 20171010 CTD MESH:C017947 sodium arsenite results in increased expression of TACC3 mRNA PMID:28595984|PMID:29301061|PMID:34032870 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:29699 tunicamycin decreases expression ISO RGD:1353438 E RGD:6480464 20141014 CTD MESH:D014415 Tunicamycin results in decreased expression of TACC3 mRNA PMID:22378314|PMID:29453283 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1550045 E RGD:6480464 20120501 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of TACC3 mRNA PMID:17942131|PMID:19770486 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of TACC3 mRNA PMID:20504355|PMID:27195522|PMID:32417428 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1353438 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA PMID:20971185 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30512 silver atom decreases expression ISO RGD:1353438 E RGD:6480464 20160210 CTD MESH:D012834 Silver results in decreased expression of TACC3 mRNA PMID:26551752 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1353438 E RGD:6480464 20221004 CTD MESH:D012822 Silicon Dioxide results in decreased expression of TACC3 mRNA PMID:34973136 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1550045 E RGD:6480464 20200310 CTD MESH:D012822 Silicon Dioxide results in increased expression of TACC3 mRNA PMID:29341224 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1353438 E RGD:6480464 20160119 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TACC3 mRNA PMID:19150397|PMID:20382639|PMID:26238291 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:30778 gallic acid decreases expression ISO RGD:1353438 E RGD:6480464 20210907 CTD MESH:D005707 Gallic Acid results in decreased expression of TACC3 mRNA PMID:34408198 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:31941 oxaliplatin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA PMID:25729387 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1550045 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of TACC3 gene PMID:35295148 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1550045 E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in increased expression of TACC3 mRNA PMID:23557971 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of TACC3 mRNA PMID:34492290 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32509 pirinixic acid affects expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of TACC3 mRNA PMID:19136022 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1550045 E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of TACC3 mRNA PMID:17950772|PMID:21318169|PMID:23811191 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:C006253 PPARA protein affects the reaction [pirinixic acid results in increased expression of TACC3 mRNA]; PPARA protein promotes the reaction [pirinixic acid results in increased expression of TACC3 mRNA] PMID:17950772|PMID:21318169 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32585 4-hydroxynon-2-enal decreases expression ISO RGD:1550045 E RGD:6480464 20120814 CTD MESH:C027576 4-hydroxy-2-nonenal results in decreased expression of TACC3 mRNA PMID:19191707 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:32585 4-hydroxynon-2-enal increases expression ISO RGD:1550045 E RGD:6480464 20120814 CTD MESH:C027576 4-hydroxy-2-nonenal results in increased expression of TACC3 mRNA PMID:19191707 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:1353438 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TACC3 mRNA PMID:38479592 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A affects binding ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:C006780 bisphenol A binds to TACC3 protein PMID:20403423 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1353438 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of TACC3 mRNA PMID:30903817 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of TACC3 mRNA PMID:25181051|PMID:30816183 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1353438 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of TACC3 mRNA; bisphenol A results in decreased expression of TACC3 protein PMID:29275510|PMID:37567409 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1353438 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of TACC3 gene PMID:31601247 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in increased expression of TACC3 mRNA PMID:32145629 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1353438 E RGD:6480464 20120412 CTD MESH:C006780 bisphenol A results in increased expression of TACC3 mRNA PMID:16474171 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:3387 carbamazepine affects expression ISO RGD:1353438 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of TACC3 mRNA PMID:25979313 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34031 1,1-dichloroethene increases expression ISO RGD:1550045 E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of TACC3 mRNA PMID:26682919 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1550045 E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA PMID:25510870 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1550045 E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TACC3 mRNA PMID:25510870 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20140408 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TACC3 mRNA PMID:23196670 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34565 benzo[b]fluoranthene increases expression ISO RGD:1550045 E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of TACC3 mRNA PMID:26377693 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1550045 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of TACC3 mRNA PMID:37019170 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34682 diazinon affects expression EXP E RGD:6480464 20141014 CTD MESH:D003976 Diazinon affects the expression of TACC3 mRNA PMID:22546817 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1550045 E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of TACC3 mRNA PMID:17361019 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1353438 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of TACC3 mRNA PMID:37042841 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35299 dibenz[a,h]anthracene increases expression ISO RGD:1550045 E RGD:6480464 20160119 CTD MESH:C026486 1,2,5,6-dibenzanthracene results in increased expression of TACC3 mRNA PMID:26377693 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35455 1-naphthyl isothiocyanate increases expression EXP E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of TACC3 mRNA PMID:30723492 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550045 E RGD:6480464 20121009 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of TACC3 mRNA PMID:22698814 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1550045 E RGD:6480464 20230704 CTD MESH:C018021 cobaltous chloride results in decreased expression of TACC3 protein PMID:36739938 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1353438 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of TACC3 mRNA PMID:24449571 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:36386 dichloroacetic acid increases expression ISO RGD:1550045 E RGD:6480464 20171114 CTD MESH:D003999 Dichloroacetic Acid results in increased expression of TACC3 mRNA PMID:28962523 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:1353438 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TACC3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TACC3 mRNA PMID:32699268 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:38604 pyrimidifen increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:C476509 pyrimidifen results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1353438 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of TACC3 mRNA PMID:31533062 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:3908 coumestrol increases expression ISO RGD:1353438 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in increased expression of TACC3 mRNA PMID:19167446 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:3908 coumestrol multiple interactions ISO RGD:1353438 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA PMID:19167446 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550045 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TACC3 mRNA PMID:36331819 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1353438 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of TACC3 gene PMID:29154799 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1353438 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of TACC3 mRNA PMID:20106945|PMID:21632981|PMID:25562108 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of TACC3 mRNA PMID:17942131 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:40909 azoxystrobin increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:C087670 azoxystrobin results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:41774 tamoxifen affects expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of TACC3 mRNA PMID:17555576 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:41922 diethylstilbestrol increases expression EXP E RGD:6480464 20230905 CTD MESH:D004054 Diethylstilbestrol results in increased expression of TACC3 mRNA PMID:36653537 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4357 deguelin increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:C107676 deguelin results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:44185 methotrexate multiple interactions ISO RGD:1353438 E RGD:6480464 20151110 CTD MESH:D008727 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA PMID:24657277 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:45863 paclitaxel decreases expression ISO RGD:1353438 E RGD:6480464 20161213 CTD MESH:D017239 Paclitaxel results in decreased expression of TACC3 protein PMID:15907983 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of TACC3 mRNA PMID:33387578 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in decreased expression of TACC3 mRNA PMID:17942131 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:46195 paracetamol increases expression ISO RGD:1353438 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of TACC3 mRNA PMID:22230336 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:46557 zoledronic acid decreases expression ISO RGD:1353438 E RGD:6480464 20161213 CTD MESH:C088658 zoledronic acid results in decreased expression of TACC3 mRNA PMID:24714768 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:47217 arsane affects methylation ISO RGD:1353438 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of TACC3 gene PMID:25304211 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of TACC3 mRNA PMID:29391264 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:47977 2-amino-2-deoxy-D-glucopyranose decreases expression EXP E RGD:6480464 20120501 CTD MESH:D005944 Glucosamine results in decreased expression of TACC3 mRNA PMID:17109745 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of TACC3 mRNA PMID:17351261 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of TACC3 mRNA PMID:17555576 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of TACC3 mRNA PMID:17942748 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA PMID:17942748 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:5011 fenpyroximate increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:C415144 fenpyroximate results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1550045 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of TACC3 mRNA; Nanotubes, Carbon results in increased expression of TACC3 mRNA PMID:25554681 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1550045 E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in increased expression of TACC3 mRNA PMID:19042947 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1353438 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of TACC3 protein PMID:32959892 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:63632 topotecan multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA PMID:25729387 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:63933 Aroclor 1254 decreases expression ISO RGD:1550045 E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of TACC3 mRNA PMID:23650126 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:6402 leflunomide decreases expression ISO RGD:1353438 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of TACC3 mRNA PMID:28988120 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20220705 CTD MESH:D008012 Lidocaine results in increased expression of TACC3 mRNA PMID:35283115 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:67895 corosolic acid decreases expression ISO RGD:1353438 E RGD:6480464 20240430 CTD MESH:C113861 corosolic acid results in decreased expression of TACC3 mRNA PMID:37939859 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1550045 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of TACC3 mRNA PMID:22206623 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:75455 2-palmitoylglycerol increases expression ISO RGD:1353438 E RGD:6480464 20240109 CTD MESH:C114956 2-palmitoylglycerol results in increased expression of TACC3 mRNA PMID:37199045 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:7553 niclosamide decreases expression ISO RGD:1353438 E RGD:6480464 20191114 CTD MESH:D009534 Niclosamide results in decreased expression of TACC3 mRNA PMID:28284560 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions EXP E RGD:6480464 20210406 CTD MESH:C074283 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TACC3 mRNA PMID:32741896 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:78492 diallyl trisulfide decreases expression ISO RGD:1353438 E RGD:6480464 20230905 CTD MESH:C042577 diallyl trisulfide results in decreased expression of TACC3 mRNA PMID:34995734 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1353438 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA PMID:27188386 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1550045 E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of TACC3 mRNA PMID:19136022|PMID:23091169 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in increased expression of TACC3 mRNA PMID:19482888 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:8069 phenobarbital multiple interactions ISO RGD:1550045 E RGD:6480464 20120412 CTD MESH:D010634 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TACC3 mRNA] PMID:19482888 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:81520 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1550045 E RGD:6480464 20200114 CTD MESH:C070055 2,3',4,4',5-pentachlorobiphenyl results in increased expression of TACC3 mRNA PMID:31388691 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:81543 Tributyltin oxide decreases expression ISO RGD:1550045 E RGD:6480464 20161213 CTD MESH:C005961 bis(tri-n-butyltin)oxide results in decreased expression of TACC3 mRNA PMID:17942131|PMID:18958704 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:1353438 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA PMID:19167446 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1550045 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of TACC3 mRNA PMID:38648751 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1353438 E RGD:6480464 20191112 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TACC3 mRNA PMID:31173147 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:82362 N-Nitrosopyrrolidine decreases expression ISO RGD:1353438 E RGD:6480464 20200714 CTD MESH:D009242 N-Nitrosopyrrolidine results in decreased expression of TACC3 mRNA PMID:32234424 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:82436 decabromodiphenyl ether decreases expression EXP E RGD:6480464 20141111 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of TACC3 mRNA PMID:23640034 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of TACC3 mRNA PMID:24780913 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:85993 palbociclib decreases expression ISO RGD:1353438 E RGD:6480464 20200331 CTD MESH:C500026 palbociclib results in decreased expression of TACC3 mRNA PMID:28620137 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:87368 diethyl malate increases expression ISO RGD:1353438 E RGD:6480464 20240702 CTD MESH:C058705 diethyl malate results in increased expression of TACC3 mRNA PMID:38498338 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:90724 AM-251 decreases expression ISO RGD:1353438 E RGD:6480464 20170303 CTD MESH:C103505 AM 251 results in decreased expression of TACC3 mRNA PMID:16500647 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1353438 E RGD:6480464 20161228 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TACC3 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA PMID:27188386|PMID:37664457 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:9141 silver(0) decreases expression ISO RGD:1353438 E RGD:6480464 20160210 CTD MESH:D012834 Silver results in decreased expression of TACC3 mRNA PMID:26551752 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:9422 tebufenpyrad increases expression ISO RGD:1353438 E RGD:6480464 20210810 CTD MESH:C429623 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of TACC3 mRNA PMID:33512557 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:9495 thiram decreases expression ISO RGD:1353438 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of TACC3 mRNA PMID:38568856 1302948 Tacc3 transforming, acidic coiled-coil containing protein 3 gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in decreased expression of TACC3 mRNA PMID:23555832 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:132082 entinostat increases expression ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:132267 triptonide decreases expression ISO RGD:1332359 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of TANC1 mRNA PMID:33045310 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20201215 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TANC1 mRNA PMID:30071829 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1604561 E RGD:6480464 20140408 CTD MESH:D014212 Tretinoin results in increased expression of TANC1 mRNA; Tretinoin results in increased expression of TANC1 protein PMID:21934132|PMID:23724009|PMID:30093655 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1332359 E RGD:6480464 20191112 CTD MESH:D014212 [bisphenol F co-treated with Tretinoin] results in decreased expression of TANC1 mRNA PMID:30951980 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:15379 dioxygen affects methylation ISO RGD:1332359 E RGD:6480464 20140114 CTD MESH:D010100 Oxygen deficiency affects the methylation of TANC1 promoter PMID:24205000 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:15379 dioxygen increases expression ISO RGD:1332359 E RGD:6480464 20140114 CTD MESH:D010100 Oxygen deficiency results in increased expression of TANC1 mRNA PMID:24205000 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:16236 ethanol affects expression ISO RGD:1332359 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of TANC1 mRNA PMID:30319688 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1604561 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TANC1 mRNA PMID:35811015 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1332359 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA PMID:25510870 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:16602 trichloroethene increases methylation EXP E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in increased methylation of TANC1 gene PMID:27618143 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1604561 E RGD:6480464 20120412 CTD MESH:D005557 Formaldehyde results in decreased expression of TANC1 mRNA PMID:20655997 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:16842 formaldehyde increases expression ISO RGD:1604561 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in increased expression of TANC1 mRNA PMID:23649840 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17347 testosterone decreases expression ISO RGD:1604561 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of TANC1 mRNA PMID:21592394 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1604561 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in decreased expression of TANC1 mRNA PMID:21592394 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:177802 Cuprizon decreases expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in decreased expression of TANC1 mRNA PMID:27523638 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:1604561 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of TANC1 protein PMID:37730182 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17823 calcitriol decreases expression ISO RGD:1604561 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in decreased expression of TANC1 mRNA PMID:21592394 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1604561 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in decreased expression of TANC1 mRNA PMID:21592394 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of TANC1 mRNA PMID:33387578 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:17967 urethane increases expression ISO RGD:1604561 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of TANC1 mRNA PMID:28818685 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1604561 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of TANC1 mRNA PMID:23649840 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1604561 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of TANC1 gene PMID:27153756 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1604561 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of TANC1 mRNA PMID:23649840 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:1604561 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of TANC1 mRNA PMID:26272509 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1604561 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:27732 caffeine increases phosphorylation ISO RGD:1604561 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in increased phosphorylation of TANC1 protein PMID:35688186 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:27744 glyphosate affects methylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the methylation of TANC1 gene PMID:35440735 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:27899 cisplatin decreases expression ISO RGD:1604561 E RGD:6480464 20120814 CTD MESH:D002945 Cisplatin results in decreased expression of TANC1 mRNA PMID:19561079 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1604561 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of TANC1 mRNA PMID:24768652|PMID:25583101 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1604561 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of TANC1 mRNA PMID:20106945|PMID:21632981 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of TANC1 mRNA PMID:34747641 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1604561 E RGD:6480464 20150512 CTD MESH:D003300 [Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA PMID:24690739 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28748 doxorubicin affects methylation EXP E RGD:6480464 20180116 CTD MESH:D004317 Doxorubicin affects the methylation of TANC1 gene PMID:28962528 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:28794 coumarin decreases phosphorylation ISO RGD:1604561 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in decreased phosphorylation of TANC1 protein PMID:35688186 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1604561 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of TANC1 5' UTR PMID:27901495 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1332359 E RGD:6480464 20120501 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of TANC1 mRNA PMID:19770486 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1604561 E RGD:6480464 20160119 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of TANC1 mRNA PMID:20106945|PMID:21632981|PMID:26238291 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1604561 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of TANC1 promoter PMID:27901495 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of TANC1 mRNA PMID:21839799 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1332359 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of TANC1 intron PMID:27901495 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1604561 E RGD:6480464 20150512 CTD MESH:D003300 [Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA PMID:24690739 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:30563 silicon dioxide decreases expression EXP E RGD:6480464 20240806 CTD MESH:D012822 Silicon Dioxide results in decreased expression of TANC1 mRNA PMID:34779285 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1604561 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TANC1 mRNA PMID:19150397 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1604561 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of TANC1 protein PMID:30093655 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1604561 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of TANC1 gene PMID:31601247 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:3179 bromobenzene increases expression EXP E RGD:6480464 20200915 CTD MESH:C032036 bromobenzene results in increased expression of TANC1 mRNA PMID:32479839 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1332359 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TANC1 mRNA PMID:19710929 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of TANC1 mRNA PMID:32145629|PMID:34947998 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of TANC1 mRNA PMID:25181051 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1604561 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in increased expression of TANC1 mRNA PMID:29275510 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of TANC1 gene PMID:28505145 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:3387 carbamazepine affects expression ISO RGD:1604561 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of TANC1 mRNA PMID:25979313 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1332359 E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA PMID:25510870 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1332359 E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TANC1 mRNA PMID:25510870 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1332359 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of TANC1 gene PMID:31683443 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34565 benzo[b]fluoranthene decreases expression ISO RGD:1332359 E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in decreased expression of TANC1 mRNA PMID:26377693 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1332359 E RGD:6480464 20191112 CTD MESH:C008745 [bisphenol F co-treated with Tretinoin] results in decreased expression of TANC1 mRNA PMID:30951980 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1604561 E RGD:6480464 20220308 CTD MESH:C008745 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of TANC1 gene PMID:31601247 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1332359 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of TANC1 mRNA PMID:37019170 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:1332359 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of TANC1 mRNA PMID:21266533 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:34696 dieldrin affects methylation ISO RGD:1332359 E RGD:6480464 20241105 CTD MESH:D004026 Dieldrin affects the methylation of TANC1 gene PMID:38995845 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1604561 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of TANC1 mRNA PMID:29024780 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of TANC1 mRNA PMID:24449571 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:1604561 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of TANC1 mRNA PMID:25979313 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:39867 valproic acid increases expression ISO RGD:1604561 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of TANC1 mRNA PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1604561 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:46024 trichostatin A increases expression ISO RGD:1604561 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in increased expression of TANC1 mRNA PMID:24935251 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:46195 paracetamol affects expression ISO RGD:1332359 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of TANC1 mRNA PMID:17562736 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:46195 paracetamol increases expression ISO RGD:1604561 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of TANC1 mRNA PMID:22230336 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:4659 disulfiram multiple interactions ISO RGD:1604561 E RGD:6480464 20150512 CTD MESH:D004221 [Disulfiram binds to Copper] which results in increased expression of TANC1 mRNA PMID:24690739 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1604561 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of TANC1 mRNA PMID:35811015 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1604561 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TANC1 mRNA PMID:22079256 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:49639 mercury dibromide increases expression ISO RGD:1604561 E RGD:6480464 20160119 CTD MESH:C042720 mercuric bromide results in increased expression of TANC1 mRNA PMID:26272509 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:49639 mercury dibromide multiple interactions ISO RGD:1604561 E RGD:6480464 20161025 CTD MESH:C042720 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1604561 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of TANC1 protein PMID:30093655 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1332359 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of TANC1 mRNA PMID:25554681 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:5063 fipronil increases expression EXP E RGD:6480464 20140408 CTD MESH:C082360 fipronil results in increased expression of TANC1 mRNA PMID:23962444 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:53050 trimellitic anhydride decreases expression ISO RGD:1332359 E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in decreased expression of TANC1 mRNA PMID:19042947 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:6842 methoxychlor affects methylation EXP E RGD:6480464 20230905 CTD MESH:D008731 Methoxychlor affects the methylation of TANC1 gene PMID:35440735 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:72564 temozolomide increases expression ISO RGD:1604561 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of TANC1 mRNA PMID:31758290 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:73755 1,2-dimethylhydrazine affects expression ISO RGD:1332359 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine affects the expression of TANC1 mRNA PMID:22206623 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:75249 potassium chromate decreases expression ISO RGD:1604561 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of TANC1 mRNA PMID:22079256 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:1604561 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TANC1 mRNA PMID:22079256 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1332359 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in increased expression of TANC1 mRNA PMID:19270015 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:81892 Brodifacoum decreases expression EXP E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in decreased expression of TANC1 protein PMID:28903499 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:85990 panobinostat increases expression ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:C496932 panobinostat results in increased expression of TANC1 mRNA PMID:26272509 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:85990 panobinostat multiple interactions ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1604561 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TANC1 mRNA PMID:27188386 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of TANC1 mRNA PMID:21346803 1302949 Tanc1 tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1332359 E RGD:6480464 20180220 CTD MESH:C057693 troglitazone results in decreased expression of TANC1 mRNA PMID:28973697 1302950 Rnf166 ring finger protein 166 gene CHEBI:132098 methoxyacetic acid increases expression EXP E RGD:6480464 20160607 CTD MESH:C013598 methoxyacetic acid results in increased expression of RNF166 mRNA PMID:20864626 1302950 Rnf166 ring finger protein 166 gene CHEBI:15743 butanal decreases expression ISO RGD:1351592 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in decreased expression of RNF166 mRNA PMID:26079696 1302950 Rnf166 ring finger protein 166 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1351592 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of RNF166 mRNA PMID:35811015 1302950 Rnf166 ring finger protein 166 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1351592 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF166 mRNA PMID:35811015 1302950 Rnf166 ring finger protein 166 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of RNF166 mRNA PMID:33387578 1302950 Rnf166 ring finger protein 166 gene CHEBI:25812 ozone multiple interactions ISO RGD:1351592 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of RNF166 mRNA PMID:35430440 1302950 Rnf166 ring finger protein 166 gene CHEBI:27470 folic acid decreases expression ISO RGD:1615102 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of RNF166 mRNA PMID:25629700 1302950 Rnf166 ring finger protein 166 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1615102 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA] PMID:22206623 1302950 Rnf166 ring finger protein 166 gene CHEBI:27732 caffeine increases expression EXP E RGD:6480464 20120412 CTD MESH:D002110 Caffeine results in increased expression of RNF166 mRNA PMID:20864626 1302950 Rnf166 ring finger protein 166 gene CHEBI:28112 nickel atom increases expression ISO RGD:1351592 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of RNF166 mRNA PMID:24768652|PMID:25583101 1302950 Rnf166 ring finger protein 166 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615102 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of RNF166 mRNA PMID:21570461 1302950 Rnf166 ring finger protein 166 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1351592 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of RNF166 mRNA PMID:20106945|PMID:21632981 1302950 Rnf166 ring finger protein 166 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of RNF166 mRNA PMID:33387578 1302950 Rnf166 ring finger protein 166 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1615102 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF166 mRNA PMID:17942748 1302950 Rnf166 ring finger protein 166 gene CHEBI:28216 methylmercury chloride increases expression EXP E RGD:6480464 20120412 CTD MESH:C004925 methylmercuric chloride results in increased expression of RNF166 mRNA PMID:20864626 1302950 Rnf166 ring finger protein 166 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1351592 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of RNF166 mRNA PMID:33212167 1302950 Rnf166 ring finger protein 166 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1351592 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of RNF166 mRNA PMID:29803840 1302950 Rnf166 ring finger protein 166 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1351592 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of RNF166 mRNA PMID:22714537 1302950 Rnf166 ring finger protein 166 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1615102 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RNF166 mRNA PMID:19710929 1302950 Rnf166 ring finger protein 166 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of RNF166 mRNA PMID:25181051 1302950 Rnf166 ring finger protein 166 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1615102 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of RNF166 promoter PMID:27312807 1302950 Rnf166 ring finger protein 166 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of RNF166 mRNA PMID:34947998 1302950 Rnf166 ring finger protein 166 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1615102 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of RNF166 mRNA PMID:38685157 1302950 Rnf166 ring finger protein 166 gene CHEBI:34761 fenthion decreases expression ISO RGD:1615102 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of RNF166 mRNA PMID:34813904 1302950 Rnf166 ring finger protein 166 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1351592 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of RNF166 mRNA PMID:37042841 1302950 Rnf166 ring finger protein 166 gene CHEBI:38940 sunitinib increases expression ISO RGD:1351592 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of RNF166 mRNA PMID:31533062 1302950 Rnf166 ring finger protein 166 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1351592 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of RNF166 gene PMID:29154799 1302950 Rnf166 ring finger protein 166 gene CHEBI:46024 trichostatin A affects expression ISO RGD:1351592 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of RNF166 mRNA PMID:28542535 1302950 Rnf166 ring finger protein 166 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1351592 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF166 mRNA PMID:35811015 1302950 Rnf166 ring finger protein 166 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1615102 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of RNF166 mRNA PMID:17942748 1302950 Rnf166 ring finger protein 166 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1615102 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF166 mRNA PMID:17942748 1302950 Rnf166 ring finger protein 166 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1615102 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of RNF166 mRNA; Nanotubes, Carbon results in decreased expression of RNF166 mRNA PMID:25554681 1302950 Rnf166 ring finger protein 166 gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1351592 E RGD:6480464 20160705 CTD MESH:C029938 nickel sulfate results in increased expression of RNF166 mRNA PMID:22714537 1302950 Rnf166 ring finger protein 166 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1615102 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA PMID:22206623 1302950 Rnf166 ring finger protein 166 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1615102 E RGD:6480464 20200804 CTD MESH:D019813 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of RNF166 mRNA] PMID:22206623 1302950 Rnf166 ring finger protein 166 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20151103 CTD MESH:C028577 monobutyl phthalate results in increased expression of RNF166 mRNA PMID:20864626 1302950 Rnf166 ring finger protein 166 gene CHEBI:9513 thalidomide multiple interactions ISO RGD:1351592 E RGD:6480464 20180828 CTD MESH:D013792 Thalidomide results in increased degradation of and results in decreased expression of RNF166 protein PMID:30067223 1302950 Rnf166 ring finger protein 166 gene CHEBI:9986 vinclozolin increases expression EXP E RGD:6480464 20150825 CTD MESH:C025643 vinclozolin results in increased expression of RNF166 mRNA PMID:23034163 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:132267 triptonide affects expression ISO RGD:1552047 E RGD:6480464 20210406 CTD MESH:C084079 triptonide affects the expression of COPS4 mRNA PMID:33045310 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1345570 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of COPS4 mRNA PMID:33167477 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:15368 acrolein multiple interactions ISO RGD:1345570 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA PMID:32699268 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:16236 ethanol affects splicing ISO RGD:1552047 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of COPS4 mRNA PMID:30319688 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:16240 hydrogen peroxide decreases expression EXP E RGD:6480464 20130514 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of COPS4 protein PMID:23178681 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20130514 CTD MESH:D006861 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of COPS4 protein] PMID:23178681 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:16243 quercetin decreases expression ISO RGD:1345570 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in decreased expression of COPS4 mRNA PMID:21632981 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:16336 hyaluronic acid multiple interactions EXP E RGD:6480464 20130514 CTD MESH:D006820 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of COPS4 protein] PMID:23178681 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1345570 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of COPS4 mRNA PMID:37042841 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:1345570 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of COPS4 mRNA PMID:21179406 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1345570 E RGD:6480464 20240702 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of COPS4 mRNA PMID:38685446 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of COPS4 mRNA PMID:33387578 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:22977 cadmium atom decreases expression ISO RGD:1345570 E RGD:6480464 20150414 CTD MESH:D002104 Cadmium results in decreased expression of COPS4 mRNA PMID:23369406 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1345570 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of COPS4 mRNA PMID:19549813 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:25812 ozone multiple interactions ISO RGD:1345570 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of COPS4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of COPS4 mRNA PMID:32699268|PMID:35430440 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:2663 amiodarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1345570 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of COPS4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COPS4 protein PMID:38598786 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1552047 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPS4 mRNA PMID:22206623 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552047 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of COPS4 mRNA PMID:21570461 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of COPS4 mRNA PMID:33387578 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552047 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS4 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to COPS4 promoter] PMID:17942748|PMID:19654925 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1345570 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of COPS4 mRNA PMID:29803840 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in decreased expression of COPS4 protein PMID:29459688 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1345570 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of COPS4 mRNA PMID:17879257 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1345570 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of COPS4 promoter PMID:27901495 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1345570 E RGD:6480464 20220405 CTD MESH:C015001 arsenite inhibits the reaction [G3BP1 protein binds to COPS4 protein]; arsenite promotes the reaction [G3BP1 protein binds to COPS4 mRNA] PMID:32406909 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:3023 benzbromarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:3048 benzatropine decreases expression ISO RGD:1345570 E RGD:6480464 20211207 CTD MESH:D001590 Benztropine results in decreased expression of COPS4 protein PMID:34122009 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1552047 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of COPS4 gene PMID:35295148 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:32497 thioacetamide affects expression EXP E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:32509 pirinixic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20160705 CTD MESH:C006780 bisphenol A results in decreased expression of COPS4 mRNA PMID:26982218 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1345570 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in decreased expression of COPS4 protein PMID:34186270 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1552047 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of COPS4 mRNA PMID:33221593 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of COPS4 mRNA PMID:25181051 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1345570 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of COPS4 protein PMID:37567409 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34569 Benzo[k]fluoranthene decreases expression ISO RGD:1552047 E RGD:6480464 20160119 CTD MESH:C022921 benzo(k)fluoranthene results in decreased expression of COPS4 mRNA PMID:26377693 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1345570 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of COPS4 protein PMID:34186270 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1552047 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of COPS4 mRNA PMID:38685157 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:1345570 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of COPS4 protein PMID:34186270 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1552047 E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of COPS4 mRNA PMID:17361019 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of COPS4 mRNA PMID:21266533 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:34768 furfural multiple interactions ISO RGD:1345570 E RGD:6480464 20250114 CTD MESH:D005662 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of COPS4 protein PMID:38598786 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1345570 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of COPS4 mRNA PMID:37042841 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1345570 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of COPS4 mRNA PMID:24449571 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:1345570 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPS4 mRNA PMID:32699268 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:3750 clofibrate affects expression EXP E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:38658 dicrotophos decreases expression ISO RGD:1345570 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of COPS4 mRNA PMID:28302478 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:39867 valproic acid affects expression ISO RGD:1552047 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of COPS4 mRNA PMID:17292431 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1345570 E RGD:6480464 20120412 CTD MESH:D014635 [Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA PMID:17183730 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:46195 paracetamol affects expression ISO RGD:1552047 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of COPS4 mRNA PMID:17562736 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of COPS4 mRNA PMID:33387578 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:4886 L-ethionine affects expression EXP E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1552047 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of COPS4 mRNA PMID:17942748 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1552047 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPS4 mRNA PMID:17942748 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:5062 finasteride increases expression EXP E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of COPS4 mRNA PMID:24136188 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of COPS4 mRNA PMID:24136188 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:5613 haloperidol decreases expression ISO RGD:1345570 E RGD:6480464 20211207 CTD MESH:D006220 Haloperidol results in decreased expression of COPS4 protein PMID:34122009 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:5775 hydralazine multiple interactions ISO RGD:1345570 E RGD:6480464 20120412 CTD MESH:D006830 [Hydralazine co-treated with Valproic Acid] results in increased expression of COPS4 mRNA PMID:17183730 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1345570 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of COPS4 protein PMID:32959892 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:6402 leflunomide increases expression EXP E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of COPS4 mRNA PMID:24136188 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1345570 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of COPS4 protein PMID:34186270 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1552047 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of COPS4 mRNA PMID:22206623 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1552047 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPS4 mRNA PMID:22206623 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:7494 nefazodone increases expression EXP E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in increased expression of COPS4 mRNA PMID:24136188 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:7772 omeprazole affects expression EXP E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:8502 6-propyl-2-thiouracil affects expression EXP E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of COPS4 mRNA PMID:19483382 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:90633 perfluorododecanoic acid increases expression EXP E RGD:6480464 20170303 CTD MESH:C522391 perfluorododecanoic acid results in increased expression of COPS4 protein PMID:26168851 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1345570 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COPS4 protein PMID:37664457 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:9516 thapsigargin decreases expression ISO RGD:1345570 E RGD:6480464 20120613 CTD MESH:D019284 Thapsigargin results in decreased expression of COPS4 protein PMID:21692457 1302952 Cops4 COP9 signalosome subunit 4 gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1345570 E RGD:6480464 20250114 CTD MESH:C010120 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of COPS4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COPS4 protein PMID:38598786 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1615544 E RGD:6480464 20240402 CTD MESH:D014212 Tretinoin results in decreased expression of SPATA21 mRNA PMID:36189433 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1615544 E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPATA21 mRNA PMID:36189433 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:167808 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:1602628 E RGD:6480464 20210406 CTD MESH:C016780 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of SPATA21 gene PMID:30521419 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1615544 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPATA21 mRNA PMID:36189433 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:17967 urethane decreases expression ISO RGD:1602628 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of SPATA21 mRNA PMID:28818685 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression EXP E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in decreased expression of SPATA21 mRNA PMID:28522335 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1602628 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of SPATA21 intron PMID:30157460 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1615544 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of SPATA21 mRNA PMID:28960355 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D019833 [bisphenol A co-treated with Genistein] results in increased methylation of SPATA21 gene PMID:28505145 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of SPATA21 mRNA PMID:33387578 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1602628 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of SPATA21 mRNA PMID:33212167 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1615544 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of SPATA21 protein PMID:28918527 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1602628 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in decreased expression of SPATA21 mRNA PMID:34032870 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1602628 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of SPATA21 intron; Benzo(a)pyrene affects the methylation of SPATA21 promoter PMID:27901495|PMID:30157460 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of SPATA21 mRNA PMID:25181051 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C006780 [bisphenol A co-treated with Genistein] results in increased methylation of SPATA21 gene PMID:28505145 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1615544 E RGD:6480464 20200519 CTD MESH:C543008 bisphenol S results in increased expression of SPATA21 mRNA PMID:31881267 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:34567 benzo[e]pyrene decreases methylation ISO RGD:1602628 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in decreased methylation of SPATA21 intron PMID:30157460 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:37187 lead nitrate decreases expression EXP E RGD:6480464 20170303 CTD MESH:C017461 lead nitrate results in decreased expression of SPATA21 mRNA PMID:21628963 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of SPATA21 mRNA PMID:33387578 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:6820 methapyrilene decreases methylation ISO RGD:1602628 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased methylation of SPATA21 intron PMID:30157460 1302954 Spata21 spermatogenesis associated 21 gene CHEBI:8069 phenobarbital decreases methylation ISO RGD:1615544 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased methylation of SPATA21 gene PMID:19233941 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:116509 diuron decreases expression EXP E RGD:6480464 20141223 CTD MESH:D004237 Diuron results in decreased expression of DDAH2 mRNA PMID:25152437 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:132082 entinostat decreases expression ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in decreased expression of DDAH2 mRNA PMID:26272509|PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:132082 entinostat multiple interactions ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:132267 triptonide decreases expression ISO RGD:1550062 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of DDAH2 mRNA PMID:33045310 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:133246 tetramethylpyrazine multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:C017953 DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D014212 Tretinoin results in decreased expression of DDAH2 mRNA PMID:17218384 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D014212 DDAH2 protein promotes the reaction [Tretinoin inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 mRNA]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 protein] PMID:19156866 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:15379 dioxygen decreases expression EXP E RGD:6480464 20180410 CTD MESH:D010100 Oxygen deficiency results in decreased expression of DDAH2 protein PMID:27313889 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:15379 dioxygen increases expression EXP E RGD:6480464 20180410 CTD MESH:D010100 Oxygen deficiency results in increased expression of DDAH2 mRNA PMID:27313889 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16467 L-arginine multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D001120 Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; Arginine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16469 17beta-estradiol affects expression ISO RGD:1346413 E RGD:6480464 20121218 CTD MESH:D004958 Estradiol affects the expression of DDAH2 mRNA PMID:22574217 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:1346413 E RGD:6480464 20130514 CTD MESH:D004958 Estradiol results in decreased expression of DDAH2 mRNA PMID:23373633 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in increased expression of DDAH2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of DDAH2 mRNA PMID:17404688|PMID:30165855 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16480 nitric oxide multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D009569 DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D008550 Melatonin inhibits the reaction [Methotrexate results in decreased expression of DDAH2 protein] PMID:36890697 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1346413 E RGD:6480464 20140211 CTD MESH:D005557 Formaldehyde results in decreased expression of DDAH2 mRNA; Formaldehyde results in decreased expression of DDAH2 protein PMID:24140967 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17026 progesterone multiple interactions ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D011374 [Progesterone co-treated with Estradiol] results in decreased expression of DDAH2 mRNA PMID:17404688 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17303 morphine increases expression EXP E RGD:6480464 20130416 CTD MESH:D009020 Morphine results in increased expression of DDAH2 protein PMID:23056601 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17303 morphine multiple interactions EXP E RGD:6480464 20130416 CTD MESH:D009020 Morphine deficiency affects the reaction [Morphine deficiency affects the reaction [Morphine results in increased expression of DDAH2 protein]]; Morphine deficiency affects the reaction [Morphine results in increased expression of DDAH2 protein] PMID:23056601 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17578 toluene decreases expression EXP E RGD:6480464 20140408 CTD MESH:D014050 Toluene results in decreased expression of DDAH2 mRNA PMID:22967744 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1550062 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of DDAH2 mRNA PMID:34319233 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:17929 N(omega),N(omega)-dimethyl-L-arginine multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:C018524 [Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine; Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1346413 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of DDAH2 mRNA PMID:19549813 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:24814 indole-3-methanol affects expression EXP E RGD:6480464 20120613 CTD MESH:C016517 indole-3-carbinol affects the expression of DDAH2 mRNA PMID:21396975 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:25812 ozone multiple interactions ISO RGD:1346413 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of DDAH2 mRNA PMID:35430440 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:25812 ozone multiple interactions ISO RGD:1550062 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DDAH2 mRNA PMID:34911549 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:26523 reactive oxygen species multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D017382 DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:2679 amphetamine increases expression EXP E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in increased expression of DDAH2 mRNA PMID:30779732 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27568 selenium atom increases expression ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of DDAH2 mRNA PMID:19244175 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27638 cobalt atom multiple interactions ISO RGD:1346413 E RGD:6480464 20120918 CTD MESH:D003035 [tungsten carbide co-treated with Cobalt] results in decreased expression of DDAH2 mRNA PMID:18078969 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D003609 Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA] PMID:17977009 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of DDAH2 mRNA PMID:31881176 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1346413 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA PMID:19167446 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27899 cisplatin decreases expression ISO RGD:1346413 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in decreased expression of DDAH2 mRNA PMID:27392435 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1346413 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in decreased expression of DDAH2 mRNA PMID:27392435 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28001 vancomycin decreases expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:D014640 Vancomycin results in decreased expression of DDAH2 mRNA PMID:18930951 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28088 genistein affects expression ISO RGD:1346413 E RGD:6480464 20160607 CTD MESH:D019833 Genistein affects the expression of DDAH2 mRNA PMID:26865667 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of DDAH2 mRNA PMID:22298810|PMID:34747641 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550062 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of DDAH2 mRNA PMID:21570461 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of DDAH2 mRNA PMID:19933214 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of DDAH2 mRNA PMID:33212167 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28304 heparin decreases expression EXP E RGD:6480464 20171010 CTD MESH:D006493 Heparin results in decreased expression of DDAH2 protein PMID:17488504 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:1346413 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of DDAH2 mRNA PMID:30851411 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1346413 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of DDAH2 mRNA PMID:29803840 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of DDAH2 mRNA PMID:22714537|PMID:38568856 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1346413 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of DDAH2 promoter PMID:27901495 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1346413 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of DDAH2 mRNA PMID:32234424 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1550062 E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of DDAH2 mRNA PMID:21569818 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1550062 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of DDAH2 mRNA PMID:22228805|PMID:32417428 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1346413 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of DDAH2 gene PMID:31601247 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1550062 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of DDAH2 gene PMID:35295148 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of DDAH2 mRNA PMID:34492290 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33216 bisphenol A affects methylation ISO RGD:1346413 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A affects the methylation of DDAH2 gene PMID:31601247 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of DDAH2 mRNA PMID:25181051 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33216 bisphenol A increases expression ISO RGD:1346413 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of DDAH2 protein PMID:37567409 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33216 bisphenol A increases expression ISO RGD:1550062 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of DDAH2 mRNA PMID:32156529 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1346413 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of DDAH2 gene PMID:31601247 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1550062 E RGD:6480464 20141223 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of DDAH2 mRNA PMID:25172293 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:33234 vitamin E increases expression ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in increased expression of DDAH2 mRNA PMID:19244175 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1550062 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of DDAH2 gene PMID:31683443 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1346413 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of DDAH2 protein PMID:34186270 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34575 bisphenol F increases expression ISO RGD:1346413 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of DDAH2 protein PMID:34186270 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1550062 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of DDAH2 mRNA PMID:37019170 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of DDAH2 mRNA PMID:21266533 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of DDAH2 mRNA PMID:32680482 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20130514 CTD MESH:D010269 Paraquat results in increased expression of DDAH2 mRNA PMID:20388547 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1346413 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of DDAH2 mRNA PMID:37042841 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1346413 E RGD:6480464 20150609 CTD MESH:D019256 Cadmium Chloride results in decreased expression of DDAH2 protein PMID:24419708 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1346413 E RGD:6480464 20150310 CTD MESH:D019256 Cadmium Chloride results in increased expression of DDAH2 protein PMID:24527689 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35559 furan increases expression EXP E RGD:6480464 20170516 CTD MESH:C039281 furan results in increased expression of DDAH2 mRNA PMID:27387713 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20120412 CTD MESH:C018021 cobaltous chloride results in decreased expression of DDAH2 mRNA; cobaltous chloride results in decreased expression of DDAH2 protein PMID:19156866 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1346413 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of DDAH2 mRNA PMID:19376846 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35696 cobalt dichloride multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C018021 DDAH2 protein promotes the reaction [Tretinoin inhibits the reaction [cobaltous chloride results in increased activity of CASP3 protein]]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 mRNA]; Tretinoin inhibits the reaction [cobaltous chloride results in decreased expression of DDAH2 protein] PMID:19156866 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of DDAH2 mRNA PMID:24449571 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:36904 elemental selenium increases expression ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of DDAH2 mRNA PMID:19244175 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:38940 sunitinib decreases expression ISO RGD:1346413 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of DDAH2 mRNA PMID:31533062 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:3908 coumestrol decreases expression ISO RGD:1346413 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in decreased expression of DDAH2 mRNA PMID:19167446 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:3908 coumestrol multiple interactions ISO RGD:1346413 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DDAH2 mRNA PMID:19167446 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:39867 valproic acid affects expression ISO RGD:1346413 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of DDAH2 mRNA PMID:25979313 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:39867 valproic acid decreases expression ISO RGD:1346413 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in decreased expression of DDAH2 mRNA PMID:23179753|PMID:26272509|PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1346413 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1346413 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in decreased expression of DDAH2 mRNA PMID:27989131 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:41774 tamoxifen affects expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of DDAH2 mRNA PMID:17555576 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1550062 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of DDAH2 mRNA PMID:28973697 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:44185 methotrexate decreases expression EXP E RGD:6480464 20231205 CTD MESH:D008727 Methotrexate results in decreased expression of DDAH2 protein PMID:36890697 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:44185 methotrexate multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D008727 Melatonin inhibits the reaction [Methotrexate results in decreased expression of DDAH2 protein] PMID:36890697 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:45716 vorinostat decreases expression ISO RGD:1346413 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of DDAH2 mRNA PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1346413 E RGD:6480464 20160119 CTD MESH:C012589 trichostatin A results in decreased expression of DDAH2 mRNA PMID:24935251|PMID:26272509 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:46024 trichostatin A multiple interactions ISO RGD:1346413 E RGD:6480464 20161025 CTD MESH:C012589 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:46195 paracetamol affects expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of DDAH2 mRNA PMID:17562736 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of DDAH2 mRNA PMID:33387578 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:46345 5-fluorouracil affects response to substance ISO RGD:1346413 E RGD:6480464 20120412 CTD MESH:D005472 DDAH2 protein affects the susceptibility to Fluorouracil PMID:16217747 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:47807 sulforaphane decreases expression ISO RGD:1346413 E RGD:6480464 20200609 CTD MESH:C016766 sulforaphane results in decreased expression of DDAH2 mRNA PMID:31838189 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of DDAH2 mRNA PMID:29391264 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20160607 CTD MESH:D004997 Ethinyl Estradiol affects the expression of DDAH2 mRNA PMID:26865667 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1346413 E RGD:6480464 20160607 CTD MESH:D004997 Ethinyl Estradiol affects the expression of DDAH2 mRNA PMID:26865667 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4903 17alpha-ethynylestradiol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of DDAH2 mRNA PMID:17557909 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of DDAH2 mRNA PMID:17555576 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1550062 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of DDAH2 mRNA PMID:25554681 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1346413 E RGD:6480464 20160705 CTD MESH:C029938 nickel sulfate results in increased expression of DDAH2 mRNA PMID:22714537 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1550062 E RGD:6480464 20120412 CTD MESH:C015559 trimellitic anhydride results in increased expression of DDAH2 mRNA PMID:16141432 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:566274 malonaldehyde multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D008315 DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:6078 ivermectin decreases expression ISO RGD:1346413 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of DDAH2 protein PMID:32959892 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:64022 nebivolol increases activity ISO RGD:1346413 E RGD:6480464 20170303 CTD MESH:D000068577 Nebivolol results in increased activity of DDAH2 protein PMID:17977009 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:64022 nebivolol increases expression ISO RGD:1346413 E RGD:6480464 20170303 CTD MESH:D000068577 Nebivolol results in increased expression of DDAH2 mRNA; Nebivolol results in increased expression of DDAH2 protein PMID:17977009 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:64022 nebivolol multiple interactions ISO RGD:1346413 E RGD:6480464 20170303 CTD MESH:D000068577 Dactinomycin inhibits the reaction [Nebivolol results in increased expression of DDAH2 mRNA] PMID:17977009 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:6456 lidocaine decreases expression EXP E RGD:6480464 20160607 CTD MESH:D008012 Lidocaine results in decreased expression of DDAH2 protein PMID:27018092 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20160607 CTD MESH:D008012 Lidocaine results in increased expression of DDAH2 mRNA PMID:27018092 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1346413 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of DDAH2 protein PMID:34186270 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1550062 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of DDAH2 mRNA PMID:22206623 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:7553 niclosamide increases expression ISO RGD:1346413 E RGD:6480464 20230704 CTD MESH:D009534 Niclosamide results in increased expression of DDAH2 mRNA PMID:36318118 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:77006 17beta-estradiol 3-benzoate increases methylation EXP E RGD:6480464 20180116 CTD MESH:C074283 estradiol 3-benzoate results in increased methylation of DDAH2 promoter PMID:27415467 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:78291 iron dextran decreases expression ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D007505 Iron-Dextran Complex results in decreased expression of DDAH2 protein PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:78291 iron dextran multiple interactions ISO RGD:1346413 E RGD:6480464 20210608 CTD MESH:D007505 [Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine; Arginine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; Arginine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased abundance of Nitric Oxide]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased activity of CAT protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased phosphorylation of NOS3 protein]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Malondialdehyde]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of N,N-dimethylarginine]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased abundance of Reactive Oxygen Species]]; DDAH2 promotes the reaction [tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in increased expression of CASP3 protein modified form]]; tetramethylpyrazine inhibits the reaction [[Iron-Dextran Complex results in decreased expression of DDAH2 protein] which results in increased abundance of N,N-dimethylarginine]; tetramethylpyrazine inhibits the reaction [Iron-Dextran Complex results in decreased expression of DDAH2 protein] PMID:32135237 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:1346413 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of DDAH2 mRNA PMID:30851411 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1346413 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA PMID:27188386 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:1346413 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DDAH2 mRNA PMID:19167446 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:82283 Tungsten carbide multiple interactions ISO RGD:1346413 E RGD:6480464 20170303 CTD MESH:C002802 [tungsten carbide co-treated with Cobalt] results in decreased expression of DDAH2 mRNA PMID:18078969 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of DDAH2 mRNA PMID:24780913 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:88212 lead(II) chloride increases expression ISO RGD:1346413 E RGD:6480464 20151103 CTD MESH:C029891 lead chloride results in increased expression of DDAH2 protein PMID:24419708 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1346413 E RGD:6480464 20161220 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDAH2 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDAH2 mRNA PMID:27188386|PMID:37664457 1302955 Ddah2 DDAH family member 2, ADMA-independent gene CHEBI:9195 Soman increases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of DDAH2 mRNA PMID:19281266 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:116509 diuron decreases expression ISO RGD:1349585 E RGD:6480464 20230905 CTD MESH:D004237 Diuron results in decreased expression of SPINK2 mRNA PMID:35967413 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:132082 entinostat increases expression ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of SPINK2 mRNA PMID:26272509|PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:132082 entinostat multiple interactions ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:136608 Theaflavin 3,3'-digallate affects expression ISO RGD:1349585 E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate affects the expression of SPINK2 mRNA PMID:34925699 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1349585 E RGD:6480464 20120515 CTD MESH:D014212 Tretinoin results in decreased expression of SPINK2 mRNA PMID:15498508 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:15743 butanal increases expression ISO RGD:1349585 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of SPINK2 mRNA PMID:26079696 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:16602 trichloroethene increases methylation EXP E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in increased methylation of SPINK2 gene PMID:27618143 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:17153 propanal increases expression ISO RGD:1349585 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in increased expression of SPINK2 mRNA PMID:26079696 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552067 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of SPINK2 mRNA PMID:34319233 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:2679 amphetamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in decreased expression of SPINK2 mRNA PMID:30779732 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:1349585 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of SPINK2 mRNA PMID:26272509 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1349585 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28088 genistein increases expression ISO RGD:1552067 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in increased expression of SPINK2 mRNA PMID:32186404 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D019833 [bisphenol A co-treated with Genistein] results in increased methylation of SPINK2 gene PMID:28505145 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:1349585 E RGD:6480464 20170516 CTD MESH:C004925 methylmercuric chloride results in decreased expression of SPINK2 mRNA PMID:28001369 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28262 dimethyl sulfoxide affects expression ISO RGD:1349585 E RGD:6480464 20140715 CTD MESH:D004121 Dimethyl Sulfoxide affects the expression of SPINK2 mRNA PMID:24834073 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of SPINK2 mRNA PMID:28959563 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1552067 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of SPINK2 protein PMID:28918527 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1349585 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of SPINK2 promoter PMID:27901495 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1349585 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of SPINK2 mRNA PMID:27829220 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:31767 lead diacetate increases expression ISO RGD:1552067 E RGD:6480464 20150303 CTD MESH:C008261 lead acetate results in increased expression of SPINK2 mRNA PMID:20542052 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:32181 tamibarotene decreases expression ISO RGD:1349585 E RGD:6480464 20120515 CTD MESH:C061133 tamibarotene results in decreased expression of SPINK2 mRNA PMID:15498508 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1552067 E RGD:6480464 20150303 CTD MESH:C009495 titanium dioxide results in decreased expression of SPINK2 mRNA PMID:23557971 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:1552067 E RGD:6480464 20150303 CTD MESH:C006253 pirinixic acid results in decreased expression of SPINK2 mRNA PMID:20813756 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of SPINK2 mRNA PMID:25181051|PMID:30816183 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of SPINK2 gene PMID:28505145 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C006780 [bisphenol A co-treated with Genistein] results in increased methylation of SPINK2 gene PMID:28505145 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:3387 carbamazepine affects expression ISO RGD:1349585 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of SPINK2 mRNA PMID:25979313 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1349585 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of SPINK2 mRNA PMID:38382870 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1349585 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of SPINK2 mRNA PMID:25979313 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:1349585 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in increased expression of SPINK2 mRNA PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1349585 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:46024 trichostatin A increases expression ISO RGD:1349585 E RGD:6480464 20160119 CTD MESH:C012589 trichostatin A results in increased expression of SPINK2 mRNA PMID:24935251|PMID:26272509 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:47381 diclofenac multiple interactions ISO RGD:1552067 E RGD:6480464 20240702 CTD MESH:D004008 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA PMID:37844793 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:4811 epoxiconazole increases expression ISO RGD:1552067 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in increased expression of SPINK2 mRNA PMID:35436446 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1552067 E RGD:6480464 20240702 CTD MESH:D004997 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA PMID:37844793 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1349585 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of SPINK2 mRNA PMID:27829220 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1552067 E RGD:6480464 20150303 CTD MESH:C015559 trimellitic anhydride results in increased expression of SPINK2 mRNA PMID:19042947 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:5855 ibuprofen multiple interactions ISO RGD:1552067 E RGD:6480464 20240702 CTD MESH:D007052 [Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of SPINK2 mRNA PMID:37844793 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:61076 belinostat increases expression ISO RGD:1349585 E RGD:6480464 20170303 CTD MESH:C487081 belinostat results in increased expression of SPINK2 mRNA PMID:26272509 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20220705 CTD MESH:D008012 Lidocaine results in increased expression of SPINK2 mRNA PMID:35283115 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1552067 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of SPINK2 mRNA PMID:38648751 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:82436 decabromodiphenyl ether affects expression ISO RGD:1349585 E RGD:6480464 20141111 CTD MESH:C010902 decabromobiphenyl ether affects the expression of SPINK2 mRNA PMID:24834073 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:84069 pentanal increases expression ISO RGD:1349585 E RGD:6480464 20150825 CTD MESH:C046012 pentanal results in increased expression of SPINK2 mRNA PMID:26079696 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:85990 panobinostat increases expression ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C496932 panobinostat results in increased expression of SPINK2 mRNA PMID:26272509 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:85990 panobinostat multiple interactions ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA PMID:27188386 1302956 Spink2 serine peptidase inhibitor, Kazal type 2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1349585 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPINK2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPINK2 mRNA PMID:27188386 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:15379 dioxygen increases expression ISO RGD:1552068 E RGD:6480464 20121113 CTD MESH:D010100 Oxygen deficiency results in increased expression of KCNE4 mRNA PMID:20880076 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:15379 dioxygen multiple interactions ISO RGD:1552068 E RGD:6480464 20190312 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCNE4 mRNA PMID:30529165 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:15930 atrazine affects methylation EXP E RGD:6480464 20230905 CTD MESH:D001280 Atrazine affects the methylation of KCNE4 gene PMID:35440735 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:164200 triclosan increases expression ISO RGD:1346142 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in increased expression of KCNE4 mRNA PMID:30510588 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1346142 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in increased expression of KCNE4 mRNA PMID:19619570 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1346142 E RGD:6480464 20120412 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in increased expression of KCNE4 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KCNE4 mRNA PMID:19619570|PMID:20660070 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of KCNE4 mRNA PMID:33387578 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:17026 progesterone increases expression ISO RGD:1346142 E RGD:6480464 20130723 CTD MESH:D011374 Progesterone results in increased expression of KCNE4 mRNA PMID:21795739 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:17026 progesterone multiple interactions ISO RGD:1346142 E RGD:6480464 20130723 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in increased expression of KCNE4 mRNA PMID:20660070 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:17967 urethane decreases expression ISO RGD:1346142 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of KCNE4 mRNA PMID:28818685 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1552068 E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCNE4 mRNA PMID:37325564 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:25812 ozone multiple interactions ISO RGD:1552068 E RGD:6480464 20120412 CTD MESH:D010126 pyrazolanthrone promotes the reaction [Ozone results in increased expression of KCNE4 mRNA] PMID:17460151 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:27470 folic acid decreases expression ISO RGD:1552068 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of KCNE4 mRNA PMID:25629700 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:27563 arsenic atom decreases expression ISO RGD:1552068 E RGD:6480464 20120412 CTD MESH:D001151 Arsenic results in decreased expression of KCNE4 mRNA PMID:19654921 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:27889 lead(0) affects expression ISO RGD:1346142 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of KCNE4 mRNA PMID:28903495 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:27899 cisplatin decreases phosphorylation ISO RGD:1552068 E RGD:6480464 20120412 CTD MESH:D002945 Cisplatin results in decreased phosphorylation of KCNE4 protein PMID:22006019 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:28112 nickel atom increases expression ISO RGD:1346142 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of KCNE4 mRNA PMID:25583101 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346142 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of KCNE4 mRNA PMID:19619570 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552068 E RGD:6480464 20180828 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of KCNE4 mRNA PMID:29673856 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1346142 E RGD:6480464 20120412 CTD MESH:D013749 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KCNE4 mRNA PMID:19619570 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1346142 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of KCNE4 mRNA PMID:33212167 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:28748 doxorubicin increases expression ISO RGD:1346142 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of KCNE4 mRNA PMID:29803840 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1346142 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of KCNE4 exon; Benzo(a)pyrene affects the methylation of KCNE4 promoter PMID:27901495 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1552068 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of KCNE4 mRNA PMID:22228805|PMID:27195522 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1552068 E RGD:6480464 20120515 CTD MESH:D001564 Benzo(a)pyrene promotes the reaction [AHR protein binds to KCNE4 promoter] PMID:19654925 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1552068 E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in increased expression of KCNE4 mRNA PMID:23557971 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of KCNE4 mRNA PMID:25181051|PMID:27178563 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1552068 E RGD:6480464 20150825 CTD MESH:C006780 bisphenol A results in decreased expression of KCNE4 mRNA PMID:25594700 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of KCNE4 mRNA PMID:30816183 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1346142 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in increased expression of KCNE4 mRNA PMID:29275510 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1552068 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of KCNE4 mRNA PMID:30951980|PMID:32156529 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1552068 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of KCNE4 mRNA PMID:30951980 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1552068 E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of KCNE4 mRNA PMID:30951980 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1552068 E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCNE4 mRNA PMID:37325564 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:35696 cobalt dichloride increases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in increased expression of KCNE4 mRNA PMID:24386269 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1346142 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of KCNE4 gene PMID:29154799 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1552068 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of KCNE4 mRNA PMID:28973697 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:44185 methotrexate affects expression ISO RGD:1552068 E RGD:6480464 20120412 CTD MESH:D008727 Methotrexate affects the expression of KCNE4 mRNA PMID:18502557 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:46195 paracetamol affects expression ISO RGD:1552068 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of KCNE4 mRNA PMID:17562736 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:46195 paracetamol increases expression ISO RGD:1346142 E RGD:6480464 20180313 CTD MESH:D000082 Acetaminophen results in increased expression of KCNE4 mRNA PMID:26690555 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1346142 E RGD:6480464 20210608 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine results in decreased expression of KCNE4 mRNA PMID:33725128 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:47217 arsane decreases expression ISO RGD:1552068 E RGD:6480464 20140805 CTD MESH:D001151 Arsenic results in decreased expression of KCNE4 mRNA PMID:19654921 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of KCNE4 mRNA PMID:29391264 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1552068 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of KCNE4 mRNA; Nanotubes, Carbon results in increased expression of KCNE4 mRNA PMID:25554681 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1552068 E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in increased expression of KCNE4 mRNA PMID:19042947 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:64163 diquat decreases expression ISO RGD:1552068 E RGD:6480464 20230704 CTD MESH:D004178 Diquat results in decreased expression of KCNE4 mRNA PMID:36851058 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:64211 8-Br-cAMP increases expression ISO RGD:1346142 E RGD:6480464 20121009 CTD MESH:D015124 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNE4 mRNA PMID:22079614 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:7590 nitrofen decreases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in decreased expression of KCNE4 mRNA PMID:33484710 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1346142 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to KCNE4 gene] PMID:28238834 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:79997 GW 4064 increases expression ISO RGD:1552068 E RGD:6480464 20170303 CTD MESH:C412815 GW 4064 results in increased expression of KCNE4 mRNA PMID:26655953 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1552068 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of KCNE4 mRNA PMID:38648751 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1346142 E RGD:6480464 20220510 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether results in increased expression of KCNE4 mRNA PMID:26705709 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of KCNE4 mRNA PMID:24780913 1302957 Kcne4 potassium voltage-gated channel subfamily E regulatory subunit 4 gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1552068 E RGD:6480464 20170303 CTD MESH:C432165 pyrazolanthrone promotes the reaction [Ozone results in increased expression of KCNE4 mRNA] PMID:17460151 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1342499 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ZBTB12 mRNA PMID:38218311 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:132267 triptonide decreases expression ISO RGD:1552092 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ZBTB12 mRNA PMID:33045310 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA] PMID:31150632 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1342499 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of ZBTB12 mRNA PMID:33167477 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:16236 ethanol affects expression ISO RGD:1552092 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of ZBTB12 mRNA PMID:30319688 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1552092 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of ZBTB12 mRNA PMID:34319233 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:17833 gentamycin decreases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ZBTB12 mRNA PMID:33387578 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:17967 urethane decreases expression ISO RGD:1342499 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of ZBTB12 mRNA PMID:28818685 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1342499 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ZBTB12 gene PMID:27153756 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:2679 amphetamine decreases expression EXP E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in decreased expression of ZBTB12 mRNA PMID:30779732 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA PMID:31150632 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZBTB12 mRNA] PMID:31150632 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:27744 glyphosate increases methylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ZBTB12 gene PMID:31011160 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1552092 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of ZBTB12 mRNA PMID:28960355 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1342499 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ZBTB12 mRNA PMID:23557933 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:28088 genistein decreases expression ISO RGD:1552092 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of ZBTB12 mRNA PMID:32186404 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ZBTB12 mRNA PMID:33387578 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1342499 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ZBTB12 mRNA PMID:33212167 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of ZBTB12 mRNA PMID:28959563 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1342499 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ZBTB12 mRNA PMID:32763439 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1342499 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ZBTB12 promoter PMID:27901495 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1342499 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ZBTB12 5' UTR PMID:27901495 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:30512 silver atom decreases expression ISO RGD:1552092 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of ZBTB12 mRNA PMID:27131904 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1552092 E RGD:6480464 20120522 CTD MESH:D012822 Silicon Dioxide results in decreased expression of ZBTB12 mRNA PMID:19073995 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1552092 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ZBTB12 promoter PMID:35295148 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ZBTB12 mRNA PMID:25181051 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1342499 E RGD:6480464 20161025 CTD MESH:C006780 bisphenol A results in increased expression of ZBTB12 mRNA PMID:27685785 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation ISO RGD:1552092 E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of ZBTB12 gene PMID:31683443 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZBTB12 mRNA PMID:35163327 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZBTB12 mRNA PMID:35163327 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of ZBTB12 mRNA PMID:24386269 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:36467 ciguatoxin CTX1B affects expression ISO RGD:1552092 E RGD:6480464 20121009 CTD MESH:D002922 Ciguatoxins affects the expression of ZBTB12 mRNA PMID:18353800 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1342499 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ZBTB12 gene PMID:29154799 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:46195 paracetamol affects expression ISO RGD:1552092 E RGD:6480464 20120522 CTD MESH:D000082 Acetaminophen affects the expression of ZBTB12 mRNA PMID:17562736 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20200915 CTD MESH:D000082 Acetaminophen results in decreased expression of ZBTB12 mRNA PMID:32479839|PMID:33387578 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:64211 8-Br-cAMP increases expression ISO RGD:1342499 E RGD:6480464 20121009 CTD MESH:D015124 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZBTB12 mRNA PMID:22079614 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1552092 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ZBTB12 mRNA PMID:22206623 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZBTB12 mRNA PMID:32109520 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of ZBTB12 mRNA PMID:24780913 1302958 Zbtb12 zinc finger and BTB domain containing 12 gene CHEBI:9141 silver(0) decreases expression ISO RGD:1552092 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of ZBTB12 mRNA PMID:27131904 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRIP2 mRNA] PMID:31150632 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:15756 hexadecanoic acid decreases phosphorylation ISO RGD:1351980 E RGD:6480464 20190702 CTD MESH:D019308 Palmitic Acid results in decreased phosphorylation of CRIP2 protein PMID:28073184 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:15930 atrazine increases expression ISO RGD:1351980 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of CRIP2 mRNA PMID:22378314 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:16236 ethanol multiple interactions ISO RGD:1331956 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of and affects the splicing of CRIP2 mRNA PMID:30319688 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:1351980 E RGD:6480464 20121113 CTD MESH:D006861 Hydrogen Peroxide affects the expression of CRIP2 mRNA PMID:21179406 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:164200 triclosan decreases expression ISO RGD:1351980 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of CRIP2 mRNA PMID:30510588 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of CRIP2 mRNA PMID:32145629 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:16563 tetrahydropalmatine decreases expression ISO RGD:1351980 E RGD:6480464 20170303 CTD MESH:C014215 tetrahydropalmatine results in decreased expression of CRIP2 protein PMID:20109541 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:16602 trichloroethene decreases expression EXP E RGD:6480464 20120412 CTD MESH:D014241 Trichloroethylene results in decreased expression of CRIP2 mRNA PMID:19448997|PMID:33387578 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:17153 propanal increases expression ISO RGD:1351980 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in increased expression of CRIP2 mRNA PMID:26079696 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:17347 testosterone increases expression ISO RGD:1331956 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone deficiency results in increased expression of CRIP2 mRNA PMID:33848595 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1331956 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of CRIP2 mRNA PMID:33754040 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:177802 Cuprizon increases expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of CRIP2 mRNA PMID:26577399 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1351980 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of CRIP2 mRNA PMID:19549813 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1351980 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of CRIP2 protein PMID:20106945 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1331956 E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of CRIP2 mRNA PMID:19770486 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of CRIP2 mRNA PMID:31150632 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CRIP2 mRNA] PMID:31150632 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27504 mitomycin C increases expression ISO RGD:1331956 E RGD:6480464 20150127 CTD MESH:D016685 Mitomycin results in increased expression of CRIP2 mRNA PMID:25270620 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1351980 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRIP2 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of CRIP2 mRNA PMID:38460933 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:1351980 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of CRIP2 protein PMID:35688186 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1331956 E RGD:6480464 20170613 CTD MESH:C024565 ethylene dichloride results in increased expression of CRIP2 mRNA PMID:28189721|PMID:28960355 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1351980 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA PMID:19167446 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27899 cisplatin increases expression ISO RGD:1331956 E RGD:6480464 20160412 CTD MESH:D002945 Cisplatin results in increased expression of CRIP2 mRNA PMID:24280081|PMID:25270620 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27899 cisplatin increases expression ISO RGD:1351980 E RGD:6480464 20160412 CTD MESH:D002945 Cisplatin results in increased expression of CRIP2 mRNA PMID:24280081|PMID:27392435 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1351980 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of CRIP2 mRNA PMID:27392435 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:27958 cocaine affects expression EXP E RGD:6480464 20120412 CTD MESH:D003042 Cocaine affects the expression of CRIP2 mRNA PMID:20187946 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20130611 CTD MESH:D019833 [Genistein co-treated with Methoxychlor] results in decreased expression of CRIP2 mRNA PMID:21782745 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of CRIP2 mRNA PMID:34747641 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331956 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of CRIP2 mRNA PMID:21570461 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20130122 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of CRIP2 mRNA PMID:18796159|PMID:20959002|PMID:21215274|PMID:32109520 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1331956 E RGD:6480464 20160119 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of CRIP2 mRNA PMID:26290441|PMID:28922406 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA PMID:33387578 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1331956 E RGD:6480464 20140715 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA PMID:24713691 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1351980 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of CRIP2 mRNA PMID:20106945 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in increased expression of CRIP2 mRNA PMID:28959563 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28748 doxorubicin affects expression ISO RGD:1351980 E RGD:6480464 20180515 CTD MESH:D004317 Doxorubicin affects the expression of CRIP2 mRNA; Doxorubicin affects the expression of CRIP2 protein PMID:29385562|PMID:29803840 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:28787 nitroglycerin decreases expression EXP E RGD:6480464 20120412 CTD MESH:D005996 Nitroglycerin results in decreased expression of CRIP2 mRNA PMID:12102619 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29073 L-ascorbic acid increases expression EXP E RGD:6480464 20120515 CTD MESH:D001205 Ascorbic Acid results in increased expression of CRIP2 mRNA PMID:15372504 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29678 sodium arsenite affects expression ISO RGD:1351980 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite affects the expression of CRIP2 mRNA PMID:34032870 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29678 sodium arsenite affects methylation ISO RGD:1351980 E RGD:6480464 20171114 CTD MESH:C017947 sodium arsenite affects the methylation of CRIP2 gene PMID:28589171 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1331956 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in increased expression of CRIP2 protein PMID:29044176 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1351980 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of CRIP2 promoter PMID:27901495 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1331956 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of CRIP2 mRNA PMID:22228805 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1351980 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of CRIP2 mRNA PMID:32234424 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29866 arsenite(3-) increases expression ISO RGD:1331956 E RGD:6480464 20241105 CTD MESH:C015001 arsenite results in increased expression of CRIP2 protein PMID:37955338 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1351980 E RGD:6480464 20220405 CTD MESH:C015001 arsenite inhibits the reaction [G3BP1 protein binds to CRIP2 protein] PMID:32406909 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:30512 silver atom decreases expression ISO RGD:1331956 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of CRIP2 mRNA PMID:27131904 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1351980 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of CRIP2 mRNA PMID:25895662 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:30614 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1351980 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CRIP2 mRNA PMID:20382639 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of CRIP2 mRNA PMID:16483693 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:3139 bleomycin A2 affects expression EXP E RGD:6480464 20151215 CTD MESH:D001761 Bleomycin affects the expression of CRIP2 protein PMID:25933445 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:31575 ethylparaben increases expression ISO RGD:1351980 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in increased expression of CRIP2 mRNA PMID:37690743 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRIP2 gene PMID:31601247 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:31767 lead diacetate affects expression EXP E RGD:6480464 20230404 CTD MESH:C008261 lead acetate affects the expression of CRIP2 protein PMID:36539177 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1331956 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of CRIP2 gene PMID:35295148 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in decreased expression of CRIP2 mRNA PMID:23411599|PMID:34492290 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of CRIP2 mRNA PMID:19162173 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1331956 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of CRIP2 mRNA PMID:18301758 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of CRIP2 mRNA PMID:30903817 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1351980 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of CRIP2 mRNA PMID:30903817 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of CRIP2 mRNA PMID:25181051 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1331956 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of CRIP2 mRNA PMID:33221593 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1351980 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of CRIP2 protein PMID:37664457 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of CRIP2 gene PMID:31601247 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in increased expression of CRIP2 mRNA PMID:32145629 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1331956 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of CRIP2 mRNA PMID:32156529 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1351980 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of CRIP2 protein PMID:37567409 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:1331956 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of CRIP2 promoter PMID:27312807 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CRIP2 gene PMID:31601247 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of CRIP2 protein PMID:31675489 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP E RGD:6480464 20130122 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CRIP2 mRNA PMID:20959002 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1331956 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in decreased methylation of CRIP2 exon PMID:33297965 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1331956 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of CRIP2 mRNA PMID:37019170 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34648 clofibric acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D002995 Clofibric Acid affects the expression of CRIP2 mRNA PMID:17602206 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34682 diazinon increases methylation ISO RGD:1351980 E RGD:6480464 20141014 CTD MESH:D003976 Diazinon results in increased methylation of CRIP2 gene PMID:22964155 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34905 paraquat increases expression ISO RGD:1351980 E RGD:6480464 20240604 CTD MESH:D010269 Paraquat results in increased expression of CRIP2 protein PMID:34064677 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:34905 paraquat multiple interactions ISO RGD:1331956 E RGD:6480464 20130514 CTD MESH:D010269 [Paraquat co-treated with Maneb] results in decreased expression of CRIP2 mRNA PMID:18386188 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35033 triphenyl phosphate decreases expression EXP E RGD:6480464 20200331 CTD MESH:C005445 triphenyl phosphate results in decreased expression of CRIP2 mRNA PMID:30589522 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35456 cadmium dichloride decreases methylation EXP E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in decreased methylation of CRIP2 promoter PMID:22457795 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1351980 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of CRIP2 mRNA PMID:38568856 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35549 perfluorooctanoic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of CRIP2 mRNA; perfluorooctanoic acid results in decreased expression of CRIP2 protein PMID:19162173|PMID:34958885 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35559 furan decreases expression EXP E RGD:6480464 20160119 CTD MESH:C039281 furan results in decreased expression of CRIP2 mRNA PMID:25539665|PMID:26194646 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression EXP E RGD:6480464 20120412 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of CRIP2 mRNA PMID:19162173 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1331956 E RGD:6480464 20171114 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of CRIP2 mRNA PMID:28903501 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1351980 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of CRIP2 mRNA PMID:19320972 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:3908 coumestrol multiple interactions ISO RGD:1351980 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with resveratrol] results in decreased expression of CRIP2 mRNA PMID:19167446 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of CRIP2 mRNA PMID:19162173 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1331956 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of CRIP2 mRNA PMID:17963808 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1351980 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of CRIP2 mRNA PMID:25979313 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:1331956 E RGD:6480464 20120814 CTD MESH:D014635 Valproic Acid results in increased expression of CRIP2 mRNA PMID:20546886 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:1351980 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of CRIP2 mRNA PMID:23179753 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1351980 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of CRIP2 gene PMID:29154799 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:40036 amitrole increases expression EXP E RGD:6480464 20240702 CTD MESH:D000640 Amitrole results in increased expression of CRIP2 mRNA PMID:38685447 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1351980 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of CRIP2 mRNA PMID:20106945|PMID:25562108|PMID:27989131 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1331956 E RGD:6480464 20120501 CTD MESH:D016572 Cyclosporine results in increased expression of CRIP2 mRNA PMID:19770486 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:41774 tamoxifen increases expression ISO RGD:1331956 E RGD:6480464 20141223 CTD MESH:D013629 Tamoxifen results in increased expression of CRIP2 mRNA PMID:25123088 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression ISO RGD:1351980 E RGD:6480464 20120412 CTD MESH:D017313 Fenretinide results in decreased expression of CRIP2 mRNA PMID:16671099 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1331956 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of CRIP2 mRNA PMID:28973697 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:46195 paracetamol affects expression ISO RGD:1331956 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of CRIP2 mRNA PMID:17562736 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of CRIP2 mRNA PMID:33387578 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:46195 paracetamol increases expression ISO RGD:1351980 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of CRIP2 mRNA PMID:22230336 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1351980 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of CRIP2 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of CRIP2 mRNA PMID:38460933 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:47696 2,4,6-tribromophenol decreases expression ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C004554 2,4,6-tribromophenol results in decreased expression of CRIP2 mRNA PMID:31675489 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:47807 sulforaphane decreases expression ISO RGD:1351980 E RGD:6480464 20200609 CTD MESH:C016766 sulforaphane results in decreased expression of CRIP2 mRNA PMID:31838189 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of CRIP2 mRNA PMID:29391264 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4811 epoxiconazole increases expression ISO RGD:1331956 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in increased expression of CRIP2 mRNA PMID:35436446 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4903 17alpha-ethynylestradiol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of CRIP2 mRNA PMID:17108234 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:4911 etoposide increases expression ISO RGD:1331956 E RGD:6480464 20150127 CTD MESH:D005047 Etoposide results in increased expression of CRIP2 mRNA PMID:25270620 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:50102 N-methyl-N-nitrosourea increases expression ISO RGD:1331956 E RGD:6480464 20150127 CTD MESH:D008770 Methylnitrosourea results in increased expression of CRIP2 mRNA PMID:25270620 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1331956 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of CRIP2 mRNA; Nanotubes, Carbon results in decreased expression of CRIP2 mRNA PMID:25554681 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1331956 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of CRIP2 mRNA PMID:25620056 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:5063 fipronil decreases expression EXP E RGD:6480464 20140408 CTD MESH:C082360 fipronil results in decreased expression of CRIP2 mRNA PMID:23962444 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in decreased expression of CRIP2 mRNA PMID:24136188 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:52497 maneb multiple interactions ISO RGD:1331956 E RGD:6480464 20130514 CTD MESH:D008344 [Paraquat co-treated with Maneb] results in decreased expression of CRIP2 mRNA PMID:18386188 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:52717 bortezomib decreases expression ISO RGD:1351980 E RGD:6480464 20170303 CTD MESH:D000069286 Bortezomib results in decreased expression of CRIP2 mRNA PMID:20977926 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1351980 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of CRIP2 protein PMID:32959892 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:63630 tolcapone increases expression EXP E RGD:6480464 20161213 CTD MESH:C066340 tolcapone results in increased expression of CRIP2 mRNA PMID:24136188 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20120412 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of CRIP2 mRNA PMID:18178546 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:64213 cantharidin decreases expression ISO RGD:1331956 E RGD:6480464 20230704 CTD MESH:D002193 Cantharidin results in decreased expression of CRIP2 mRNA PMID:36907384 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:6842 methoxychlor multiple interactions EXP E RGD:6480464 20130611 CTD MESH:D008731 [Genistein co-treated with Methoxychlor] results in decreased expression of CRIP2 mRNA PMID:21782745 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:72564 temozolomide increases expression ISO RGD:1351980 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of CRIP2 mRNA PMID:31758290 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1331956 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of CRIP2 mRNA PMID:22206623 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:7494 nefazodone decreases expression EXP E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in decreased expression of CRIP2 mRNA PMID:24136188 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:1331956 E RGD:6480464 20160315 CTD MESH:C072553 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CRIP2 mRNA PMID:25566086 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:75249 potassium chromate decreases expression ISO RGD:1351980 E RGD:6480464 20160705 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of CRIP2 mRNA PMID:22714537 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:77013 beta-naphthoflavone decreases expression ISO RGD:1351980 E RGD:6480464 20210406 CTD MESH:D019324 beta-Naphthoflavone results in decreased expression of CRIP2 mRNA PMID:32858204 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1351980 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of CRIP2 mRNA PMID:19159669 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of CRIP2 mRNA PMID:19162173 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:8069 phenobarbital decreases expression ISO RGD:1331956 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of CRIP2 mRNA PMID:19270015 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1331956 E RGD:6480464 20141111 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CRIP2 mRNA PMID:24713691 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CRIP2 protein PMID:31675489 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:81892 Brodifacoum decreases expression EXP E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in decreased expression of CRIP2 protein PMID:28903499 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:82436 decabromodiphenyl ether decreases expression ISO RGD:1351980 E RGD:6480464 20220308 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of CRIP2 protein PMID:31675489 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:8493 Propiverine affects binding EXP E RGD:6480464 20180410 CTD MESH:C015586 propiverine binds to CRIP2 protein PMID:29273565 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of CRIP2 mRNA PMID:24780913 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:9141 silver(0) decreases expression ISO RGD:1331956 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of CRIP2 mRNA PMID:27131904 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:9195 Soman decreases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of CRIP2 mRNA PMID:19281266 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of CRIP2 mRNA PMID:21346803 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:9747 Triptolide increases expression ISO RGD:1331956 E RGD:6480464 20210706 CTD MESH:C001899 triptolide results in increased expression of CRIP2 mRNA PMID:32835833 1302959 Crip2 cysteine-rich protein 2 gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20150825 CTD MESH:C025643 vinclozolin results in decreased expression of CRIP2 mRNA PMID:23034163 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:15948 lycopene decreases expression EXP E RGD:6480464 20170613 CTD MESH:C015329 lycopene results in decreased expression of SCGB1D4 mRNA PMID:15084515 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1606365 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of SCGB1D4 gene PMID:27153756 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:27086 tributylstannane multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in increased expression of SCGB1D4 mRNA PMID:31129395 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1606365 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SCGB1D4 mRNA PMID:23557933 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1606365 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of SCGB1D4 promoter PMID:27901495 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20170613 CTD MESH:D000643 Ammonium Chloride affects the expression of SCGB1D4 mRNA PMID:16483693 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20170613 CTD MESH:C006780 bisphenol A results in decreased expression of SCGB1D4 mRNA PMID:18180321|PMID:25181051 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of SCGB1D4 mRNA PMID:31129395 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with tributyltin] results in increased expression of SCGB1D4 mRNA PMID:31129395 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:33234 vitamin E decreases expression EXP E RGD:6480464 20170613 CTD MESH:D024502 Vitamin E results in decreased expression of SCGB1D4 mRNA PMID:15084515 1302961 Scgb1d4 secretoglobin family 1D member 4 gene CHEBI:82436 decabromodiphenyl ether increases expression EXP E RGD:6480464 20170613 CTD MESH:C010902 decabromobiphenyl ether results in increased expression of SCGB1D4 mRNA PMID:23914054 1302962 Mug2 murinoglobulin 2 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MUG2 mRNA]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PZP mRNA] PMID:31150632 1302962 Mug2 murinoglobulin 2 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1616849 E RGD:6480464 20240402 CTD MESH:D014212 Tretinoin results in decreased expression of MUG2 mRNA PMID:36189433 1302962 Mug2 murinoglobulin 2 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1616849 E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUG2 mRNA PMID:36189433 1302962 Mug2 murinoglobulin 2 gene CHEBI:15443 inulin multiple interactions ISO RGD:1616849 E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MUG2 mRNA PMID:36331819 1302962 Mug2 murinoglobulin 2 gene CHEBI:15930 atrazine increases expression EXP E RGD:6480464 20230606 CTD MESH:D001280 Atrazine results in increased expression of PZP mRNA PMID:36841081 1302962 Mug2 murinoglobulin 2 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20230404 CTD MESH:D000431 Ethanol results in increased expression of PZP protein PMID:19609968 1302962 Mug2 murinoglobulin 2 gene CHEBI:16243 quercetin increases expression EXP E RGD:6480464 20161213 CTD MESH:D011794 Quercetin results in increased expression of MUG2 mRNA PMID:21565894 1302962 Mug2 murinoglobulin 2 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol affects the expression of MUG2 mRNA PMID:32145629 1302962 Mug2 murinoglobulin 2 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D004958 Estradiol results in decreased expression of PZP mRNA PMID:16705744 1302962 Mug2 murinoglobulin 2 gene CHEBI:16602 trichloroethene decreases expression ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:D014241 Trichloroethylene results in decreased expression of MUG2 mRNA PMID:19448997 1302962 Mug2 murinoglobulin 2 gene CHEBI:16602 trichloroethene decreases methylation EXP E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in decreased methylation of MUG2 gene PMID:27618143 1302962 Mug2 murinoglobulin 2 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20230404 CTD MESH:D014241 Trichloroethylene results in increased expression of PZP mRNA PMID:33387578 1302962 Mug2 murinoglobulin 2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1616849 E RGD:6480464 20240402 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of MUG2 mRNA PMID:36189433 1302962 Mug2 murinoglobulin 2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1616849 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MUG2 mRNA PMID:36189433 1302962 Mug2 murinoglobulin 2 gene CHEBI:174733 Licochalcone B decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C541528 licochalcone B results in decreased expression of PZP mRNA PMID:33647349 1302962 Mug2 murinoglobulin 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of PZP mRNA PMID:31163220 1302962 Mug2 murinoglobulin 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1616849 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of MUG2 mRNA PMID:34319233 1302962 Mug2 murinoglobulin 2 gene CHEBI:17833 gentamycin decreases expression EXP E RGD:6480464 20230404 CTD MESH:D005839 Gentamicins results in decreased expression of PZP mRNA PMID:22061828 1302962 Mug2 murinoglobulin 2 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20230404 CTD MESH:D005839 Gentamicins results in increased expression of PZP mRNA PMID:33387578 1302962 Mug2 murinoglobulin 2 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1616849 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MUG2 mRNA PMID:36331819 1302962 Mug2 murinoglobulin 2 gene CHEBI:22977 cadmium atom affects binding ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D002104 PZP protein binds to Cadmium PMID:23896426 1302962 Mug2 murinoglobulin 2 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D019327 Copper Sulfate results in decreased expression of PZP mRNA PMID:19549813 1302962 Mug2 murinoglobulin 2 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of PZP mRNA PMID:27153756 1302962 Mug2 murinoglobulin 2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of PZP gene PMID:27153756 1302962 Mug2 murinoglobulin 2 gene CHEBI:25812 ozone multiple interactions ISO RGD:736140 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of PZP mRNA PMID:35430440 1302962 Mug2 murinoglobulin 2 gene CHEBI:2663 amiodarone affects expression EXP E RGD:6480464 20230404 CTD MESH:D000638 Amiodarone affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:27363 zinc atom affects binding ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D015032 PZP protein binds to Zinc PMID:23896426 1302962 Mug2 murinoglobulin 2 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190611 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of MUG2 mRNA; Carbon Tetrachloride results in decreased expression of PZP mRNA PMID:31150632 1302962 Mug2 murinoglobulin 2 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MUG2 mRNA]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PZP mRNA] PMID:31150632 1302962 Mug2 murinoglobulin 2 gene CHEBI:27856 acetamide decreases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of MUG2 mRNA; acetamide results in decreased expression of PZP mRNA PMID:31881176 1302962 Mug2 murinoglobulin 2 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1616849 E RGD:6480464 20200211 CTD MESH:C059514 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of MUG2 mRNA] PMID:31298478 1302962 Mug2 murinoglobulin 2 gene CHEBI:27889 lead(0) affects binding ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D007854 PZP protein binds to Lead PMID:23896426 1302962 Mug2 murinoglobulin 2 gene CHEBI:28088 genistein decreases expression ISO RGD:1616849 E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of MUG2 mRNA PMID:32186404 1302962 Mug2 murinoglobulin 2 gene CHEBI:28088 genistein increases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D019833 Genistein results in increased expression of PZP mRNA PMID:16705744 1302962 Mug2 murinoglobulin 2 gene CHEBI:28112 nickel atom affects binding ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D009532 PZP protein binds to Nickel PMID:23896426 1302962 Mug2 murinoglobulin 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20230404 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of PZP mRNA PMID:18178546 1302962 Mug2 murinoglobulin 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20230404 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of PZP mRNA; Tetrachlorodibenzodioxin results in increased expression of PZP protein PMID:15822908|PMID:33387578 1302962 Mug2 murinoglobulin 2 gene CHEBI:28262 dimethyl sulfoxide increases expression EXP E RGD:6480464 20230404 CTD MESH:D004121 Dimethyl Sulfoxide results in increased expression of PZP mRNA; Dimethyl Sulfoxide results in increased expression of PZP protein PMID:14757319 1302962 Mug2 murinoglobulin 2 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20230404 CTD MESH:D020106 Acrylamide results in decreased expression of PZP mRNA PMID:28959563 1302962 Mug2 murinoglobulin 2 gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20230404 CTD MESH:D012969 Sodium Fluoride results in decreased expression of PZP protein PMID:29653260 1302962 Mug2 murinoglobulin 2 gene CHEBI:28741 sodium fluoride decreases expression ISO RGD:1616849 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in decreased expression of MUG2 protein PMID:28918527 1302962 Mug2 murinoglobulin 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C017947 sodium arsenite results in decreased expression of PZP mRNA PMID:29301061 1302962 Mug2 murinoglobulin 2 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20230404 CTD MESH:C017947 sodium arsenite results in increased expression of PZP protein PMID:29459688 1302962 Mug2 murinoglobulin 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of PZP mRNA PMID:22316170 1302962 Mug2 murinoglobulin 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of PZP exon; Benzo(a)pyrene results in increased methylation of PZP promoter PMID:27901495 1302962 Mug2 murinoglobulin 2 gene CHEBI:30185 zinc(0) affects binding ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D015032 PZP protein binds to Zinc PMID:23896426 1302962 Mug2 murinoglobulin 2 gene CHEBI:3023 benzbromarone affects expression EXP E RGD:6480464 20230404 CTD MESH:D001553 Benzbromarone affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of PZP mRNA PMID:20458559 1302962 Mug2 murinoglobulin 2 gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20230404 CTD MESH:D000643 Ammonium Chloride affects the expression of PZP mRNA PMID:16483693 1302962 Mug2 murinoglobulin 2 gene CHEBI:3139 bleomycin A2 increases expression EXP E RGD:6480464 20230404 CTD MESH:D001761 Bleomycin results in increased expression of PZP protein PMID:25933445 1302962 Mug2 murinoglobulin 2 gene CHEBI:3179 bromobenzene decreases expression EXP E RGD:6480464 20230404 CTD MESH:C032036 bromobenzene results in decreased expression of PZP mRNA PMID:12628495 1302962 Mug2 murinoglobulin 2 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1616849 E RGD:6480464 20200211 CTD MESH:C009495 titanium dioxide results in increased expression of MUG2 mRNA PMID:31298478 1302962 Mug2 murinoglobulin 2 gene CHEBI:32234 titanium dioxide multiple interactions ISO RGD:1616849 E RGD:6480464 20200211 CTD MESH:C009495 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of MUG2 mRNA] PMID:31298478 1302962 Mug2 murinoglobulin 2 gene CHEBI:32497 thioacetamide affects expression EXP E RGD:6480464 20230404 CTD MESH:D013853 Thioacetamide affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20160621 CTD MESH:D013853 Thioacetamide results in decreased expression of MUG2 mRNA; Thioacetamide results in decreased expression of PZP mRNA PMID:23411599|PMID:34492290 1302962 Mug2 murinoglobulin 2 gene CHEBI:32497 thioacetamide multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D013853 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of MUG2 mRNA PMID:28943392 1302962 Mug2 murinoglobulin 2 gene CHEBI:32509 pirinixic acid affects expression EXP E RGD:6480464 20230404 CTD MESH:C006253 pirinixic acid affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:C006253 pirinixic acid results in decreased expression of MUG2 mRNA PMID:15302862|PMID:16221962|PMID:20813756|PMID:23811191 1302962 Mug2 murinoglobulin 2 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:C006253 [pirinixic acid co-treated with PPARA] results in decreased expression of MUG2 mRNA PMID:20813756 1302962 Mug2 murinoglobulin 2 gene CHEBI:33007 chromium(6+) increases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C074702 chromium hexavalent ion results in increased expression of PZP protein PMID:28596144 1302962 Mug2 murinoglobulin 2 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of MUG2 mRNA; bisphenol A affects the expression of PZP mRNA PMID:30903817|PMID:32145629 1302962 Mug2 murinoglobulin 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230404 CTD MESH:C006780 bisphenol A results in decreased expression of PZP mRNA PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 1302962 Mug2 murinoglobulin 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1616849 E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of MUG2 mRNA PMID:32156529 1302962 Mug2 murinoglobulin 2 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C006780 bisphenol A results in decreased methylation of PZP gene PMID:31601247 1302962 Mug2 murinoglobulin 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250114 CTD MESH:C006780 bisphenol A results in increased expression of PZP mRNA PMID:36779543 1302962 Mug2 murinoglobulin 2 gene CHEBI:3423 carmustine decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D002330 Carmustine results in decreased expression of PZP mRNA PMID:15980968 1302962 Mug2 murinoglobulin 2 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1616849 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of MUG2 mRNA PMID:38685157 1302962 Mug2 murinoglobulin 2 gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20230404 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of PZP mRNA PMID:21266533 1302962 Mug2 murinoglobulin 2 gene CHEBI:34873 N-nitrosodiethylamine increases expression ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:D004052 Diethylnitrosamine results in increased expression of MUG2 mRNA PMID:17942915 1302962 Mug2 murinoglobulin 2 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D004052 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PZP mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of MUG2 mRNA PMID:20360939|PMID:28943392 1302962 Mug2 murinoglobulin 2 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:D004052 MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MUG2 mRNA] PMID:17942915 1302962 Mug2 murinoglobulin 2 gene CHEBI:35456 cadmium dichloride affects expression EXP E RGD:6480464 20230404 CTD MESH:D019256 Cadmium Chloride affects the expression of PZP mRNA PMID:22110744 1302962 Mug2 murinoglobulin 2 gene CHEBI:35549 perfluorooctanoic acid decreases expression EXP E RGD:6480464 20230404 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of PZP mRNA PMID:19162173 1302962 Mug2 murinoglobulin 2 gene CHEBI:35559 furan decreases expression EXP E RGD:6480464 20160621 CTD MESH:C039281 furan results in decreased expression of MUG2 mRNA; furan results in decreased expression of PZP mRNA PMID:25539665|PMID:26194646 1302962 Mug2 murinoglobulin 2 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1616849 E RGD:6480464 20171114 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of MUG2 mRNA PMID:28903501 1302962 Mug2 murinoglobulin 2 gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20230404 CTD MESH:C018021 cobaltous chloride results in decreased expression of PZP mRNA PMID:24386269 1302962 Mug2 murinoglobulin 2 gene CHEBI:3750 clofibrate affects expression EXP E RGD:6480464 20230404 CTD MESH:D002994 Clofibrate affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:38922 dibenzofurans increases expression ISO RGD:1616849 E RGD:6480464 20230704 CTD MESH:D000072318 Dibenzofurans results in increased expression of MUG2 mRNA PMID:34254344 1302962 Mug2 murinoglobulin 2 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1616849 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MUG2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MUG2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MUG2 mRNA PMID:36331819 1302962 Mug2 murinoglobulin 2 gene CHEBI:39483 sodium dichromate affects expression EXP E RGD:6480464 20230404 CTD MESH:C016104 sodium bichromate affects the expression of PZP mRNA PMID:22110744 1302962 Mug2 murinoglobulin 2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D014635 Valproic Acid results in decreased expression of PZP mRNA PMID:29154799 1302962 Mug2 murinoglobulin 2 gene CHEBI:39867 valproic acid increases expression EXP E RGD:6480464 20230404 CTD MESH:D014635 Valproic Acid results in increased expression of PZP mRNA PMID:35594946 1302962 Mug2 murinoglobulin 2 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20230404 CTD MESH:D000082 Acetaminophen affects the expression of PZP protein PMID:16099942 1302962 Mug2 murinoglobulin 2 gene CHEBI:4886 L-ethionine affects expression EXP E RGD:6480464 20230404 CTD MESH:D005001 Ethionine affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of PZP mRNA PMID:20458559 1302962 Mug2 murinoglobulin 2 gene CHEBI:50866 3H-1,2-dithiole-3-thione decreases expression EXP E RGD:6480464 20230404 CTD MESH:C049325 1,2-dithiol-3-thione results in decreased expression of PZP mRNA PMID:19162173 1302962 Mug2 murinoglobulin 2 gene CHEBI:53444 potassium dichromate affects expression ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:D011192 Potassium Dichromate affects the expression of MUG2 mRNA PMID:23608068 1302962 Mug2 murinoglobulin 2 gene CHEBI:6078 ivermectin decreases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D007559 Ivermectin results in decreased expression of PZP protein PMID:32959892 1302962 Mug2 murinoglobulin 2 gene CHEBI:64211 8-Br-cAMP increases expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D015124 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PZP mRNA PMID:22079614 1302962 Mug2 murinoglobulin 2 gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20230404 CTD MESH:D008012 Lidocaine results in increased expression of PZP mRNA PMID:35283115 1302962 Mug2 murinoglobulin 2 gene CHEBI:65585 carnosic acid decreases expression ISO RGD:1616849 E RGD:6480464 20230404 CTD MESH:C018381 salvin results in decreased expression of MUG2 protein PMID:35926579 1302962 Mug2 murinoglobulin 2 gene CHEBI:6801 metformin decreases expression ISO RGD:1616849 E RGD:6480464 20160621 CTD MESH:D008687 Metformin results in decreased expression of MUG2 mRNA PMID:23457588 1302962 Mug2 murinoglobulin 2 gene CHEBI:6842 methoxychlor affects methylation EXP E RGD:6480464 20230905 CTD MESH:D008731 Methoxychlor affects the methylation of MUG2 gene PMID:35440735 1302962 Mug2 murinoglobulin 2 gene CHEBI:72544 flavonoids increases expression EXP E RGD:6480464 20230404 CTD MESH:D005419 Flavonoids results in increased expression of PZP mRNA PMID:18035473 1302962 Mug2 murinoglobulin 2 gene CHEBI:7494 nefazodone decreases expression EXP E RGD:6480464 20230404 CTD MESH:C051752 nefazodone results in decreased expression of PZP mRNA PMID:24136188 1302962 Mug2 murinoglobulin 2 gene CHEBI:75701 sarin increases expression EXP E RGD:6480464 20230404 CTD MESH:D012524 Sarin results in increased expression of PZP protein PMID:26778279 1302962 Mug2 murinoglobulin 2 gene CHEBI:7590 nitrofen increases expression EXP E RGD:6480464 20230404 CTD MESH:C007350 nitrofen results in increased expression of PZP mRNA PMID:33484710 1302962 Mug2 murinoglobulin 2 gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP E RGD:6480464 20230404 CTD MESH:D009853 Omeprazole affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:7772 omeprazole affects expression EXP E RGD:6480464 20230404 CTD MESH:D009853 Omeprazole affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:8062 phenethyl caffeate multiple interactions EXP E RGD:6480464 20230404 CTD MESH:C055494 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PZP mRNA PMID:20360939 1302962 Mug2 murinoglobulin 2 gene CHEBI:8069 phenobarbital affects expression ISO RGD:736140 E RGD:6480464 20230404 CTD MESH:D010634 Phenobarbital affects the expression of PZP mRNA PMID:19159669 1302962 Mug2 murinoglobulin 2 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1616849 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of MUG2 mRNA PMID:38648751 1302962 Mug2 murinoglobulin 2 gene CHEBI:81892 Brodifacoum decreases expression EXP E RGD:6480464 20230404 CTD MESH:C013418 bromfenacoum results in decreased expression of PZP protein PMID:28903499 1302962 Mug2 murinoglobulin 2 gene CHEBI:8502 6-propyl-2-thiouracil affects expression EXP E RGD:6480464 20230404 CTD MESH:D011441 Propylthiouracil affects the expression of PZP mRNA PMID:19483382 1302962 Mug2 murinoglobulin 2 gene CHEBI:90633 perfluorododecanoic acid decreases expression EXP E RGD:6480464 20230404 CTD MESH:C522391 perfluorododecanoic acid results in decreased expression of PZP protein PMID:26168851 1302962 Mug2 murinoglobulin 2 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20160621 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of MUG2 mRNA; 2,4-dinitrotoluene affects the expression of PZP mRNA PMID:21346803 1302962 Mug2 murinoglobulin 2 gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20160621 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of MUG2 mRNA; 2,6-dinitrotoluene affects the expression of PZP mRNA PMID:21346803 1302962 Mug2 murinoglobulin 2 gene CHEBI:9747 Triptolide decreases expression ISO RGD:1616849 E RGD:6480464 20210706 CTD MESH:C001899 triptolide results in decreased expression of MUG2 mRNA PMID:32835833 1302962 Mug2 murinoglobulin 2 gene CHEBI:9986 vinclozolin decreases methylation EXP E RGD:6480464 20211012 CTD MESH:C025643 vinclozolin results in decreased methylation of MUG2 gene PMID:31682807 1302962 Mug2 murinoglobulin 2 gene CHEBI:9986 vinclozolin increases expression EXP E RGD:6480464 20230404 CTD MESH:C025643 vinclozolin results in increased expression of PZP mRNA PMID:23034163 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:1552119 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of DHX16 mRNA PMID:37995155 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:15930 atrazine decreases expression ISO RGD:1344132 E RGD:6480464 20160712 CTD MESH:D001280 Atrazine results in decreased expression of DHX16 mRNA PMID:22378314 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:16236 ethanol affects expression ISO RGD:1552119 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of DHX16 mRNA PMID:30319688 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:1344132 E RGD:6480464 20160712 CTD MESH:C044887 beta-methylcholine affects the expression of DHX16 mRNA PMID:21179406 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:177802 Cuprizon affects expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone affects the expression of DHX16 mRNA PMID:27523638 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:177802 Cuprizon decreases expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in decreased expression of DHX16 mRNA PMID:26577399 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:1344132 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of DHX16 protein PMID:37730182 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552119 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DHX16 mRNA PMID:36331819 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1344132 E RGD:6480464 20160712 CTD MESH:D019327 Copper Sulfate results in decreased expression of DHX16 mRNA PMID:19549813 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:25812 ozone multiple interactions ISO RGD:1344132 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of DHX16 mRNA PMID:35430440 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:2663 amiodarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1344132 E RGD:6480464 20210504 CTD MESH:D001151 Arsenic affects the methylation of DHX16 gene PMID:32603190 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:1344132 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of DHX16 protein PMID:35688186 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:27881 resveratrol decreases expression ISO RGD:1552119 E RGD:6480464 20160822 CTD MESH:C059514 resveratrol results in decreased expression of DHX16 protein PMID:25505154 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552119 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of DHX16 mRNA PMID:21570461 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of DHX16 mRNA PMID:21215274 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of DHX16 mRNA PMID:33387578 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1344132 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of DHX16 mRNA PMID:32763439 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1344132 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of DHX16 promoter PMID:27901495 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:3023 benzbromarone affects expression EXP E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1552119 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of DHX16 gene PMID:35295148 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:32497 thioacetamide affects expression EXP E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:32509 pirinixic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33128 C60 fullerene affects expression EXP E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 affects the expression of DHX16 mRNA PMID:19167457 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of DHX16 mRNA PMID:25181051 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1344132 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of DHX16 protein PMID:33376534 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1344132 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of DHX16 gene PMID:31601247 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of DHX16 mRNA PMID:34947998 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1344132 E RGD:6480464 20220208 CTD MESH:C006780 [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of DHX16 protein] PMID:33376534 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:3423 carmustine decreases expression ISO RGD:1344132 E RGD:6480464 20160712 CTD MESH:D002330 Carmustine results in decreased expression of DHX16 mRNA PMID:15980968 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1552119 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of DHX16 mRNA PMID:38685157 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:34696 dieldrin affects expression EXP E RGD:6480464 20141014 CTD MESH:D004026 Dieldrin affects the expression of DHX16 mRNA PMID:22546817 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1344132 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of DHX16 mRNA PMID:37042841 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:35456 cadmium dichloride decreases methylation EXP E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in decreased methylation of DHX16 promoter PMID:22457795 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:3750 clofibrate affects expression EXP E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552119 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DHX16 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DHX16 mRNA PMID:36331819 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:39867 valproic acid increases expression ISO RGD:1344132 E RGD:6480464 20160712 CTD MESH:D014635 Valproic Acid results in increased expression of DHX16 mRNA PMID:23179753|PMID:29154799 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:47217 arsane affects methylation ISO RGD:1344132 E RGD:6480464 20210504 CTD MESH:D001151 Arsenic affects the methylation of DHX16 gene PMID:32603190 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:4886 L-ethionine affects expression EXP E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:49553 copper(II) chloride increases expression ISO RGD:1344132 E RGD:6480464 20240702 CTD MESH:C029892 cupric chloride results in increased expression of DHX16 mRNA PMID:38568856 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1552119 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DHX16 mRNA PMID:35964746 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of DHX16 mRNA PMID:24136188 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1344132 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of DHX16 protein PMID:32959892 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:6402 leflunomide increases expression EXP E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of DHX16 mRNA PMID:24136188 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:6809 methamphetamine increases expression ISO RGD:1552119 E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in increased expression of DHX16 mRNA PMID:26307267 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:72564 temozolomide increases expression ISO RGD:1344132 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of DHX16 mRNA PMID:31758290 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1552119 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of DHX16 mRNA PMID:22206623 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:7772 omeprazole affects expression EXP E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1344132 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to DHX16 gene] PMID:28238834 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of DHX16 mRNA PMID:19162173 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1552119 E RGD:6480464 20200310 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether affects the expression of DHX16 mRNA PMID:30294300 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:8502 6-propyl-2-thiouracil affects expression EXP E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of DHX16 mRNA PMID:19483382 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of DHX16 mRNA PMID:24780913 1302963 Dhx16 DEAH-box helicase 16 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1552119 E RGD:6480464 20180220 CTD MESH:C057693 troglitazone results in decreased expression of DHX16 mRNA PMID:28973697 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:132267 triptonide increases expression ISO RGD:1621447 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of TSGA10IP mRNA PMID:33045310 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:164200 triclosan decreases expression ISO RGD:1346501 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of TSGA10IP mRNA PMID:30510588 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of TSGA10IP mRNA PMID:33387578 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1346501 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of TSGA10IP mRNA PMID:31163220 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1621447 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of TSGA10IP mRNA PMID:33754040 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1621447 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of TSGA10IP mRNA PMID:28960355 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1346501 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of TSGA10IP mRNA PMID:33212167 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1621447 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of TSGA10IP mRNA PMID:37682722 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1346501 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of TSGA10IP promoter PMID:27901495 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:31575 ethylparaben decreases expression ISO RGD:1346501 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in decreased expression of TSGA10IP mRNA PMID:37690743 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of TSGA10IP mRNA PMID:25181051 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1346501 E RGD:6480464 20191210 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of TSGA10IP mRNA PMID:31326446 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1621447 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of TSGA10IP mRNA PMID:37019170 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in decreased expression of TSGA10IP mRNA PMID:33453195 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1346501 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of TSGA10IP mRNA PMID:38568856 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:39867 valproic acid increases methylation ISO RGD:1346501 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of TSGA10IP gene PMID:29154799 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:46195 paracetamol affects expression ISO RGD:1621447 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of TSGA10IP mRNA PMID:17562736 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:72564 temozolomide decreases expression ISO RGD:1346501 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in decreased expression of TSGA10IP mRNA PMID:31758290 1302964 Tsga10ip testis specific 10 interacting protein gene CHEBI:9986 vinclozolin increases methylation EXP E RGD:6480464 20201215 CTD MESH:C025643 vinclozolin results in increased methylation of TSGA10IP gene PMID:31079544 1302965 Pon3 paraoxonase 3 gene CHEBI:116509 diuron decreases expression EXP E RGD:6480464 20141223 CTD MESH:D004237 Diuron results in decreased expression of PON3 mRNA PMID:21551480|PMID:25152437 1302965 Pon3 paraoxonase 3 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1552156 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of PON3 mRNA PMID:37995155 1302965 Pon3 paraoxonase 3 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA] PMID:31150632 1302965 Pon3 paraoxonase 3 gene CHEBI:15379 dioxygen increases expression ISO RGD:1344009 E RGD:6480464 20160119 CTD MESH:D010100 Oxygen deficiency results in increased expression of PON3 mRNA PMID:26516004 1302965 Pon3 paraoxonase 3 gene CHEBI:15443 inulin multiple interactions ISO RGD:1552156 E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PON3 mRNA PMID:36331819 1302965 Pon3 paraoxonase 3 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of PON3 mRNA PMID:32145629 1302965 Pon3 paraoxonase 3 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of PON3 mRNA PMID:33387578 1302965 Pon3 paraoxonase 3 gene CHEBI:16856 glutathione multiple interactions ISO RGD:1344009 E RGD:6480464 20120918 CTD MESH:D005978 PON3 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Glutathione] PMID:20079818 1302965 Pon3 paraoxonase 3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate affects expression ISO RGD:1552156 E RGD:6480464 20120515 CTD MESH:D004051 Diethylhexyl Phthalate affects the expression of PON3 mRNA alternative form PMID:21636974 1302965 Pon3 paraoxonase 3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1552156 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of PON3 mRNA PMID:34319233 1302965 Pon3 paraoxonase 3 gene CHEBI:177802 Cuprizon multiple interactions ISO RGD:1344009 E RGD:6480464 20211207 CTD MESH:D003471 [Cuprizone co-treated with Benztropine] results in decreased expression of PON3 protein PMID:34122009 1302965 Pon3 paraoxonase 3 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552156 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PON3 mRNA PMID:36331819 1302965 Pon3 paraoxonase 3 gene CHEBI:18721 3-chloropropane-1,2-diol increases expression EXP E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of PON3 mRNA; alpha-Chlorohydrin results in increased expression of PON3 protein PMID:28522335|PMID:34915118 1302965 Pon3 paraoxonase 3 gene CHEBI:23403 coumarins increases hydrolysis ISO RGD:1344009 E RGD:6480464 20170110 CTD MESH:D003374 PON3 protein results in increased hydrolysis of Coumarins analog PMID:16099434|PMID:16139510 1302965 Pon3 paraoxonase 3 gene CHEBI:24858 iodide salt decreases expression EXP E RGD:6480464 20200714 CTD MESH:D007454 Iodides deficiency results in decreased expression of PON3 protein PMID:26795019 1302965 Pon3 paraoxonase 3 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of PON3 protein PMID:20106945 1302965 Pon3 paraoxonase 3 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1344009 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of PON3 gene PMID:27153756 1302965 Pon3 paraoxonase 3 gene CHEBI:25812 ozone multiple interactions ISO RGD:1344009 E RGD:6480464 20240109 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the methylation of PON3 gene PMID:35835166 1302965 Pon3 paraoxonase 3 gene CHEBI:27385 tetrachloromethane affects expression ISO RGD:1552156 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride affects the expression of PON3 mRNA PMID:17484886 1302965 Pon3 paraoxonase 3 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20160315 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of PON3 mRNA; Carbon Tetrachloride results in decreased expression of PON3 protein PMID:25478064|PMID:31150632 1302965 Pon3 paraoxonase 3 gene CHEBI:27385 tetrachloromethane decreases response to substance ISO RGD:1344009 E RGD:6480464 20120918 CTD MESH:D002251 PON3 protein results in decreased susceptibility to Carbon Tetrachloride PMID:20079818 1302965 Pon3 paraoxonase 3 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D002251 Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA] PMID:25478064|PMID:31150632 1302965 Pon3 paraoxonase 3 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:1344009 E RGD:6480464 20120918 CTD MESH:D002251 PON3 protein inhibits the reaction [Carbon Tetrachloride results in decreased abundance of Glutathione]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased abundance of Malondialdehyde]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of IL1B protein]; PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of TNF protein] PMID:20079818 1302965 Pon3 paraoxonase 3 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1552156 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PON3 mRNA PMID:22206623 1302965 Pon3 paraoxonase 3 gene CHEBI:27856 acetamide decreases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of PON3 mRNA PMID:31881176 1302965 Pon3 paraoxonase 3 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1344009 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of PON3 mRNA PMID:24768652|PMID:25583101 1302965 Pon3 paraoxonase 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of PON3 mRNA PMID:22298810 1302965 Pon3 paraoxonase 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552156 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of PON3 mRNA PMID:21570461 1302965 Pon3 paraoxonase 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552156 E RGD:6480464 20210907 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of PON3 mRNA PMID:33956508 1302965 Pon3 paraoxonase 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of PON3 mRNA; Tetrachlorodibenzodioxin results in increased expression of PON3 protein PMID:16497791|PMID:26006071 1302965 Pon3 paraoxonase 3 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1344009 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of PON3 mRNA PMID:33212167 1302965 Pon3 paraoxonase 3 gene CHEBI:28527 rutin multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D012431 Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 mRNA]; Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PON3 protein] PMID:25478064 1302965 Pon3 paraoxonase 3 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1552156 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of PON3 protein PMID:28918527 1302965 Pon3 paraoxonase 3 gene CHEBI:28869 menadione affects expression ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:D024483 Vitamin K 3 affects the expression of PON3 mRNA PMID:20044591 1302965 Pon3 paraoxonase 3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1552156 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of PON3 mRNA PMID:37682722 1302965 Pon3 paraoxonase 3 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1344009 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of PON3 exon; Benzo(a)pyrene affects the methylation of PON3 promoter PMID:27901495 1302965 Pon3 paraoxonase 3 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1344009 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of PON3 mRNA PMID:32234424 1302965 Pon3 paraoxonase 3 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1552156 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of PON3 mRNA PMID:22228805 1302965 Pon3 paraoxonase 3 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1344009 E RGD:6480464 20250114 CTD MESH:D001564 [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein PMID:36982514 1302965 Pon3 paraoxonase 3 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:1344009 E RGD:6480464 20140610 CTD MESH:C015001 arsenite results in increased methylation of PON3 promoter PMID:23974009 1302965 Pon3 paraoxonase 3 gene CHEBI:3048 benzatropine multiple interactions ISO RGD:1344009 E RGD:6480464 20211207 CTD MESH:D001590 [Cuprizone co-treated with Benztropine] results in decreased expression of PON3 protein PMID:34122009 1302965 Pon3 paraoxonase 3 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1344009 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of PON3 mRNA PMID:23806026|PMID:25895662 1302965 Pon3 paraoxonase 3 gene CHEBI:30745 phenylacetic acid increases hydrolysis ISO RGD:1344009 E RGD:6480464 20120717 CTD MESH:C025136 PON3 protein results in increased hydrolysis of phenylacetic acid PMID:16099434|PMID:16139510 1302965 Pon3 paraoxonase 3 gene CHEBI:3093 bifenthrin increases expression ISO RGD:1552156 E RGD:6480464 20160822 CTD MESH:C099952 bifenthrin results in increased expression of PON3 mRNA PMID:26071804 1302965 Pon3 paraoxonase 3 gene CHEBI:31575 ethylparaben increases expression ISO RGD:1344009 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in increased expression of PON3 mRNA PMID:37690743 1302965 Pon3 paraoxonase 3 gene CHEBI:31653 glafenine decreases expression EXP E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:32161 sulfadimethoxine decreases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in decreased expression of PON3 mRNA PMID:30047161 1302965 Pon3 paraoxonase 3 gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of PON3 mRNA PMID:34492290 1302965 Pon3 paraoxonase 3 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PON3 mRNA PMID:19710929 1302965 Pon3 paraoxonase 3 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of PON3 mRNA PMID:25181051 1302965 Pon3 paraoxonase 3 gene CHEBI:33234 vitamin E increases activity ISO RGD:1552156 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in increased activity of PON3 protein PMID:12615656 1302965 Pon3 paraoxonase 3 gene CHEBI:34031 1,1-dichloroethene increases expression ISO RGD:1552156 E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of PON3 mRNA PMID:26682919 1302965 Pon3 paraoxonase 3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1552156 E RGD:6480464 20140513 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PON3 mRNA PMID:22653878 1302965 Pon3 paraoxonase 3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20150609 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of PON3 mRNA PMID:25530946|PMID:26006071 1302965 Pon3 paraoxonase 3 gene CHEBI:34342 3-methylcholanthrene increases expression EXP E RGD:6480464 20180410 CTD MESH:D008748 Methylcholanthrene results in increased expression of PON3 mRNA PMID:26006071 1302965 Pon3 paraoxonase 3 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1552156 E RGD:6480464 20180828 CTD MESH:D004390 Chlorpyrifos results in decreased expression of PON3 mRNA PMID:29404631 1302965 Pon3 paraoxonase 3 gene CHEBI:34631 chlorpyrifos multiple interactions ISO RGD:1552156 E RGD:6480464 20180828 CTD MESH:D004390 [APOE protein results in increased susceptibility to Chlorpyrifos] which results in decreased expression of PON3 mRNA PMID:29404631 1302965 Pon3 paraoxonase 3 gene CHEBI:34674 dextran sulfate decreases expression ISO RGD:1552156 E RGD:6480464 20220607 CTD MESH:D016264 Dextran Sulfate results in decreased expression of PON3 mRNA PMID:35093514 1302965 Pon3 paraoxonase 3 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA PMID:18544905 1302965 Pon3 paraoxonase 3 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of PON3 mRNA PMID:32680482 1302965 Pon3 paraoxonase 3 gene CHEBI:35456 cadmium dichloride affects expression EXP E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride affects the expression of PON3 mRNA PMID:22110744 1302965 Pon3 paraoxonase 3 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1344009 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of PON3 mRNA PMID:38382870 1302965 Pon3 paraoxonase 3 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1552156 E RGD:6480464 20150310 CTD MESH:D019256 Cadmium Chloride results in decreased expression of PON3 mRNA PMID:24982889 1302965 Pon3 paraoxonase 3 gene CHEBI:35456 cadmium dichloride increases methylation EXP E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in increased methylation of PON3 promoter PMID:22457795 1302965 Pon3 paraoxonase 3 gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of PON3 mRNA PMID:24386269 1302965 Pon3 paraoxonase 3 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1344009 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of PON3 mRNA PMID:19376846 1302965 Pon3 paraoxonase 3 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20120613 CTD MESH:D002994 Clofibrate results in decreased expression of PON3 mRNA PMID:12851107 1302965 Pon3 paraoxonase 3 gene CHEBI:3766 clozapine increases expression ISO RGD:1344009 E RGD:6480464 20211207 CTD MESH:D003024 Clozapine results in increased expression of PON3 protein PMID:34122009 1302965 Pon3 paraoxonase 3 gene CHEBI:38658 dicrotophos decreases expression ISO RGD:1344009 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of PON3 mRNA PMID:28302478 1302965 Pon3 paraoxonase 3 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552156 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PON3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PON3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PON3 mRNA PMID:36331819 1302965 Pon3 paraoxonase 3 gene CHEBI:39483 sodium dichromate affects expression EXP E RGD:6480464 20120717 CTD MESH:C016104 sodium bichromate affects the expression of PON3 mRNA PMID:22110744 1302965 Pon3 paraoxonase 3 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1344009 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of PON3 gene PMID:29154799 1302965 Pon3 paraoxonase 3 gene CHEBI:40036 amitrole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in decreased expression of PON3 mRNA PMID:30047161 1302965 Pon3 paraoxonase 3 gene CHEBI:40303 lovastatin increases hydrolysis ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:D008148 PON3 protein results in increased hydrolysis of Lovastatin PMID:15772423 1302965 Pon3 paraoxonase 3 gene CHEBI:40303 lovastatin increases metabolic processing ISO RGD:1552156 E RGD:6480464 20120412 CTD MESH:D008148 PON3 protein results in increased metabolism of Lovastatin PMID:12615656 1302965 Pon3 paraoxonase 3 gene CHEBI:40303 lovastatin multiple interactions ISO RGD:1552156 E RGD:6480464 20120412 CTD MESH:D008148 7-ketocholesterol inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]; Phosphatidylcholines inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin] PMID:12615656 1302965 Pon3 paraoxonase 3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1344009 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of PON3 mRNA PMID:20106945|PMID:25562108 1302965 Pon3 paraoxonase 3 gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1344009 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in increased expression of PON3 mRNA PMID:27989131 1302965 Pon3 paraoxonase 3 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression ISO RGD:1552156 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of PON3 mRNA PMID:28973697 1302965 Pon3 paraoxonase 3 gene CHEBI:43572 kojic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C011890 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA PMID:18544905 1302965 Pon3 paraoxonase 3 gene CHEBI:44445 nimesulide decreases expression EXP E RGD:6480464 20160412 CTD MESH:C012655 nimesulide results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:4489 Diallyl sulfide decreases expression ISO RGD:1552156 E RGD:6480464 20141111 CTD MESH:C038491 allyl sulfide results in decreased expression of PON3 mRNA PMID:22653878 1302965 Pon3 paraoxonase 3 gene CHEBI:46195 paracetamol affects expression ISO RGD:1552156 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of PON3 mRNA PMID:17562736 1302965 Pon3 paraoxonase 3 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1344009 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of PON3 mRNA PMID:29067470 1302965 Pon3 paraoxonase 3 gene CHEBI:46195 paracetamol increases expression ISO RGD:1344009 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of PON3 mRNA PMID:22230336 1302965 Pon3 paraoxonase 3 gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of PON3 mRNA PMID:29391264 1302965 Pon3 paraoxonase 3 gene CHEBI:4811 epoxiconazole increases expression ISO RGD:1552156 E RGD:6480464 20141111 CTD MESH:C109476 epoxiconazole results in increased expression of PON3 mRNA PMID:22334560 1302965 Pon3 paraoxonase 3 gene CHEBI:4918 O-methyleugenol decreases expression ISO RGD:1344009 E RGD:6480464 20200714 CTD MESH:C005223 methyleugenol results in decreased expression of PON3 mRNA PMID:32234424 1302965 Pon3 paraoxonase 3 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1552156 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of PON3 mRNA PMID:25554681 1302965 Pon3 paraoxonase 3 gene CHEBI:5062 finasteride decreases expression EXP E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:50673 methimazole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in decreased expression of PON3 mRNA PMID:30047161 1302965 Pon3 paraoxonase 3 gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:566274 malonaldehyde multiple interactions ISO RGD:1344009 E RGD:6480464 20120918 CTD MESH:D008315 PON3 protein inhibits the reaction [Carbon Tetrachloride results in increased abundance of Malondialdehyde] PMID:20079818 1302965 Pon3 paraoxonase 3 gene CHEBI:6067 isotretinoin decreases expression ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of PON3 mRNA PMID:20436886 1302965 Pon3 paraoxonase 3 gene CHEBI:64211 8-Br-cAMP increases expression ISO RGD:1344009 E RGD:6480464 20121009 CTD MESH:D015124 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PON3 mRNA PMID:22079614 1302965 Pon3 paraoxonase 3 gene CHEBI:64294 7-ketocholesterol multiple interactions ISO RGD:1552156 E RGD:6480464 20120412 CTD MESH:C003001 7-ketocholesterol inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin] PMID:12615656 1302965 Pon3 paraoxonase 3 gene CHEBI:64482 phosphatidylcholine multiple interactions ISO RGD:1552156 E RGD:6480464 20170228 CTD MESH:D010713 Phosphatidylcholines inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin] PMID:12615656 1302965 Pon3 paraoxonase 3 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1552156 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of PON3 mRNA PMID:22206623 1302965 Pon3 paraoxonase 3 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1552156 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PON3 mRNA PMID:22206623 1302965 Pon3 paraoxonase 3 gene CHEBI:7494 nefazodone decreases expression EXP E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:7590 nitrofen increases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of PON3 mRNA PMID:33484710 1302965 Pon3 paraoxonase 3 gene CHEBI:79089 ceric oxide multiple interactions ISO RGD:1344009 E RGD:6480464 20250114 CTD MESH:C030583 [Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of PON3 protein PMID:36982514 1302965 Pon3 paraoxonase 3 gene CHEBI:80630 irinotecan affects expression EXP E RGD:6480464 20181113 CTD MESH:D000077146 Irinotecan affects the expression of PON3 mRNA PMID:20097248 1302965 Pon3 paraoxonase 3 gene CHEBI:8069 phenobarbital decreases expression ISO RGD:1552156 E RGD:6480464 20140513 CTD MESH:D010634 Phenobarbital results in decreased expression of PON3 mRNA PMID:22653878 1302965 Pon3 paraoxonase 3 gene CHEBI:8082 phenyl acetate affects hydrolysis ISO RGD:1344009 E RGD:6480464 20170303 CTD MESH:C570634 PON3 gene SNP affects the hydrolysis of phenyl acetate PMID:20839225 1302965 Pon3 paraoxonase 3 gene CHEBI:81758 cyproconazole increases expression ISO RGD:1552156 E RGD:6480464 20141111 CTD MESH:C093628 cyproconazole results in increased expression of PON3 mRNA PMID:22334560 1302965 Pon3 paraoxonase 3 gene CHEBI:8489 propiconazole increases expression ISO RGD:1552156 E RGD:6480464 20120918 CTD MESH:C045950 propiconazole results in increased expression of PON3 mRNA PMID:21278054|PMID:22334560 1302965 Pon3 paraoxonase 3 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of PON3 mRNA PMID:24780913|PMID:30047161 1302965 Pon3 paraoxonase 3 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of PON3 mRNA PMID:21346803 1302965 Pon3 paraoxonase 3 gene CHEBI:9241 spironolactone increases hydrolysis ISO RGD:1344009 E RGD:6480464 20120412 CTD MESH:D013148 PON3 protein results in increased hydrolysis of Spironolactone PMID:15772423 1302965 Pon3 paraoxonase 3 gene CHEBI:9352 sulindac decreases expression EXP E RGD:6480464 20160412 CTD MESH:D013467 Sulindac results in decreased expression of PON3 mRNA PMID:24136188 1302965 Pon3 paraoxonase 3 gene CHEBI:9986 vinclozolin affects expression EXP E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin affects the expression of PON3 mRNA PMID:19015723 1302966 Nrm nurim gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1352240 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of NRM mRNA PMID:38218311 1302966 Nrm nurim gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1614232 E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRM mRNA PMID:26251327 1302966 Nrm nurim gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1614232 E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of NRM promoter PMID:26251327 1302966 Nrm nurim gene CHEBI:15354 choline multiple interactions ISO RGD:1614232 E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene PMID:20938992 1302966 Nrm nurim gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1614232 E RGD:6480464 20191112 CTD MESH:D014212 [bisphenol S co-treated with Tretinoin] results in decreased expression of NRM mRNA PMID:30951980 1302966 Nrm nurim gene CHEBI:16598 DDE increases expression ISO RGD:1352240 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased expression of NRM mRNA PMID:38568856 1302966 Nrm nurim gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1614232 E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene PMID:20938992 1302966 Nrm nurim gene CHEBI:17347 testosterone decreases expression ISO RGD:1352240 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of NRM mRNA PMID:21592394 1302966 Nrm nurim gene CHEBI:17347 testosterone multiple interactions ISO RGD:1352240 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in decreased expression of NRM mRNA PMID:21592394 1302966 Nrm nurim gene CHEBI:177802 Cuprizon increases expression EXP E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of NRM mRNA PMID:26577399 1302966 Nrm nurim gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:1352240 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of NRM protein PMID:37730182 1302966 Nrm nurim gene CHEBI:17823 calcitriol decreases expression ISO RGD:1352240 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in decreased expression of NRM mRNA PMID:21592394 1302966 Nrm nurim gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1352240 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in decreased expression of NRM mRNA PMID:21592394 1302966 Nrm nurim gene CHEBI:17833 gentamycin decreases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of NRM mRNA PMID:33387578 1302966 Nrm nurim gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1352240 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRM mRNA PMID:35301059 1302966 Nrm nurim gene CHEBI:25812 ozone multiple interactions ISO RGD:1614232 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NRM mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NRM mRNA PMID:34911549 1302966 Nrm nurim gene CHEBI:27470 folic acid decreases expression ISO RGD:1614232 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of NRM mRNA PMID:25629700 1302966 Nrm nurim gene CHEBI:27470 folic acid multiple interactions ISO RGD:1614232 E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NRM; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRM gene PMID:20938992 1302966 Nrm nurim gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of NRM mRNA PMID:31881176 1302966 Nrm nurim gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1352240 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in increased expression of NRM mRNA PMID:19167446 1302966 Nrm nurim gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352240 E RGD:6480464 20121218 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of NRM mRNA PMID:22574217 1302966 Nrm nurim gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614232 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of NRM mRNA PMID:21570461 1302966 Nrm nurim gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of NRM mRNA PMID:19933214 1302966 Nrm nurim gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRM mRNA PMID:17942748 1302966 Nrm nurim gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1614232 E RGD:6480464 20170516 CTD MESH:D012969 Sodium Fluoride results in increased expression of NRM mRNA PMID:27862939 1302966 Nrm nurim gene CHEBI:29678 sodium arsenite affects expression ISO RGD:1352240 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite affects the expression of NRM mRNA PMID:34032870 1302966 Nrm nurim gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1352240 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of NRM mRNA PMID:38568856 1302966 Nrm nurim gene CHEBI:29699 tunicamycin decreases expression ISO RGD:1352240 E RGD:6480464 20141014 CTD MESH:D014415 Tunicamycin results in decreased expression of NRM mRNA PMID:22378314 1302966 Nrm nurim gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1614232 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of NRM exon; Benzo(a)pyrene results in decreased methylation of NRM intron PMID:27901495 1302966 Nrm nurim gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1352240 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of NRM mRNA PMID:32234424 1302966 Nrm nurim gene CHEBI:30512 silver atom multiple interactions EXP E RGD:6480464 20150310 CTD MESH:D012834 [Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA PMID:25194297 1302966 Nrm nurim gene CHEBI:32161 sulfadimethoxine increases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of NRM mRNA PMID:30047161 1302966 Nrm nurim gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1614232 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of NRM gene PMID:35295148 1302966 Nrm nurim gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1352240 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NRM mRNA PMID:19710929 1302966 Nrm nurim gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:1352240 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NRM mRNA PMID:38479592 1302966 Nrm nurim gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of NRM mRNA PMID:25181051 1302966 Nrm nurim gene CHEBI:33216 bisphenol A affects expression ISO RGD:1352240 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of NRM mRNA PMID:30903817 1302966 Nrm nurim gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1352240 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of NRM gene PMID:31601247 1302966 Nrm nurim gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA PMID:36041667 1302966 Nrm nurim gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1614232 E RGD:6480464 20141223 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of NRM mRNA PMID:25172293 1302966 Nrm nurim gene CHEBI:3387 carbamazepine affects expression ISO RGD:1352240 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of NRM mRNA PMID:25979313 1302966 Nrm nurim gene CHEBI:34031 1,1-dichloroethene increases expression ISO RGD:1614232 E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of NRM mRNA PMID:26682919 1302966 Nrm nurim gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20140408 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NRM mRNA PMID:23196670 1302966 Nrm nurim gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA PMID:36041667 1302966 Nrm nurim gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1614232 E RGD:6480464 20191112 CTD MESH:C543008 [bisphenol S co-treated with Tretinoin] results in decreased expression of NRM mRNA PMID:30951980 1302966 Nrm nurim gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1614232 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of NRM mRNA PMID:38685157 1302966 Nrm nurim gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NRM mRNA PMID:36041667 1302966 Nrm nurim gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1614232 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of NRM mRNA PMID:37019170 1302966 Nrm nurim gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of NRM mRNA PMID:21266533 1302966 Nrm nurim gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of NRM mRNA PMID:21266533 1302966 Nrm nurim gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1352240 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of NRM mRNA PMID:37042841 1302966 Nrm nurim gene CHEBI:351346 phenethyl isothiocyanate decreases expression ISO RGD:1352240 E RGD:6480464 20160210 CTD MESH:C058305 phenethyl isothiocyanate results in decreased expression of NRM mRNA PMID:26678675 1302966 Nrm nurim gene CHEBI:3537 cefaloridine increases expression EXP E RGD:6480464 20120412 CTD MESH:D002509 Cephaloridine results in increased expression of NRM mRNA PMID:18500788 1302966 Nrm nurim gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1352240 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRM mRNA PMID:35301059 1302966 Nrm nurim gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:1352240 E RGD:6480464 20230502 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of NRM mRNA PMID:36326898 1302966 Nrm nurim gene CHEBI:3908 coumestrol increases expression ISO RGD:1352240 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in increased expression of NRM mRNA PMID:19167446 1302966 Nrm nurim gene CHEBI:3908 coumestrol multiple interactions ISO RGD:1352240 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of NRM mRNA PMID:19167446 1302966 Nrm nurim gene CHEBI:40036 amitrole increases expression EXP E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of NRM mRNA PMID:30047161 1302966 Nrm nurim gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1352240 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of NRM mRNA PMID:25562108 1302966 Nrm nurim gene CHEBI:41774 tamoxifen affects expression ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of NRM mRNA PMID:17555576 1302966 Nrm nurim gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression ISO RGD:1614232 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of NRM mRNA PMID:28973697 1302966 Nrm nurim gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of NRM mRNA PMID:33387578 1302966 Nrm nurim gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of NRM mRNA PMID:29391264 1302966 Nrm nurim gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of NRM mRNA PMID:17555576 1302966 Nrm nurim gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of NRM mRNA PMID:17942748 1302966 Nrm nurim gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1614232 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRM mRNA PMID:17942748 1302966 Nrm nurim gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1614232 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of NRM mRNA; Nanotubes, Carbon results in increased expression of NRM mRNA PMID:25554681 1302966 Nrm nurim gene CHEBI:50673 methimazole increases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of NRM mRNA PMID:30047161 1302966 Nrm nurim gene CHEBI:51081 nitrates multiple interactions ISO RGD:1614232 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NRM mRNA PMID:35964746 1302966 Nrm nurim gene CHEBI:53248 poly(vinylpyrrolidone) multiple interactions EXP E RGD:6480464 20150310 CTD MESH:D011205 [Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA PMID:25194297 1302966 Nrm nurim gene CHEBI:6402 leflunomide decreases expression ISO RGD:1352240 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of NRM mRNA PMID:28988120 1302966 Nrm nurim gene CHEBI:6809 methamphetamine decreases expression EXP E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in decreased expression of NRM mRNA PMID:19564919 1302966 Nrm nurim gene CHEBI:6809 methamphetamine multiple interactions EXP E RGD:6480464 20151215 CTD MESH:D008694 [Methamphetamine co-treated with SCH 23390] results in decreased expression of NRM mRNA PMID:19564919 1302966 Nrm nurim gene CHEBI:73297 SCH 23390 multiple interactions EXP E RGD:6480464 20170303 CTD MESH:C534628 [Methamphetamine co-treated with SCH 23390] results in decreased expression of NRM mRNA PMID:19564919 1302966 Nrm nurim gene CHEBI:75142 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1614232 E RGD:6480464 20160315 CTD MESH:C072553 [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of NRM mRNA PMID:25566086 1302966 Nrm nurim gene CHEBI:8069 phenobarbital affects expression ISO RGD:1614232 E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of NRM mRNA PMID:23091169 1302966 Nrm nurim gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRM mRNA PMID:32109520 1302966 Nrm nurim gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:1352240 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NRM mRNA PMID:19167446 1302966 Nrm nurim gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of NRM mRNA PMID:24780913 1302966 Nrm nurim gene CHEBI:9141 silver(0) multiple interactions EXP E RGD:6480464 20150310 CTD MESH:D012834 [Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA PMID:25194297 1302966 Nrm nurim gene CHEBI:9495 thiram decreases expression ISO RGD:1352240 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of NRM mRNA PMID:38568856 1302966 Nrm nurim gene CHEBI:9546 thimerosal decreases expression ISO RGD:1352240 E RGD:6480464 20161025 CTD MESH:D013849 Thimerosal results in decreased expression of NRM mRNA PMID:27188386 1302966 Nrm nurim gene CHEBI:9665 triadimefon increases expression EXP E RGD:6480464 20230606 CTD MESH:C032910 triadimefon results in increased expression of NRM mRNA PMID:30047161 1302967 Tmprss11c transmembrane protease, serine 11C gene CHEBI:35456 cadmium dichloride decreases methylation EXP E RGD:6480464 20150818 CTD MESH:D019256 Cadmium Chloride results in decreased methylation of TMPRSS11C promoter PMID:22457795 1302967 Tmprss11c transmembrane protease, serine 11C gene CHEBI:35559 furan increases methylation EXP E RGD:6480464 20150818 CTD MESH:C039281 furan results in increased methylation of TMPRSS11C gene PMID:22079235 1302968 Krt77 keratin 77 gene CHEBI:15743 butanal increases expression ISO RGD:1352886 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of KRT77 mRNA PMID:26079696 1302968 Krt77 keratin 77 gene CHEBI:164200 triclosan decreases expression ISO RGD:1352886 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of KRT77 mRNA PMID:30510588 1302968 Krt77 keratin 77 gene CHEBI:165219 PCB138 increases expression EXP E RGD:6480464 20201208 CTD MESH:C029790 2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of KRT77 mRNA PMID:23829299 1302968 Krt77 keratin 77 gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression EXP E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin analog results in decreased expression of KRT77 protein; alpha-Chlorohydrin results in decreased expression of KRT77 protein PMID:26597043 1302968 Krt77 keratin 77 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1352886 E RGD:6480464 20121009 CTD MESH:D016604 Aflatoxin B1 results in increased expression of KRT77 mRNA PMID:22100608 1302968 Krt77 keratin 77 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1352886 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT77 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT77 protein PMID:38598786 1302968 Krt77 keratin 77 gene CHEBI:27563 arsenic atom multiple interactions ISO RGD:1352886 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA PMID:32525701 1302968 Krt77 keratin 77 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1352886 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of KRT77 mRNA PMID:24768652|PMID:25583101 1302968 Krt77 keratin 77 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1618726 E RGD:6480464 20140909 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of KRT77 mRNA PMID:24680724 1302968 Krt77 keratin 77 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352886 E RGD:6480464 20130514 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of KRT77 mRNA PMID:23152189 1302968 Krt77 keratin 77 gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of KRT77 mRNA PMID:26033743 1302968 Krt77 keratin 77 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1352886 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in increased expression of KRT77 mRNA PMID:34032870 1302968 Krt77 keratin 77 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1618726 E RGD:6480464 20180220 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of KRT77 mRNA PMID:27195522 1302968 Krt77 keratin 77 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1352886 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of KRT77 exon; Benzo(a)pyrene results in increased methylation of KRT77 promoter PMID:27901495 1302968 Krt77 keratin 77 gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of KRT77 mRNA PMID:26033743 1302968 Krt77 keratin 77 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of KRT77 mRNA PMID:25181051 1302968 Krt77 keratin 77 gene CHEBI:34768 furfural multiple interactions ISO RGD:1352886 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of KRT77 protein PMID:38598786 1302968 Krt77 keratin 77 gene CHEBI:35559 furan decreases expression EXP E RGD:6480464 20170516 CTD MESH:C039281 furan results in decreased expression of KRT77 mRNA PMID:27387713 1302968 Krt77 keratin 77 gene CHEBI:47217 arsane multiple interactions ISO RGD:1352886 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA PMID:32525701 1302968 Krt77 keratin 77 gene CHEBI:4806 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1352886 E RGD:6480464 20191008 CTD MESH:C045651 epigallocatechin gallate results in increased expression of KRT77 protein PMID:31195006 1302968 Krt77 keratin 77 gene CHEBI:84069 pentanal increases expression ISO RGD:1352886 E RGD:6480464 20150825 CTD MESH:C046012 pentanal results in increased expression of KRT77 mRNA PMID:26079696 1302968 Krt77 keratin 77 gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:1352886 E RGD:6480464 20200915 CTD MESH:C009277 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KRT77 mRNA PMID:32525701 1302968 Krt77 keratin 77 gene CHEBI:91108 SB 431542 increases expression ISO RGD:1352886 E RGD:6480464 20161220 CTD MESH:C459179 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of KRT77 protein PMID:25670856 1302968 Krt77 keratin 77 gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1352886 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT77 protein PMID:38598786 1302969 Phf23 PHD finger protein 23 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1601853 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of PHF23 mRNA PMID:38218311 1302969 Phf23 PHD finger protein 23 gene CHEBI:15930 atrazine decreases expression ISO RGD:1601853 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in decreased expression of PHF23 mRNA PMID:22378314 1302969 Phf23 PHD finger protein 23 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1601853 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of PHF23 mRNA PMID:37042841 1302969 Phf23 PHD finger protein 23 gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1601853 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in decreased expression of PHF23 mRNA PMID:20655997|PMID:23649840 1302969 Phf23 PHD finger protein 23 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:1601853 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of PHF23 mRNA PMID:21179406 1302969 Phf23 PHD finger protein 23 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:1601853 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of PHF23 protein PMID:37730182 1302969 Phf23 PHD finger protein 23 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of PHF23 mRNA PMID:33387578 1302969 Phf23 PHD finger protein 23 gene CHEBI:17967 urethane decreases expression ISO RGD:1601853 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of PHF23 mRNA PMID:28818685 1302969 Phf23 PHD finger protein 23 gene CHEBI:23994 ethyl methanesulfonate decreases expression ISO RGD:1601853 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in decreased expression of PHF23 mRNA PMID:23649840 1302969 Phf23 PHD finger protein 23 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1601853 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of PHF23 gene PMID:27153756 1302969 Phf23 PHD finger protein 23 gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1601853 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of PHF23 mRNA PMID:23649840 1302969 Phf23 PHD finger protein 23 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1622205 E RGD:6480464 20160822 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of PHF23 mRNA PMID:27339419|PMID:31919559 1302969 Phf23 PHD finger protein 23 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1622205 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF23 mRNA PMID:22206623 1302969 Phf23 PHD finger protein 23 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1601853 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of PHF23 gene PMID:25304211 1302969 Phf23 PHD finger protein 23 gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:1601853 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of PHF23 protein PMID:35688186 1302969 Phf23 PHD finger protein 23 gene CHEBI:27889 lead(0) affects expression ISO RGD:1601853 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of PHF23 mRNA PMID:28903495 1302969 Phf23 PHD finger protein 23 gene CHEBI:27889 lead(0) affects methylation ISO RGD:1601853 E RGD:6480464 20230307 CTD MESH:D007854 Lead affects the methylation of PHF23 gene PMID:31636367 1302969 Phf23 PHD finger protein 23 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1601853 E RGD:6480464 20150609 CTD MESH:D009532 Nickel results in decreased expression of PHF23 mRNA PMID:23195993 1302969 Phf23 PHD finger protein 23 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of PHF23 mRNA PMID:21570461 1302969 Phf23 PHD finger protein 23 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of PHF23 mRNA PMID:33387578 1302969 Phf23 PHD finger protein 23 gene CHEBI:28794 coumarin affects phosphorylation ISO RGD:1601853 E RGD:6480464 20221004 CTD MESH:C030123 coumarin affects the phosphorylation of PHF23 protein PMID:35688186 1302969 Phf23 PHD finger protein 23 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1601853 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of PHF23 mRNA PMID:38568856 1302969 Phf23 PHD finger protein 23 gene CHEBI:30614 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1601853 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of PHF23 mRNA PMID:20382639 1302969 Phf23 PHD finger protein 23 gene CHEBI:30812 iron dichloride decreases expression ISO RGD:1601853 E RGD:6480464 20231003 CTD MESH:C029451 ferrous chloride results in decreased expression of PHF23 mRNA PMID:35984750 1302969 Phf23 PHD finger protein 23 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1622205 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of PHF23 gene PMID:35295148 1302969 Phf23 PHD finger protein 23 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1622205 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of PHF23 gene; titanium dioxide results in increased methylation of PHF23 promoter PMID:35295148 1302969 Phf23 PHD finger protein 23 gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of PHF23 mRNA PMID:34492290 1302969 Phf23 PHD finger protein 23 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of PHF23 mRNA PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998 1302969 Phf23 PHD finger protein 23 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1622205 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of PHF23 mRNA PMID:37019170 1302969 Phf23 PHD finger protein 23 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1601853 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of PHF23 mRNA PMID:37042841 1302969 Phf23 PHD finger protein 23 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1601853 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of PHF23 mRNA PMID:38568856 1302969 Phf23 PHD finger protein 23 gene CHEBI:3750 clofibrate multiple interactions ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA] PMID:17585979 1302969 Phf23 PHD finger protein 23 gene CHEBI:39867 valproic acid affects expression ISO RGD:1601853 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of PHF23 mRNA PMID:25979313 1302969 Phf23 PHD finger protein 23 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1601853 E RGD:6480464 20140909 CTD MESH:D014635 Valproic Acid results in decreased expression of PHF23 mRNA PMID:19101580|PMID:24935251|PMID:29154799 1302969 Phf23 PHD finger protein 23 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D014635 Valproic Acid results in decreased expression of PHF23 mRNA PMID:20546886|PMID:21427059 1302969 Phf23 PHD finger protein 23 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1601853 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of PHF23 mRNA PMID:25562108|PMID:27989131 1302969 Phf23 PHD finger protein 23 gene CHEBI:41774 tamoxifen affects expression ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D013629 Tamoxifen affects the expression of PHF23 mRNA PMID:17555576 1302969 Phf23 PHD finger protein 23 gene CHEBI:44185 methotrexate decreases expression ISO RGD:1601853 E RGD:6480464 20151110 CTD MESH:D008727 Methotrexate results in decreased expression of PHF23 mRNA PMID:24449571 1302969 Phf23 PHD finger protein 23 gene CHEBI:46024 trichostatin A affects expression ISO RGD:1601853 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of PHF23 mRNA PMID:28542535 1302969 Phf23 PHD finger protein 23 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:1601853 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in decreased expression of PHF23 mRNA PMID:24935251 1302969 Phf23 PHD finger protein 23 gene CHEBI:46195 paracetamol affects expression ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D000082 Acetaminophen affects the expression of PHF23 mRNA PMID:17562736 1302969 Phf23 PHD finger protein 23 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of PHF23 mRNA PMID:33387578 1302969 Phf23 PHD finger protein 23 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1601853 E RGD:6480464 20120918 CTD MESH:D000082 Acetaminophen results in decreased expression of PHF23 mRNA PMID:21420995 1302969 Phf23 PHD finger protein 23 gene CHEBI:46195 paracetamol multiple interactions ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PHF23 mRNA] PMID:17585979 1302969 Phf23 PHD finger protein 23 gene CHEBI:47217 arsane affects methylation ISO RGD:1601853 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of PHF23 gene PMID:25304211 1302969 Phf23 PHD finger protein 23 gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1622205 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of PHF23 mRNA PMID:35436446 1302969 Phf23 PHD finger protein 23 gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1622205 E RGD:6480464 20130618 CTD MESH:D004997 Ethinyl Estradiol affects the expression of PHF23 mRNA PMID:17555576 1302969 Phf23 PHD finger protein 23 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1622205 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of PHF23 mRNA PMID:25554681 1302969 Phf23 PHD finger protein 23 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1622205 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PHF23 mRNA PMID:35964746 1302969 Phf23 PHD finger protein 23 gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in decreased expression of PHF23 mRNA PMID:24793618 1302969 Phf23 PHD finger protein 23 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1601853 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of PHF23 protein PMID:32959892 1302969 Phf23 PHD finger protein 23 gene CHEBI:6402 leflunomide decreases expression ISO RGD:1601853 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of PHF23 mRNA PMID:28988120 1302969 Phf23 PHD finger protein 23 gene CHEBI:73755 1,2-dimethylhydrazine affects expression ISO RGD:1622205 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine affects the expression of PHF23 mRNA PMID:22206623 1302969 Phf23 PHD finger protein 23 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1622205 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF23 mRNA PMID:22206623 1302969 Phf23 PHD finger protein 23 gene CHEBI:9195 Soman increases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of PHF23 mRNA PMID:19281266 1302969 Phf23 PHD finger protein 23 gene CHEBI:9495 thiram decreases expression ISO RGD:1601853 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of PHF23 mRNA PMID:38568856 1302970 Prss46 protease, serine, 46 gene CHEBI:15930 atrazine decreases expression EXP E RGD:6480464 20230606 CTD MESH:D001280 Atrazine results in decreased expression of PRSS46 mRNA PMID:36841081 1302970 Prss46 protease, serine, 46 gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of PRSS46 mRNA PMID:33387578 1302970 Prss46 protease, serine, 46 gene CHEBI:27744 glyphosate increases methylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of PRSS46 gene PMID:31011160 1302970 Prss46 protease, serine, 46 gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of PRSS46 mRNA PMID:26033743 1302970 Prss46 protease, serine, 46 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1552176 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of PRSS46 protein PMID:28918527 1302970 Prss46 protease, serine, 46 gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of PRSS46 mRNA PMID:26033743 1302970 Prss46 protease, serine, 46 gene CHEBI:30512 silver atom decreases expression ISO RGD:1552176 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of PRSS46 mRNA PMID:27131904 1302970 Prss46 protease, serine, 46 gene CHEBI:30512 silver atom increases expression ISO RGD:1552176 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in increased expression of PRSS46 mRNA PMID:27131904 1302970 Prss46 protease, serine, 46 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1552176 E RGD:6480464 20191008 CTD MESH:D012822 Silicon Dioxide results in increased expression of PRSS46 mRNA PMID:29203145 1302970 Prss46 protease, serine, 46 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of PRSS46 mRNA PMID:25181051 1302970 Prss46 protease, serine, 46 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1552176 E RGD:6480464 20210706 CTD MESH:D004390 Chlorpyrifos results in decreased expression of PRSS46 mRNA PMID:32715474 1302970 Prss46 protease, serine, 46 gene CHEBI:41879 dexamethasone decreases expression ISO RGD:1552176 E RGD:6480464 20140408 CTD MESH:D003907 Dexamethasone results in decreased expression of PRSS46 mRNA PMID:22733784 1302970 Prss46 protease, serine, 46 gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of PRSS46 mRNA PMID:29391264 1302970 Prss46 protease, serine, 46 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1552176 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of PRSS46 mRNA PMID:25554681 1302970 Prss46 protease, serine, 46 gene CHEBI:9141 silver(0) decreases expression ISO RGD:1552176 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in decreased expression of PRSS46 mRNA PMID:27131904 1302970 Prss46 protease, serine, 46 gene CHEBI:9141 silver(0) increases expression ISO RGD:1552176 E RGD:6480464 20161115 CTD MESH:D012834 Silver results in increased expression of PRSS46 mRNA PMID:27131904 1302971 Adm2 adrenomedullin 2 gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1348112 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of ADM2 mRNA PMID:38218311 1302971 Adm2 adrenomedullin 2 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ADM2 mRNA] PMID:31150632 1302971 Adm2 adrenomedullin 2 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1622982 E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM2 mRNA PMID:36189433 1302971 Adm2 adrenomedullin 2 gene CHEBI:15379 dioxygen increases expression ISO RGD:1348112 E RGD:6480464 20120717 CTD MESH:D010100 Oxygen deficiency results in increased expression of ADM2 mRNA PMID:16474185 1302971 Adm2 adrenomedullin 2 gene CHEBI:15379 dioxygen multiple interactions ISO RGD:1348112 E RGD:6480464 20120717 CTD MESH:D010100 VULM 1457 inhibits the reaction [Oxygen deficiency results in increased expression of ADM2 mRNA] PMID:16474185 1302971 Adm2 adrenomedullin 2 gene CHEBI:15743 butanal increases expression ISO RGD:1348112 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ADM2 mRNA PMID:26079696 1302971 Adm2 adrenomedullin 2 gene CHEBI:15930 atrazine increases expression ISO RGD:1348112 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of ADM2 mRNA PMID:22378314 1302971 Adm2 adrenomedullin 2 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in increased expression of ADM2 mRNA PMID:16002435|PMID:32145629 1302971 Adm2 adrenomedullin 2 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1348112 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in increased expression of ADM2 mRNA PMID:31614463 1302971 Adm2 adrenomedullin 2 gene CHEBI:16480 nitric oxide increases expression EXP E RGD:6480464 20120412 CTD MESH:D009569 Nitric Oxide deficiency results in increased expression of ADM2 mRNA PMID:16326922 1302971 Adm2 adrenomedullin 2 gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1622982 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA PMID:25510870 1302971 Adm2 adrenomedullin 2 gene CHEBI:16598 DDE decreases expression ISO RGD:1348112 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in decreased expression of ADM2 mRNA PMID:38568856 1302971 Adm2 adrenomedullin 2 gene CHEBI:16602 trichloroethene increases methylation EXP E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in increased methylation of ADM2 gene PMID:27618143 1302971 Adm2 adrenomedullin 2 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1348112 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ADM2 mRNA PMID:37042841 1302971 Adm2 adrenomedullin 2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1348112 E RGD:6480464 20230905 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in increased expression of ADM2 mRNA PMID:36695872 1302971 Adm2 adrenomedullin 2 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1622982 E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADM2 mRNA PMID:36189433 1302971 Adm2 adrenomedullin 2 gene CHEBI:17300 tetrachloroethene increases expression ISO RGD:1622982 E RGD:6480464 20180116 CTD MESH:D013750 Tetrachloroethylene results in increased expression of ADM2 mRNA PMID:28973375 1302971 Adm2 adrenomedullin 2 gene CHEBI:17688 (S)-nicotine multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D009538 [Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein PMID:19910445 1302971 Adm2 adrenomedullin 2 gene CHEBI:17967 urethane affects expression ISO RGD:1348112 E RGD:6480464 20171114 CTD MESH:D014520 Urethane affects the expression of ADM2 mRNA PMID:28818685 1302971 Adm2 adrenomedullin 2 gene CHEBI:181932 3-Nitrobenzanthrone decreases expression ISO RGD:1348112 E RGD:6480464 20211109 CTD MESH:C117220 3-nitrobenzanthrone results in decreased expression of ADM2 mRNA PMID:34036453 1302971 Adm2 adrenomedullin 2 gene CHEBI:18723 nicotine multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D009538 [Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein PMID:19910445 1302971 Adm2 adrenomedullin 2 gene CHEBI:188855 Octicizer multiple interactions ISO RGD:1622982 E RGD:6480464 20220104 CTD MESH:C018535 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA PMID:33367866 1302971 Adm2 adrenomedullin 2 gene CHEBI:2663 amiodarone multiple interactions ISO RGD:1348112 E RGD:6480464 20230801 CTD MESH:D000638 ADM2 protein inhibits the reaction [Amiodarone results in decreased activity of CAT protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of CAT mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of GPX1 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 protein]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD1 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD2 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 protein]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF mRNA]; ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF protein]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 protein]]; CTNNB1 protein affects the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased activity of CAT protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of and results in decreased phosphorylation of CTNNB1 protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of BCL2 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of CAT mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of GPX1 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of IL10 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD1 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in decreased expression of SOD2 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of BAX protein]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of CASP3 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL1B mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of IL6 mRNA]]; IWR-1 compound inhibits the reaction [ADM2 protein inhibits the reaction [Amiodarone results in increased expression of TNF mRNA]] PMID:34434487 1302971 Adm2 adrenomedullin 2 gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ADM2 mRNA PMID:31150632 1302971 Adm2 adrenomedullin 2 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ADM2 mRNA] PMID:31150632 1302971 Adm2 adrenomedullin 2 gene CHEBI:27856 acetamide decreases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ADM2 mRNA PMID:31881176 1302971 Adm2 adrenomedullin 2 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1348112 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ADM2 mRNA PMID:23557933 1302971 Adm2 adrenomedullin 2 gene CHEBI:27899 cisplatin affects expression ISO RGD:1348112 E RGD:6480464 20140513 CTD MESH:D002945 Cisplatin affects the expression of ADM2 mRNA PMID:23300844 1302971 Adm2 adrenomedullin 2 gene CHEBI:28619 acrylamide increases expression ISO RGD:1348112 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in increased expression of ADM2 mRNA PMID:32763439 1302971 Adm2 adrenomedullin 2 gene CHEBI:28940 calciol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D002762 [Cholecalciferol co-treated with Nicotine] results in decreased expression of ADM2 protein PMID:19910445 1302971 Adm2 adrenomedullin 2 gene CHEBI:29678 sodium arsenite affects expression ISO RGD:1348112 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite affects the expression of ADM2 mRNA PMID:34032870 1302971 Adm2 adrenomedullin 2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1348112 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of ADM2 mRNA PMID:38568856 1302971 Adm2 adrenomedullin 2 gene CHEBI:29699 tunicamycin increases expression ISO RGD:1348112 E RGD:6480464 20141014 CTD MESH:D014415 Tunicamycin results in increased expression of ADM2 mRNA PMID:22378314 1302971 Adm2 adrenomedullin 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1348112 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADM2 promoter PMID:27901495 1302971 Adm2 adrenomedullin 2 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1622982 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADM2 mRNA PMID:21715664 1302971 Adm2 adrenomedullin 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1348112 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ADM2 5' UTR PMID:27901495 1302971 Adm2 adrenomedullin 2 gene CHEBI:3179 bromobenzene increases expression EXP E RGD:6480464 20200915 CTD MESH:C032036 bromobenzene results in increased expression of ADM2 mRNA PMID:32479839 1302971 Adm2 adrenomedullin 2 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1622982 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased expression of ADM2 mRNA PMID:35295148 1302971 Adm2 adrenomedullin 2 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ADM2 mRNA PMID:25181051 1302971 Adm2 adrenomedullin 2 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1348112 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ADM2 mRNA PMID:30903817 1302971 Adm2 adrenomedullin 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in increased expression of ADM2 mRNA PMID:32145629 1302971 Adm2 adrenomedullin 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1348112 E RGD:6480464 20201103 CTD MESH:C006780 bisphenol A analog results in increased expression of ADM2 mRNA PMID:32387340 1302971 Adm2 adrenomedullin 2 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ADM2 gene PMID:28505145 1302971 Adm2 adrenomedullin 2 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1622982 E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA PMID:25510870 1302971 Adm2 adrenomedullin 2 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1622982 E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADM2 mRNA PMID:25510870 1302971 Adm2 adrenomedullin 2 gene CHEBI:34421 4-Hydroxybenzophenone increases expression ISO RGD:1622982 E RGD:6480464 20221101 CTD MESH:C024292 4-hydroxybenzophenone results in increased expression of ADM2 mRNA PMID:35476924 1302971 Adm2 adrenomedullin 2 gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in increased expression of ADM2 mRNA PMID:32680482 1302971 Adm2 adrenomedullin 2 gene CHEBI:35019 tributyl phosphate multiple interactions ISO RGD:1622982 E RGD:6480464 20210406 CTD MESH:C009524 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA PMID:33367866 1302971 Adm2 adrenomedullin 2 gene CHEBI:35033 triphenyl phosphate multiple interactions ISO RGD:1622982 E RGD:6480464 20210406 CTD MESH:C005445 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA PMID:33367866 1302971 Adm2 adrenomedullin 2 gene CHEBI:35037 tris(2-chloroethyl) phosphate multiple interactions ISO RGD:1622982 E RGD:6480464 20210406 CTD MESH:C031324 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA PMID:33367866 1302971 Adm2 adrenomedullin 2 gene CHEBI:35038 tris(2-butoxyethyl) phosphate multiple interactions ISO RGD:1622982 E RGD:6480464 20210406 CTD MESH:C013320 [tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in increased expression of ADM2 mRNA PMID:33367866 1302971 Adm2 adrenomedullin 2 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1348112 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ADM2 mRNA PMID:38382870 1302971 Adm2 adrenomedullin 2 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1348112 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of ADM2 mRNA PMID:38568856 1302971 Adm2 adrenomedullin 2 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1348112 E RGD:6480464 20230502 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ADM2 mRNA PMID:36326898 1302971 Adm2 adrenomedullin 2 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1348112 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ADM2 gene PMID:29154799 1302971 Adm2 adrenomedullin 2 gene CHEBI:41922 diethylstilbestrol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ADM2 mRNA PMID:16002435 1302971 Adm2 adrenomedullin 2 gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20190507 CTD MESH:D000082 Acetaminophen results in increased expression of ADM2 mRNA PMID:30723492|PMID:32479839 1302971 Adm2 adrenomedullin 2 gene CHEBI:46557 zoledronic acid decreases expression ISO RGD:1348112 E RGD:6480464 20161213 CTD MESH:C088658 zoledronic acid results in decreased expression of ADM2 mRNA PMID:24714768 1302971 Adm2 adrenomedullin 2 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1348112 E RGD:6480464 20210608 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine results in increased expression of ADM2 mRNA PMID:33725128 1302971 Adm2 adrenomedullin 2 gene CHEBI:46666 crocidolite asbestos affects expression ISO RGD:1348112 E RGD:6480464 20161115 CTD MESH:D017638 Asbestos, Crocidolite affects the expression of ADM2 mRNA PMID:25757056 1302971 Adm2 adrenomedullin 2 gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of ADM2 mRNA PMID:29391264 1302971 Adm2 adrenomedullin 2 gene CHEBI:50131 5-aza-2'-deoxycytidine affects expression ISO RGD:1348112 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine affects the expression of ADM2 mRNA PMID:23300844 1302971 Adm2 adrenomedullin 2 gene CHEBI:53063 2,4,6-trinitrobenzenesulfonic acid increases expression EXP E RGD:6480464 20150512 CTD MESH:D014302 Trinitrobenzenesulfonic Acid results in increased expression of ADM2 mRNA PMID:21808981 1302971 Adm2 adrenomedullin 2 gene CHEBI:6402 leflunomide increases expression ISO RGD:1348112 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in increased expression of ADM2 mRNA PMID:28988120 1302971 Adm2 adrenomedullin 2 gene CHEBI:641 N-methyl-4-phenylpyridinium increases expression ISO RGD:1348112 E RGD:6480464 20170725 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in increased expression of ADM2 mRNA PMID:24810058 1302971 Adm2 adrenomedullin 2 gene CHEBI:64648 enniatin increases expression ISO RGD:1348112 E RGD:6480464 20230502 CTD MESH:C100264 enniatins results in increased expression of ADM2 mRNA PMID:36016515 1302971 Adm2 adrenomedullin 2 gene CHEBI:7553 niclosamide increases expression ISO RGD:1348112 E RGD:6480464 20230704 CTD MESH:D009534 Niclosamide results in increased expression of ADM2 mRNA PMID:36318118 1302971 Adm2 adrenomedullin 2 gene CHEBI:77006 17beta-estradiol 3-benzoate decreases expression EXP E RGD:6480464 20210406 CTD MESH:C074283 estradiol 3-benzoate results in decreased expression of ADM2 mRNA PMID:32741896 1302971 Adm2 adrenomedullin 2 gene CHEBI:82036 prothioconazole increases expression ISO RGD:1348112 E RGD:6480464 20221101 CTD MESH:C550005 prothioconazole results in increased expression of ADM2 mRNA PMID:35048155 1302971 Adm2 adrenomedullin 2 gene CHEBI:84069 pentanal increases expression ISO RGD:1348112 E RGD:6480464 20150825 CTD MESH:C046012 pentanal results in increased expression of ADM2 mRNA PMID:26079696 1302971 Adm2 adrenomedullin 2 gene CHEBI:9495 thiram increases expression ISO RGD:1348112 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of ADM2 mRNA PMID:38568856 1302971 Adm2 adrenomedullin 2 gene CHEBI:9516 thapsigargin increases expression ISO RGD:1348112 E RGD:6480464 20141014 CTD MESH:D019284 Thapsigargin results in increased expression of ADM2 mRNA PMID:22378314 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:10106 zearalenone increases expression ISO RGD:1605700 E RGD:6480464 20200804 CTD MESH:D015025 Zearalenone results in increased expression of EHMT2 mRNA PMID:32119988 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:1605700 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of EHMT2 mRNA PMID:38218311 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:132267 triptonide decreases expression ISO RGD:1550173 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of EHMT2 mRNA PMID:33045310 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:15365 acetylsalicylic acid increases expression ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D001241 Aspirin results in increased expression of EHMT2 mRNA PMID:11906190 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1605700 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of EHMT2 mRNA PMID:33167477 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D014212 EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to POU5F1 promoter]]; EHMT2 protein promotes the reaction [Tretinoin promotes the reaction [CBX1 protein binds to ZFP42 promoter]]; EHMT2 protein promotes the reaction [Tretinoin results in increased methylation of POU5F1 promoter] PMID:16415856 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16236 ethanol affects splicing ISO RGD:1550173 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of EHMT2 mRNA PMID:30319688 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16236 ethanol multiple interactions ISO RGD:1550173 E RGD:6480464 20201215 CTD MESH:D000431 Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]; Rimonabant inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]]; Roscovitine inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]] PMID:30143782 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1605700 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of EHMT2 mRNA PMID:35811015 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1605700 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EHMT2 mRNA PMID:35811015 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1605700 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in increased expression of EHMT2 mRNA PMID:32030086 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16480 nitric oxide decreases expression ISO RGD:1605700 E RGD:6480464 20140211 CTD MESH:D009569 Nitric Oxide results in decreased expression of EHMT2 protein PMID:23546878 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16643 L-methionine increases expression ISO RGD:1550173 E RGD:6480464 20221206 CTD MESH:D008715 Methionine deficiency results in increased expression of EHMT2 mRNA PMID:35314295 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1605700 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of EHMT2 mRNA PMID:37042841 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:16796 melatonin multiple interactions ISO RGD:1550173 E RGD:6480464 20241105 CTD MESH:D008550 Melatonin inhibits the reaction [[Particulate Matter co-treated with Dietary Fats] results in decreased expression of EHMT2 protein] PMID:37994397 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17303 morphine affects expression ISO RGD:1550173 E RGD:6480464 20220111 CTD MESH:D009020 Morphine affects the expression of EHMT2 mRNA PMID:33891991 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17347 testosterone decreases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of EHMT2 mRNA PMID:21669218 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17401 myo-inositol hexakisphosphate multiple interactions ISO RGD:1550173 E RGD:6480464 20141223 CTD MESH:D010833 Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein] PMID:25168426 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17594 hydroquinone decreases expression ISO RGD:1605700 E RGD:6480464 20180116 CTD MESH:C031927 hydroquinone results in decreased expression of EHMT2 protein PMID:27979589 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1550173 E RGD:6480464 20150825 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of EHMT2 mRNA; Diethylhexyl Phthalate results in decreased expression of EHMT2 protein PMID:25975992 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1605700 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of EHMT2 protein PMID:37730182 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17967 urethane decreases expression ISO RGD:1605700 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of EHMT2 mRNA PMID:28818685 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17967 urethane increases expression ISO RGD:1550173 E RGD:6480464 20141223 CTD MESH:D014520 Urethane results in increased expression of EHMT2 mRNA; Urethane results in increased expression of EHMT2 protein PMID:25168426 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:17967 urethane multiple interactions ISO RGD:1550173 E RGD:6480464 20141223 CTD MESH:D014520 Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EHMT2 protein] PMID:25168426 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:22977 cadmium atom decreases expression ISO RGD:1550173 E RGD:6480464 20140311 CTD MESH:D002104 Cadmium results in decreased expression of EHMT2 mRNA PMID:24067728 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1550173 E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHMT2 mRNA PMID:37325564 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1605700 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of EHMT2 mRNA PMID:19549813 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:24757 hypochlorous acid decreases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D006997 Hypochlorous Acid results in decreased expression of EHMT2 mRNA PMID:19376150 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1605700 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of EHMT2 gene PMID:27153756 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1550173 E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of EHMT2 mRNA PMID:19770486 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1605700 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of EHMT2 polyA tail PMID:30157460 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:25812 ozone decreases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D010126 Ozone results in decreased expression of EHMT2 mRNA PMID:17460151 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:1605700 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of EHMT2 gene PMID:25304211 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27563 arsenic atom multiple interactions ISO RGD:1605700 E RGD:6480464 20210309 CTD MESH:D001151 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein PMID:33378118 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:1605700 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of EHMT2 mRNA PMID:26272509 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1605700 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA PMID:27188386 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:1605700 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of EHMT2 protein PMID:35688186 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27744 glyphosate increases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of EHMT2 mRNA PMID:26302742 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27744 glyphosate increases methylation EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of EHMT2 gene PMID:31011160 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27889 lead(0) affects methylation ISO RGD:1605700 E RGD:6480464 20230307 CTD MESH:D007854 Lead affects the methylation of EHMT2 gene PMID:31636367 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1605700 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of EHMT2 mRNA PMID:27392435 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27958 cocaine decreases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D003042 Cocaine results in decreased expression of EHMT2 mRNA; Cocaine results in decreased expression of EHMT2 protein PMID:20056891 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27958 cocaine decreases response to substance ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D003042 EHMT2 results in decreased susceptibility to Cocaine PMID:20056891 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:27958 cocaine multiple interactions ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D003042 Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TGFBR1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of USP9X mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of WNK3 mRNA]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA] PMID:20056891 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28112 nickel atom multiple interactions ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D009532 Nickel results in decreased expression of and results in decreased activity of EHMT2 protein PMID:16648469 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550173 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of EHMT2 mRNA PMID:21570461 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of EHMT2 mRNA PMID:33387578 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA PMID:17942748 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1605700 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of EHMT2 protein PMID:33212167 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1605700 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of EHMT2 mRNA PMID:29803840 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:28748 doxorubicin multiple interactions ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin promotes the reaction [EHMT2 protein binds to BIRC5 promoter] PMID:17124180 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in decreased expression of EHMT2 mRNA PMID:30557709 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1550173 E RGD:6480464 20171010 CTD MESH:C017947 sodium arsenite results in decreased expression of EHMT2 mRNA PMID:28414027 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1605700 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of EHMT2 mRNA PMID:38568856 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1605700 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of EHMT2 protein PMID:27217333 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite multiple interactions ISO RGD:1550173 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite promotes the reaction [EHMT2 protein binds to CDKN2A promoter] PMID:22733434 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29678 sodium arsenite multiple interactions ISO RGD:1605700 E RGD:6480464 20161228 CTD MESH:C017947 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein; BRD4770 inhibits the reaction [sodium arsenite promotes the reaction [EHMT2 protein binds to PDK4 promoter]]; sodium arsenite inhibits the reaction [BRD4770 results in decreased expression of EHMT2 protein]; sodium arsenite promotes the reaction [EHMT2 protein binds to PDK4 promoter] PMID:27217333|PMID:33378118 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1605700 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of EHMT2 exon PMID:30157460 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1605700 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of EHMT2 promoter PMID:27901495 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:29866 arsenite(3-) increases expression ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:C015001 arsenite results in increased expression of EHMT2 mRNA; arsenite results in increased expression of EHMT2 protein PMID:18321869 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1605700 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of EHMT2 mRNA PMID:22521957 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:32161 sulfadimethoxine decreases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in decreased expression of EHMT2 mRNA PMID:30047161 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1550173 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of EHMT2 gene PMID:35295148 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of EHMT2 mRNA PMID:18648102 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33128 C60 fullerene increases expression EXP E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in increased expression of EHMT2 mRNA PMID:19167457 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of EHMT2 mRNA PMID:25181051 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of EHMT2 mRNA PMID:30816183 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1605700 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of EHMT2 protein PMID:37567409 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1605700 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of EHMT2 gene PMID:31601247 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1605700 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased expression of EHMT2 mRNA PMID:28765096|PMID:29275510 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA PMID:36041667 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:3387 carbamazepine affects expression ISO RGD:1605700 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of EHMT2 mRNA PMID:25979313 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA PMID:36041667 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EHMT2 mRNA PMID:36041667 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34578 Bisphenol A diglycidyl ether affects expression ISO RGD:1550173 E RGD:6480464 20240305 CTD MESH:C019273 bisphenol A diglycidyl ether affects the expression of EHMT2 mRNA PMID:36464114 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1550173 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of EHMT2 mRNA PMID:37019170 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34674 dextran sulfate increases expression ISO RGD:1550173 E RGD:6480464 20220607 CTD MESH:D016264 Dextran Sulfate results in increased expression of EHMT2 mRNA PMID:35093514 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34837 methidathion increases expression ISO RGD:1550173 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in increased expression of EHMT2 mRNA PMID:34813904 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:34967 rimonabant multiple interactions ISO RGD:1550173 E RGD:6480464 20210202 CTD MESH:D000077285 Rimonabant inhibits the reaction [Ethanol promotes the reaction [EHMT2 protein binds to RAC1 promoter]] PMID:30143782 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1605700 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of EHMT2 mRNA PMID:37042841 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1550173 E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EHMT2 mRNA PMID:37325564 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:3750 clofibrate decreases expression ISO RGD:1550173 E RGD:6480464 20140610 CTD MESH:D002994 Clofibrate results in decreased expression of EHMT2 mRNA PMID:23811191 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:38658 dicrotophos increases expression ISO RGD:1605700 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of EHMT2 mRNA PMID:28302478 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of EHMT2 mRNA PMID:17963808 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1605700 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in decreased expression of EHMT2 mRNA PMID:19101580|PMID:23179753|PMID:26272509|PMID:28001369 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1605700 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of EHMT2 gene PMID:29154799 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D014635 [Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA PMID:17183730|PMID:27188386 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:40036 amitrole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in decreased expression of EHMT2 mRNA PMID:30047161 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1605700 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of EHMT2 mRNA PMID:25562108 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:4356 desferrioxamine B decreases expression ISO RGD:1605700 E RGD:6480464 20140715 CTD MESH:D003676 Deferoxamine results in decreased expression of EHMT2 mRNA PMID:23483119 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:46195 paracetamol affects expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of EHMT2 mRNA PMID:17562736 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of EHMT2 mRNA PMID:33387578 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1605700 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of EHMT2 mRNA PMID:29067470 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1605700 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EHMT2 mRNA PMID:35811015 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:47217 arsane affects methylation ISO RGD:1605700 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of EHMT2 gene PMID:25304211 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:47217 arsane multiple interactions ISO RGD:1605700 E RGD:6480464 20210309 CTD MESH:D001151 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with BIX 01294] results in decreased expression of EHMT2 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MPG protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PARP1 protein; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 mRNA; [EHMT2 protein co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of XRCC1 protein PMID:33378118 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:4811 epoxiconazole decreases expression ISO RGD:1550173 E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of EHMT2 mRNA PMID:35436446 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:48765 dimethylarsinic acid increases expression ISO RGD:1550173 E RGD:6480464 20200804 CTD MESH:D002101 Cacodylic Acid results in increased expression of EHMT2 mRNA PMID:32052077 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of EHMT2 mRNA PMID:17942748 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EHMT2 mRNA PMID:17942748 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1605700 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of EHMT2 mRNA PMID:22521957 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:50131 5-aza-2'-deoxycytidine affects response to substance ISO RGD:1605700 E RGD:6480464 20191114 CTD MESH:C014347 EHMT2 protein affects the susceptibility to Decitabine PMID:19531572 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1550173 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of EHMT2 mRNA PMID:25554681 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:50673 methimazole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in decreased expression of EHMT2 mRNA PMID:30047161 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:51081 nitrates multiple interactions ISO RGD:1550173 E RGD:6480464 20250204 CTD MESH:D009566 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EHMT2 mRNA PMID:35964746 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:52717 bortezomib decreases expression ISO RGD:1605700 E RGD:6480464 20170303 CTD MESH:D000069286 Bortezomib results in decreased expression of EHMT2 mRNA PMID:20977926 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1605700 E RGD:6480464 20160705 CTD MESH:C029938 nickel sulfate results in increased expression of EHMT2 mRNA PMID:22714537 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1605700 E RGD:6480464 20180828 CTD MESH:D011192 Potassium Dichromate results in increased expression of EHMT2 protein PMID:29391238 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:53444 potassium dichromate multiple interactions ISO RGD:1605700 E RGD:6480464 20180828 CTD MESH:D011192 EHMT2 protein promotes the reaction [Potassium Dichromate results in increased expression of H2AX protein modified form] PMID:29391238 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:5775 hydralazine multiple interactions ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D006830 [Hydralazine co-treated with Valproic Acid] results in increased expression of EHMT2 mRNA PMID:17183730 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:59001 4-vinylcyclohexene dioxide affects expression ISO RGD:1550173 E RGD:6480464 20161213 CTD MESH:C012606 4-vinyl-1-cyclohexene dioxide affects the expression of EHMT2 mRNA PMID:20829426 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1605700 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of EHMT2 protein PMID:32959892 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:61390 afatinib multiple interactions ISO RGD:1605700 E RGD:6480464 20171114 CTD MESH:C522924 afatinib inhibits the reaction [EGF protein results in increased expression of EHMT2 protein] PMID:28787001 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:6809 methamphetamine increases expression ISO RGD:1550173 E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in increased expression of EHMT2 mRNA PMID:26307267 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:6842 methoxychlor affects expression ISO RGD:1550173 E RGD:6480464 20120412 CTD MESH:D008731 Methoxychlor affects the expression of EHMT2 mRNA PMID:20829426 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1550173 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of EHMT2 mRNA PMID:22206623 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1605700 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA PMID:27188386 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1605700 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to EHMT2 gene] PMID:28238834 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in decreased expression of EHMT2 mRNA PMID:30047161 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:88046 cylindrospermopsin increases expression ISO RGD:1605700 E RGD:6480464 20151006 CTD MESH:C089595 cylindrospermopsin results in increased expression of EHMT2 mRNA; cylindrospermopsin results in increased expression of EHMT2 protein PMID:24921660 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1605700 E RGD:6480464 20161220 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EHMT2 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EHMT2 mRNA PMID:27188386|PMID:37664457 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:9352 sulindac decreases expression ISO RGD:1605700 E RGD:6480464 20120412 CTD MESH:D013467 Sulindac results in decreased expression of EHMT2 mRNA PMID:11906190 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:94552 sepantronium decreases expression ISO RGD:1605700 E RGD:6480464 20221101 CTD MESH:C523798 sepantronium results in decreased expression of EHMT2 protein PMID:28787001 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:94552 sepantronium multiple interactions ISO RGD:1605700 E RGD:6480464 20221101 CTD MESH:C523798 EGF protein inhibits the reaction [sepantronium results in decreased expression of EHMT2 protein] PMID:28787001 1302972 Ehmt2 euchromatic histone lysine methyltransferase 2 gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of EHMT2 mRNA PMID:21346803 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1552181 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of RXFP1 mRNA PMID:37995155 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20201215 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RXFP1 mRNA PMID:30071829 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:15379 dioxygen increases expression ISO RGD:1351067 E RGD:6480464 20160119 CTD MESH:D010100 Oxygen deficiency results in increased expression of RXFP1 mRNA PMID:26516004 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:1351067 E RGD:6480464 20141014 CTD MESH:D002392 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RXFP1 mRNA PMID:24763279 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:15930 atrazine decreases expression ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:D001280 Atrazine results in decreased expression of RXFP1 protein PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:15930 atrazine multiple interactions ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:D001280 Atrazine inhibits the reaction [RLN1 protein binds to RXFP1 protein] PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1351067 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RXFP1 mRNA PMID:35811015 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D004958 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA PMID:32741896 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1351067 E RGD:6480464 20130723 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in decreased expression of RXFP1 mRNA PMID:20660070 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:17026 progesterone multiple interactions ISO RGD:1351067 E RGD:6480464 20130723 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in decreased expression of RXFP1 mRNA PMID:20660070 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D013739 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA PMID:32741896 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of RXFP1 mRNA PMID:33387578 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:232612 Azoxymethane multiple interactions ISO RGD:1552181 E RGD:6480464 20241203 CTD MESH:D001397 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA PMID:29950665 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:27496 simazine decreases expression ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:D012839 Simazine results in decreased expression of RXFP1 mRNA; Simazine results in decreased expression of RXFP1 protein PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:27496 simazine decreases expression ISO RGD:1552181 E RGD:6480464 20121113 CTD MESH:D012839 Simazine results in decreased expression of RXFP1 mRNA; Simazine results in decreased expression of RXFP1 protein PMID:22984576|PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:27496 simazine multiple interactions ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:D012839 Simazine inhibits the reaction [RLN1 protein binds to RXFP1 protein] PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1552181 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of RXFP1 mRNA PMID:28960355 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:28201 rotenone decreases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in decreased expression of RXFP1 mRNA PMID:28374803 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20190409 CTD MESH:D003300 Copper results in increased expression of RXFP1 mRNA PMID:30556269 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1351067 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in decreased expression of RXFP1 mRNA PMID:34032870 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1552181 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of RXFP1 mRNA PMID:37682722 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1351067 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of RXFP1 mRNA PMID:22316170 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1351067 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of RXFP1 3' UTR PMID:27901495 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20190409 CTD MESH:D003300 Copper results in increased expression of RXFP1 mRNA PMID:30556269 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:30263 terbutylazine decreases expression ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:C037565 terbutylazine results in decreased expression of RXFP1 protein PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:30263 terbutylazine multiple interactions ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:C037565 terbutylazine inhibits the reaction [RLN1 protein binds to RXFP1 protein] PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1552181 E RGD:6480464 20131008 CTD MESH:C009495 titanium dioxide results in increased expression of RXFP1 mRNA PMID:23131501 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:32234 titanium dioxide multiple interactions ISO RGD:1552181 E RGD:6480464 20190702 CTD MESH:C009495 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA PMID:29950665 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of RXFP1 mRNA PMID:25181051 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of RXFP1 mRNA PMID:34947998 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of RXFP1 gene PMID:28505145 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:34674 dextran sulfate multiple interactions ISO RGD:1552181 E RGD:6480464 20190702 CTD MESH:D016264 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RXFP1 mRNA PMID:29950665 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:38067 propazine decreases expression ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:C100043 propazine results in decreased expression of RXFP1 protein PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:38067 propazine multiple interactions ISO RGD:1351067 E RGD:6480464 20170516 CTD MESH:C100043 propazine inhibits the reaction [RLN1 protein binds to RXFP1 protein] PMID:27431321 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:46557 zoledronic acid increases expression ISO RGD:1351067 E RGD:6480464 20161213 CTD MESH:C088658 zoledronic acid results in increased expression of RXFP1 mRNA PMID:24714768 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1351067 E RGD:6480464 20221101 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine results in decreased expression of RXFP1 mRNA PMID:35811015 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1351067 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RXFP1 mRNA PMID:35811015 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:47807 sulforaphane decreases expression ISO RGD:1351067 E RGD:6480464 20160607 CTD MESH:C016766 sulforaphane results in decreased expression of RXFP1 mRNA PMID:26833863 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:50692 mifepristone decreases expression EXP E RGD:6480464 20130723 CTD MESH:D015735 Mifepristone results in decreased expression of RXFP1 mRNA; Mifepristone results in decreased expression of RXFP1 protein PMID:20686183 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:6121 ketamine decreases expression EXP E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in decreased expression of RXFP1 mRNA PMID:20080153 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:7590 nitrofen increases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of RXFP1 mRNA PMID:33484710 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions EXP E RGD:6480464 20210406 CTD MESH:C074283 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RXFP1 mRNA PMID:32741896 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20180703 CTD MESH:D011441 Propylthiouracil results in decreased expression of RXFP1 mRNA PMID:25825206 1302973 Rxfp1 relaxin family peptide receptor 1 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of RXFP1 mRNA PMID:24780913 1302974 Tcf19 transcription factor 19 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression ISO RGD:1550178 E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of TCF19 mRNA PMID:37995155 1302974 Tcf19 transcription factor 19 gene CHEBI:15368 acrolein multiple interactions ISO RGD:1345711 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA PMID:32699268 1302974 Tcf19 transcription factor 19 gene CHEBI:15379 dioxygen decreases expression ISO RGD:1345711 E RGD:6480464 20160119 CTD MESH:D010100 Oxygen deficiency results in decreased expression of TCF19 mRNA PMID:26516004 1302974 Tcf19 transcription factor 19 gene CHEBI:16243 quercetin increases expression ISO RGD:1345711 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in increased expression of TCF19 mRNA PMID:21632981 1302974 Tcf19 transcription factor 19 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol affects the expression of TCF19 mRNA PMID:32145629 1302974 Tcf19 transcription factor 19 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1345711 E RGD:6480464 20130212 CTD MESH:D004958 Estradiol results in increased expression of TCF19 mRNA PMID:18310284|PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:16482 naphthalene increases expression ISO RGD:1550178 E RGD:6480464 20121009 CTD MESH:C031721 naphthalene results in increased expression of TCF19 mRNA PMID:18978301 1302974 Tcf19 transcription factor 19 gene CHEBI:16598 DDE increases expression ISO RGD:1345711 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased expression of TCF19 mRNA PMID:38568856 1302974 Tcf19 transcription factor 19 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1345711 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of TCF19 mRNA PMID:37042841 1302974 Tcf19 transcription factor 19 gene CHEBI:16842 formaldehyde increases expression ISO RGD:1345711 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in increased expression of TCF19 mRNA PMID:23649840 1302974 Tcf19 transcription factor 19 gene CHEBI:17234 glucose affects activity ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose affects the activity of TCF19 protein PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:17234 glucose affects response to substance ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 TCF19 protein affects the susceptibility to Glucose PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:17234 glucose multiple interactions ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:17270 glycerol 2-phosphate multiple interactions ISO RGD:1345711 E RGD:6480464 20151215 CTD MESH:C031463 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA PMID:26424790 1302974 Tcf19 transcription factor 19 gene CHEBI:17347 testosterone decreases expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of TCF19 mRNA PMID:21592394 1302974 Tcf19 transcription factor 19 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in decreased expression of TCF19 mRNA PMID:21592394 1302974 Tcf19 transcription factor 19 gene CHEBI:17634 D-glucose affects activity ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose affects the activity of TCF19 protein PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:17634 D-glucose affects response to substance ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 TCF19 protein affects the susceptibility to Glucose PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:17634 D-glucose multiple interactions ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1345711 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of TCF19 protein PMID:37730182 1302974 Tcf19 transcription factor 19 gene CHEBI:17823 calcitriol decreases expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in decreased expression of TCF19 mRNA PMID:21592394 1302974 Tcf19 transcription factor 19 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in decreased expression of TCF19 mRNA PMID:21592394 1302974 Tcf19 transcription factor 19 gene CHEBI:22977 cadmium atom decreases expression ISO RGD:1345711 E RGD:6480464 20151013 CTD MESH:D002104 Cadmium results in decreased expression of TCF19 mRNA PMID:21120746 1302974 Tcf19 transcription factor 19 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1345711 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of TCF19 mRNA PMID:19549813 1302974 Tcf19 transcription factor 19 gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1345711 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of TCF19 mRNA PMID:23649840 1302974 Tcf19 transcription factor 19 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of TCF19 protein PMID:20106945 1302974 Tcf19 transcription factor 19 gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20180703 CTD MESH:D016604 Aflatoxin B1 results in increased expression of TCF19 mRNA PMID:25378103 1302974 Tcf19 transcription factor 19 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1345711 E RGD:6480464 20121009 CTD MESH:D016604 Aflatoxin B1 results in increased expression of TCF19 mRNA PMID:22100608 1302974 Tcf19 transcription factor 19 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1345711 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of TCF19 mRNA PMID:23649840 1302974 Tcf19 transcription factor 19 gene CHEBI:25812 ozone multiple interactions ISO RGD:1345711 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TCF19 mRNA PMID:32699268 1302974 Tcf19 transcription factor 19 gene CHEBI:25812 ozone multiple interactions ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TCF19 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TCF19 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TCF19 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of TCF19 mRNA] PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549 1302974 Tcf19 transcription factor 19 gene CHEBI:27385 tetrachloromethane affects expression ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride affects the expression of TCF19 mRNA PMID:17484886 1302974 Tcf19 transcription factor 19 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1550178 E RGD:6480464 20160822 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of TCF19 mRNA PMID:27339419|PMID:31919559 1302974 Tcf19 transcription factor 19 gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of TCF19 mRNA PMID:31881176 1302974 Tcf19 transcription factor 19 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1345711 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in increased expression of TCF19 mRNA PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:27899 cisplatin increases expression ISO RGD:1345711 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of TCF19 mRNA PMID:27594783 1302974 Tcf19 transcription factor 19 gene CHEBI:27958 cocaine decreases expression EXP E RGD:6480464 20120412 CTD MESH:D003042 Cocaine results in decreased expression of TCF19 mRNA PMID:17898221 1302974 Tcf19 transcription factor 19 gene CHEBI:28001 vancomycin decreases expression ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D014640 Vancomycin results in decreased expression of TCF19 mRNA PMID:18930951 1302974 Tcf19 transcription factor 19 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550178 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of TCF19 mRNA PMID:21570461 1302974 Tcf19 transcription factor 19 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of TCF19 mRNA PMID:34747641 1302974 Tcf19 transcription factor 19 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCF19 mRNA PMID:17942748 1302974 Tcf19 transcription factor 19 gene CHEBI:28201 rotenone decreases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in decreased expression of TCF19 mRNA PMID:28374803 1302974 Tcf19 transcription factor 19 gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:1345711 E RGD:6480464 20170516 CTD MESH:C004925 methylmercuric chloride results in decreased expression of TCF19 mRNA PMID:28001369 1302974 Tcf19 transcription factor 19 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1345711 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of TCF19 mRNA PMID:33212167 1302974 Tcf19 transcription factor 19 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:1345711 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of TCF19 mRNA PMID:30851411 1302974 Tcf19 transcription factor 19 gene CHEBI:28445 vincristine decreases expression ISO RGD:1345711 E RGD:6480464 20161213 CTD MESH:D014750 Vincristine results in decreased expression of TCF19 mRNA PMID:23649840 1302974 Tcf19 transcription factor 19 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1345711 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of TCF19 mRNA PMID:32763439 1302974 Tcf19 transcription factor 19 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1345711 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of TCF19 mRNA PMID:20971185 1302974 Tcf19 transcription factor 19 gene CHEBI:28741 sodium fluoride increases expression ISO RGD:1550178 E RGD:6480464 20170516 CTD MESH:D012969 Sodium Fluoride results in increased expression of TCF19 mRNA PMID:27862939 1302974 Tcf19 transcription factor 19 gene CHEBI:29073 L-ascorbic acid multiple interactions ISO RGD:1345711 E RGD:6480464 20151215 CTD MESH:D001205 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA PMID:26424790 1302974 Tcf19 transcription factor 19 gene CHEBI:2948 azathioprine decreases expression ISO RGD:1345711 E RGD:6480464 20171114 CTD MESH:D001379 Azathioprine results in decreased expression of TCF19 mRNA PMID:22623647 1302974 Tcf19 transcription factor 19 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1345711 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of TCF19 mRNA PMID:38568856 1302974 Tcf19 transcription factor 19 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1345711 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in increased expression of TCF19 mRNA PMID:29301061|PMID:34032870 1302974 Tcf19 transcription factor 19 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1345711 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of TCF19 5' UTR PMID:27901495 1302974 Tcf19 transcription factor 19 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1345711 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of TCF19 mRNA PMID:32234424 1302974 Tcf19 transcription factor 19 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1550178 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of TCF19 mRNA PMID:22228805 1302974 Tcf19 transcription factor 19 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1550178 E RGD:6480464 20170516 CTD MESH:D001564 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA PMID:27858113 1302974 Tcf19 transcription factor 19 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1345711 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in decreased expression of TCF19 mRNA PMID:20971185 1302974 Tcf19 transcription factor 19 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1345711 E RGD:6480464 20140610 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of TCF19 mRNA PMID:23806026 1302974 Tcf19 transcription factor 19 gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1345711 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TCF19 mRNA PMID:20382639 1302974 Tcf19 transcription factor 19 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1345711 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of TCF19 mRNA PMID:26705709 1302974 Tcf19 transcription factor 19 gene CHEBI:30966 glycidol increases expression EXP E RGD:6480464 20150127 CTD MESH:C004312 glycidol results in increased expression of TCF19 mRNA PMID:24915197 1302974 Tcf19 transcription factor 19 gene CHEBI:31638 fulvestrant decreases expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:C070081 fulvestrant results in decreased expression of TCF19 mRNA PMID:19016759 1302974 Tcf19 transcription factor 19 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:C070081 [fulvestrant co-treated with Sirolimus] results in decreased expression of TCF19 mRNA PMID:19016759 1302974 Tcf19 transcription factor 19 gene CHEBI:31941 oxaliplatin decreases expression EXP E RGD:6480464 20161213 CTD MESH:C030110 oxaliplatin results in decreased expression of TCF19 mRNA PMID:25729387 1302974 Tcf19 transcription factor 19 gene CHEBI:31941 oxaliplatin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of TCF19 mRNA PMID:25729387 1302974 Tcf19 transcription factor 19 gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1550178 E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in increased expression of TCF19 mRNA PMID:23557971 1302974 Tcf19 transcription factor 19 gene CHEBI:32234 titanium dioxide increases methylation ISO RGD:1550178 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of TCF19 gene PMID:35295148 1302974 Tcf19 transcription factor 19 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1550178 E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of TCF19 mRNA PMID:23811191 1302974 Tcf19 transcription factor 19 gene CHEBI:33007 chromium(6+) affects expression ISO RGD:1550178 E RGD:6480464 20171010 CTD MESH:C074702 chromium hexavalent ion affects the expression of TCF19 mRNA PMID:28472532 1302974 Tcf19 transcription factor 19 gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:1345711 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TCF19 mRNA PMID:38479592 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of TCF19 mRNA PMID:25181051|PMID:32145629 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1345711 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of TCF19 mRNA PMID:30903817 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A affects methylation ISO RGD:1550178 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A affects the methylation of TCF19 promoter PMID:27334623 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of TCF19 mRNA PMID:30816183|PMID:32528016|PMID:34947998 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1345711 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of TCF19 mRNA PMID:29275510 1302974 Tcf19 transcription factor 19 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1550178 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of TCF19 mRNA PMID:30951980 1302974 Tcf19 transcription factor 19 gene CHEBI:34031 1,1-dichloroethene increases expression ISO RGD:1550178 E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of TCF19 mRNA PMID:26682919 1302974 Tcf19 transcription factor 19 gene CHEBI:34342 3-methylcholanthrene increases expression ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D008748 Methylcholanthrene results in increased expression of TCF19 mRNA PMID:20713471 1302974 Tcf19 transcription factor 19 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1550178 E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in decreased methylation of TCF19 promoter PMID:33297965 1302974 Tcf19 transcription factor 19 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1550178 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of TCF19 mRNA PMID:30951980 1302974 Tcf19 transcription factor 19 gene CHEBI:34565 benzo[b]fluoranthene increases expression ISO RGD:1550178 E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of TCF19 mRNA PMID:26377693 1302974 Tcf19 transcription factor 19 gene CHEBI:34565 benzo[b]fluoranthene multiple interactions ISO RGD:1550178 E RGD:6480464 20170516 CTD MESH:C006703 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA PMID:27858113 1302974 Tcf19 transcription factor 19 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1550178 E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of TCF19 mRNA PMID:30951980|PMID:38685157 1302974 Tcf19 transcription factor 19 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1550178 E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of TCF19 mRNA PMID:17361019|PMID:21266533 1302974 Tcf19 transcription factor 19 gene CHEBI:34696 dieldrin affects expression EXP E RGD:6480464 20141014 CTD MESH:D004026 Dieldrin affects the expression of TCF19 mRNA PMID:22546817 1302974 Tcf19 transcription factor 19 gene CHEBI:34873 N-nitrosodiethylamine increases expression ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in increased expression of TCF19 mRNA PMID:17854601 1302974 Tcf19 transcription factor 19 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TCF19 mRNA PMID:18164116 1302974 Tcf19 transcription factor 19 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D004052 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TCF19 mRNA] PMID:17854601 1302974 Tcf19 transcription factor 19 gene CHEBI:34887 nickel dichloride affects expression EXP E RGD:6480464 20141014 CTD MESH:C022838 nickel chloride affects the expression of TCF19 mRNA PMID:22110744|PMID:22546817 1302974 Tcf19 transcription factor 19 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of TCF19 mRNA PMID:32680482 1302974 Tcf19 transcription factor 19 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1345711 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of TCF19 mRNA PMID:37042841 1302974 Tcf19 transcription factor 19 gene CHEBI:35033 triphenyl phosphate increases expression EXP E RGD:6480464 20200331 CTD MESH:C005445 triphenyl phosphate results in increased expression of TCF19 mRNA PMID:30589522 1302974 Tcf19 transcription factor 19 gene CHEBI:3537 cefaloridine increases expression EXP E RGD:6480464 20120412 CTD MESH:D002509 Cephaloridine results in increased expression of TCF19 mRNA PMID:18500788 1302974 Tcf19 transcription factor 19 gene CHEBI:35455 1-naphthyl isothiocyanate increases expression EXP E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of TCF19 mRNA PMID:30723492 1302974 Tcf19 transcription factor 19 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20150825 CTD MESH:D019256 Cadmium Chloride results in decreased expression of TCF19 mRNA PMID:25993096 1302974 Tcf19 transcription factor 19 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1345711 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of TCF19 mRNA PMID:38568856 1302974 Tcf19 transcription factor 19 gene CHEBI:35559 furan increases expression EXP E RGD:6480464 20150414 CTD MESH:C039281 furan results in increased expression of TCF19 mRNA PMID:25539665 1302974 Tcf19 transcription factor 19 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550178 E RGD:6480464 20121009 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of TCF19 mRNA PMID:22698814 1302974 Tcf19 transcription factor 19 gene CHEBI:35696 cobalt dichloride decreases expression EXP E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of TCF19 mRNA PMID:24386269 1302974 Tcf19 transcription factor 19 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1345711 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of TCF19 mRNA PMID:19320972 1302974 Tcf19 transcription factor 19 gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:C018021 cobaltous chloride results in increased expression of TCF19 mRNA PMID:20105288 1302974 Tcf19 transcription factor 19 gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:1345711 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCF19 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCF19 mRNA PMID:32699268 1302974 Tcf19 transcription factor 19 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1345711 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of TCF19 mRNA PMID:31533062 1302974 Tcf19 transcription factor 19 gene CHEBI:3908 coumestrol increases expression ISO RGD:1345711 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in increased expression of TCF19 mRNA PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:3908 coumestrol multiple interactions ISO RGD:1345711 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TCF19 mRNA PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:39478 buta-1,3-diene increases expression ISO RGD:1550178 E RGD:6480464 20180703 CTD MESH:C031763 1,3-butadiene results in increased expression of TCF19 mRNA PMID:29038090 1302974 Tcf19 transcription factor 19 gene CHEBI:39867 valproic acid affects expression ISO RGD:1345711 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of TCF19 mRNA PMID:25979313 1302974 Tcf19 transcription factor 19 gene CHEBI:39867 valproic acid increases expression ISO RGD:1345711 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in increased expression of TCF19 mRNA PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369 1302974 Tcf19 transcription factor 19 gene CHEBI:39867 valproic acid increases expression ISO RGD:1550178 E RGD:6480464 20120918 CTD MESH:D014635 Valproic Acid results in increased expression of TCF19 mRNA PMID:19136453|PMID:20546886|PMID:21427059 1302974 Tcf19 transcription factor 19 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1345711 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA PMID:27188386 1302974 Tcf19 transcription factor 19 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1345711 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of TCF19 mRNA PMID:20106945|PMID:21632981|PMID:25562108 1302974 Tcf19 transcription factor 19 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1345711 E RGD:6480464 20151215 CTD MESH:D003907 [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of TCF19 mRNA PMID:26424790 1302974 Tcf19 transcription factor 19 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1550178 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of TCF19 mRNA PMID:28973697 1302974 Tcf19 transcription factor 19 gene CHEBI:42758 aldehydo-D-glucose affects activity ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose affects the activity of TCF19 protein PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:42758 aldehydo-D-glucose affects response to substance ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 TCF19 protein affects the susceptibility to Glucose PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:42758 aldehydo-D-glucose multiple interactions ISO RGD:1345711 E RGD:6480464 20180828 CTD MESH:D005947 Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] PMID:29042441 1302974 Tcf19 transcription factor 19 gene CHEBI:4393 (-)-demecolcine decreases expression ISO RGD:1345711 E RGD:6480464 20140408 CTD MESH:D003703 Demecolcine results in decreased expression of TCF19 mRNA PMID:23649840 1302974 Tcf19 transcription factor 19 gene CHEBI:46195 paracetamol increases expression ISO RGD:1345711 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of TCF19 mRNA PMID:22230336 1302974 Tcf19 transcription factor 19 gene CHEBI:46345 5-fluorouracil affects response to substance ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D005472 TCF19 protein affects the susceptibility to Fluorouracil PMID:15331170 1302974 Tcf19 transcription factor 19 gene CHEBI:46345 5-fluorouracil increases expression ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D005472 Fluorouracil results in increased expression of TCF19 mRNA PMID:15331170 1302974 Tcf19 transcription factor 19 gene CHEBI:47807 sulforaphane decreases expression ISO RGD:1345711 E RGD:6480464 20200609 CTD MESH:C016766 sulforaphane results in decreased expression of TCF19 mRNA PMID:31838189 1302974 Tcf19 transcription factor 19 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1550178 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TCF19 mRNA PMID:17942748 1302974 Tcf19 transcription factor 19 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1345711 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of TCF19 mRNA PMID:26705709 1302974 Tcf19 transcription factor 19 gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1550178 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of TCF19 mRNA; Nanotubes, Carbon results in increased expression of TCF19 mRNA PMID:25554681 1302974 Tcf19 transcription factor 19 gene CHEBI:51348 tetraphene multiple interactions ISO RGD:1550178 E RGD:6480464 20170516 CTD MESH:C030935 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA PMID:27858113 1302974 Tcf19 transcription factor 19 gene CHEBI:51687 chrysene multiple interactions ISO RGD:1550178 E RGD:6480464 20170516 CTD MESH:C031180 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TCF19 mRNA PMID:27858113 1302974 Tcf19 transcription factor 19 gene CHEBI:52717 bortezomib decreases expression ISO RGD:1345711 E RGD:6480464 20170303 CTD MESH:D000069286 Bortezomib results in decreased expression of TCF19 mRNA PMID:17659339 1302974 Tcf19 transcription factor 19 gene CHEBI:53050 trimellitic anhydride increases expression ISO RGD:1550178 E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in increased expression of TCF19 mRNA PMID:19042947 1302974 Tcf19 transcription factor 19 gene CHEBI:63632 topotecan decreases expression EXP E RGD:6480464 20160315 CTD MESH:D019772 Topotecan results in decreased expression of TCF19 mRNA PMID:25729387 1302974 Tcf19 transcription factor 19 gene CHEBI:63632 topotecan multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of TCF19 mRNA PMID:25729387 1302974 Tcf19 transcription factor 19 gene CHEBI:6382 Lasiocarpine increases expression ISO RGD:1345711 E RGD:6480464 20200714 CTD MESH:C005136 lasiocarpine results in increased expression of TCF19 mRNA PMID:32234424 1302974 Tcf19 transcription factor 19 gene CHEBI:6402 leflunomide decreases expression ISO RGD:1345711 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of TCF19 mRNA PMID:28988120 1302974 Tcf19 transcription factor 19 gene CHEBI:641 N-methyl-4-phenylpyridinium decreases expression EXP E RGD:6480464 20130611 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in decreased expression of TCF19 mRNA PMID:16026605 1302974 Tcf19 transcription factor 19 gene CHEBI:6456 lidocaine increases expression EXP E RGD:6480464 20220705 CTD MESH:D008012 Lidocaine results in increased expression of TCF19 mRNA PMID:35283115 1302974 Tcf19 transcription factor 19 gene CHEBI:7590 nitrofen decreases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in decreased expression of TCF19 mRNA PMID:33484710 1302974 Tcf19 transcription factor 19 gene CHEBI:76290 PhIP decreases expression EXP E RGD:6480464 20140107 CTD MESH:C049584 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of TCF19 mRNA PMID:15059925 1302974 Tcf19 transcription factor 19 gene CHEBI:76989 phytoestrogen increases expression ISO RGD:1345711 E RGD:6480464 20170228 CTD MESH:D048789 Phytoestrogens results in increased expression of TCF19 mRNA PMID:18310284 1302974 Tcf19 transcription factor 19 gene CHEBI:77013 beta-naphthoflavone multiple interactions EXP E RGD:6480464 20140204 CTD MESH:D019324 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TCF19 mRNA PMID:18164116 1302974 Tcf19 transcription factor 19 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:1345711 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of TCF19 mRNA PMID:30851411 1302974 Tcf19 transcription factor 19 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1345711 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA PMID:27188386 1302974 Tcf19 transcription factor 19 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1345711 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to TCF19 gene] PMID:28238834 1302974 Tcf19 transcription factor 19 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1550178 E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital results in increased expression of TCF19 mRNA PMID:23091169 1302974 Tcf19 transcription factor 19 gene CHEBI:81555 Enterolactone increases expression ISO RGD:1345711 E RGD:6480464 20151103 CTD MESH:C029497 2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TCF19 mRNA PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:1345711 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TCF19 mRNA PMID:19167446 1302974 Tcf19 transcription factor 19 gene CHEBI:8502 6-propyl-2-thiouracil increases expression EXP E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of TCF19 mRNA PMID:24780913 1302974 Tcf19 transcription factor 19 gene CHEBI:9107 senecionine increases expression EXP E RGD:6480464 20200915 CTD MESH:C009237 senecionine results in increased expression of TCF19 mRNA PMID:32419051 1302974 Tcf19 transcription factor 19 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1345711 E RGD:6480464 20161228 CTD MESH:C459179 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TCF19 mRNA PMID:27188386 1302974 Tcf19 transcription factor 19 gene CHEBI:9168 sirolimus multiple interactions ISO RGD:1345711 E RGD:6480464 20120412 CTD MESH:D020123 [fulvestrant co-treated with Sirolimus] results in decreased expression of TCF19 mRNA PMID:19016759 1302974 Tcf19 transcription factor 19 gene CHEBI:9195 Soman increases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of TCF19 mRNA PMID:19281266 1302974 Tcf19 transcription factor 19 gene CHEBI:9495 thiram decreases expression ISO RGD:1345711 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of TCF19 mRNA PMID:38568856 1302974 Tcf19 transcription factor 19 gene CHEBI:9516 thapsigargin decreases expression ISO RGD:1345711 E RGD:6480464 20141014 CTD MESH:D019284 Thapsigargin results in decreased expression of TCF19 mRNA PMID:22378314 1302974 Tcf19 transcription factor 19 gene CHEBI:9763 trovafloxacin decreases expression ISO RGD:1550178 E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in decreased expression of TCF19 mRNA PMID:35537566 1302975 Mcpt8l3 mast cell protease 8-like 3 gene CHEBI:2208 purine-6-thiol increases expression EXP E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT8L3 mRNA PMID:23358152 1302975 Mcpt8l3 mast cell protease 8-like 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of MCPT8L3 mRNA PMID:34747641 1302975 Mcpt8l3 mast cell protease 8-like 3 gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression EXP E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of MCPT8L3 mRNA PMID:30723492 1302975 Mcpt8l3 mast cell protease 8-like 3 gene CHEBI:50667 mercaptopurine increases expression EXP E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT8L3 mRNA PMID:23358152 1302975 Mcpt8l3 mast cell protease 8-like 3 gene CHEBI:94796 3,7-dihydropurine-6-thione increases expression EXP E RGD:6480464 20170307 CTD MESH:D015122 Mercaptopurine results in increased expression of MCPT8L3 mRNA PMID:23358152 1302976 Rpl18a ribosomal protein L18A gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1345925 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of RPL18A mRNA PMID:38218311 1302976 Rpl18a ribosomal protein L18A gene CHEBI:132267 triptonide increases expression ISO RGD:1552187 E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of RPL18A mRNA PMID:33045310 1302976 Rpl18a ribosomal protein L18A gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of RPL18A mRNA PMID:33387578 1302976 Rpl18a ribosomal protein L18A gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552187 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of RPL18A mRNA PMID:33754040 1302976 Rpl18a ribosomal protein L18A gene CHEBI:177802 Cuprizon decreases expression ISO RGD:1345925 E RGD:6480464 20211207 CTD MESH:D003471 Cuprizone results in decreased expression of RPL18A protein PMID:34122009 1302976 Rpl18a ribosomal protein L18A gene CHEBI:177802 Cuprizon multiple interactions ISO RGD:1345925 E RGD:6480464 20211207 CTD MESH:D003471 [Cuprizone co-treated with Haloperidol] results in increased expression of RPL18A protein PMID:34122009 1302976 Rpl18a ribosomal protein L18A gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:1345925 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of RPL18A protein PMID:37730182 1302976 Rpl18a ribosomal protein L18A gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552187 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL18A mRNA PMID:36331819 1302976 Rpl18a ribosomal protein L18A gene CHEBI:22977 cadmium atom increases expression ISO RGD:1345925 E RGD:6480464 20140513 CTD MESH:D002104 Cadmium results in increased expression of RPL18A mRNA PMID:24376830 1302976 Rpl18a ribosomal protein L18A gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:1345925 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL18A protein PMID:23301498 1302976 Rpl18a ribosomal protein L18A gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1345925 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of RPL18A protein PMID:38598786 1302976 Rpl18a ribosomal protein L18A gene CHEBI:27470 folic acid decreases expression ISO RGD:1552187 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of RPL18A mRNA PMID:25629700 1302976 Rpl18a ribosomal protein L18A gene CHEBI:27470 folic acid multiple interactions ISO RGD:1552187 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA PMID:22206623 1302976 Rpl18a ribosomal protein L18A gene CHEBI:27789 1,2-dichloroethane increases expression ISO RGD:1552187 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of RPL18A mRNA PMID:28960355 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of RPL18A mRNA PMID:34747641 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of RPL18A mRNA PMID:33387578 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552187 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of RPL18A mRNA PMID:18796159|PMID:31511937 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552187 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA PMID:17942748 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28201 rotenone decreases expression EXP E RGD:6480464 20221101 CTD MESH:D012402 Rotenone results in decreased expression of RPL18A protein PMID:35544339 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28201 rotenone increases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in increased expression of RPL18A mRNA PMID:28374803 1302976 Rpl18a ribosomal protein L18A gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1345925 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of RPL18A protein PMID:33212167 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28741 sodium fluoride decreases expression ISO RGD:1552187 E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in decreased expression of RPL18A protein PMID:28918527 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28748 doxorubicin affects expression ISO RGD:1345925 E RGD:6480464 20180515 CTD MESH:D004317 Doxorubicin affects the expression of RPL18A protein PMID:29385562 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28794 coumarin increases phosphorylation ISO RGD:1345925 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in increased phosphorylation of RPL18A protein PMID:35688186 1302976 Rpl18a ribosomal protein L18A gene CHEBI:28824 stigmasterol decreases expression ISO RGD:1552187 E RGD:6480464 20181113 CTD MESH:D013265 Stigmasterol results in decreased expression of RPL18A mRNA PMID:30245210 1302976 Rpl18a ribosomal protein L18A gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1345925 E RGD:6480464 20220405 CTD MESH:C017947 sodium arsenite results in decreased expression of RPL18A protein PMID:30528433 1302976 Rpl18a ribosomal protein L18A gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1345925 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to RPL18A mRNA] PMID:32406909 1302976 Rpl18a ribosomal protein L18A gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1345925 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of RPL18A mRNA PMID:15725085 1302976 Rpl18a ribosomal protein L18A gene CHEBI:31206 ammonium chloride affects expression EXP E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of RPL18A mRNA PMID:16483693 1302976 Rpl18a ribosomal protein L18A gene CHEBI:31653 glafenine increases expression EXP E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in increased expression of RPL18A mRNA PMID:24136188 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33146 vanadyl sulfate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C034028 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA] PMID:16684804 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in decreased expression of RPL18A mRNA PMID:32145629 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1345925 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of RPL18A mRNA; bisphenol A results in decreased expression of RPL18A protein PMID:29275510|PMID:37567409 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1552187 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of RPL18A mRNA PMID:33221593 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of RPL18A mRNA PMID:25181051 1302976 Rpl18a ribosomal protein L18A gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA PMID:36041667 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34372 4,4'-sulfonyldiphenol affects expression ISO RGD:1345925 E RGD:6480464 20230117 CTD MESH:C543008 bisphenol S affects the expression of RPL18A protein PMID:31945527 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA PMID:36041667 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1552187 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of RPL18A mRNA PMID:38685157 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34575 bisphenol F increases expression ISO RGD:1345925 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of RPL18A protein PMID:34186270 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL18A mRNA PMID:36041667 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34581 Bisphenol B increases expression ISO RGD:1345925 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of RPL18A protein PMID:34186270 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1552187 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of RPL18A mRNA PMID:37019170 1302976 Rpl18a ribosomal protein L18A gene CHEBI:34768 furfural multiple interactions ISO RGD:1345925 E RGD:6480464 20250114 CTD MESH:D005662 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of RPL18A protein PMID:38598786 1302976 Rpl18a ribosomal protein L18A gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1345925 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of RPL18A mRNA PMID:37042841 1302976 Rpl18a ribosomal protein L18A gene CHEBI:35455 1-naphthyl isothiocyanate increases expression EXP E RGD:6480464 20121009 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of RPL18A mRNA PMID:20551477 1302976 Rpl18a ribosomal protein L18A gene CHEBI:35456 cadmium dichloride decreases methylation EXP E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in decreased methylation of RPL18A promoter PMID:22457795 1302976 Rpl18a ribosomal protein L18A gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1345925 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of RPL18A mRNA PMID:38568856 1302976 Rpl18a ribosomal protein L18A gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of RPL18A mRNA PMID:19162173 1302976 Rpl18a ribosomal protein L18A gene CHEBI:39285 chloropicrin increases expression ISO RGD:1345925 E RGD:6480464 20151215 CTD MESH:C100187 chloropicrin results in increased expression of RPL18A mRNA PMID:26352163 1302976 Rpl18a ribosomal protein L18A gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552187 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL18A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL18A mRNA PMID:36331819 1302976 Rpl18a ribosomal protein L18A gene CHEBI:39483 sodium dichromate increases expression EXP E RGD:6480464 20121009 CTD MESH:C016104 sodium bichromate results in increased expression of RPL18A mRNA PMID:22561333 1302976 Rpl18a ribosomal protein L18A gene CHEBI:39867 valproic acid increases methylation ISO RGD:1345925 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of RPL18A gene PMID:29154799 1302976 Rpl18a ribosomal protein L18A gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1345925 E RGD:6480464 20120412 CTD MESH:D014635 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA PMID:17183730 1302976 Rpl18a ribosomal protein L18A gene CHEBI:44445 nimesulide increases expression EXP E RGD:6480464 20160412 CTD MESH:C012655 nimesulide results in increased expression of RPL18A mRNA PMID:24136188 1302976 Rpl18a ribosomal protein L18A gene CHEBI:46195 paracetamol affects expression ISO RGD:1552187 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of RPL18A mRNA PMID:17562736 1302976 Rpl18a ribosomal protein L18A gene CHEBI:4791 endosulfan increases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of RPL18A mRNA PMID:29391264 1302976 Rpl18a ribosomal protein L18A gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1345925 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA PMID:22079256 1302976 Rpl18a ribosomal protein L18A gene CHEBI:48843 disodium selenite increases expression ISO RGD:1345925 E RGD:6480464 20120412 CTD MESH:D018038 Sodium Selenite results in increased expression of RPL18A mRNA PMID:18175754 1302976 Rpl18a ribosomal protein L18A gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1552187 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of RPL18A mRNA PMID:17942748 1302976 Rpl18a ribosomal protein L18A gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1552187 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA PMID:17942748 1302976 Rpl18a ribosomal protein L18A gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1345925 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of RPL18A mRNA PMID:15725085 1302976 Rpl18a ribosomal protein L18A gene CHEBI:5063 fipronil increases expression EXP E RGD:6480464 20211109 CTD MESH:C082360 fipronil results in increased expression of RPL18A mRNA PMID:34044035 1302976 Rpl18a ribosomal protein L18A gene CHEBI:50859 bexarotene increases expression EXP E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of RPL18A mRNA PMID:16648578 1302976 Rpl18a ribosomal protein L18A gene CHEBI:50866 3H-1,2-dithiole-3-thione increases expression EXP E RGD:6480464 20120412 CTD MESH:C049325 1,2-dithiol-3-thione results in increased expression of RPL18A mRNA PMID:19162173 1302976 Rpl18a ribosomal protein L18A gene CHEBI:5132 flutamide increases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of RPL18A mRNA PMID:24136188 1302976 Rpl18a ribosomal protein L18A gene CHEBI:5613 haloperidol multiple interactions ISO RGD:1345925 E RGD:6480464 20211207 CTD MESH:D006220 [Cuprizone co-treated with Haloperidol] results in increased expression of RPL18A protein PMID:34122009 1302976 Rpl18a ribosomal protein L18A gene CHEBI:5775 hydralazine multiple interactions ISO RGD:1345925 E RGD:6480464 20120412 CTD MESH:D006830 [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA PMID:17183730 1302976 Rpl18a ribosomal protein L18A gene CHEBI:6078 ivermectin decreases expression ISO RGD:1345925 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of RPL18A protein PMID:32959892 1302976 Rpl18a ribosomal protein L18A gene CHEBI:63630 tolcapone affects binding EXP E RGD:6480464 20161213 CTD MESH:C066340 tolcapone binds to RPL18A protein PMID:19783845 1302976 Rpl18a ribosomal protein L18A gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1345925 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of RPL18A protein PMID:34186270 1302976 Rpl18a ribosomal protein L18A gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1552187 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA PMID:22206623 1302976 Rpl18a ribosomal protein L18A gene CHEBI:7494 nefazodone increases expression EXP E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in increased expression of RPL18A mRNA PMID:24136188 1302976 Rpl18a ribosomal protein L18A gene CHEBI:75249 potassium chromate increases expression ISO RGD:1345925 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in increased expression of RPL18A mRNA PMID:22079256 1302976 Rpl18a ribosomal protein L18A gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:1345925 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA PMID:22079256 1302976 Rpl18a ribosomal protein L18A gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1552187 E RGD:6480464 20200310 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL18A mRNA PMID:30294300 1302976 Rpl18a ribosomal protein L18A gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP E RGD:6480464 20170303 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RPL18A mRNA PMID:21394737 1302976 Rpl18a ribosomal protein L18A gene CHEBI:81892 Brodifacoum decreases expression EXP E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in decreased expression of RPL18A protein PMID:28903499 1302976 Rpl18a ribosomal protein L18A gene CHEBI:88046 cylindrospermopsin increases expression ISO RGD:1552187 E RGD:6480464 20180703 CTD MESH:C089595 cylindrospermopsin results in increased expression of RPL18A mRNA PMID:20936652 1302976 Rpl18a ribosomal protein L18A gene CHEBI:88522 Monobutylphthalate decreases expression ISO RGD:1552187 E RGD:6480464 20151103 CTD MESH:C028577 monobutyl phthalate results in decreased expression of RPL18A protein PMID:20553848 1302976 Rpl18a ribosomal protein L18A gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1345925 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL18A protein PMID:37664457 1302976 Rpl18a ribosomal protein L18A gene CHEBI:9288 streptozocin increases expression EXP E RGD:6480464 20120412 CTD MESH:D013311 Streptozocin results in increased expression of RPL18A mRNA PMID:16684804 1302976 Rpl18a ribosomal protein L18A gene CHEBI:9288 streptozocin multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013311 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA] PMID:16684804 1302976 Rpl18a ribosomal protein L18A gene CHEBI:9495 thiram increases expression ISO RGD:1345925 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of RPL18A mRNA PMID:38568856 1302976 Rpl18a ribosomal protein L18A gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1345925 E RGD:6480464 20250114 CTD MESH:C010120 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL18A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of RPL18A protein PMID:38598786 1302977 Slpi-ps2 secretory leukocyte peptidase inhibitor, pseudogene 2 gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression EXP E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in decreased expression of SLPI-PS2 mRNA PMID:28522335 1302977 Slpi-ps2 secretory leukocyte peptidase inhibitor, pseudogene 2 gene CHEBI:28216 methylmercury chloride increases expression EXP E RGD:6480464 20200211 CTD MESH:C004925 methylmercuric chloride results in increased expression of SLPI-PS2 mRNA PMID:31378766 1302977 Slpi-ps2 secretory leukocyte peptidase inhibitor, pseudogene 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of SLPI-PS2 mRNA PMID:25181051 1302977 Slpi-ps2 secretory leukocyte peptidase inhibitor, pseudogene 2 gene CHEBI:35559 furan increases methylation EXP E RGD:6480464 20120918 CTD MESH:C039281 furan results in increased methylation of SLPI-PS2 gene PMID:22079235 1302977 Slpi-ps2 secretory leukocyte peptidase inhibitor, pseudogene 2 gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in decreased expression of SLPI-PS2 mRNA PMID:23869203 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:15930 atrazine increases expression ISO RGD:1343556 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of GGNBP2 mRNA PMID:22378314 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:16236 ethanol affects expression ISO RGD:1614194 E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of GGNBP2 mRNA PMID:30319688 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:16240 hydrogen peroxide multiple interactions ISO RGD:1614194 E RGD:6480464 20200211 CTD MESH:D006861 [Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of GGNBP2 protein PMID:31494107 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1343556 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of GGNBP2 mRNA PMID:37042841 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1343556 E RGD:6480464 20170207 CTD MESH:D005557 Formaldehyde results in decreased expression of GGNBP2 mRNA PMID:27664576 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:1343556 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of GGNBP2 protein PMID:37730182 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:181914 Aflatoxin B2 alpha decreases methylation ISO RGD:1343556 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in decreased methylation of GGNBP2 intron PMID:30157460 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1343556 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of GGNBP2 gene PMID:27153756 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1614194 E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of GGNBP2 mRNA PMID:19770486 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1614194 E RGD:6480464 20150127 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of GGNBP2 mRNA PMID:25270620 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27470 folic acid multiple interactions ISO RGD:1614194 E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGNBP2 mRNA PMID:22206623 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:1343556 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of GGNBP2 protein PMID:35688186 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27881 resveratrol decreases expression EXP E RGD:6480464 20160822 CTD MESH:C059514 resveratrol results in decreased expression of GGNBP2 mRNA PMID:25905778 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1343556 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of GGNBP2 mRNA PMID:23557933 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1343556 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in decreased expression of GGNBP2 mRNA PMID:27392435 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614194 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of GGNBP2 mRNA PMID:21570461 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of GGNBP2 mRNA PMID:21215274 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1614194 E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of GGNBP2 mRNA PMID:11728448|PMID:19770486 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GGNBP2 mRNA PMID:17942748 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:1343556 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of GGNBP2 mRNA PMID:30851411 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:28794 coumarin increases phosphorylation ISO RGD:1343556 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in increased phosphorylation of GGNBP2 protein PMID:35688186 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1343556 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of GGNBP2 mRNA PMID:38568856 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1614194 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of GGNBP2 mRNA PMID:22228805 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:30614 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1343556 E RGD:6480464 20160119 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GGNBP2 mRNA PMID:26238291 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:32234 titanium dioxide affects methylation ISO RGD:1614194 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide affects the methylation of GGNBP2 gene PMID:35295148 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of GGNBP2 mRNA PMID:34947998 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of GGNBP2 mRNA PMID:25181051 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of GGNBP2 mRNA PMID:21266533 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1343556 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of GGNBP2 mRNA PMID:37042841 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1343556 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of GGNBP2 mRNA PMID:38568856 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:1343556 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in increased expression of GGNBP2 mRNA PMID:19320972|PMID:19376846 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:38658 dicrotophos decreases expression ISO RGD:1343556 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of GGNBP2 mRNA PMID:28302478 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1343556 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of GGNBP2 mRNA PMID:25979313 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1343556 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in decreased expression of GGNBP2 mRNA PMID:23179753 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1343556 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of GGNBP2 gene PMID:29154799 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:1614194 E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of GGNBP2 mRNA PMID:28973697 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:44185 methotrexate affects expression ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:D008727 Methotrexate affects the expression of GGNBP2 mRNA PMID:18502557 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of GGNBP2 mRNA PMID:17942748 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GGNBP2 mRNA PMID:17942748 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression ISO RGD:1614194 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of GGNBP2 mRNA PMID:22206623 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:1614194 E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GGNBP2 mRNA PMID:22206623 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:1343556 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of GGNBP2 mRNA PMID:30851411 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1614194 E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of GGNBP2 mRNA PMID:23091169 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:8489 propiconazole decreases expression ISO RGD:1614194 E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of GGNBP2 mRNA PMID:21278054 1302978 Ggnbp2 gametogenetin binding protein 2 gene CHEBI:9495 thiram increases expression ISO RGD:1343556 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of GGNBP2 mRNA PMID:38568856 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HABP2 mRNA] PMID:31150632 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:132889 graphene oxide increases expression ISO RGD:1350340 E RGD:6480464 20230905 CTD MESH:C000628730 graphene oxide results in increased expression of HABP2 protein PMID:33219560|PMID:33219584 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:15443 inulin multiple interactions ISO RGD:1550193 E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HABP2 mRNA PMID:36331819 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:15743 butanal decreases expression ISO RGD:1350340 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in decreased expression of HABP2 mRNA PMID:26079696 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in decreased expression of HABP2 mRNA PMID:20106945 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:16469 17beta-estradiol increases expression EXP E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of HABP2 mRNA PMID:32145629 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:D004958 [Progesterone co-treated with Estradiol] results in decreased expression of HABP2 mRNA PMID:17404688 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17026 progesterone increases expression ISO RGD:1350340 E RGD:6480464 20130723 CTD MESH:D011374 Progesterone results in increased expression of HABP2 mRNA PMID:21540246 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17026 progesterone multiple interactions ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:D011374 [Progesterone co-treated with Estradiol] results in decreased expression of HABP2 mRNA PMID:17404688 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17153 propanal decreases expression ISO RGD:1350340 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in decreased expression of HABP2 mRNA PMID:26079696 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17347 testosterone decreases expression ISO RGD:1550193 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of HABP2 mRNA PMID:21669218 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1550193 E RGD:6480464 20250204 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased methylation of and results in decreased expression of HABP2 mRNA PMID:34120004 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:17967 urethane increases expression ISO RGD:1350340 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of HABP2 mRNA PMID:28818685 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions ISO RGD:1550193 E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HABP2 mRNA PMID:36331819 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of HABP2 protein PMID:20106945 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1550193 E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of HABP2 mRNA PMID:19770486 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1350340 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of HABP2 gene PMID:27153756 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:27385 tetrachloromethane affects expression ISO RGD:1550193 E RGD:6480464 20140610 CTD MESH:D002251 Carbon Tetrachloride affects the expression of HABP2 mRNA PMID:11510480 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of HABP2 mRNA PMID:31150632 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:27385 tetrachloromethane increases activity ISO RGD:1550193 E RGD:6480464 20140610 CTD MESH:D002251 Carbon Tetrachloride results in increased activity of HABP2 protein PMID:11510480 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HABP2 mRNA] PMID:31150632 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:27928 parathion decreases expression ISO RGD:1550193 E RGD:6480464 20220607 CTD MESH:D010278 Parathion results in decreased expression of HABP2 mRNA PMID:34813904 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of HABP2 mRNA PMID:22298810 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1550193 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of HABP2 mRNA PMID:21570461 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1350340 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of HABP2 mRNA PMID:29301061|PMID:32844245 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1550193 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of HABP2 mRNA PMID:37682722 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29678 sodium arsenite increases methylation ISO RGD:1350340 E RGD:6480464 20210309 CTD MESH:C017947 sodium arsenite results in increased methylation of HABP2 exon PMID:32844245 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1350340 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of HABP2 promoter PMID:27901495 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of HABP2 mRNA PMID:21839799 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1350340 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of HABP2 mRNA PMID:32234424 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1350340 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of HABP2 3' UTR PMID:27901495 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1350340 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of HABP2 mRNA PMID:25895662 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:32497 thioacetamide decreases expression EXP E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of HABP2 mRNA PMID:34492290 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:32497 thioacetamide multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D013853 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HABP2 mRNA PMID:28943392 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1550193 E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of HABP2 mRNA PMID:18648102 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HABP2 mRNA PMID:19710929 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of HABP2 mRNA PMID:25181051 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1550193 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of HABP2 mRNA PMID:34585602 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of HABP2 gene PMID:28505145 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:34107 1-nitropyrene decreases expression ISO RGD:1350340 E RGD:6480464 20140415 CTD MESH:C032668 1-nitropyrene results in decreased expression of HABP2 mRNA PMID:19041380 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1550193 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of HABP2 mRNA PMID:30951980 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:34761 fenthion decreases expression ISO RGD:1550193 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of HABP2 mRNA PMID:34813904 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:34837 methidathion decreases expression ISO RGD:1550193 E RGD:6480464 20220607 CTD MESH:C005828 methidathion results in decreased expression of HABP2 mRNA PMID:34813904 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions EXP E RGD:6480464 20180116 CTD MESH:D004052 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of HABP2 mRNA PMID:28943392 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:3750 clofibrate decreases expression ISO RGD:1550193 E RGD:6480464 20120515 CTD MESH:D002994 Clofibrate results in decreased expression of HABP2 mRNA PMID:17585979 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:1350340 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of HABP2 mRNA PMID:32588087 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1550193 E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HABP2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HABP2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of HABP2 mRNA PMID:36331819 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:39867 valproic acid affects expression ISO RGD:1350340 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of HABP2 mRNA PMID:25979313 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1350340 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of HABP2 mRNA PMID:29154799 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1350340 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of HABP2 gene PMID:29154799 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1350340 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of HABP2 mRNA PMID:20106945|PMID:27989131 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1350340 E RGD:6480464 20120918 CTD MESH:D000082 Acetaminophen results in decreased expression of HABP2 mRNA PMID:21420995|PMID:29067470 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:50594 carbon nanotube decreases expression ISO RGD:1550193 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of HABP2 mRNA PMID:25620056 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:60312 2-amino-2-deoxy-D-galactopyranose increases activity ISO RGD:1550193 E RGD:6480464 20140610 CTD MESH:D005688 Galactosamine results in increased activity of HABP2 protein PMID:11510480 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:7438 N-methylformamide increases expression ISO RGD:1550193 E RGD:6480464 20120412 CTD MESH:C002950 methylformamide analog results in increased expression of HABP2 mRNA; methylformamide results in increased expression of HABP2 mRNA PMID:17040096 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:7590 nitrofen increases expression EXP E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of HABP2 mRNA PMID:33484710 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:77006 17beta-estradiol 3-benzoate increases methylation EXP E RGD:6480464 20180116 CTD MESH:C074283 estradiol 3-benzoate results in increased methylation of HABP2 promoter PMID:27415467 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1350340 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to HABP2 gene] PMID:28238834 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1550193 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in increased expression of HABP2 mRNA PMID:19270015 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:1550193 E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of HABP2 mRNA PMID:38648751 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:82436 decabromodiphenyl ether multiple interactions EXP E RGD:6480464 20200714 CTD MESH:C010902 [Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in increased expression of HABP2 mRNA PMID:32207525 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:84069 pentanal decreases expression ISO RGD:1350340 E RGD:6480464 20150825 CTD MESH:C046012 pentanal results in decreased expression of HABP2 mRNA PMID:26079696 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of HABP2 mRNA PMID:21346803 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:957 2,6-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of HABP2 mRNA PMID:21346803 1302979 Habp2 hyaluronan binding protein 2 gene CHEBI:9753 troglitazone decreases expression ISO RGD:1550193 E RGD:6480464 20180220 CTD MESH:C057693 troglitazone results in decreased expression of HABP2 mRNA PMID:28973697 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:15379 dioxygen increases expression ISO RGD:1347436 E RGD:6480464 20160119 CTD MESH:D010100 Oxygen deficiency results in increased expression of XIRP2 mRNA PMID:26516004 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20220510 CTD MESH:D010100 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of XIRP2 mRNA PMID:33729688 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:16842 formaldehyde decreases expression ISO RGD:1347436 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in decreased expression of XIRP2 mRNA PMID:23649840 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1552200 E RGD:6480464 20170516 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of XIRP2 mRNA PMID:28085963 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of XIRP2 mRNA PMID:33387578 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:23994 ethyl methanesulfonate decreases expression ISO RGD:1347436 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in decreased expression of XIRP2 mRNA PMID:23649840 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1347436 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of XIRP2 mRNA PMID:23649840 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:28445 vincristine decreases expression ISO RGD:1347436 E RGD:6480464 20161213 CTD MESH:D014750 Vincristine results in decreased expression of XIRP2 mRNA PMID:23649840 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:28619 acrylamide increases expression EXP E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in increased expression of XIRP2 mRNA PMID:28959563 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1347436 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of XIRP2 mRNA PMID:29803840|PMID:30031762 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:28794 coumarin increases phosphorylation ISO RGD:1347436 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in increased phosphorylation of XIRP2 protein PMID:35688186 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1347436 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of XIRP2 3' UTR; Benzo(a)pyrene results in decreased methylation of XIRP2 exon PMID:27901495 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1552200 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of XIRP2 exon PMID:27901495 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1347436 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of XIRP2 mRNA PMID:22316170 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:3048 benzatropine decreases expression ISO RGD:1347436 E RGD:6480464 20211207 CTD MESH:D001590 Benztropine results in decreased expression of XIRP2 protein PMID:34122009 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of XIRP2 gene PMID:31601247 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1552200 E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in decreased expression of XIRP2 mRNA PMID:23557971 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of XIRP2 mRNA PMID:25181051 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased expression of XIRP2 protein PMID:31675489 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of XIRP2 gene PMID:31601247 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of XIRP2 gene PMID:31601247 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of XIRP2 protein PMID:31675489 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1347436 E RGD:6480464 20210504 CTD MESH:C543008 bisphenol S results in increased expression of XIRP2 mRNA PMID:33476716 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:35064 alpha-Zearalanol decreases expression EXP E RGD:6480464 20240430 CTD MESH:D015029 Zeranol results in decreased expression of XIRP2 mRNA PMID:35163327 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP2 mRNA PMID:35163327 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP2 mRNA PMID:35163327 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1347436 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of XIRP2 mRNA PMID:31533062 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:1347436 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of XIRP2 gene PMID:29154799 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:1347436 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of XIRP2 mRNA PMID:24383497 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:47696 2,4,6-tribromophenol decreases expression ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C004554 2,4,6-tribromophenol results in decreased expression of XIRP2 mRNA PMID:31675489 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of XIRP2 mRNA PMID:29391264 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1552200 E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate results in increased expression of XIRP2 mRNA PMID:23608068 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:5613 haloperidol decreases expression ISO RGD:1347436 E RGD:6480464 20211207 CTD MESH:D006220 Haloperidol results in decreased expression of XIRP2 protein PMID:34122009 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1347436 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to XIRP2 gene] PMID:28238834 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of XIRP2 mRNA PMID:32109520 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XIRP2 protein PMID:31675489 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:8228 pioglitazone multiple interactions ISO RGD:1552200 E RGD:6480464 20180220 CTD MESH:C060836 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP2 mRNA PMID:27935865 1302980 Xirp2 xin actin-binding repeat containing 2 gene CHEBI:82436 decabromodiphenyl ether decreases expression ISO RGD:1347436 E RGD:6480464 20220308 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of XIRP2 protein PMID:31675489 1302981 Zfp57 zinc finger protein 57 gene CHEBI:132471 (+)-schisandrin B multiple interactions EXP E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZFP57 mRNA] PMID:31150632 1302981 Zfp57 zinc finger protein 57 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D004958 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA PMID:32741896 1302981 Zfp57 zinc finger protein 57 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1344217 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in increased expression of ZFP57 mRNA PMID:30165855 1302981 Zfp57 zinc finger protein 57 gene CHEBI:165219 PCB138 multiple interactions ISO RGD:1332036 E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA PMID:25510870 1302981 Zfp57 zinc finger protein 57 gene CHEBI:16548 chlordecone decreases expression ISO RGD:1332036 E RGD:6480464 20201103 CTD MESH:D007631 Chlordecone results in decreased expression of ZFP57 protein PMID:29980752 1302981 Zfp57 zinc finger protein 57 gene CHEBI:17153 propanal decreases expression ISO RGD:1344217 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in decreased expression of ZFP57 mRNA PMID:26079696 1302981 Zfp57 zinc finger protein 57 gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20210406 CTD MESH:D013739 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA PMID:32741896 1302981 Zfp57 zinc finger protein 57 gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of ZFP57 mRNA PMID:33387578 1302981 Zfp57 zinc finger protein 57 gene CHEBI:205919 clobetasol increases expression ISO RGD:1332036 E RGD:6480464 20190910 CTD MESH:D002990 Clobetasol results in increased expression of ZFP57 mRNA PMID:27462272 1302981 Zfp57 zinc finger protein 57 gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ZFP57 mRNA PMID:31150632 1302981 Zfp57 zinc finger protein 57 gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZFP57 mRNA] PMID:31150632 1302981 Zfp57 zinc finger protein 57 gene CHEBI:27470 folic acid decreases expression ISO RGD:1344217 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ZFP57 mRNA PMID:21867686 1302981 Zfp57 zinc finger protein 57 gene CHEBI:27470 folic acid increases methylation ISO RGD:1344217 E RGD:6480464 20201103 CTD MESH:D005492 Folic Acid results in increased methylation of ZFP57 promoter PMID:30777123 1302981 Zfp57 zinc finger protein 57 gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ZFP57 mRNA PMID:31881176 1302981 Zfp57 zinc finger protein 57 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1332036 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ZFP57 mRNA PMID:21570461 1302981 Zfp57 zinc finger protein 57 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ZFP57 mRNA PMID:33387578 1302981 Zfp57 zinc finger protein 57 gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:1344217 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ZFP57 mRNA PMID:30851411 1302981 Zfp57 zinc finger protein 57 gene CHEBI:28498 acadesine multiple interactions ISO RGD:1332036 E RGD:6480464 20230404 CTD MESH:C011651 acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 mRNA]; acadesine inhibits the reaction [Palmitates results in increased expression of ZFP57 protein] PMID:36375515 1302981 Zfp57 zinc finger protein 57 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1332036 E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of ZFP57 mRNA PMID:37682722 1302981 Zfp57 zinc finger protein 57 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1344217 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ZFP57 promoter PMID:27901495 1302981 Zfp57 zinc finger protein 57 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1344217 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of ZFP57 mRNA PMID:25895662 1302981 Zfp57 zinc finger protein 57 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1344217 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFP57 gene PMID:31601247 1302981 Zfp57 zinc finger protein 57 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:1332036 E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of ZFP57 mRNA PMID:29264374 1302981 Zfp57 zinc finger protein 57 gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1332036 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ZFP57 promoter PMID:35295148 1302981 Zfp57 zinc finger protein 57 gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in increased expression of ZFP57 mRNA PMID:23411599|PMID:34492290 1302981 Zfp57 zinc finger protein 57 gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ZFP57 mRNA PMID:25181051 1302981 Zfp57 zinc finger protein 57 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1332036 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of ZFP57 mRNA PMID:38074096 1302981 Zfp57 zinc finger protein 57 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1344217 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFP57 gene PMID:31601247 1302981 Zfp57 zinc finger protein 57 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1332036 E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA PMID:25510870 1302981 Zfp57 zinc finger protein 57 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1332036 E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP57 mRNA PMID:25510870 1302981 Zfp57 zinc finger protein 57 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1344217 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in decreased methylation of ZFP57 gene PMID:31601247 1302981 Zfp57 zinc finger protein 57 gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1332036 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of ZFP57 mRNA PMID:38685157 1302981 Zfp57 zinc finger protein 57 gene CHEBI:34631 chlorpyrifos decreases expression ISO RGD:1332036 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ZFP57 mRNA PMID:37019170 1302981 Zfp57 zinc finger protein 57 gene CHEBI:35033 triphenyl phosphate affects expression EXP E RGD:6480464 20200331 CTD MESH:C005445 triphenyl phosphate affects the expression of ZFP57 mRNA PMID:30589522 1302981 Zfp57 zinc finger protein 57 gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP57 mRNA PMID:35163327 1302981 Zfp57 zinc finger protein 57 gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ZFP57 mRNA PMID:35163327 1302981 Zfp57 zinc finger protein 57 gene CHEBI:35559 furan increases expression EXP E RGD:6480464 20150414 CTD MESH:C039281 furan results in increased expression of ZFP57 mRNA PMID:25539665 1302981 Zfp57 zinc finger protein 57 gene CHEBI:39867 valproic acid increases expression ISO RGD:1344217 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased expression of ZFP57 mRNA PMID:29154799 1302981 Zfp57 zinc finger protein 57 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of ZFP57 mRNA PMID:33387578 1302981 Zfp57 zinc finger protein 57 gene CHEBI:6121 ketamine decreases expression EXP E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in decreased expression of ZFP57 mRNA PMID:20080153 1302981 Zfp57 zinc finger protein 57 gene CHEBI:6801 metformin multiple interactions ISO RGD:1332036 E RGD:6480464 20230404 CTD MESH:D008687 Metformin inhibits the reaction [Dietary Fats results in increased expression of ZFP57 protein] PMID:36375515 1302981 Zfp57 zinc finger protein 57 gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions EXP E RGD:6480464 20210406 CTD MESH:C074283 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ZFP57 mRNA PMID:32741896 1302981 Zfp57 zinc finger protein 57 gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:1344217 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ZFP57 mRNA PMID:30851411 1302981 Zfp57 zinc finger protein 57 gene CHEBI:8984 sodium dodecyl sulfate increases expression ISO RGD:1344217 E RGD:6480464 20200519 CTD MESH:D012967 Sodium Dodecyl Sulfate results in increased expression of ZFP57 mRNA PMID:31734321 1302981 Zfp57 zinc finger protein 57 gene CHEBI:9195 Soman decreases expression EXP E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of ZFP57 mRNA PMID:19281266 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1552207 E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLA2G15 mRNA PMID:20188158|PMID:26251327 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:16412 lipopolysaccharide decreases expression ISO RGD:1344350 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of PLA2G15 mRNA PMID:35811015 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1344350 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA PMID:35811015 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1344350 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of PLA2G15 mRNA PMID:37042841 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:17347 testosterone decreases expression ISO RGD:1552207 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of PLA2G15 mRNA PMID:21669218 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1344350 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of PLA2G15 protein PMID:31163220 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:17967 urethane increases expression ISO RGD:1344350 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of PLA2G15 mRNA PMID:28818685 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:18721 3-chloropropane-1,2-diol increases expression EXP E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of PLA2G15 mRNA PMID:28522335 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1344350 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of PLA2G15 mRNA PMID:23649840 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1344350 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of PLA2G15 mRNA PMID:23649840 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:2663 amiodarone affects expression ISO RGD:1344350 E RGD:6480464 20180515 CTD MESH:D000638 Amiodarone affects the expression of PLA2G15 mRNA PMID:29248575 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:27889 lead(0) affects expression ISO RGD:1344350 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of PLA2G15 mRNA PMID:28903495 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:27899 cisplatin increases expression ISO RGD:1344350 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of PLA2G15 mRNA PMID:27594783 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:27899 cisplatin increases expression ISO RGD:1552207 E RGD:6480464 20120412 CTD MESH:D002945 Cisplatin results in increased expression of PLA2G15 mRNA PMID:15464296 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA PMID:22298810 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552207 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of PLA2G15 mRNA PMID:21570461 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of PLA2G15 mRNA PMID:21215274 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of PLA2G15 mRNA PMID:34747641 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28201 rotenone increases expression EXP E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in increased expression of PLA2G15 mRNA PMID:28374803 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28428 beta-hexachlorocyclohexane decreases expression ISO RGD:1552207 E RGD:6480464 20150127 CTD MESH:C023888 beta-hexachlorocyclohexane results in decreased expression of PLA2G15 mRNA PMID:25270620 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:28748 doxorubicin increases expression ISO RGD:1344350 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of PLA2G15 mRNA PMID:29803840 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1552207 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of PLA2G15 mRNA PMID:22228805 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1552207 E RGD:6480464 20120501 CTD MESH:D012822 Silicon Dioxide results in decreased expression of PLA2G15 mRNA PMID:19073995 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:30563 silicon dioxide increases expression EXP E RGD:6480464 20210706 CTD MESH:D012822 Silicon Dioxide results in increased expression of PLA2G15 mRNA PMID:32721576 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1344350 E RGD:6480464 20161115 CTD MESH:D012822 Silicon Dioxide results in increased expression of PLA2G15 mRNA PMID:25351596 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:32161 sulfadimethoxine decreases expression EXP E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in decreased expression of PLA2G15 mRNA PMID:30047161 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:32234 titanium dioxide decreases methylation ISO RGD:1552207 E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of PLA2G15 promoter PMID:35295148 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in increased expression of PLA2G15 mRNA PMID:23411599 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1344350 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLA2G15 mRNA PMID:19710929 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:33128 C60 fullerene increases expression EXP E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in increased expression of PLA2G15 mRNA PMID:19167457 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in decreased expression of PLA2G15 mRNA PMID:32145629 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1552207 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of PLA2G15 promoter PMID:27312807 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of PLA2G15 mRNA PMID:25181051|PMID:30816183|PMID:32528016 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:3374 capsaicin decreases expression EXP E RGD:6480464 20120613 CTD MESH:D002211 Capsaicin results in decreased expression of PLA2G15 mRNA PMID:20349343 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1552207 E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of PLA2G15 mRNA PMID:37019170 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:34761 fenthion decreases expression ISO RGD:1552207 E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in decreased expression of PLA2G15 mRNA PMID:34813904 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of PLA2G15 mRNA PMID:32680482 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:35036 fentin chloride increases expression EXP E RGD:6480464 20231205 CTD MESH:C012594 triphenyltin chloride results in increased expression of PLA2G15 mRNA PMID:37156404 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:39867 valproic acid increases expression ISO RGD:1344350 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of PLA2G15 mRNA PMID:23179753|PMID:27188386|PMID:29154799 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:39867 valproic acid increases methylation ISO RGD:1344350 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of PLA2G15 gene PMID:29154799 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:41774 tamoxifen affects expression ISO RGD:1552207 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of PLA2G15 mRNA PMID:17555576 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in increased expression of PLA2G15 mRNA PMID:33387578 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:46195 paracetamol increases expression ISO RGD:1344350 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of PLA2G15 mRNA PMID:22230336|PMID:29067470 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1344350 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLA2G15 mRNA PMID:35811015 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of PLA2G15 mRNA PMID:29391264 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:1552207 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of PLA2G15 mRNA PMID:17555576 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1552207 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of PLA2G15 mRNA PMID:25554681 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:5062 finasteride increases expression EXP E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of PLA2G15 mRNA PMID:24136188 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:50673 methimazole decreases expression EXP E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in decreased expression of PLA2G15 mRNA PMID:30047161 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in decreased expression of PLA2G15 mRNA PMID:24136188 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:64243 monosodium L-glutamate increases expression ISO RGD:1552207 E RGD:6480464 20200317 CTD MESH:D012970 Sodium Glutamate results in increased expression of PLA2G15 mRNA PMID:22078008 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:70778 GW 7647 decreases expression EXP E RGD:6480464 20200519 CTD MESH:C453899 GW 7647 results in decreased expression of PLA2G15 mRNA PMID:31628012 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:73755 1,2-dimethylhydrazine increases expression ISO RGD:1552207 E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of PLA2G15 mRNA PMID:22206623 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:8502 6-propyl-2-thiouracil decreases expression EXP E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in decreased expression of PLA2G15 mRNA PMID:30047161 1302982 Pla2g15 phospholipase A2, group XV gene CHEBI:920 2,4-dinitrotoluene affects expression EXP E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of PLA2G15 mRNA PMID:21346803 1302983 Osmr oncostatin M receptor gene CHEBI:15354 choline multiple interactions ISO RGD:1552210 E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA PMID:20938992 1302983 Osmr oncostatin M receptor gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1352311 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in increased expression of OSMR mRNA PMID:21934132 1302983 Osmr oncostatin M receptor gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:D014212 [bisphenol A co-treated with Tretinoin] results in decreased expression of OSMR mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of OSMR mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:15379 dioxygen multiple interactions ISO RGD:1552210 E RGD:6480464 20190312 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of OSMR mRNA PMID:30529165 1302983 Osmr oncostatin M receptor gene CHEBI:15551 prostaglandin E2 multiple interactions ISO RGD:1552210 E RGD:6480464 20150310 CTD MESH:D015232 Dinoprostone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]] PMID:25432964 1302983 Osmr oncostatin M receptor gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:1552210 E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in increased expression of OSMR mRNA PMID:15919760|PMID:22687549 1302983 Osmr oncostatin M receptor gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:1552210 E RGD:6480464 20161228 CTD MESH:D008070 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of OSMR mRNA] PMID:22687549 1302983 Osmr oncostatin M receptor gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in increased expression of OSMR mRNA PMID:19619570 1302983 Osmr oncostatin M receptor gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D004958 [Estradiol co-treated with EGF protein] results in increased expression of OSMR mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OSMR mRNA PMID:19619570|PMID:24758408 1302983 Osmr oncostatin M receptor gene CHEBI:16598 DDE decreases expression ISO RGD:1352311 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in decreased expression of OSMR mRNA PMID:38568856 1302983 Osmr oncostatin M receptor gene CHEBI:16643 L-methionine multiple interactions ISO RGD:1552210 E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA PMID:20938992 1302983 Osmr oncostatin M receptor gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1352311 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of OSMR mRNA PMID:37042841 1302983 Osmr oncostatin M receptor gene CHEBI:16842 formaldehyde increases expression EXP E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in increased expression of OSMR mRNA PMID:24304932 1302983 Osmr oncostatin M receptor gene CHEBI:16907 4-nitroquinoline N-oxide increases expression ISO RGD:1552210 E RGD:6480464 20121009 CTD MESH:D015112 4-Nitroquinoline-1-oxide results in increased expression of OSMR mRNA PMID:22561872 1302983 Osmr oncostatin M receptor gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:1352311 E RGD:6480464 20240702 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of OSMR mRNA PMID:38685446 1302983 Osmr oncostatin M receptor gene CHEBI:17356 2-acetamidofluorene increases expression EXP E RGD:6480464 20120412 CTD MESH:D015073 2-Acetylaminofluorene results in increased expression of OSMR mRNA PMID:15743783 1302983 Osmr oncostatin M receptor gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1352311 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of OSMR mRNA PMID:31163220 1302983 Osmr oncostatin M receptor gene CHEBI:17833 gentamycin increases expression EXP E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of OSMR mRNA PMID:33387578 1302983 Osmr oncostatin M receptor gene CHEBI:17967 urethane decreases expression ISO RGD:1352311 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of OSMR mRNA PMID:28818685 1302983 Osmr oncostatin M receptor gene CHEBI:22977 cadmium atom increases expression ISO RGD:1352311 E RGD:6480464 20120717 CTD MESH:D002104 Cadmium results in increased expression of OSMR mRNA PMID:22562489 1302983 Osmr oncostatin M receptor gene CHEBI:232612 Azoxymethane multiple interactions ISO RGD:1552210 E RGD:6480464 20241203 CTD MESH:D001397 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA PMID:29950665 1302983 Osmr oncostatin M receptor gene CHEBI:2340 docebenone multiple interactions ISO RGD:1552210 E RGD:6480464 20150310 CTD MESH:C036837 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]] PMID:25432964 1302983 Osmr oncostatin M receptor gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 affects the expression of OSMR protein PMID:20106945 1302983 Osmr oncostatin M receptor gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20180703 CTD MESH:D016604 Aflatoxin B1 results in increased expression of OSMR mRNA PMID:25378103 1302983 Osmr oncostatin M receptor gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1352311 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in increased expression of OSMR mRNA PMID:21632981|PMID:21641981|PMID:27153756 1302983 Osmr oncostatin M receptor gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1552210 E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of OSMR mRNA PMID:19770486 1302983 Osmr oncostatin M receptor gene CHEBI:25812 ozone multiple interactions ISO RGD:1552210 E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of OSMR mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of OSMR mRNA PMID:34911549 1302983 Osmr oncostatin M receptor gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:1552210 E RGD:6480464 20150310 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of OSMR mRNA PMID:25432964|PMID:31919559 1302983 Osmr oncostatin M receptor gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D002251 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]; [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of OSMR mRNA; Dinoprostone inhibits the reaction [PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased activity of MMP9 protein]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; OSMR protein affects the reaction [Carbon Tetrachloride results in increased expression of TIMP2 mRNA]; PTGS1 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA]; SC 560 inhibits the reaction [Carbon Tetrachloride results in increased expression of OSMR mRNA] PMID:14999682|PMID:25432964|PMID:29974145 1302983 Osmr oncostatin M receptor gene CHEBI:27470 folic acid decreases expression ISO RGD:1552210 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of OSMR mRNA PMID:25629700 1302983 Osmr oncostatin M receptor gene CHEBI:27470 folic acid multiple interactions ISO RGD:1552210 E RGD:6480464 20121113 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of OSMR mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OSMR mRNA PMID:20938992|PMID:22206623 1302983 Osmr oncostatin M receptor gene CHEBI:27563 arsenic atom decreases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D001151 Arsenic results in decreased expression of OSMR mRNA PMID:19654921 1302983 Osmr oncostatin M receptor gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:1352311 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of OSMR mRNA PMID:26272509 1302983 Osmr oncostatin M receptor gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1352311 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OSMR mRNA PMID:27188386 1302983 Osmr oncostatin M receptor gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:1352311 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of OSMR protein PMID:35688186 1302983 Osmr oncostatin M receptor gene CHEBI:27744 glyphosate decreases expression ISO RGD:1352311 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of OSMR mRNA PMID:31295307 1302983 Osmr oncostatin M receptor gene CHEBI:27789 1,2-dichloroethane decreases expression ISO RGD:1552210 E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of OSMR mRNA PMID:28960355 1302983 Osmr oncostatin M receptor gene CHEBI:27856 acetamide increases expression EXP E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of OSMR mRNA PMID:31881176 1302983 Osmr oncostatin M receptor gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1352311 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of OSMR mRNA PMID:23557933 1302983 Osmr oncostatin M receptor gene CHEBI:27889 lead(0) affects expression ISO RGD:1352311 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of OSMR mRNA PMID:28903495 1302983 Osmr oncostatin M receptor gene CHEBI:28001 vancomycin decreases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D014640 Vancomycin results in decreased expression of OSMR mRNA PMID:18930951 1302983 Osmr oncostatin M receptor gene CHEBI:28112 nickel atom increases expression ISO RGD:1352311 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of OSMR mRNA PMID:24768652|PMID:25583101 1302983 Osmr oncostatin M receptor gene CHEBI:28112 nickel atom increases expression ISO RGD:1552210 E RGD:6480464 20120717 CTD MESH:D009532 Nickel results in increased expression of OSMR mRNA PMID:12540486 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552210 E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of OSMR mRNA PMID:21570461 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA PMID:34747641 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA PMID:19619570 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1552210 E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of OSMR mRNA PMID:19770486 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of OSMR mRNA PMID:15251184 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D013749 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OSMR mRNA PMID:19619570 1302983 Osmr oncostatin M receptor gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of OSMR mRNA PMID:15251184 1302983 Osmr oncostatin M receptor gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:1352311 E RGD:6480464 20170516 CTD MESH:C004925 methylmercuric chloride results in increased expression of OSMR mRNA PMID:28001369 1302983 Osmr oncostatin M receptor gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:1352311 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of OSMR mRNA; aristolochic acid I results in decreased expression of OSMR protein PMID:33212167 1302983 Osmr oncostatin M receptor gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:1352311 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of OSMR mRNA PMID:30851411 1302983 Osmr oncostatin M receptor gene CHEBI:28694 copper atom increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of OSMR mRNA PMID:26033743 1302983 Osmr oncostatin M receptor gene CHEBI:28694 copper atom multiple interactions ISO RGD:1352311 E RGD:6480464 20150512 CTD MESH:D003300 [Chelating Agents binds to Copper] which results in increased expression of OSMR mRNA; [Disulfiram binds to Copper] which results in increased expression of OSMR mRNA PMID:24690739|PMID:30911355 1302983 Osmr oncostatin M receptor gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1352311 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of OSMR mRNA PMID:29803840 1302983 Osmr oncostatin M receptor gene CHEBI:28748 doxorubicin increases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin results in increased expression of OSMR mRNA PMID:19277126 1302983 Osmr oncostatin M receptor gene CHEBI:28748 doxorubicin multiple interactions ISO RGD:1552210 E RGD:6480464 20120918 CTD MESH:D004317 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of OSMR mRNA PMID:21040762 1302983 Osmr oncostatin M receptor gene CHEBI:29365 phosgene affects expression ISO RGD:1552210 E RGD:6480464 20120515 CTD MESH:D010705 Phosgene affects the expression of OSMR mRNA PMID:16300373 1302983 Osmr oncostatin M receptor gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1352311 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of OSMR mRNA PMID:38568856 1302983 Osmr oncostatin M receptor gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1552210 E RGD:6480464 20120501 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of OSMR mRNA PMID:19770486 1302983 Osmr oncostatin M receptor gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1352311 E RGD:6480464 20160119 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of OSMR mRNA PMID:21632981|PMID:21871943|PMID:26238291|PMID:32234424 1302983 Osmr oncostatin M receptor gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1552210 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of OSMR mRNA PMID:20713471|PMID:22228805 1302983 Osmr oncostatin M receptor gene CHEBI:30052 copper(0) increases expression EXP E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of OSMR mRNA PMID:26033743 1302983 Osmr oncostatin M receptor gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1352311 E RGD:6480464 20150512 CTD MESH:D003300 [Chelating Agents binds to Copper] which results in increased expression of OSMR mRNA; [Disulfiram binds to Copper] which results in increased expression of OSMR mRNA PMID:24690739|PMID:30911355 1302983 Osmr oncostatin M receptor gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1352311 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of OSMR mRNA PMID:25895662 1302983 Osmr oncostatin M receptor gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1552210 E RGD:6480464 20140715 CTD MESH:D012822 Silicon Dioxide results in increased expression of OSMR mRNA PMID:23221170 1302983 Osmr oncostatin M receptor gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352311 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of OSMR mRNA PMID:19150397|PMID:20018196 1302983 Osmr oncostatin M receptor gene CHEBI:31521 doxifluridine decreases response to substance ISO RGD:1352311 E RGD:6480464 20130806 CTD MESH:C025034 OSMR protein results in decreased susceptibility to doxifluridine PMID:16734730 1302983 Osmr oncostatin M receptor gene CHEBI:31575 ethylparaben increases expression ISO RGD:1352311 E RGD:6480464 20240109 CTD MESH:C012313 ethyl-p-hydroxybenzoate results in increased expression of OSMR mRNA PMID:37690743 1302983 Osmr oncostatin M receptor gene CHEBI:31767 lead diacetate increases expression ISO RGD:1552210 E RGD:6480464 20120814 CTD MESH:C008261 lead acetate results in increased expression of OSMR mRNA PMID:21829687 1302983 Osmr oncostatin M receptor gene CHEBI:32234 titanium dioxide affects expression ISO RGD:1552210 E RGD:6480464 20140812 CTD MESH:C009495 titanium dioxide affects the expression of OSMR mRNA PMID:17656681 1302983 Osmr oncostatin M receptor gene CHEBI:32234 titanium dioxide increases expression ISO RGD:1552210 E RGD:6480464 20180220 CTD MESH:C009495 titanium dioxide results in increased expression of OSMR mRNA PMID:27760801 1302983 Osmr oncostatin M receptor gene CHEBI:32234 titanium dioxide multiple interactions ISO RGD:1552210 E RGD:6480464 20190702 CTD MESH:C009495 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA PMID:29950665 1302983 Osmr oncostatin M receptor gene CHEBI:32497 thioacetamide increases expression EXP E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in increased expression of OSMR mRNA PMID:23411599|PMID:34492290 1302983 Osmr oncostatin M receptor gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression EXP E RGD:6480464 20190507 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of OSMR mRNA PMID:30723492 1302983 Osmr oncostatin M receptor gene CHEBI:32509 pirinixic acid increases expression ISO RGD:1552210 E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of OSMR mRNA PMID:23811191 1302983 Osmr oncostatin M receptor gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OSMR mRNA PMID:19710929 1302983 Osmr oncostatin M receptor gene CHEBI:33007 chromium(6+) affects expression ISO RGD:1552210 E RGD:6480464 20171010 CTD MESH:C074702 chromium hexavalent ion affects the expression of OSMR mRNA PMID:28472532 1302983 Osmr oncostatin M receptor gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:1552210 E RGD:6480464 20170725 CTD MESH:C007738 [1-methylanthracene co-treated with fluoranthene] results in increased expression of OSMR mRNA PMID:28329830 1302983 Osmr oncostatin M receptor gene CHEBI:33216 bisphenol A affects expression EXP E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of OSMR mRNA PMID:25181051 1302983 Osmr oncostatin M receptor gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of OSMR mRNA PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998 1302983 Osmr oncostatin M receptor gene CHEBI:33216 bisphenol A increases expression ISO RGD:1352311 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in increased expression of OSMR mRNA PMID:29275510 1302983 Osmr oncostatin M receptor gene CHEBI:33216 bisphenol A increases expression ISO RGD:1552210 E RGD:6480464 20150825 CTD MESH:C006780 bisphenol A results in increased expression of OSMR mRNA PMID:25594700 1302983 Osmr oncostatin M receptor gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with Tretinoin] results in decreased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1552210 E RGD:6480464 20141223 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of OSMR mRNA PMID:25172293 1302983 Osmr oncostatin M receptor gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP E RGD:6480464 20140114 CTD MESH:C009407 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of OSMR mRNA PMID:23829299 1302983 Osmr oncostatin M receptor gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP E RGD:6480464 20140408 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of OSMR mRNA PMID:23196670 1302983 Osmr oncostatin M receptor gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:C543008 [bisphenol S co-treated with Tretinoin] results in decreased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:34569 Benzo[k]fluoranthene decreases expression ISO RGD:1552210 E RGD:6480464 20160119 CTD MESH:C022921 benzo(k)fluoranthene results in decreased expression of OSMR mRNA PMID:26377693 1302983 Osmr oncostatin M receptor gene CHEBI:34575 bisphenol F decreases expression ISO RGD:1552210 E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of OSMR mRNA PMID:38685157 1302983 Osmr oncostatin M receptor gene CHEBI:34575 bisphenol F increases expression ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1552210 E RGD:6480464 20191112 CTD MESH:C008745 [bisphenol F co-treated with Tretinoin] results in decreased expression of OSMR mRNA PMID:30951980 1302983 Osmr oncostatin M receptor gene CHEBI:34674 dextran sulfate multiple interactions ISO RGD:1552210 E RGD:6480464 20190702 CTD MESH:D016264 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of OSMR mRNA PMID:29950665 1302983 Osmr oncostatin M receptor gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:1552210 E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of OSMR mRNA PMID:17361019|PMID:21266533 1302983 Osmr oncostatin M receptor gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in increased expression of OSMR mRNA PMID:32680482 1302983 Osmr oncostatin M receptor gene CHEBI:35064 alpha-Zearalanol multiple interactions EXP E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSMR mRNA PMID:35163327 1302983 Osmr oncostatin M receptor gene CHEBI:3537 cefaloridine increases expression EXP E RGD:6480464 20120412 CTD MESH:D002509 Cephaloridine results in increased expression of OSMR mRNA PMID:18500788 1302983 Osmr oncostatin M receptor gene CHEBI:35455 1-naphthyl isothiocyanate increases expression EXP E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of OSMR mRNA PMID:30723492 1302983 Osmr oncostatin M receptor gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSMR mRNA PMID:35163327 1302983 Osmr oncostatin M receptor gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1552210 E RGD:6480464 20171114 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of OSMR mRNA PMID:28903501 1302983 Osmr oncostatin M receptor gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1352311 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of OSMR mRNA PMID:24449571 1302983 Osmr oncostatin M receptor gene CHEBI:38658 dicrotophos increases expression ISO RGD:1352311 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of OSMR mRNA PMID:28302478 1302983 Osmr oncostatin M receptor gene CHEBI:39426 perfluorobutyric acid increases expression ISO RGD:1552210 E RGD:6480464 20220308 CTD MESH:C033094 perfluorobutyric acid results in increased expression of OSMR mRNA PMID:34474067 1302983 Osmr oncostatin M receptor gene CHEBI:3962 curcumin multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D003474 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA] PMID:18200517 1302983 Osmr oncostatin M receptor gene CHEBI:39867 valproic acid increases expression ISO RGD:1352311 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of OSMR mRNA PMID:27188386 1302983 Osmr oncostatin M receptor gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1352311 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in increased expression of OSMR mRNA PMID:20106945|PMID:25562108 1302983 Osmr oncostatin M receptor gene CHEBI:41774 tamoxifen affects expression ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of OSMR mRNA PMID:14699072 1302983 Osmr oncostatin M receptor gene CHEBI:41774 tamoxifen multiple interactions ISO RGD:1552210 E RGD:6480464 20181016 CTD MESH:D013629 [Carbon Tetrachloride co-treated with Tamoxifen] affects the expression of OSMR mRNA PMID:29974145 1302983 Osmr oncostatin M receptor gene CHEBI:45863 paclitaxel increases response to substance ISO RGD:1352311 E RGD:6480464 20161213 CTD MESH:D017239 OSMR protein results in increased susceptibility to Paclitaxel PMID:16734730 1302983 Osmr oncostatin M receptor gene CHEBI:46195 paracetamol affects expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of OSMR mRNA PMID:17562736 1302983 Osmr oncostatin M receptor gene CHEBI:46195 paracetamol decreases expression ISO RGD:1352311 E RGD:6480464 20120918 CTD MESH:D000082 Acetaminophen results in decreased expression of OSMR mRNA PMID:21420995 1302983 Osmr oncostatin M receptor gene CHEBI:46195 paracetamol increases expression ISO RGD:1352311 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in increased expression of OSMR mRNA PMID:29067470 1302983 Osmr oncostatin M receptor gene CHEBI:46195 paracetamol increases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in increased expression of OSMR mRNA PMID:19420014 1302983 Osmr oncostatin M receptor gene CHEBI:4659 disulfiram multiple interactions ISO RGD:1352311 E RGD:6480464 20150512 CTD MESH:D004221 [Disulfiram binds to Copper] which results in increased expression of OSMR mRNA PMID:24690739 1302983 Osmr oncostatin M receptor gene CHEBI:46666 crocidolite asbestos increases expression ISO RGD:1552210 E RGD:6480464 20161213 CTD MESH:D017638 Asbestos, Crocidolite results in increased expression of OSMR mRNA PMID:23917077 1302983 Osmr oncostatin M receptor gene CHEBI:47217 arsane decreases expression ISO RGD:1552210 E RGD:6480464 20140805 CTD MESH:D001151 Arsenic results in decreased expression of OSMR mRNA PMID:19654921 1302983 Osmr oncostatin M receptor gene CHEBI:4791 endosulfan decreases expression EXP E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of OSMR mRNA PMID:29391264 1302983 Osmr oncostatin M receptor gene CHEBI:49668 gefitinib affects response to substance ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:C419708 OSMR protein affects the susceptibility to gefitinib PMID:15496427 1302983 Osmr oncostatin M receptor gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression ISO RGD:1552210 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of OSMR mRNA PMID:15251184 1302983 Osmr oncostatin M receptor gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1552210 E RGD:6480464 20191114 CTD MESH:C014347 [Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of OSMR mRNA PMID:15251184 1302983 Osmr oncostatin M receptor gene CHEBI:50594 carbon nanotube increases expression ISO RGD:1552210 E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of OSMR mRNA; Nanotubes, Carbon results in increased expression of OSMR mRNA PMID:25554681|PMID:25620056 1302983 Osmr oncostatin M receptor gene CHEBI:50845 doxycycline multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D004318 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of OSMR mRNA] PMID:18089841 1302983 Osmr oncostatin M receptor gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in decreased expression of OSMR mRNA PMID:24793618 1302983 Osmr oncostatin M receptor gene CHEBI:5298 Genipin multiple interactions ISO RGD:1552210 E RGD:6480464 20141111 CTD MESH:C007834 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of OSMR mRNA] PMID:22687549 1302983 Osmr oncostatin M receptor gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1552210 E RGD:6480464 20120717 CTD MESH:C029938 nickel sulfate results in increased expression of OSMR mRNA PMID:16166746 1302983 Osmr oncostatin M receptor gene CHEBI:53063 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D014302 Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA PMID:17982090|PMID:18200517 1302983 Osmr oncostatin M receptor gene CHEBI:53063 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:1552210 E RGD:6480464 20120412 CTD MESH:D014302 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of OSMR mRNA] PMID:18200517 1302983 Osmr oncostatin M receptor gene CHEBI:53444 potassium dichromate increases expression ISO RGD:1552210 E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate results in increased expression of OSMR mRNA PMID:23608068 1302983 Osmr oncostatin M receptor gene CHEBI:6402 leflunomide increases expression ISO RGD:1352311 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in increased expression of OSMR mRNA PMID:28988120 1302983 Osmr oncostatin M receptor gene CHEBI:64227 ciglitazone multiple interactions ISO RGD:1352311 E RGD:6480464 20120412 CTD MESH:C039671 [ciglitazone binds to PPARG protein] which results in increased expression of OSMR mRNA PMID:16197558 1302983 Osmr oncostatin M receptor gene CHEBI:64317 isoprenaline increases expression ISO RGD:1552210 E RGD:6480464 20120515 CTD MESH:D007545 Isoproterenol results in increased expression of OSMR mRNA PMID:18089841|PMID:20003209 1302983 Osmr oncostatin M receptor gene CHEBI:64317 isoprenaline multiple interactions ISO RGD:1552210 E RGD:6480464 20120515 CTD MESH:D007545 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of OSMR mRNA] PMID:18089841 1302983 Osmr oncostatin M receptor gene CHEBI:6820 methapyrilene increases expression EXP E RGD:6480464